<SEC-DOCUMENT>0001193125-19-268215.txt : 20191016
<SEC-HEADER>0001193125-19-268215.hdr.sgml : 20191016
<ACCEPTANCE-DATETIME>20191016115514
ACCESSION NUMBER:		0001193125-19-268215
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		10
CONFORMED PERIOD OF REPORT:	20191205
FILED AS OF DATE:		20191016
DATE AS OF CHANGE:		20191016
EFFECTIVENESS DATE:		20191016

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		191152282

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d805243ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Under Rule <FONT STYLE="white-space:nowrap">14a-12</FONT></TD></TR></TABLE>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>Myriad Genetics, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name
of Registrant as Specified In Its Charter) </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">1)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">2)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">3)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11</FONT>
(set forth the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">4)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">5)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing party:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">October&nbsp;16, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholders, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend the 2019 Annual Meeting of Stockholders of Myriad Genetics, Inc. (the &#147;Annual Meeting&#148;) to be
held at 8:00 a.m. MST on December&nbsp;5, 2019, at our offices at 320 Wakara Way, Salt Lake City, Utah. Details regarding the meeting, the business to be conducted, and information about Myriad Genetics, Inc. that you should consider when you vote
your shares are described in this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, three persons will be elected to our Board of Directors. We
also will seek stockholder approval (i)&nbsp;of our proposal to increase the number of shares authorized under our 2017 Employee, Director and Consultant Equity Incentive Plan as amended; and (ii)&nbsp;to ask stockholders to ratify the selection of
Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending June&nbsp;30, 2020. In addition, we will seek stockholder approval, on an advisory basis, of the compensation of our named executive officers,
as disclosed in this proxy statement. The Board of Directors recommends the approval of all of these proposals. Other business will be transacted that may be properly addressed during the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Securities and Exchange Commission rules that allow companies to furnish proxy materials to stockholders over the Internet, we have
elected to deliver our proxy materials to the majority of our stockholders in this manner. We believe this process will facilitate the accelerated delivery of proxy materials, save costs and reduce the environmental impact of our Annual Meeting. On
or about October&nbsp;16, 2019, we began sending our stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy statement for our 2019 Annual Meeting of Stockholders and our 2019 annual
report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> to stockholders. The Notice also provides instructions on how to vote online or by telephone and how to receive a paper copy of the proxy materials by mail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hope you will be able to attend the Annual Meeting. Whether you plan to attend the meeting or not, it is important that you cast your vote.
You may vote over the Internet as well as by telephone. In addition, if you requested printed proxy materials, you may vote by completing, signing, dating and returning your proxy card by mail. You are urged to vote promptly in accordance with the
instructions provided in the Notice of Internet Availability of Proxy Materials or on your proxy card. We encourage you to vote by proxy so that your shares will be represented and voted at the meeting, whether or not you attend. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely,</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g805243dsp03.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark C. Capone</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Your vote is important. Please vote as soon as possible by using the Internet or by telephone or, if you received a
paper copy of the proxy card by mail, by completing, signing, dating, and returning the enclosed proxy card. Instructions for your voting options are described on the Notice of Internet Availability of Proxy Materials or proxy card. </B></P>

<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>320 Wakara Way </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Salt Lake
City, Utah 84108 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF 2019 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TIME: 8:00 a.m. MST </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATE: December&nbsp;5, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PLACE: The offices of Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PURPOSES: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To elect three Class&nbsp;II directors to the Board of Directors to serve three-year terms expiring in 2022;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve the proposed amendment to our 2017 Employee, Director and Consultant Equity Incentive Plan, as
amended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for
the fiscal year ending June&nbsp;30, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy
statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To transact such other business that is properly presented at the Annual Meeting and any adjournments or
postponements thereof. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHO MAY VOTE: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You
may vote if you were an owner of record of Myriad Genetics, Inc. common stock at the close of business on October&nbsp;8, 2019. A list of stockholders of record will be available at the Annual Meeting and, during the 10 days prior to the meeting, at
the office of the Secretary at the above address. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All stockholders are cordially invited to attend the Annual Meeting. Whether you plan to attend the
meeting or not, please vote by following the instructions on the Notice of Internet Availability of Proxy Materials that you have previously received, which we refer to as the Notice, or in the section of this proxy statement entitled
&#147;Important Information About the Annual Meeting and Voting &#151; How Do I Vote?&#148; or, if you requested printed proxy materials, your proxy card. You may change or revoke your proxy at any time before it is voted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On or about October&nbsp;16, 2019, we began sending the Notice of Internet Availability of Proxy Materials to all stockholders entitled to vote at the annual
meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BY ORDER OF THE BOARD OF DIRECTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benjamin G. Jackson</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;16, 2019 </P>

<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDER MEETING TO BE HELD ON DECEMBER&nbsp;5, 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This proxy statement and our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> to stockholders for the fiscal year ended
June&nbsp;30, 2019 are available for viewing, printing, and downloading at </B><B><I><U>www.proxyvote.com</U></I></B><B>. To view these materials, please have available your <FONT STYLE="white-space:nowrap">12-digit</FONT> control number(s) that
appears on your Notice or proxy card. On this website, you can also elect to receive future distributions of our proxy statements and annual reports to stockholders by electronic delivery. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Additionally, you may find a copy of our annual report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which includes our financial
statements for the fiscal year ended June&nbsp;30, 2019, on the website of the Securities and Exchange Commission at </B><B><I><U>www.sec.gov</U></I></B><B>, or in the &#147;Financial Reporting/SEC Filings&#148; section of the &#147;Investors&#148;
section of our website at </B><B><I><U>www.myriad.com</U></I></B><B></B><B><I>.</I></B><B> You also may obtain a printed copy of our annual report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as amended, including our financial statements
from us, free of charge, by sending a written request to: Secretary, Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108. Exhibits will be provided upon written request and payment of an appropriate processing fee. </B></P>

<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>320 WAKARA WAY </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SALT LAKE
CITY, UTAH 84108 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(801) <FONT STYLE="white-space:nowrap">584-3600</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT FOR THE MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2019 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER&nbsp;5, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement, along with the accompanying Notice of 2019 Annual Meeting of Stockholders, contains information about the 2019 Annual
Meeting of Stockholders of Myriad Genetics, Inc., including any adjournments or postponements of the annual meeting, which we refer to as the Annual Meeting. In this proxy statement, we refer to Myriad Genetics, Inc. as &#147;Myriad,&#148; &#147;the
Company,&#148; &#147;we&#148; and &#147;us.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement relates to the solicitation of proxies by our Board of Directors
for use at the Annual Meeting. On or about October&nbsp;16, 2019, we began sending the Notice of Internet Availability of Proxy Materials, which we refer to throughout this proxy statement as the Notice, to all stockholders entitled to vote at the
Annual Meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why is the Company Soliciting My Proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors of Myriad Genetics, Inc. is soliciting your proxy to vote at the Annual Meeting to be held at our offices, 320 Wakara
Way, Salt Lake City, Utah, on December&nbsp;5, 2019, at 8:00 a.m. MST and any adjournments of the Annual Meeting. The proxy statement, along with the accompanying Notice of 2019 Annual Meeting of Stockholders, summarizes the purposes of the Annual
Meeting and the information you need to know to vote at the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have sent you the Notice and made this proxy statement, the
Notice of 2019 Annual Meeting of Stockholders, and our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> to stockholders for the fiscal year ended June&nbsp;30, 2019 available to you on the Internet because you owned shares of
Myriad Genetics, Inc. common stock on the record date. We also have delivered printed versions of these materials to certain stockholders by mail. The Company commenced distribution of the Notice and the proxy materials to stockholders on or about
October&nbsp;16, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why Did I Receive a Notice in the Mail Regarding the Internet Availability of Proxy Materials Instead of a Full Set of Proxy
Materials? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by the rules of the U.S. Securities and Exchange Commission, or the SEC, we may furnish our proxy materials to
our stockholders by providing access to such documents on the Internet, rather than mailing printed copies of these materials to each stockholder. Most stockholders will not receive printed copies of the proxy materials unless they request them. We
believe that this process should expedite stockholders&#146; receipt of proxy materials, lower the costs of the Annual Meeting and help to conserve natural resources. If you received a Notice by mail or electronically, you will not receive a printed
or email copy of the proxy materials, unless you request one by following the instructions included in the Notice. Instead, the Notice will provide instructions on how you may access and review all of the proxy materials and submit your proxy on the
Internet or by telephone. If you requested a paper copy of the proxy materials, you may authorize the voting of your shares by following the instructions on the enclosed proxy card, in addition to the other methods of voting described in this proxy
statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who Can Vote? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only stockholders who owned Myriad Genetics, Inc. common stock at the close of business on October&nbsp;8, 2019 are entitled to vote at the
Annual Meeting. On this record date, there were 74,381,310 shares of our common stock outstanding and entitled to vote. Common stock is our only class of voting stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You do not need to attend the Annual Meeting to vote your shares. Shares represented by valid proxies, received in time for the Annual Meeting
and not revoked prior to the meeting, will be voted at the meeting. For instructions on how to change or revoke your proxy, see &#147;May I Change or Revoke My Proxy?&#148; below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How Many Votes Do I Have? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of
Myriad Genetics, Inc. common stock that you owned at the close of business on the record date, October&nbsp;8, 2019, entitles you to one vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How Do
I Vote? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether you plan to attend the Annual Meeting or not, we urge you to vote by proxy. All shares represented by valid proxies
that we receive through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the proxy card or as instructed via Internet or telephone. You may specify whether your shares should be voted for or withheld
for each nominee for director, and whether your shares should be voted for, against or abstain with respect to each of the other proposals. If you properly submit a proxy without giving specific voting instructions, your shares will be voted in
accordance with the board&#146;s recommendations as noted below. Voting by proxy will not affect your right to attend the Annual Meeting. If your shares are registered directly in your name through our stock transfer agent, American Stock Transfer
and Trust Company, or you have stock certificates registered in your name, you may vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>By Internet or by telephone.</B> Follow the instructions included in the Notice or, if you received printed
materials, in the proxy card, to vote by Internet or telephone. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>By mail.</B> If you received your proxy materials by mail, you can vote by completing, signing, dating and
returning the proxy card as instructed on the card. If you sign the proxy card but do not specify how you want your shares voted, they will be voted in accordance with the board&#146;s recommendations as noted below. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>In person at the meeting.</B> If you attend the Annual Meeting, you may deliver a completed proxy card in
person or you may vote by completing a ballot that will be available at the Annual Meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone and Internet
voting facilities for stockholders of record will be available <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">24-hours-a-day</FONT></FONT></FONT> and will close at 11:59 p.m. EST on
December&nbsp;4, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; (held in the name of a bank, broker or other holder of record),
you will receive instructions from the holder of record. You must follow the instructions of the holder of record in order for your shares to be voted. Telephone and Internet voting also will be offered to stockholders owning shares through certain
banks and brokers. If your shares are not registered in your own name and you plan to vote your shares in person at the Annual Meeting, you should contact your broker or agent to obtain a legal proxy or broker&#146;s proxy card and bring it to the
meeting in order to vote. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How Does the Board of Directors Recommend That I Vote on the Proposals? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors recommends that you vote as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>FOR&#148;</B> the election of the three Class&nbsp;II directors for director; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>FOR</B>&#148; the approval of the amendment to our 2017 Employee, Director and Consultant Equity
Incentive Plan, as amended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>FOR</B>&#148; the ratification of the selection of Ernst&nbsp;&amp; Young LLP as our independent
registered public accounting firm for our fiscal year ending June&nbsp;30, 2020; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>&#147;FOR&#148;</B> the compensation of our named executive officers, as disclosed in this proxy statement.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any other matter is presented, your proxy provides that your shares will be voted by the proxy holder listed in the
proxy in accordance with his or her best judgment. At the time this proxy statement was first made available, we knew of no matters that needed to be acted on at the Annual Meeting, other than those described in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>May I Change or Revoke My Proxy? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you
give us your proxy, you may change or revoke it at any time before the Annual Meeting. You may change or revoke your proxy in any of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By <FONT STYLE="white-space:nowrap">re-voting</FONT> by Internet or by telephone as instructed above;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If you received printed proxy materials, by signing a new proxy card with a date later than your previously
delivered proxy and submitting it as instructed above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By notifying our Secretary in writing before the Annual Meeting that you have revoked your proxy; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By attending the Annual Meeting and voting in person. Attending the Annual Meeting in person will not in and of
itself revoke a previously submitted proxy unless you specifically request it. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your most current vote, whether by
telephone, Internet or proxy card, is the one that will be counted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I Receive More Than One Notice or Proxy Card? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may receive more than one Notice or proxy card if you hold shares of our common stock in more than one account, which may be in registered
form or held in street name. Please vote in the manner described under &#147;How Do I Vote?&#148; for each account to ensure that all of your shares are voted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will My Shares Be Voted if I Do Not Vote? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are registered in your name, they will not be voted if you do not vote as described above under &#147;How Do I Vote?&#148; If
your shares are held in street name and you do not provide voting instructions to the bank, broker or other holder of record of your shares as described above, the holder of record has the authority to vote your unvoted shares only on Proposal 3 if
it does not receive instructions from you and does not have the ability to vote your uninstructed shares on any other proposal. Therefore, we encourage you to provide voting instructions. This ensures that your shares will be voted at the Annual
Meeting and in the manner you desire. When your broker cannot vote your shares on a particular matter because it has not received instructions from you and does not have discretionary voting authority or because your broker chooses not to vote on a
matter for which it does have discretionary voting authority, it is referred to as a &#147;broker <FONT STYLE="white-space:nowrap">non-vote.&#148;</FONT> Thus, if you hold your shares in a street name and do not instruct your bank, broker or other
nominee how to vote, no votes will be cast on any proposal on your behalf other than the ratification of the selection of the public accounting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Vote is Required to Approve Each Proposal and How are Votes Counted? </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>Proposal 1: Elect Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The nominees for director who receive the most votes (also known as a &#147;plurality&#148; of the votes) will be elected. Abstentions are not counted for purposes of electing directors. You may vote either FOR all of the nominees,
WITHHOLD your vote from all of the nominees or WITHHOLD your vote from any one or more of the nominees. Votes that are withheld will not be included in the vote tally for the election of directors. Brokerage firms do not have the authority to vote
customers&#146; unvoted shares held by the firms in a street name on this proposal; therefore, any shares not voted by a customer will be treated as a broker <FONT STYLE="white-space:nowrap">non-vote.</FONT> Such broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the results of this vote.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>Proposal 2: Approve the Amendment to Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive
Plan, as Amended</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The affirmative vote of a majority of the shares voted affirmatively or negatively for this proposal is required to approve the amendment to the Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as
amended. Abstentions will have no effect on the results of this vote. Brokerage firms do not have authority to vote customers&#146; unvoted shares held by the firms in street name on this proposal; therefore, any shares not voted by a customer will
be treated as a broker <FONT STYLE="white-space:nowrap">non-vote.</FONT> Such broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the results of this vote.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>Proposal 3: Ratify the Selection of our Registered Independent Public Accounting Firm</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The affirmative vote of a majority of the shares voted affirmatively or negatively for this proposal is required to ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm. Abstentions
will have no effect on the results of this vote. Brokerage firms have authority to vote customers&#146; unvoted shares held by the firms in a street name on this proposal. If a broker does not exercise this authority, such broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the results of this vote. We are not required to obtain the approval of our stockholders to select our independent registered public accounting firm. However, if our stockholders do
not ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending June&nbsp;30, 2020, our Audit Committee of our Board of Directors will reconsider its
selection.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>Proposal 4: Approve, on an Advisory Basis, the Compensation of Our Named Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The affirmative vote of a majority of the shares voted affirmatively or negatively for this proposal is required to approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy
statement. Abstentions will have no effect on the result of this vote. Brokerage firms do not have authority to vote customers&#146; unvoted shares held by such firms in street name on this proposal. As a result, any shares not voted by a customer
will be treated as a broker <FONT STYLE="white-space:nowrap">non-vote.</FONT> Such broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the results of this vote. Although the advisory vote is
<FONT STYLE="white-space:nowrap">non-binding,</FONT> the Compensation Committee and the Board of Directors will review the voting results and take them into consideration when making future decisions regarding the compensation of our named executive
officers.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Is Voting Confidential? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will keep all the proxies, ballots and voting tabulations private. We only let our Inspector of Elections and our transfer agent, American
Stock Transfer and Trust, examine these documents. Management, other than the Inspector of Elections Benjamin G. Jackson, General Counsel and Secretary, will not know how you voted on a specific proposal unless it is necessary to meet legal
requirements. We will, however, forward to management any written comments you make on the proxy card or elsewhere. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Where Can I Find the Voting
Results of the Annual Meeting? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preliminary voting results will be announced at the Annual Meeting, and we will publish
preliminary, or final results if available, in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days of the Annual Meeting. If final results are unavailable at the time the Form
<FONT STYLE="white-space:nowrap">8-K</FONT> is filed, we will file an amended report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to disclose the final voting results within four business days after the final results are known. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Are the Costs of Soliciting these Proxies? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all of the costs of soliciting these proxies. Our directors and employees may solicit proxies in person or by telephone, fax or
email. We will pay these employees and directors no additional compensation for these services. We may ask banks, brokers and other institutions, nominees and fiduciaries to forward these proxy materials to their principals and to obtain authority
to deliver proxies. We will then reimburse them for their expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Constitutes a Quorum for the Annual Meeting? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The presence, in person or by proxy, of the holders of a majority of the voting power of the outstanding shares of our common stock is
necessary to constitute a quorum at the Annual Meeting. Votes of stockholders of record who are present at the meeting in person or by proxy, abstentions, and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are counted for purposes of
determining whether a quorum exists. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Attending the Annual Meeting </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Annual Meeting will be held at 8:00 a.m. MST on Thursday, December&nbsp;5, 2019 at the offices of Myriad Genetics, Inc., 320 Wakara Way,
Salt Lake City, Utah 84108. When you arrive at our offices, our personnel will direct you to the appropriate meeting room. You need not attend the Annual Meeting to vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Householding of Annual Disclosure Documents </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SEC rules concerning the delivery of annual disclosure documents allow us or your broker to send a single Notice or, if applicable, a single
set of our proxy materials to any household at which two or more of our stockholders reside, if we or your broker believe that the stockholders are members of the same family. This practice, referred to as &#147;householding,&#148; benefits both you
and us. It reduces the volume of duplicate information received at your household and helps to reduce our expenses. The rule applies to our Notices, annual reports, proxy statements and information statements. Once you receive notice from your
broker or from us that communications to your address will be &#147;householded,&#148; the practice will continue until you are otherwise notified or until you revoke your consent to the practice. Stockholders who participate in householding will
continue to have access to and utilize separate proxy voting instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your household received a single Notice or, if applicable,
set of proxy materials this year, but you would prefer to receive your own copy, please contact Broadridge by calling their toll free number
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-540-7095.</FONT></FONT></FONT> If you do not wish to participate in &#147;householding&#148; and would like to receive your own Notice or, if
applicable, a set of proxy materials in future years, follow the instructions described below. Conversely, if you share an address with another Myriad Genetics, Inc. stockholder and together both of you would like to receive only a single Notice or,
if applicable, set of proxy materials, follow these instructions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If your Myriad Genetics, Inc. shares are registered in your own name, please contact Broadridge and inform them
of your request by calling them at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-540-7095</FONT></FONT></FONT> or writing them at Broadridge Householding Department, 51 Mercedes Way,
Edgewood, NY 11717. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If a broker or other nominee holds your Myriad Genetics, Inc. shares, please contact the broker or other nominee
directly and inform them of your request. Be sure to include your name, the name of your brokerage firm and your account number. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Delivery of Company Stockholder Communications </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most stockholders can elect to receive notices of the availability of future proxy materials by email instead of receiving a paper copy in the
mail. You can choose this option and save the cost of producing and mailing these documents by following the instructions provided on your Notice or proxy card or following the instructions provided when you vote over the Internet at
<I><U>www.proxyvote.com</U></I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the beneficial ownership of our common stock as of September&nbsp;1, 2019
for (a)&nbsp;each stockholder that we know to be the beneficial owner of more than 5% of our common stock, (b)&nbsp;each of our executive officers named in the Summary Compensation Table of this proxy statement (the &#147;Named Executive
Officers&#148; or &#147;NEOs&#148;), (c) each of our directors and director nominees, and (d)&nbsp;all of our current directors and executive officers as a group. Beneficial ownership is determined in accordance with the rules of the SEC and
includes voting or investment power with respect to the securities. We deem shares of common stock that may be acquired by an individual or group within 60 days of September&nbsp;1, 2019 pursuant to the exercise of options and the vesting of
restricted stock unit awards to be outstanding for the purpose of computing the percentage ownership of an individual or group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in
the table. Except as indicated in footnotes, we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of common stock shown to be beneficially owned by them based on information provided
to us by these stockholders. Percentage of ownership is based on 73,867,321 shares of common stock outstanding on September&nbsp;1, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares&nbsp;Beneficially&nbsp;Owned</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name and Address**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Percent</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% or More Stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,202,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">55 East 52<SUP STYLE="font-size:85%; vertical-align:top">nd </SUP>Street</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, NY 10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Baillie Gifford&nbsp;&amp; Co. (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9,484,944</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12.8</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calton Square &#151; 1 Greenside Row</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edinburgh, Scotland EH13AN</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Vanguard Group (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9,192,715</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12.4</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">100 Vanguard Blvd.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Malvern, PA 19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D.E. Shaw &amp; Co, L.P. (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,922,852</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.3</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1166 Avenue of the Americas, 9<SUP STYLE="font-size:85%; vertical-align:top">th </SUP>Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, NY 10036</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State Street Corporation (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,706,264</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1 Lincoln St.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Boston, MA 02111</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,172,342</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">63,579</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">176,330</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D. (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">748,112</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">785,666</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Directors and Director Nominees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D. (11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">200,043</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D. (12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">87,243</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best (13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">189,743</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">33,743</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D. (14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">99,743</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel (15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">185,743</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lee N. Newcomer M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers and directors as a group (19 persons) (15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4,568,054</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.9</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1% of our outstanding shares of common stock.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise indicated, the address for each beneficial owner is c/o Myriad Genetics, Inc., 320 Wakara Way,
Salt Lake City, Utah 84108. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G filed with the SEC on January&nbsp;29, 2019 with respect to Myriad
Genetics common stock. BlackRock, Inc. beneficially owns these shares and has sole dispositive power for these shares and sole voting power for 12,014,175 of these shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G/A filed with the SEC on January&nbsp;15, 2019 with respect to
Myriad Genetics common stock. Baillie Gifford and Co beneficially owns these shares and has sole dispositive power for these shares and has sole voting power for 8,076,569 shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G/A filed with the SEC on February&nbsp;11, 2019 with respect to
Myriad Genetics common stock. The Vanguard Group beneficially owns these shares and has sole dispositive power for 9,052,805 of these shares and sole voting power for 137,879 of these shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G filed with the SEC on February&nbsp;14, 2019 with respect to Myriad
Genetics common stock. D.E. Shaw&nbsp;&amp; Co, L.P. beneficially owns these shares and has sole dispositive power and sole voting power for 0 of these shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G filed with the SEC on February&nbsp;13, 2019 with respect to Myriad
Genetics common stock. D.E. Shaw&nbsp;&amp; Co, L.P. beneficially owns these shares and has sole dispositive power and sole voting power for 0 of these shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 1,020,052 shares of common stock subject to currently exercisable options and restricted stock unit
awards which vest within 60 days of September&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 53,800 shares of common stock subject to restricted stock unit awards which vest within 60 days of
September&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 154,551 shares of common stock subject to restricted stock unit awards which vest within 60 days of
September&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 676,799 shares of common stock subject to currently exercisable options and restricted stock unit
awards which vest within 60 days of September&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 752,268 shares of common stock subject to currently exercisable options and restricted stock unit
awards which vest within 60 days of September&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes shares held directly by Dr.&nbsp;Henderson and his wife, as well as 150,000 shares of common stock
subject to currently exercisable options as of September&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 60,000 shares of common stock subject to currently exercisable options as of September&nbsp;1, 2019.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 150,000 shares of common stock subject to currently exercisable options as of September&nbsp;1, 2019.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 60,000 shares of common stock subject to currently exercisable options as of September&nbsp;1, 2019.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 150,000 shares of common stock subject to currently exercisable options as of September&nbsp;1, 2019.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Notes <FONT STYLE="white-space:nowrap">5-14</FONT> above. Also includes 536,337 shares of common stock
subject to currently exercisable options and options exercisable and restricted stock unit awards which vest within 60 days of September&nbsp;1, 2019 held by other current executive officers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANAGEMENT AND CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Restated
Certificate of Incorporation, as amended, and Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> provide that our business is to be managed by or under the direction of our Board of Directors. Our Board of Directors is divided into three
classes for purposes of election. One class is elected at each annual meeting of stockholders to serve for a three-year term. The Board of Directors currently consists of nine members, classified into three classes as follows: John T. Henderson,
M.D. and S. Louise Phanstiel constitute a class with a term ending at the 2021 Annual Meeting (the &#147;Class&nbsp;I Directors&#148;); Mark C. Capone, Heiner Dreismann, Ph.D., and Colleen F. Reitan constitute a class with a term ending at the 2019
Annual Meeting (the &#147;Class&nbsp;II Directors&#148;); and Walter Gilbert, Ph.D., Dennis H. Langer, M.D., J.D., Lawrence C. Best, and Lee N. Newcomer constitute a class with a term ending at the 2020 Annual Meeting (the &#147;Class&nbsp;III
Directors&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;25, 2019, our Board of Directors accepted the recommendation of the Nominating and Governance
Committee and voted to nominate Mark C. Capone, Heiner Dreismann, Ph.D., and Colleen F. Reitan for election at the Annual Meeting for a term of three years until the 2022 Annual Meeting of stockholders, and until their respective successors have
been elected and qualified, or until their earlier death, resignation, retirement or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Set forth below are the names of the
persons nominated as directors and directors whose terms do not expire this year, their ages as of September&nbsp;1, 2019, their offices in the Company, if any, their principal occupations or employment for at least the past five years, the length
of their tenure as directors and the names of other public companies in which such persons currently hold directorships or have held directorships in the past five years. Additionally, information about the specific experience, qualifications,
attributes or skills that led to the Board&#146;s conclusion at the time of the filing of this proxy statement that each person listed below should serve as a director is set forth below for each individual director.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NAME</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="right"><B>AGE</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>POSITION WITH MYRIAD</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D. (2) (3) (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board of Directors</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D. (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vice Chairman of the Board of Directors</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer, Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best (1) (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D. (2) (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D. (1) (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel (1) (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lee N. Newcomer (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Audit Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Compensation Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Nominating and Governance Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Strategic Committee </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief summary of the background and business experience of each of our
directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>John T. Henderson, M.D.,</B> Chairman of the Board of Directors, has been a director of Myriad since May 2004 and Chairman
of the Board since April 2005. Since December 2000, Dr.&nbsp;Henderson has served as a consultant to the pharmaceutical industry as President of Futurepharm LLC. Dr.&nbsp;Henderson currently serves on the Board of Directors of Cytokinetics, Inc.
Until his retirement in December 2000, he was with Pfizer for over 25 years, most recently as a Vice President in the Pfizer Pharmaceuticals Group. Dr.&nbsp;Henderson previously held vice presidential level positions with Pfizer in Research and
Development in Europe and later in Japan. He also was Vice President, Medical for the Europe, U.S. and International Pharmaceuticals groups at Pfizer. He earned his bachelor&#146;s and medical degrees from the University of Edinburgh and is a Fellow
of the Royal College of Physicians (Ed.). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Dr.&nbsp;Henderson should serve on the Board for the
following reasons: His medical background provides the Board with expertise in developing predictive, personalized and prognostic testing services. Dr.&nbsp;Henderson provides the Board with business and management expertise from his senior
positions at Pfizer for over 25 years, including expertise in research and development, which is critical to our development of molecular diagnostic testing services. He brings to the Board international experience as the Company implements
strategies for international expansion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Walter Gilbert, Ph.D.</B>, Vice Chairman of the Board of Directors, joined Myriad as a founder
and director in March 1992. Dr.&nbsp;Gilbert won the Nobel Prize in Chemistry in 1980 for his contributions to the development of DNA sequencing technology.&nbsp;He was a founder of Biogen, Inc. and its Chairman of the Board and Chief Executive
Officer from 1981 to 1985.&nbsp;Dr.&nbsp;Gilbert has held professorships at Harvard University in the departments of Physics, Biophysics, Biology, Biochemistry and Molecular Biology, and Molecular and Cellular Biology.&nbsp;He is a Carl M. Loeb
University Professor Emeritus at Harvard University.&nbsp;Dr.&nbsp;Gilbert founded and served on the Board of Directors of both Memory Pharmaceuticals Corp. and Paratek Pharmaceuticals, Inc. He also currently serves on the board of Amylyx
Pharmaceuticals and is a General Partner of BioVentures Investors, an investment fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that
Dr.&nbsp;Gilbert should serve on the Board for the following reasons:&nbsp;He provides the Board with a unique and extensive scientific background and expertise important to us in developing and commercializing molecular diagnostic products, and
understanding technological developments in the industry.&nbsp;Dr.&nbsp;Gilbert provides the Board with business, managerial and financial expertise based on having founded, managed, and directed several companies in the healthcare industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mark C. Capone</B>, was appointed as the President and Chief Executive Officer, or CEO, of Myriad Genetics, Inc., and a member of the Board
of Directors, effective July&nbsp;1, 2015. Previously, he served as the President of Myriad Genetic Laboratories, Inc., a wholly owned subsidiary of Myriad. Mr.&nbsp;Capone joined the Company in October 2002, initially as Vice President of Sales
until being named Chief Operating Officer in February 2006, a position he held until his promotion to President of Myriad Genetic Laboratories, Inc. in March 2010. Prior to joining Myriad, he served 17 years with Eli Lilly and Company, where he held
positions as Product Development Manager, Manufacturing Plant Manager, and Area Sales Director. Mr.&nbsp;Capone received his B.S. degree in Chemical Engineering from Penn State University, graduating with highest distinction, his M.S. degree in
Chemical Engineering from the Massachusetts Institute of Technology, and his M.S. in Management from the Massachusetts Institute of Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Mr.&nbsp;Capone should serve on the Board for the following reasons: He provides the Board with
business and management expertise at a molecular diagnostic company from his 14 years of service as President, Chief Operating Officer and Vice President of Sales at Myriad Genetic Laboratories. Mr.&nbsp;Capone brings to the Board additional
experience in operations management, product development, finance, sales, and other operational areas from his experience at Eli Lilly and Company. He also provides us with important expertise in investor relations based on his past interactions
with our investor base. Additionally, Mr.&nbsp;Capone&#146;s scientific, engineering and business management background and education provide important insights for the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Lawrence C. Best</B>, a director of Myriad since September 2009, is the Chairman and Founder
of OXO Capital LLC, an investment firm focused on life sciences and therapeutic medical device companies, since 2007.&nbsp;He joined Boston Scientific Corporation in 1992 and served for 15 years as the Executive Vice President-Finance&nbsp;&amp;
Administration and Chief Financial Officer.&nbsp;Prior to joining Boston Scientific, Mr.&nbsp;Best was a partner in the accounting firm of Ernst&nbsp;&amp; Young, where he specialized in serving multinational companies in the high technology and
life sciences fields.&nbsp;He served a <FONT STYLE="white-space:nowrap">two-year</FONT> fellowship at the SEC from 1979 to 1981 and a <FONT STYLE="white-space:nowrap">one-year</FONT> term as a White House-appointed Presidential Exchange Executive in
Washington, D.C.&nbsp;He is a founding director of the President&#146;s Council at Massachusetts General Hospital.&nbsp;Within the past five years Mr.&nbsp;Best also has served on the Board of Directors of Haemonetics Corp, Biogen, Inc. and as
Executive Chairman of Cardiovalve Ltd., a privately held medical device company based in Tel Aviv, Israel.&nbsp;He received a B.B.A. degree from Kent State University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Mr.&nbsp;Best should serve on the Board for the following reasons:&nbsp;He provides the Board with
broad financial accounting and reporting expertise in the technology and life sciences fields.&nbsp;Mr.&nbsp;Best provides extensive financial, business, management and investment expertise from his 15 years of service as the Chief Financial Officer
at Boston Scientific.&nbsp;He also provides the Board with substantial experience in the event of potential mergers, acquisitions and licensing opportunities.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Heiner Dreismann, Ph.D.</B>, a director of Myriad since June 2010, had a successful career at the Roche Group from 1985 to 2006 where he
held several senior positions, including President and CEO of Roche Molecular Systems, Head of Global Business Development for Roche Diagnostics and member of Roche&#146;s Global Diagnostic Executive Committee. From 2006 to 2009, Dr.&nbsp;Dreismann
served as the CEO of Vectrant Technologies, Inc., and until 2013 was the Interim CEO for GeneNews Limited. During the past five years, Dr.&nbsp;Dreismann served on the Board of Directors of Med BioGene, Inc., Genenews Limited, Interpace Diagnostics
and Ignyta, Inc.. He earned a M.S. degree in biology and his Ph.D. in microbiology/molecular biology (summa cum laude) from Westfaelische Wilhelms University (The University of M&uuml;nster) in Germany. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Dr.&nbsp;Dreismann should serve on the Board for the following reasons:&nbsp;He provides the Board
with important business and managerial expertise from his more than 20 years at Roche, including specific expertise in developing and commercially launching diagnostic products.&nbsp;Furthermore, Dr.&nbsp;Dreismann has extensive experience in
international markets, specifically in Europe, while he was CEO of Roche Molecular Systems, the international leader in molecular diagnostics, which is important as we seek to expand internationally.&nbsp;His scientific background and expertise also
enable him to provide the Board with technical advice on product research and development.&nbsp;Dr.&nbsp;Dreismann has a diversified background in managing and serving as a director of several companies in the healthcare industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dennis H. Langer, M.D., J.D.</B>, has been a director of Myriad since May 2004. From January 2013 to July 2014 he served as Chairman and
Chief Executive Officer of AdvanDx, Inc. From August 2005 to May 2010, Dr.&nbsp;Langer served as Managing Partner of Phoenix IP Ventures, LLC. From January 2004 to July 2005, he was President, North America for Dr.&nbsp;Reddy&#146;s Laboratories,
Inc. From September 1994 until January 2004, Dr.&nbsp;Langer held several high-level positions at GlaxoSmithKline, and its predecessor, SmithKline Beecham, including most recently as a Senior Vice President of Research and Development. He has a
broad base of experience in innovative R&amp;D companies such as Eli Lilly, Abbott and Searle. He is also a clinical professor at the Department of Psychiatry, Georgetown University School of Medicine. Dr.&nbsp;Langer received a J.D. from Harvard
Law School, an M.D. from Georgetown University School of Medicine, and a B.A. in Biology from Columbia University. He currently serves on the Board of Directors of Dicerna Pharmaceuticals, Inc. During the past five years, Dr.&nbsp;Langer served on
the Board of Pernix Therapeutics Holdings, Inc and Delcath Systems, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Dr.&nbsp;Langer
should serve on the Board for the following reasons: His medical background provides the Board with expertise in developing predictive, personalized, and prognostic testing products. Dr.&nbsp;Langer provides the Board with business and management
expertise from senior positions at several major pharmaceutical companies, including expertise in research and development, which is critical to our development of molecular diagnostic testing services. He brings international experience as we
implement strategies for global expansion. Dr.&nbsp;Langer&#146;s background as a board certified psychiatrist with extensive experience in neuropsychiatric drug development and personalized medicine provides the Board with expertise in developing
and commercializing diagnostics for patients suffering from neuropsychiatric and other medical conditions. Dr.&nbsp;Langer also has a diversified background in managing and serving as a director of several companies in the healthcare industry. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Lee Newcomer, M.D.</B>, was appointed as a member of the board of directors in September 2019.
Dr.&nbsp;Newcomer currently manages his own consulting business, Lee N. Newcomer Consulting, LLC, and previously held senior executive roles at United Healthcare including Senior Vice President for Oncology and Genetics, Chief Medical Officer and
Senior Vice President of Health Policy and Strategy for UnitedHealth Group. Dr.&nbsp;Newcomer also worked for Vivius, Inc., a consumer directed health plan, holding the position of Executive Vice President and Chief Medical Officer.
Dr.&nbsp;Newcomer received a Master&#146;s Degree in Healthcare Administration&nbsp;&amp; Management from the University of Wisconsin, Madison, an M.D. from the University of Nebraska, Omaha, and a B.S. from Nebraska Wesleyan University.
Dr.&nbsp;Newcomer currently serves on the Board of Cellworks Group Inc., a private precision medicine company and Intervention Insights, a genomic test deision support company. He also served on the board of directors of Park Nicollet Health
Systems, a hospital health care system with approximately 1,000 physicians and 400 beds, for 10 years including two years as Chairman. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Dr.&nbsp;Newcomer should serve on the Board for the following reasons: His extensive reimbursement
and managed care experience will aid the Company in its efforts to expand reimbursement for its new innovative precision medicine tests. He provides the Board with expertise on the medical insurance industry based on his extensive experience in
several senior positions at UnitedHealth Group, Inc. and CIGNA Corporation. Additionally, Dr.&nbsp;Newcomer&#146;s medical background provides the Board with expertise in developing predictive, personalized and prognostic testing products.
Furthermore, Dr.&nbsp;Newcomer brings extensive business management experience from his 28 years of work in the managed care and pharmaceutical industries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>S. Louise Phanstiel</B>, a director of Myriad since September 2009, held several important positions at WellPoint, Inc. from 1996 to 2007,
including as President, Specialty Products (2003 to 2007), Senior Vice President, Chief of Staff and Corporate Planning in the Office of the Chairman (2000 to 2003), and Senior Vice President, Chief Accounting Officer, Controller, and Chief
Financial Officer for all WellPoint, Inc. subsidiaries, including Blue Cross of California (1996 to 2000). Previously, Ms.&nbsp;Phanstiel was a partner at the international services firm of Coopers&nbsp;&amp; Lybrand (now PricewaterhouseCoopers LLP)
where she served clients in life and property/casualty insurance, high technology, and higher education. She currently serves on the Board of Trustees of Syracuse University and the Board of Directors of the Southampton Hospital Association.
Ms.&nbsp;Phanstiel received a B.A. degree in Accounting from Golden Gate University and is a Certified Public Accountant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of
Directors has determined that Ms.&nbsp;Phanstiel should serve on the Board for the following reasons: She provides the Board with important expertise on the medical insurance industry based on her extensive experience in several senior positions at
WellPoint and Blue Cross of California. This expertise is critical as we rely on third-party reimbursement for our molecular diagnostic services. Ms.&nbsp;Phanstiel also provides the Board with financial accounting and reporting expertise from her
work at Coopers&nbsp;&amp; Lybrand and as a Certified Public Accountant. In addition, she provides the Board with financial and investment expertise, as well as management expertise, resulting from managing and serving as a director of
publicly-traded companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Colleen F. Reitan</B>, was appointed as a member of the board of directors in September of 2019.
Ms.&nbsp;Reitan previously held numerous senior leadership positions at Health Care Services Corporation (HCSC) including most recently as the Executive Vice President and President of Plan Operations and as the Chief Operating Officer. Prior to
working at HCSC, Ms.&nbsp;Reitan held numerous senior management positions at Blue Cross and Blue Shield of Minnesota including Chief Operating Officer. In aggregate, Ms.&nbsp;Reitan has over 35 years of experience in the managed care industry.
Ms.&nbsp;Reitan holds a B.A from Minnesota State University at Mankato and a M.S. in Health Care Administration from the University of Minnesota-Twin Cities. She currently serves on the board of Alnylam Pharmaceuticals, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Ms.&nbsp;Reitan should serve on the Board for the
following reasons: Her extensive reimbursement and managed care experience will aid the Company in its efforts to expand reimbursement for its new innovative precision medicine tests.&nbsp;Furthermore, she provides the Board with important expertise
on the medical insurance industry based on her extensive experience in several senior positions at Health Care Services Corporation and Blue Cross and Blue Shield of Minnesota. In addition, she provides the Board with management expertise, resulting
from managing private companies and serving as a director of a publicly-traded company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors has reviewed the materiality of any relationship that each of our directors has with Myriad, either directly or
indirectly. Based on this review, the Board has determined that the following members of the Board are &#147;independent directors&#148; as defined by The Nasdaq Stock Market LLC &#147;Nasdaq&#148;: Mr.&nbsp;Best, Dr.&nbsp;Dreismann,
Dr.&nbsp;Gilbert, Dr.&nbsp;Henderson, Dr.&nbsp;Langer, Dr.&nbsp;Newcomer, Ms.&nbsp;Phanstiel, and Ms.&nbsp;Reitan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure of the Board
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board does not have a policy regarding the separation of the roles of Chairman of the Board and Chief Executive Officer because
the Board believes that it is in our best interests to make that determination based on the position and direction of the Company and the membership of the Board. However, at this time, and since our inception, the Board has determined that having
an independent director serve as Chairman of the Board is in the best interests of our stockholders. Thus, the roles of Chairman of the Board and Chief Executive Officer are separated. This structure enables a greater role for the independent
directors in the oversight of the Company and their active participation in setting agendas and establishing Board policies, priorities and procedures. This structure also allows the Chief Executive Officer to focus on the management of our <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Role in the Oversight of Risk Management
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has an active role, directly and through its committees, in the oversight of our risk management efforts. The Board carries
out this oversight role through several levels of review. It regularly reviews and discusses with members of management information regarding the management of risks inherent in the operations of our businesses and the implementation of our
strategic plan, including our risk mitigation efforts.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Board&#146;s committees also oversees the
management of risks that are under each committee&#146;s areas of responsibility. For example, the Audit Committee oversees management of accounting, auditing, external reporting, internal controls and cash investment risks. The Nominating and
Governance Committee oversees our compliance policies, Code of Conduct, conflicts of interest, director independence and corporate governance policies. The Compensation Committee oversees risks arising from compensation practices and policies. While
each committee has specific responsibilities for oversight of risk, the Board is regularly informed by each committee about such risks. In this manner the Board is able to coordinate its risk oversight. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Consideration of Diversity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board and Nominating and Governance Committee do not have a formal policy with respect to the consideration of diversity in identifying
nominees for director positions. However, the Board and Nominating and Governance Committee strive to nominate individuals with a variety of diverse backgrounds, skills, qualifications, attributes and experience such that the Board, as a group, will
possess the appropriate expertise, talent and skills to fulfill its responsibilities to manage the Company in the long-term interests of the stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Disclosure of Third Party Director and Nominee Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No member of the Board of Directors has any agreement or arrangement with any person or entity other than the Company relating to compensation
or other payment in connection with the Director&#146;s service as a Director of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of the Board of Directors and Meetings
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Meeting Attendance.</I> During the fiscal year ended June&nbsp;30, 2019, or fiscal 2019, there were four meetings of the Board of
Directors, and the various committees of the Board met a total of 16 times. No director attended fewer than 75&nbsp;percent of the total number of meetings and of committees of the Board on which he or she served during fiscal 2019. The Board has
adopted a policy under which each member is encouraged, but not required to attend each Annual Meeting of Stockholders. At the time of our 2018 Annual Meeting, all members of the Board of Directors were in attendance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit Committee.</I> Our Audit Committee met six times during fiscal 2019. This committee currently has four members: Ms.&nbsp;Phanstiel
(chair), Mr.&nbsp;Best, Dr.&nbsp;Langer, and Ms.&nbsp;Reitan. The Audit Committee&#146;s roles and responsibilities are set forth in its written charter and include the authority to retain and terminate the services of our independent registered
public accounting firm. In addition, the Audit Committee reviews annual financial statements; considers matters relating to accounting policy and internal controls; reviews the scope of annual audits; and monitors our processes for complying with
laws, regulations and our Code of Conduct. Our Board of Directors has determined that all members of the Audit Committee satisfy the current independence standards promulgated by the SEC and by Nasdaq, as such standards apply specifically to members
of audit committees. The Board has determined that Ms.&nbsp;Phanstiel is an &#147;audit committee financial expert,&#148; as the SEC has defined that term in Item 407 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act
of 1933, as amended, or the Securities Act. A copy of the Audit Committee&#146;s written charter is publicly available on the Investor Information &#150; Understanding Myriad/Corporate Governance section of our website at
<I><U>www.myriad.com</U></I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please also see the report of the Audit Committee set forth elsewhere in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Compensation Committee.</I> Our Compensation Committee met two times during fiscal 2019. This committee currently has four members:
Dr.&nbsp;Dreismann (chair), Dr.&nbsp;Gilbert, Dr.&nbsp;Henderson, and Dr.&nbsp;Newcomer. The Compensation Committee&#146;s role and responsibilities are set forth in its written charter and include reviewing, approving and making recommendations
regarding our compensation policies, practices and procedures to ensure that legal and fiduciary responsibilities of the Board of Directors are carried out and that such policies, practices and procedures contribute to our success. The Compensation
Committee also is responsible for evaluating and determining the compensation of our President and Chief Executive Officer, and conducts its decision making process with respect to that issue without the President and Chief Executive Officer
present. The Board has determined that all members of the Compensation Committee qualify as independent under the definition promulgated by Nasdaq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is charged with establishing a compensation policy for our executives and directors that is designed to attract and
retain qualified executive talent, to motivate them to achieve corporate objectives, and reward them for superior performance. Our Compensation Committee is also responsible for establishing and administering our executive compensation policies and
equity compensation plans. The Compensation Committee meets at least two times per year and more often as necessary to review and make decisions with regard to executive compensation matters. As part of its review of these matters, the Compensation
Committee may delegate any of the powers given to it to a subcommittee. A copy of the Compensation Committee&#146;s written charter is publicly available on the Investor Information &#151; Understanding Myriad/Corporate Governance section of our
website at <I><U>www.myriad.com</U></I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further discussion of the process and procedures for considering and determining executive
compensation, including the role that our executive officers play in determining compensation for other executive officers is included below in the section entitled &#147;Executive Compensation &#151; Compensation Discussion and Analysis.&#148; The
Compensation Committee has the authority to directly retain the services of independent consultants and other experts to assist in fulfilling its duties. For purposes of fiscal 2019 executive compensation determinations, the Compensation Committee
retained Mercer (US), Inc. (&#147;Mercer&#148;) to update our peer group of companies and provide competitive market data on the salaries and short-term and long-term incentive compensation of executive officers at comparable companies within our
industry. Mercer also was engaged to provide the Compensation Committee an analysis of, and recommendations for, annual salary compensation, short-term incentive compensation, and long-term incentive compensation for the President and CEO and other
executive officers. Mercer performs services solely on behalf of the Compensation Committee and has no relationship with Myriad or its management except as may relate to performing such services. The Compensation Committee has assessed the
independence of Mercer pursuant to SEC rules and the corporate governance rules of the Nasdaq and concluded that no conflict of interest exists that would prevent Mercer from independently representing the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please also see the report of the Compensation Committee set forth elsewhere in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Compensation Committee Interlocks and Insider Participation</I>. No member of our Compensation Committee has at any time been an employee
of the Company. None of our executive officers is a member of the Compensation Committee, nor do any of our executive officers serve as a member of the Board of Directors or Compensation Committee of any entity that has one or more executive
officers serving as a member of our Board of directors or Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Nominating and Governance Committee. </I>Our
Nominating and Governance Committee met two times during fiscal 2019. This committee currently has three members: Dr.&nbsp;Langer (chair), Dr.&nbsp;Henderson, and Ms.&nbsp;Phanstiel. This committee&#146;s role and responsibilities are set forth in
the Nominating and Governance Committee&#146;s written charter and include evaluating and making recommendations to the full Board as to the size and composition of the Board and its committees, identifying and evaluating potential candidates and
recommending the director nominees for election, developing and recommending corporate governance guidelines applicable to us, and reviewing and approving potential or actual conflicts of interest between our executive officers or members of the
Board. The committee also oversees the annual Board performance evaluations, which may be submitted anonymously at the discretion of the director concerned, as well as our policy on plurality voting for director elections, which is described in
&#147;Proposal 1 &#151; Election of Directors&#148; of this proxy statement. The Board of Directors has determined that all members of the Nominating and Governance Committee qualify as independent under the definition promulgated by Nasdaq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a stockholder wishes to nominate a candidate for director who is not included in our proxy statement, the stockholder must follow the
procedures described in our Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> and in &#147;Stockholder Proposals and Nominations for Director&#148; at the end of this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under our current corporate governance policies, the Nominating and Governance Committee may consider candidates recommended by
stockholders as well as from other sources such as other directors or officers, third-party search firms or other appropriate sources. For all potential candidates, the Nominating and Governance Committee may consider all factors it deems relevant,
such as a candidate&#146;s personal integrity and sound judgment; business and professional skills and experience; independence, knowledge of the industry in which we operate, possible conflicts of interest, the extent to which the candidate would
fill a present need on the Board; and concern for the long-term interests of the stockholders. In general, persons recommended by stockholders will be considered on the same basis as candidates from other sources. If a stockholder wishes to propose
a candidate for consideration by the Nominating and Governance Committee under our corporate governance policies, for each annual meeting, the Committee will consider only one recommended nominee from any stockholder or group of affiliated
stockholders, and such recommending stockholder or group must have held at least 5&nbsp;percent of common stock for at least one year. All stockholder recommendations for proposed director nominees must be made in writing to the Nominating and
Governance Committee, care of Myriad&#146;s Secretary at 320 Wakara Way, Salt Lake City, Utah 84108, and must be received no later than 120 days prior to the first anniversary of the date of the proxy statement for the previous year&#146;s Annual
Meeting. The recommendation must be accompanied by the following information concerning the recommending stockholder: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The name, address and telephone number of the recommending stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The number of shares of our common stock owned by the recommending stockholder and the time period for which such
shares have been held; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the recommending stockholder is not a stockholder of record, a statement from the record holder verifying the
holdings of the recommending stockholder and a statement from the recommending stockholder of the length of time such shares have been held (alternatively, the recommending stockholder may furnish a current Schedule 13D, Schedule 13G, Form 3, Form 4
or Form 5 filed with the SEC, together with a statement of the length of time that the shares have been held); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A statement from the recommending stockholder as to the good faith intention to continue to hold such shares
through the date of the next annual meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recommendation must also be accompanied by the following information
concerning the proposed nominee: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The information required by Items 401, 403 and 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT>
under the Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A description of all relationships between the proposed nominee and the recommending stockholder, including any
agreements or understandings regarding the nomination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A description of all relationships between the proposed nominee and any of our competitors, customers, suppliers,
labor unions or other persons with special interests regarding the Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The contact information for the proposed nominee. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recommending stockholder must also furnish a statement supporting a view that the proposed nominee possesses the minimum qualifications as
set forth below for director nominees and describing the contributions that the proposed nominee would be expected to make to the Board and to the governance of Myriad and must state whether, in the stockholder&#146;s view, the proposed nominee, if
elected, would represent all stockholders and not serve for the purpose of advancing or favoring any particular stockholder or other constituency of Myriad. The recommendation must also be accompanied by the written consent of the proposed nominee
(i)&nbsp;to be considered by the Nominating and Governance Committee and interviewed if the Nominating and Governance Committee chooses to do so in its discretion, and (ii)&nbsp;if nominated and elected, to serve as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all potential candidates, the Nominating and Governance Committee may consider all factors it deems relevant, including the following
threshold criteria: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates should possess the highest personal and professional standards of integrity and ethical values;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates must be committed to promoting and enhancing the long-term value of Myriad for its stockholders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates must be able to represent fairly and equally all stockholders without favoring or advancing any
particular stockholder or other constituency of Myriad; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates must have demonstrated achievements in one or more fields of business, professional, governmental,
community, scientific or educational endeavor, and possess mature and objective business judgment and expertise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates are expected to have sound judgment, derived from management or policy making experience that
demonstrates an ability to function effectively in an oversight role; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates must have a general appreciation regarding major issues facing public companies of a size and
operational scope similar to Myriad, including governance concerns, regulatory obligations, strategic business planning, competition and basic concepts of accounting and finance; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Candidates must have, and be prepared to devote, adequate time to the Board of Directors and its committees.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Nominating and Governance Committee will take into account the extent to which the candidate would
fill a present need on the Board, including the extent to which a candidate meets the independence and experience standards promulgated by the SEC and by Nasdaq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Nominating and Governance Committee&#146;s written charter is publicly available on the Investor Information &#150;
Understanding Myriad/Corporate Governance section of our website at <I><U>www.myriad.com</U></I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The descriptions of our corporate
governance policies contained in this proxy statement are qualified in their entirety and subject to the terms of such policies as modified by the Board of Directors from time to time. The following corporate governance documents are publicly
available on the Investor Information &#151; Understanding Myriad/Corporate Governance section of our website at <I><U>www.myriad.com</U></I>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Annual Shareholder Meeting Attendance by Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Security Holder Communications with Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Security Holder Recommendation of Candidates for Election as Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Procedures for Security Holders Submitting Nominating Recommendations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy Regarding Qualifications of Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy For Handling Complaints Regarding Accounting and Auditing Matters and Code of Conduct Matters;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Plurality Vote for Director Elections; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Limiting Service on Public Company Boards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on New Director Orientation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Continuing Education for the Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Related Person Transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Director and Executive Officer Stock Ownership Guidelines; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Equity Award Holding Requirements for Named Executive Officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Corporate Governance Principles; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Corporate Code of Conduct and Ethics and Whistleblower Policy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Policy on Incentive Compensation Repayment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominating and Governance Committee Charter; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Audit Committee Charter; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Compensation Committee Charter; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Strategic Committee Charter. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Strategic Committee. </I>Our Strategic Committee met two times during fiscal 2019.<I> </I>This committee currently has three members:
Dr.&nbsp;Henderson (chair), Mr.&nbsp;Best and Dr.&nbsp;Dreismann. The committee&#146;s roles and responsibilities are set forth in the Strategic Committee&#146;s written charter and include advising and consulting with senior management on a broad
range of strategic initiatives and making recommendations to the Board regarding such opportunities. A copy of the Strategic Committee&#146;s written charter is publicly available on the Investor Information &#151; Understanding Myriad/Corporate
Governance section of our website at <I><U>www.myriad.com</U></I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications to the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, stockholders who have questions or concerns should contact our Investor Relations department at (801)
<FONT STYLE="white-space:nowrap">584-1143.</FONT> However, any stockholder who wishes to address questions regarding our business directly with the Board of Directors, or any individual director, should send his or her questions in writing to the
Chairman of the Board<B> </B>or a designated member of the Board at 320 Wakara Way, Salt Lake City, Utah 84108. Communications will be distributed to the Board, to the Nominating and Governance Committee, or to any individual director or directors
as appropriate, depending on the facts and circumstances outlined in the communications. Items that are unrelated to the duties and responsibilities of the Board may be excluded, such as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Junk mail and mass mailings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Resumes and other forms of job inquiry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Surveys; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Solicitations or advertisements. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, any material that is unduly hostile, threatening, or illegal in nature may be excluded, provided that any communication that is
excluded will be made available to any outside director upon request. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the name, age (as of September&nbsp;1, 2019) and position of each of our current executive officers. Unless
indicated otherwise, general references to &#147;executive officers&#148; throughout this proxy refer to the following officers: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="right">Age</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">Position</P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Myriad Women&#146;s Health</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benjamin G. Jackson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, General Counsel and Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gary A. King</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, International Operations</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicole Lambert</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Myriad Oncology</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Scientific Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ralph L. McDade, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Myriad RBM</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer and Treasurer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Myriad Autoimmune</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Verratti</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Myriad Neuroscience</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mark C. Capone</B>. Please see biography above under &#147;Management and Corporate Governance &#151; The
Board of Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Alexander Ford</B>, President of Myriad Women&#146;s Health, Inc., a wholly owned subsidiary of Myriad, and
our Myriad Women&#146;s Health business unit, has served in his current role since August&nbsp;1, 2018. Mr.&nbsp;Ford joined Myriad in June 2010. Before being named to his current position, he served as President of Myriad Genetic Laboratories Inc.
(&#147;MGL&#148;) from 2015 to 2018, as the MGL Chief Commerical Officer from 2013 to 2015, as the MGL General Manager of Preventive Care from 2011 to 2013 and as the MGL VP of Sales from 2010 to 2011. Prior to joining Myriad, Mr.&nbsp;Ford held
leadership positions at Novartis, Sanofi-Aventis, Nektar Therapeutics and Pfizer in the areas of Marketing Research, Product Marketing, Managed Care, Sales and Business Development. He has more than 25 years of experience in the pharmaceutical and
biotechnology industries. Mr.&nbsp;Ford received his B.A. degree in Communications from the University of North Carolina, Wilmington and his M.A. degree from New York University.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Benjamin G. Jackson</B>, Executive<B> </B>Vice President, General Counsel and Secretary,
joined Myriad in February 2006. He has held various positions in Myriad&#146;s Legal Department, including serving as associate general counsel prior to assuming the role of general counsel. Mr.&nbsp;Jackson received his J.D. degree from the J.
Reuben Clark Law School at Brigham Young University and a B.S. degree in microbiology, immunology, and molecular genetics from the University of California Los Angeles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Gary A. King</B>, Executive Vice President, International Operations, joined us in July 2010. Mr.&nbsp;King has been employed in the life
sciences industry for more than 25 years. From June 2008 to June 2010, he was the Chief Executive Officer of AverDx Incorporated, an international biotechnology company that develops novel biomarker diagnostics for critical diseases. From June 2002
to February 2008, he served as Vice President, International Operations at Biosite Incorporated, a developer of diagnostic products and antibody development technologies where he spent six years building and leading all of the company&#146;s
commercial activities outside the United States. Mr.&nbsp;King received his B.A. degree in Zoology from Pomona College and a M.B.A. degree from Stanford University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Nicole Lambert</B>, President of Myriad Genetic Laboratories, Inc, a wholly owned subsidiary of Myriad and our Myriad Oncology business
unit, has served in her current role since April&nbsp;1, 2019. Mrs.&nbsp;Lambert joined the company in June 2001. Prior to her current position, she served as General Manager for the Oncology and Urology business units and Vice President of
Dermatology. Prior to joining Myriad, she was a genetic councilor at LabCorp. Mrs.&nbsp;Lambert received her Bachelor&#146;s degree in Biology and Sociology from Boston College and her Master&#146;s degree in Genetic Counseling from Mt. Sinai School
of Medicine at New York University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Jerry S. Lanchbury, Ph.D.</B>, Chief Scientific Officer, joined the Company in September 2002 as
Senior Vice President of Research. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named to his current position in February 2010. Dr.&nbsp;Lanchbury came to us from GKT School of Medicine,
King&#146;s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr.&nbsp;Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1<SUP
STYLE="font-size:85%; vertical-align:top">st</SUP> Class&nbsp;Honours, B.Sc. &#147;Biology of Man&nbsp;&amp; his Environment&#148; degree from the University of Aston. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Ralph L. McDade, Ph.D.</B>, President of Myriad RBM, Inc., a wholly owned subsidiary of Myriad, and our Myriad RMB business unit, has
served in his current role since January 2014. Previously, he served as Chief Operating Officer of Myriad RBM. Dr.&nbsp;McDade was formerly Strategic Development Officer for Myriad RBM and was in that position since the company&#146;s inception in
2002. Prior to joining Myriad RBM, he was Chief Scientific Officer for Luminex Corporation from 1996 to 2002, where he was closely involved with the development of xMAP technology. Dr.&nbsp;McDade received his Ph.D. in Microbiology from the
University of Texas Southwestern Medical School in 1980. Following postdoctoral training at The University of Connecticut Medical Center in Farmington, he held faculty positions at the Rockefeller University in New York and at Louisiana State
University School of Medicine in New Orleans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>R. Bryan Riggsbee</B>, Chief Financial Officer and Treasurer, joined us in October 2014.
He previously served 10 years with Laboratory Corporation of America (LabCorp) where his most recent position was as Senior Vice President of Corporate Finance with responsibility for the financial planning and analysis and treasury functions. Prior
to LabCorp, Mr.&nbsp;Riggsbee served in various finance roles with General Electric and began his career in the audit division of KPMG. He received a B.A. in Accounting from North Carolina State University, a B.A. in political science from the
University of North Carolina at Chapel Hill and an M.B.A. from Northwestern University. Mr.&nbsp;Riggsbee is a Certified Public Accountant licensed in the State of North Carolina. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Bernard F. Tobin</B>, President of Crescendo Bioscience, Inc., a wholly owned subsidiary of
Myriad, and our Myriad Autoimmune business unit, has served in that role since January 2015. He previously held several senior positions at Amgen over the course of 8 years, including Executive Director of National Accounts, General Manager of both
the Netherlands and Brazil, and Global Head of Commercial Excellence. In addition, he led the global integration of business development acquisition in more than 100 countries. Prior to that, Mr.&nbsp;Tobin held a variety of leadership roles in the
commercial organization at Eli Lilly and Co. over the course of 16 years. He received his B.S. degree in public service and administration from Iowa State University and his M.B.A from the Fuqua School of Business, Duke University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mark Verratti</B>, President of Assurex Health, Inc., a wholly owned subsidiary of Myriad, and our Myriad Neuroscience business unit, has
served in his current role since August&nbsp;1, 2017. He previously served as SVP, Chief Sales and Business Development officer at Assurex since January 2016. Mr.&nbsp;Verratti also held senior leadership positions with Cyberonics (now known as
LivaNova) from 2005-2016, and earlier with Forest Pharmaceuticals where he led commercial teams with revenues approaching $500&nbsp;million dollars. He received a B.S. in Life Sciences with a minor in Physiology from The Pennsylvania State
University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into our standard employment agreements with each of our executive officers. The employment agreements for
each of our named executive officers are described elsewhere in the proxy statement under the caption &#147;Executive Compensation &#151; Narrative Disclosure to Summary Compensation Table and 2019 Fiscal Year Grants of Plan-Based Awards
Table.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Compensation Discussion and Analysis </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Executive Summary </U></I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Overview
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a leading molecular diagnostic company, with the goal of providing physicians and their patients with critical information to
guide healthcare management. Our goal is to manage our business to maximize the value we provide through our services, making the Company more successful and valuable, and hence maximizing our long-term stockholder value. Our compensation programs
are designed to support these goals, with the primary objectives of attracting and retaining executive talent, motivating our executive officers through
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> metrics to enhance our growth and profitability, and increasing long-term stockholder value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The four principal components of our compensation program for executive officers are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual salary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Short-term incentive compensation in the form of an annual cash incentive bonus; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Long-term incentive compensation in the form of a three-year cash incentive bonus; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Long-term incentive compensation in the form of restricted stock units or RSUs, subject to time-based vesting,
with a performance-based factor applicable to our NEOs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that these compensation components provide the
appropriate balance of short-term and long-term compensation and incentives to our executives to drive our performance, success and long-term growth. As indicated in the charts below, our pay mix largely follows that of our peers, with the majority
of our compensation in the form of long-term incentive compensation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp26.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Peer Pay Mix data is a composite of our peer group data and published survey data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation program seeks to align compensation with Company performance, and hence reward our executive officers for their contribution
to our growth, profitability and increased stockholder value through the recognition of individual leadership, initiatives, achievements and other contributions. Each year our Compensation Committee approves Management Business Objectives
(&#147;MBOs&#148;) for each executive officer that consist of individual objectives tailored to each executive. For some executive officers the individual MBOs also include <FONT STYLE="white-space:nowrap">pre-established</FONT> financial
performance targets for the Company such as revenue and adjusted operating income. The Compensation Committee reviews the achievement of these MBOs in determining compensation to be paid to our executive officers. The Compensation Committee believes
that the MBOs are based on an appropriate mix of individual objectives, and where applicable financial performance targets, that provide appropriate <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT>
metrics to incentivize executive officers to increase our profitability, success and long-term stockholder value. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Fiscal Year 2019 Performance </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2019 our revenues were up 14&nbsp;percent year-over-year to $851&nbsp;million and we achieved GAAP earnings per share of $0.06
and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> earnings per share of $1.67 which represents 18% year-over-year growth. During fiscal year 2019, we believe we accomplished a number of our strategic objectives that position the Company for
long-term growth. We made substantial progress on our five strategic critical success factors to: i) build upon a solid hereditary cancer foundation, ii) grow new product volume, iii) expand reimbursement coverage for new products, iv) increase RNA
kit revenue internationally, and v) improve profitability with our Elevate 2020 Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We continued generating strong cash flows from
operations and in fiscal year 2019 we generated over $101&nbsp;million in <FONT STYLE="white-space:nowrap">non-GAAP</FONT> free cash flow. We ended the year with $192&nbsp;million in cash, cash equivalents, and marketable investment securities and
plan to continue to exercise a balanced approach to capital deployment, including investing for future growth, paying down debt associated with recent acquisitions, business development activities and share repurchases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An explanation of the adjustments to our GAAP financial measures used in this proxy and a reconciliation of the adjusted financial measures to
the comparable GAAP financial measures are included in Appendix A to this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During fiscal year 2019 we repurchased
$50&nbsp;million of additional shares of our stock under an accelerated share repurchase program. Since fiscal year 2010, we have purchased over 50&nbsp;million shares of our common stock under our stock repurchase program for $1.29&nbsp;billion at
a weighted average price of $24.27 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp27.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Focusing on our longer-term growth, over the past five years, our revenue has grown at a compound annual
growth rate of four percent since fiscal year 2015. This growth trajectory is primarily due to declines in hereditary cancer revenue, as a result of competition following the loss of our patents related to hereditary cancer testing, being offset by
new product growth. In fiscal year 2019, 75&nbsp;percent of our test volume and 44&nbsp;percent of our revenue was derived from new <FONT STYLE="white-space:nowrap">(non-hereditary</FONT> cancer) products. Additionally, in fiscal year 2019 the
hereditary cancer business returned to year-over-year growth. Going forward, we believe the Company is positioned to return to higher revenue growth rates given increasing stability in hereditary cancer revenues and continued growth from new
products. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp28.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past five years, we experienced a <FONT STYLE="white-space:nowrap">-7&nbsp;percent</FONT> annual
stockholder return on our stock price versus a 13&nbsp;percent return for the NASDAQ composite index and a 7% return for the NASDAQ Healthcare Providers Stock Index reflecting the increased competition we faced after the loss of key hereditary
cancer patents in fiscal year 2013. We included the NASDAQ Healthcare Providers Stock Index in our Stock Performance Chart as the NASDAQ Healthcare Providers Stock Index is comprised of companies which also operate in the healthcare industry. We
caution that historical stock price performance, including the stock price performance shown in the chart below, is not necessarily indicative of, nor is it intended to forecast, the potential future performance of our common stock. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp28a.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our financial results during fiscal year 2019, we also achieved the following
progress on our five critical success factors: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Build Upon a Solid Hereditary Cancer Foundation</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Returned hereditary cancer business to year-over-year revenue growth, with total hereditary cancer revenue of
$480&nbsp;million which increased by 2&nbsp;percent relative to fiscal year 2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achieved 10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> consecutive quarter of year-over-year volume
growth in hereditary cancer tests. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Presented validation study for riskScore<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> with over
9,000 women of Hispanic descent at the 2018 San Antonio Breast Cancer Symposium demonstrating the test was highly accurate at predicting breast cancer risk among Hispanic women. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Received U.S. Food and Drug Administration approval for BRACAnalysis CDx for use in conjunction with olaparib for
maintenance therapy in first-line ovarian cancer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The American Society of Breast Surgeons issued new clinical guidelines calling for hereditary cancer testing in
all breast cancer patients regardless of family history. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Grow New Product Volume</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Performed over one million diagnostic tests in fiscal year 2019 representing a 32&nbsp;percent compound annual
growth rate in test volume over the last five years. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Grew GeneSight volume by 17&nbsp;percent year-over-year and added approximately 3,000 new ordering physicians in
fiscal year 2019. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Completed acquisition of Counsyl adding two new tests in the high-growth prenatal diagnostic market. Integrated
sales forces expanding physician reach three fold. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Set a record for new product revenue with $302&nbsp;million in revenue coming from our prenatal tests, GeneSight,
Vectra, Prolaris, and EndoPredict. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Published landmark research in rheumatoid arthritis demonstrating Vectra was more than three times better at
predicting radiographic progression than other disease activity measures. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Expand Reimbursement Coverage for New
Products</U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expanded the reimbursed addressable market for our new products to over $1.2&nbsp;billion in fiscal year 2019.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Published the GUIDED study which is the largest pharmacogenomics study ever completed in depression. GeneSight
became the first pharmacogenomics technology to demonstrate a statistically significant change in response and remission rates versus an active drug arm. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Announced first commercial coverage decisions for GeneSight with UnitedHealthcare, the largest commercial payer
in the country and CareFirst, the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> largest commercial insurer in the U.S. both covering the test. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Published the first evidence based expanded carrier screening study in <I>Genetics in Medicine </I>comprising
over 55,000 patients.<I> </I>Demonstrated that 38 genes in the Foresight test met all panel inclusion criteria commonly recommended in medical guidelines. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Launched managed care sales effort to the self-funded employer channel. Signed first major self-funded employer
contract with Kroger, the fourth largest employer in the United States. Launched medical intervention pilot at Kroger retail pharmacies. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Increase RNA Kit Revenue Internationally</U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Announced new EndoPredict reimbursement decision in the United Kingdom, Italy and Greece. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Received approval from the Japanese Ministry of Health, Labour and Welfare for BRACAnalysis CDx as a companion
diagnostic in both metastatic breast cancer and ovarian cancer. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Submitted application for marketing authorization for BRACAnalysis to the Japanese Ministry of Health, Labour and
Welfare for hereditary cancer testing. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Improve Profitability With Elevate 2020</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Continued implementation of Elevate 2020 program and exceeded operating profit increase target of
$50&nbsp;million in the first quarter of fiscal year 2019. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Brought Counsyl from a $12&nbsp;million quarterly loss to generating a positive operating profit in three
quarters through successful integration activities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achieved 300 basis point improvement in organic gross margins based upon laboratory efficiency programs across
the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Completed movement of the Vectra DA laboratory and customer service groups to Salt Lake City to reduce overall
cost. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Performance Pay for Fiscal Year 2019 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To reflect our pay for performance philosophy, based on the Company&#146;s performance for fiscal year 2019, our Compensation Committee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">awarded fiscal year 2019 annual cash incentive bonuses to our NEOs at 81 to 88&nbsp;percent of target based on
each NEO&#146;s MBOs score reflecting the degree to which individual company objectives were achieved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">awarded cash payments at 34&nbsp;percent of the target under our fiscal year 2017-2019 three-year, long term cash
incentive plan based upon the achievement of certain target metrics; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased executive officer salaries on average at a 3.5&nbsp;percent rate consistent with the average pay
increases for our employees as a whole; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">awarded long-term equity incentive compensation in the form of restricted stock units of Company stock which vest
over a greater than four year period and which have an additional performance based vesting feature for our NEOs. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> Results </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our last annual meeting of
stockholders in November 2018, we held a stockholder advisory vote on the fiscal year 2018 compensation of our NEOs. This is generally referred to as a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Say-on-Pay&#148;</FONT></FONT> vote. ISS and Glass Lewis recommended for the approval of our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> vote and our stockholders approved the compensation of our NEOs with 94&nbsp;percent of stockholder votes cast in favor of our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> resolution for fiscal year 2018. Notwithstanding this high approval percentage, we continued our outreach to our stockholders to identify and understand
feedback that they may have about our executive compensation with the goal of sustaining a high level of approval. Our stockholders consistently made the following comments: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Continued support for switching from granting stock options to restricted stock units and the stated goal to
target compensation at the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of our compensation benchmarks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support for CEO and CFO total compensation to be within the
50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of our compensation benchmarks; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Recommendation to continue the alignment of performance metrics for our three-year long term cash incentive plan
to our disclosed strategic goals. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, our Compensation Committee discussed the comments raised in the ISS and
Glass Lewis reports, as well as previous actions we undertook in prior years to address ISS and Glass Lewis concerns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our Pay Practices and Philosophy </I></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In response to the feedback expressed by our stockholders, as well as ISS and Glass Lewis, we have made the following changes over the last
several years to our executive compensation program: </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We amended our Claw Back Policy to now require an executive officer to repay to us the amount of any cash and
equity incentive compensation that an executive officer receives to the extent that: </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of such payment was based on the achievement of certain financial results that were subsequently the
subject of a restatement that occurred within 12 months of such payment; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the executive officer had engaged in theft, dishonesty or intentional falsification of documents or records that
resulted in the obligation to restate our financial results; and </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lower cash or equity incentive compensation payment would have been made to the executive officer based upon
the restated financial results. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We adopted our 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#147;2017
Plan&#148;) which provides: </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any stock right awarded under the 2017 Plan must be in the form of a restricted stock unit or a restricted stock
grant; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incentive stock options and <FONT STYLE="white-space:nowrap">non-qualified</FONT> options are not permitted under
the 2017 Plan; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all stock rights awarded must have a minimum vesting period of at least one year (we have historically provided
for a four year vesting period for our equity incentive awards, and intend to continue this practice); </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the vesting of any stock right awarded under the 2017 Plan cannot be accelerated from the original grant vesting
schedule except in connection with death, disability or a change in control; and </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no dividend payment may be made on any stock right which is not fully vested. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Based on the 2019 Mercer Executive Compensation Review for fiscal year 2019 the total compensation for our
executive officers in aggregate was within the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles of our compensation data. For our CEO, total compensation was
generally in line with the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile and has been at or consistently below the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile in FY17, FY18, FY19, and when evaluating
forecasted compensation for FY20. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The performance target metrics for our 3 year cash incentive plan for fiscal years 2019-2021 have performance
metrics which align with our strategic goals based on revenue growth, adjusted operating margin, and diversification from <FONT STYLE="white-space:nowrap">non-hereditary</FONT> cancer revenue; and </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">With our change to granting restricted stock units, we have reduced our equity dilution from 3% down to
approximately 1.5%. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp32.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Pay Practices </I></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we have adopted other practices that reflect the high standards our Compensation Committee seeks to attain for our compensation
philosophy and pay practices, such as: </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The period required for full vesting of restricted stock units shall be greater than four years;
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All restricted stock units awarded to our NEOs are granted subject to a predetermined, objective, formula-based,
financial performance metric; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stock ownership guidelines for our directors (three times annual cash retainer) and executive officers (for
President and CEO, three times annual base salary, and for other executive officers, two times annual base salary); </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual cash incentive bonus an executive officer may receive is capped at a percent of his or her target bonus
percentage amount; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prohibiting any tax <FONT STYLE="white-space:nowrap">gross-up</FONT> payments by the Company with respect to
compensation paid to any employee or director; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prohibiting hedging the economic risk of holding our stock, including trading in our stock on a short-term basis,
short sales of our stock and similar transactions, for which waivers are not granted; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prohibiting the pledge or use of our stock to secure a margin or other loan, for which waivers are not granted;
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prohibiting the Company&#146;s repurchase of underwater stock options; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prohibiting the repricing of stock options and other awards without stockholder approval; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prohibiting the grant of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> stock options; and </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Employing each executive officer on an &#147;at will&#148; basis without any guarantee as to employment term,
salary, or bonus. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the annual review of our executive compensation program and compensation pay
components, we will continue our general approach of establishing MBOs for our executive officers. These MBOs assist the Compensation Committee in evaluating the performance of our executive officers and to then reward them through short- and
long-term incentive compensation for the value they deliver to our stockholders as demonstrated by the enhanced growth and profitability of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>CEO Pay Ratio </U></I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following is a
reasonable estimate prepared under the Securities and Exchange Commission (SEC) rules, of the ratio of the annual total compensation of our President and Chief Executive Officer to the median of the annual total compensation of our other employees.
We determined that as of April&nbsp;30, 2019 our employee population consisted of approximately 2,694 U.S. employees. All international employees were excluded in the 5% De Minimis Exemption adjustment as permitted by SEC rules. We then selected our
median employee based on the <FONT STYLE="white-space:nowrap">W-2</FONT> calculated income of our U.S. employees as of December&nbsp;31, 2018. For employees hired on or after January&nbsp;1, 2018, we used their
<FONT STYLE="white-space:nowrap">W-2</FONT> income earned as of April&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For Fiscal Year 2019: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The annual total compensation of the employee identified at median of the Company (excluding the CEO) was
$77,814; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As disclosed in the summary compensation table on page 42 the annual total compensation of our President and CEO
for purposes of determining the CEO Pay Ratio was $8,896,392; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">based on this information, for FY2019, the ratio of the annual total compensation of our President and CEO, to
the median of the annual total compensation of all other U.S. employees was estimated to be 114 to 1. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This pay ratio is
a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records and the methodologies prescribed by the SEC. The SEC rules for identifying the median compensated employee and calculating the pay
ratio based on that employee&#146;s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. Using
consistently applied measures, we did not make any assumptions, adjustments or estimates with respect to base pay and we did not annualize compensation for any employee not employed for the entire year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the flexibility afforded by the rules of the SEC in calculating the pay ratio amount, the ratio calculated may not be comparable to the
CEO pay ratio presented by other companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Fiscal Year 2019 Named Executive Officer Compensation </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Elements of our Compensation Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation program for our executive officers consists principally of a base salary, an annual cash incentive bonus, long-term
compensation in the form of a three-year cash incentive bonus award and equity incentive compensation in the form of restricted stock units with a performance-based factor applicable to our NEOs. We believe that these elements of our compensation
strike an appropriate balance to incentivize and reward our executive officers for ongoing, short- and long-term performance. An annual base salary provides the foundation of our compensation program and ensures that the executive officer is being
paid ongoing compensation, which allows us to attract and retain high-quality talent. The annual cash incentive bonus forms an important part of our compensation strategy by providing an incentive to reward short-term performance as measured by
Company performance and accomplishment of Individual MBOs. The long-term cash incentive bonus awards and equity incentive compensation also form an important part of our compensation strategy. These incentive bonus awards and equity grants reward
our executive officers for the long-term performance of Myriad, and help to ensure that our executive officers have a stake in our long-term success by providing an incentive to improve our overall growth and value. For example, under our long-term
cash incentive awards, performance metrics are measured by achieving three-year financial performance targets reflecting growth of revenue, diversifying revenues and improving operating margins. These performance metrics align with our strategic
goals and objectives and thus aligns the executive officers&#146; interests with stockholders&#146; long-term interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation
Committee, in collaboration with management, attempts to develop an overall compensation program that incentivizes the executive officers to achieve their objectives without encouraging them to take excessive risks to the business. We believe that
this is accomplished through the balance of the various elements of our compensation program, including the establishment of annual MBOs for each of the executive officers to appropriately guide their performance objectives, establishment of preset
annual and three-year growth financial performance targets, and preset limits on cash incentive compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Formulating and Setting
Executive Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is responsible for formulating, evaluating and approving the compensation, including
the award of equity compensation, for our executive officers, including our President and CEO. The Compensation Committee also assists the full board in establishing appropriate incentive compensation and equity-based plans generally for all
employees and is responsible for administering these plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2019, the Compensation Committee retained Mercer for the purpose of updating our
peer group of companies and to provide competitive market data on the salary, short-term incentive compensation and long-term incentive compensation of executive officers at comparable companies within our industry. The Compensation Committee uses
this competitive market data on compensation in determining annual salary compensation, short-term (annual) incentive compensation and long-term incentive compensation (both cash and equity incentive compensation) for the President and CEO and other
executive officers of the Company (the &#147;2019 Mercer Executive Compensation Review&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a basis for the source market data for
the 2019 Mercer Executive Compensation Review, Mercer utilized compensation data from the following group of 13 peer companies. Mercer recommended that we retain 11 companies from last year&#146;s peer group and added two new companies. We believe
the selected peer group of companies reflects our industry and aligns with the ISS and Glass Lewis selected peer group for Myriad. Presently, 11 of the 13 companies in our peer group are companies which were selected by ISS as part of ISS&#146;s
compensation pay review from last year, and 6 of the 13 companies in our peer group of companies are companies selected by Glass Lewis as part of Glass Lewis&#146; compensation pay review from last year. Only one of the 13 companies in our peer
group were not in either the ISS or Glass Lewis peer group from last year. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ABIOMED, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Acorda Therapeutics, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Alkermes plc</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BioMarin Pharmaceutical Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Exact Sciences Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Exelixis Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Genomic Health, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jazz Pharmaceuticals plc</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">lncyte Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">lonis Pharmaceuticals, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NuVasive, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Seattle Genetics, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">United Therapeutics Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Mercer gathered competitive market data from published survey data in the biotech industry
for similarly sized entities as reflected in the 2018 Mercer US Global Premium Executive Remuneration Suite and the 2019 Radford Global Life Sciences Survey. To determine competitive market compensation, where possible, composite survey data were
equally blended with the proxy data from our peer group set forth above. Compensation data for the peer group were collected from available proxy-disclosed data. This information was gathered and analyzed for the 25th, 50th and 75th percentiles for
annual salary, short-term incentive pay elements and long-term incentive pay elements. Where possible, our executive officers were matched to appropriate proxy and survey positions based on job content and level of responsibility. Proxy-based and
survey-based salaries were aged to 2019 at an annual rate of 3.5&nbsp;percent, the average 2018/2019 salary increase for executives in the U.S. Restricted stock units were valued at fair market value (the closing price of our common stock) on the
date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the compensation information obtained from the 2019 Mercer Executive Compensation Review provides us
appropriate compensation data and benchmarks, because it is derived from companies that are in our industry, share similar corporate structures, and have similar factors such as number of employees, market value, revenues, net income, product
pipeline and gross margins. Through Mercer, we have selected those companies that we believe represent the various factors of our business as outlined above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilizing the composite peer group data provided to us in the 2019 Mercer Executive Compensation Review, the Compensation Committee analyzed,
among other criteria, the average salary, short-term incentive bonus compensation and long-term incentive bonus compensation (both cash and equity compensation) for each of our executive officers at the 25<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>,<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile ranges. In
addition, for long-term incentive equity compensation, the Compensation Committee analyzed, among other criteria, the average equity compensation for each of our executive officers at the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>,<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile range from the Mercer composite compensation data. The Compensation
Committee also analyzed our equity burn rate, issued equity overhang, total equity overhang and stockholder value transfer.&nbsp;&nbsp;&nbsp;&nbsp;Finally, the Compensation Committee considered the number of restricted stock units awarded to
executive officers as a group, as compared to all restricted stock units awarded. In so doing, the Compensation Committee noted that it anticipates that this ratio will become increasingly weighted towards overall employees based upon recent
initiatives to increase equity ownership among a broader set of Myriad employees. For example, all company employees with management roles now receive stock based compensation and all employees ranked as
<FONT STYLE="white-space:nowrap">top-25&nbsp;percent</FONT> employees receive a small equity grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has
approved a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> philosophy for the compensation of our executive officers that is intended, in general, to provide base salary, bonus and total
compensation within the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of comparable companies in our industry. However, we may award compensation above the 75<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> percentile when deemed appropriate to further promote and achieve the primary objectives of our compensation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
programs. The comparable group of companies on which we rely to corroborate our determinations are those represented by the peer groups utilized in the Mercer Executive Compensation Review and
those that participated in the industry survey reports used by Mercer. Within the scope of this <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> philosophy, we have determined the various components
of each executive&#146;s compensation package based on various factors, including: the executive&#146;s particular background, training and relevant work experience; the executive&#146;s role and responsibilities and the compensation paid to similar
persons in comparable companies represented in the compensation data that we utilized; the demand for individuals with the executive&#146;s specific talents and expertise and our ability to attract and retain comparable talent; Individual MBOs; the
other expectations of the executive for the position; and the comparison to other executives within our Company having similar skills and experience levels and responsibilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Base Salary </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each year we
evaluate base salaries as part of our management performance program, and establish each executive&#146;s base salary for the ensuing year. In establishing base salaries, we assess the executive officer&#146;s performance in each of the areas in
which individual MBOs were established, the financial performance of the Company in the areas of responsibility of the executive officer, the overall financial performance of the Company, the experience of the executive, the executive&#146;s role
and responsibilities and particular background, and other significant accomplishments and contributions of the executive officer. An executive&#146;s base salary is also evaluated together with other components of the executive&#146;s compensation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2019, the base salary of our President and CEO and CFO and Treasurer and our named executive officers were increased by
an average of 4.4% and all were between the 50 to 75&nbsp;percent range of our peer group. For fiscal year 2020, the base salary of our President and CEO and CFO and Treasurer, and our named executive officers were increased by an average of 3.5%
and all were between the 50 to 75&nbsp;percent range of our peer group. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;2020</B><br><B>Base&nbsp;Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;2019</B><br><B>Base&nbsp;Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%<BR>Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone<BR>President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">918,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">887,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford<BR>President, Myriad Women&#146;s Health, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">519,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee<BR>Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">483,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">466,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.<BR>Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">526,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh(1)<BR>Executive Vice President, General Counsel and Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Richard Marsh retired from the Company effective July&nbsp;1, 2019. As such, he did not receive any salary
increase and, apart from consulting fees, will not receive a salary in FY2020. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that increasing our executive
officers&#146; base salary for FY 2020 reflects the commitment and contribution of the executive officers to our goal of increasing our operating profitability, while being set at a level that appropriately attracts and retains key talent necessary
to support the continued growth of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Annual Cash Incentive Bonus </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual cash incentive bonus amount is determined as part of our management performance program. As a part of this review, we assess the
executive officer&#146;s performance in each of the areas in which Individual MBOs were established, our financial performance in the areas of responsibility of the executive officer, our overall financial performance and other significant
accomplishments and contributions of the executive officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2019, for purposes of determining the annual cash incentive bonuses paid to our
executive officers including our President and CEO, the Compensation Committee used a formulaic approach, based on a target incentive bonus as a percentage of base salary determined in early fiscal year 2019, Company performance, and the achievement
of Individual MBOs. The target incentive bonus as a percentage of base salary for each executive officer (other than our President and CEO) ranged from 45 to 60&nbsp;percent, depending on the responsibilities and experience of the executive officer,
and was based on the target incentive bonus percentage from our peer group for each of the individual executive officers. For our President and CEO the target incentive bonus as a percentage of base salary was 100&nbsp;percent. The annual cash
incentive bonus amount for each executive officer and our President and CEO was then determined based on the following formula: annual base salary of the executive officer times (a)&nbsp;the executive officer&#146;s applicable target incentive bonus
percentage, times (b)&nbsp;the executive officer&#146;s performance goals score (based on degree of accomplishment of individual MBOs as determined by the Compensation Committee), and times (c)&nbsp;a Company multiplier based on the Company&#146;s
adjusted operating income. The annual cash bonus amount is capped by the Company multiplier, and, as a percentage, can never exceed 130&nbsp;percent of the executive officer&#146;s applicable target incentive bonus percentage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2019, we achieved adjusted operating income of $145.2&nbsp;million and based on these financial results, the Compensation
Committee determined that the company multiplier applicable to each executive officer had been achieved at the 90&nbsp;percent level. Each executive officer was then scored on his or her individual MBOs, as discussed below for our NEOs under
&#147;<I>Named Executive Officer Performance for Fiscal 2019&#148;</I>. The MBO Performance Goals Score for the executive officer group ranged from 90 to 98&nbsp;percent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee determined the annual cash incentive bonuses for our NEOs for fiscal year 2019 as set forth in the chart below.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman; "><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Incentive<BR>Bonus&nbsp;(as&nbsp;a&nbsp;%&nbsp;of<BR>Fiscal 2019 Base<BR>Salary)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>MBO<BR>Performance<BR>Goals Score<BR>(as a %)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Company<BR>Multiplier<BR>(as a %)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Performance</B><br><B>Factor</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;2019<BR>Bonus</B><br><B>Payment<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone<BR>President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">742,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford<BR>President, Myriad Women&#146;s Health, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">257,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee<BR>Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.<BR>Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh<BR>EVP, General Counsel and Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that this cash incentive bonus compensation is appropriate based on the performance of the
executive officer group for fiscal year 2019. The Compensation Committee believed the financial performance targets set for our annual cash incentive bonuses for our NEOs to be challenging, without any guarantee that the performance targets could be
accomplished. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2020, the Compensation Committee has decided to utilize the same comparable
formulaic approach for determining the annual cash incentive bonus for executive officers as used for fiscal year 2019. The Compensation Committee established the following target incentive bonus percentages for our NEOs which will be used in
determining annual cash incentive bonus amounts for fiscal year 2019 performance. These are unchanged from the targets established for fiscal year 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive Officer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Incentive&nbsp;Bonus<BR>(% of base salary for<BR>Fiscal Year 2020)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone<BR>President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford<BR>President, Myriad Genetic Laboratories, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee<BR>Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury<BR>Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh(1)<BR>EVP, General Counsel and Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Richard Marsh retired from the Company effective July&nbsp;1, 2019. As such, he will not receive any bonus for
FY2020. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Long-Term Incentive Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To incentivize and reward long-term performance by our executives, we currently provide two forms of long-term incentive compensation: a
three-year cash incentive bonus and the award of restricted stock units. These cash and equity-based incentive awards help ensure that our executive officers have a stake in our long-term success by providing an incentive to improve the overall
growth and value of Myriad. We believe that this fosters an executive culture that aligns our officers&#146; interests with the long-term interests of our stockholders. The Compensation Committee determines the terms of all equity incentive awards
for our NEOs, including our President and CEO. Beginning in fiscal year 2015, we granted our employees, executive officers and Board restricted stock units rather than stock options in order to reduce the dilutive effect of our equity compensation
program.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Three-Year Cash Incentive Bonus</U>. In December 2012, the Compensation Committee established a
long-term cash incentive bonus program for our executive officers based on predetermined, objective financial formula-based performance targets to be accomplished at the end of the third ensuing fiscal year. For any amount to be paid, the minimum
predetermined financial metric thresholds must be surpassed; otherwise, no bonus amount will be paid. As reflected in the following table, the financial metrics for these payouts are reviewed and determined when each three-year award is established.
The three-year incentive bonus award amount is based on a target bonus amount as a percentage of base salary of 20&nbsp;percent for our President and CEO and 15&nbsp;percent for our other executive officers. For all executive officers, the target
bonus percentage and bonus amount is capped at 150% of the target bonus. Based on the Company&#146;s financial performance, we have only made a payout under our long-term cash incentive bonus program for the three-year performance period ending with
FY2015 and FY2019. For the other three-year performance periods ending in FY2016, FY2017, and FY2018, none of the target thresholds were achieved, so no payouts were made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes each of the three-year cash incentive awards established for our
executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Award</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three-Year</B><br><B>Performance</B><br><B>Period</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Performance Criteria</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Payout Under Plan</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">December 2012</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">FY&nbsp;2013-2015</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%), EBITDA (25%) and EPS (25%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Payout at 47.55% of Target Award</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2013</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY 2014-2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%) and EBITDA (50%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No Payout</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2014</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY&nbsp;2015-2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%) and Net Income (50%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No Payout</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY 2016-2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%) and EBITDA (50%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">No Payout</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY 2017-2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%), Adjusted Operating Margin (25%)<BR>and Diversification of Product Revenue (25%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Payout at 34% of Target Award</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY 2018-2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%), Adjusted Operating Margin (25%)<BR>and Diversification of Product Revenue (25%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">TBD</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY 2019-2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%), Adjusted Operating Margin (25%)<BR>and Diversification of Product Revenue (25%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">TBD</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FY 2020-2022</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Revenue (50%), Adjusted Operating Margin (25%)<BR>and Diversification of Product Revenue (25%)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">TBD</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the three-year cash incentive bonus adds an additional long-term incentive metric to motivate
our executives to achieve financial metrics and operational goals, which will benefit long-term shareholder value. In particular, the recent performance objectives tied to adjusted operating margin and diversification of our product revenues are
aligned with our announced strategic, long-term goals. The Compensation Committee believes the financial performance targets to be challenging, without any guarantee that the performance targets could be accomplished, in light of growing
operational, reimbursement and competitive factors which may adversely affect the Company&#146;s financial performance. Thus, the performance targets are set at a level that, if obtained, the Company would have accomplished strong financial
performance. The three-year cash incentive bonus awards made to our NEOs in fiscal year 2019, and the maximum amount payable under these awards, are reported in the table for 2019 Fiscal Year Grants of Plan Based Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Initial Equity Awards</U>. Executives who join us, who are granted equity, are granted restricted stock unit awards. The amount of the
initial restricted stock unit award is determined based on the executive&#146;s position and analysis of the competitive practices of the companies similar in size as represented in the compensation data that we review with the goal of creating a
total compensation package for new executives that is competitive with other similar companies and that will enable us to attract high quality management personnel. <FONT STYLE="white-space:nowrap">One-fourth</FONT> of each initial equity award will
vest on an annual basis over four-plus years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Annual Equity Incentive Awards</U>. In response to consistent comments from our
stockholders, we will continue to issue long-term equity incentive compensation grants in restricted stock units with <FONT STYLE="white-space:nowrap">one-fourth</FONT> of the units granted vesting on an annual basis over four-plus years.
Additionally, for our NEOs, the restricted stock units awarded are subject to achievement of a predetermined, formula-based, financial target that must be achieved in order for the award to commence vesting. Thus, for our NEOs, the actual number of
restricted stock units earned will be determined based on the percentage achievement of the predetermined financial target with no award being earned if the minimum threshold is not achieved; thereafter, and only if the minimum threshold has been
achieved, vesting of the award is based on the NEO&#146;s continued employment with us. In determining the amount of equity compensation to be awarded, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Compensation Committee will consider various factors, including our financial and operating performance for the applicable period; the executive officer&#146;s contribution to our
performance; the anticipated contribution of the executive officer to our future performance; the accomplishments of the executive officer as measured by achievement of MBOs; a review of compensation for comparable positions in our peer group from
our benchmarking studies; and the total compensation of the executive officer and the anticipated retentive effect of the grant of additional equity compensation. We also take into consideration the total number of our outstanding shares of our
common stock, the relative dilution to stockholders, as well as our gross equity burn rate, issued equity overhang and total equity overhang. The size of the restricted stock unit award generally increases as the rank and responsibilities of the
executive officer increases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock unit awards are made once a year at our Compensation Committee meeting held in connection
with the Board of Director meetings generally in September. The Board customarily determines the dates of its meetings for the ensuing year at a meeting of the Board in the preceding year. Thus, the dates on which equity compensation is granted are
set well in advance. The Compensation Committee does not time the grant of equity compensation with respect to the release of material nonpublic information, whether or not that information may favorably or unfavorably impact the price of our common
stock. Restricted stock unit awards for the executive officers, including our President and CEO, are approved by the Compensation Committee.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the 2019 Mercer Executive Compensation Review, which calculated market annual guidelines at the 50th and 75th percentile, the
long-term incentive value of the annual restricted stock unit awards made on September&nbsp;19, 2018, based on fiscal year 2018 performance, to our executive officers were generally between the 50th and 75<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> percentile. For our NEOs, it was determined that, based on our revenues for fiscal year 2019, that the financial performance metric for fiscal year 2019 associated with the grant of these restricted
stock units was achieved at the 95&nbsp;percent threshold; hence, there was a reduction in the number of restricted stock units originally awarded to our NEOs. The long-term incentive value of the annual restricted stock unit awards made to our NEOs
in fiscal year 2019 is reported in the table for 2019 Fiscal Year Grants of Plan Based Awards and was determined at their grant date fair value calculated in accordance with ASC Topic 718 based on achieving 95&nbsp;percent of the award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We felt the RSU award levels were appropriate based on the comparative long-term peer group compensation data from the 2019 Mercer Executive
Compensation Review, given the Company&#146;s performance relative to its peers, the individual accomplishments of our NEOs during fiscal year 2018, including our President and CEO, relative to their MBOs and our goal of continuing to place an
increased weighting of compensation on long term equity compensation. We also believe these equity awards are consistent with our goal of placing our president and CEO and CFO in the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>-75<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> percentile, and are appropriate based upon the Company&#146;s financial performance. Thus, these equity awards appropriately reward our executives for their consistent past performance, and
incentivize our executives to work hard to continue to deliver similar performance and to remain employed at the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Compensation Objectives
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary objectives of our Compensation Committee in establishing and maintaining our executive compensation programs are to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Attract and retain the best possible executive talent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Motivate our executive officers to enhance our growth and profitability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increase long-term stockholder value; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reward the executive officers for their contribution to our growth, profitability and increased stockholder value
through the recognition of individual leadership, initiatives, achievements and other contributions. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The specific
directives of the Compensation Committee are to provide appropriate short and long-term compensation and incentives, in the form of cash and equity, that motivate and reward the accomplishment of individual and corporate objectives and that align
executive officer compensation with the creation of stockholder value. To achieve these objectives, the Compensation Committee has adopted and implemented a compensation plan that bases our executive officers&#146; compensation on a variety of
factors set forth in MBOs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Establishment and Use of Management Business Objectives </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has implemented an annual management performance program for the purpose of establishing annual performance
objectives for our executive officers to align their performance with the overall goals and objectives for the Company. This process commences in the fourth quarter of each fiscal year as each executive officer meets with our President and CEO to
establish annual MBOs for the ensuing fiscal year. After review and discussion, the President and CEO finalizes the executive officer&#146;s MBOs for the ensuing fiscal year. Similarly, our President and CEO meets with the Compensation Committee at
the end of each fiscal year to establish his MBOs for the ensuing fiscal year which, after review and discussion, are finalized by the Compensation Committee. On September&nbsp;25, 2019, the Compensation Committee approved all fiscal year 2020 MBOs
for our executive officers. During the fiscal year, additional MBOs may be established and assigned to an executive officer, including our President and CEO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the end of the ensuing fiscal year, each executive officer&#146;s performance for the fiscal year is reviewed, including an assessment by
management and the Compensation Committee of the achievement of each executive officer&#146;s respective MBOs. At this time, the President and CEO calculates and recommends to the Compensation Committee an annual cash incentive bonus amount and
salary adjustment for the executive officers, other than himself. The Compensation Committee, after further review and discussion with our President and CEO, then determines the annual cash incentive bonus for the concluding fiscal year and base
salary amount for the ensuing fiscal year for the executive officers, other than the President and CEO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of our President and
CEO, the Compensation Committee makes its review and determinations for the President and CEO&#146;s salary and annual cash incentive compensation without any recommendations from our President and CEO, who is not present in any portions of the
meetings of the Compensation Committee where his compensation is calculated, discussed and approved. At the end of the fiscal year, the Compensation Committee determines the annual salary amount of our President and CEO for the ensuing fiscal year.
The annual cash incentive bonus for our President and CEO is based on the accomplishment of his performance metrics as previously determined by our Compensation Committee as measured against our final, audited financial statements for the fiscal
year. In determining the annual cash incentive bonus amount, the Compensation Committee also reviews and discusses the accomplishment of the President and CEO&#146;s MBOs for the fiscal year in determining whether any reductions of the annual
incentive bonus amount is appropriate. The annual cash incentive bonus amount, salary adjustments, and long-term incentive compensation for our President and CEO are reported to the independent members of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The MBOs for each executive officer for each fiscal year consist of individual objectives tailored to each executive. As applicable, each
executive officer may also be given one or more <FONT STYLE="white-space:nowrap">pre-established</FONT> financial performance targets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The MBOs for our NEOs for fiscal year 2019 were as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mark C. Capone, President and CEO</B> &#151; manage the Company to achieve designated financial targets for total revenues and adjusted
operating income for fiscal year 2019; achieve financial targets for increased revenue potential resulting from new reimbursement coverage decisions; achieve designated milestones to advance the Company&#146;s product pipeline; and achieve Elevate
2020 projects to increased operating income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Alexander Ford, President Myriad Women&#146;s Health, Inc. &#151;</B> achieve designated
financial targets for Myriad Women&#146;s Health for total revenue and adjusted operating income in fiscal year 2019; complete the integration of Myriad Women&#146;s Health to achieve designated financial targets; achieve financial targets for
increased revenue potential resulting from new reimbursement coverage decisions pertaining to Myriad Women&#146;s Health products; complete the integration of Myriad&#146;s hereditary cancer tests with Counsyl by a designated timeline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>R. Bryan Riggsbee,</B> <B>Chief Financial Officer and Treasurer</B> &#151; manage the Company to achieve designated financial targets for
total revenues and adjusted operating income for fiscal year 2019; lead the integration of Myriad Women&#146;s Health to achieve designated financial synergies and financial targets; oversee Elevate 2020 cost reduction or revenue enhancement
initiatives to deliver increased operating income and achieve designated financial target for cost savings; improve Company productivity to achieve designated financial cost savings target; and continued management of Enterprise Risk Management
function. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Jerry S. Lanchbury, Ph.D., Chief Scientific Officer</B> &#151; develop and validate new technologies for operations;
complete designated clinical studies; and complete development of designated new products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Richard M. Marsh, EVP, General Counsel and
Secretary </B>&#151; organize new compliance department and lead implementation of the program; provide legal support for key company integration and strategic initiatives; provide intellectual property support for new pipeline products; and
implement new contract management system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Named Executive Officer Performance for Fiscal 2019 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">President and CEO: Based on our financial results for fiscal year 2019, and the degree of accomplishment of Individual MBOs, the Compensation
Committee determined that Mr.&nbsp;Capone achieved a Total Performance Factor of 84% for determining his annual cash incentive bonus. As part of this determination, the Compensation Committee noted the attainment of additional reimbursement coverage
for new products, key advancements in our product pipeline, and increased operating income attributable to implementation of Elevate 2020 initiatives. Additionally, the Compensation Committee noted, under Mr.&nbsp;Capone&#146;s supervision, the
accomplishments of the Company as discussed above under the caption: &#147;<I>Fiscal Year 2019 Performance</I>.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other Named
Executive Officers. The Compensation Committee determined that the other NEOs had substantially accomplished their respective Individual MBOs based on the accomplishments of the Company as discussed above under the caption: &#147;<I>Fiscal Year 2019
Performance</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of Management in Our Compensation Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management, including our President and CEO, supports the Compensation Committee, attends portions of its meetings upon request, and
performs various administrative functions at its request. Our President and CEO provides input to the Compensation Committee on the effectiveness of our compensation program and makes specific recommendations as to the base salary amounts, annual
cash incentive bonus amounts, long-term cash incentive bonus awards and equity incentive awards for the executive officers, other than for himself. At the end of each fiscal year, our President and CEO evaluates the annual performance of each of our
executive officers, including an assessment of the accomplishment of each executive officer&#146;s MBOs, and submits his calculations and recommendations to the Compensation Committee which then determines an annual cash incentive bonus amount for
the concluding fiscal year, the base salary amount for the ensuing fiscal year and long term equity incentive compensation for each of the executive officers. Except for our President and CEO, no executive officer is present when the Compensation
Committee discusses and determines the salary and bonus amounts and equity compensation to be awarded to the executive officers. Our President and CEO is excused from all meetings, and is not present, where matters pertaining to his compensation are
determined and approved by the Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain broad-based benefits that are provided to all employees, including health and dental insurance, life and disability insurance, a
401(k) plan, and a discretionary December holiday bonus. Additionally, we may provide other benefits to new executive officers such as a relocation package or other related compensation as determined on a
<FONT STYLE="white-space:nowrap">case-by-case</FONT> basis. We may also provide certain compensation benefits in connection with the retirement of our executive officers based on their accomplishments and tenure of employment with us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-of-Control-Based</FONT></FONT> Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize that, as is the case with many publicly-held corporations, the possibility of a change in control of the Company exists and that
such possibility, and the uncertainty and questions which it may raise among key personnel, may result in the departure or distraction of key personnel to the detriment of us and our stockholders. Therefore, we have entered into a retention
agreement with each of our executive officers to reinforce and encourage the continued employment and dedication of our executive officers without distraction from the possibility of a change in control of the Company and related events and
circumstances. We believe that the terms of our retention agreement are consistent with those historically maintained by others in our industry and therefore are important for attracting and retaining key employees who are critical to our long-term
success. The potential benefits provided under the retention agreement are in addition to the current compensation arrangements we have with our executive officers. In September 2015 in response to shareholder concerns, we entered into amendment to
these retention agreement with our executive officers in order to eliminate the tax <FONT STYLE="white-space:nowrap">gross-up</FONT> set forth therein that allowed for payments to be made by the Company to the executive officers to offset any excise
taxes incurred by the executive officer in the event that any change of control payments are subject to excise tax under Section&nbsp;4999 of the Internal Revenue Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the payments each of our NEOs is entitled to receive upon a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">change-in-control</FONT></FONT> see &#147;Executive Compensation &#151; Potential Payments Upon Termination or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control&#148;</FONT></FONT> later
in this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Relationship of Elements of Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, our compensation structure is primarily comprised of a base salary, an annual cash incentive bonus, long-term incentive
compensation in the form of a three-year cash incentive bonus award and equity incentive awards. In setting executive compensation, the Compensation Committee considers the aggregate compensation payable to an executive officer and the form of the
compensation. The Compensation Committee seeks to achieve an appropriate balance between immediate cash rewards and long-term financial incentives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We utilize long-term equity incentive compensation in the form of restricted stock units as a substantial component of compensation (prior to
fiscal year 2015 we utilized stock options). The Compensation Committee views the award of restricted stock units as a primary long-term retention benefit by tying the earning of these awards to a vesting schedule that will be over a period greater
than four years for full vesting of restricted stock units. If an employee leaves the Company before the completion of the vesting period, then that employee will not be entitled to any benefit from the
<FONT STYLE="white-space:nowrap">non-vested</FONT> portion of the award. Additionally, for our NEOs, the restricted stock unit award also has a performance metric that, if not met, would require the NEO to forfeit a portion up to the entire
restricted stock unit award regardless of the additional requirement of vesting. We believe that this vesting feature makes it more attractive to remain as our employee and this arrangement does not require substantial cash payments by the Company.
Similarly, our three-year cash incentive bonus awards promote long-term performance by establishing significant growth performance targets that must be met over a three-year period. This long-term cash incentive bonus also promotes retention of our
executives as no payment is made under our three-year cash incentive bonus awards if the executive officer is not employed on the last day of the three-year performance period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee reviews from time to time the mix of the compensation elements for executive officers against comparable companies
in our industry as represented in the compensation data we utilize. The size and mix of each element in a compensation package is based on the impact of the position on the Company, market practice and overall corporate and individual performance
relative to stated corporate goals. The level of incentive compensation typically increases in relation to an executive officer&#146;s responsibilities and ability to meet individual and corporate goals. The Compensation Committee believes that
making a significant portion of an executive officer&#146;s compensation contingent on corporate performance more closely aligns the executive officer&#146;s interests with those of our stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conclusion </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation policies are
designed and are continually being developed to retain and motivate our executive officers and to ultimately reward them for outstanding individual and corporate performance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
table shows the total compensation paid or accrued during the fiscal years indicated to (1)&nbsp;our President and Chief Executive Officer, (2)&nbsp;our Chief Financial Officer, and (3)&nbsp;our three next most highly compensated executive officers
who earned more than $100,000 during the fiscal year ended June&nbsp;30, 2019 and were serving as executive officers as of June&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards ($)<BR>(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan<BR>Compensation<BR>($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($) (3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">887,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,177,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">802,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,896,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Officer and Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">852,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,374,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">817,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,054,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">852,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,613,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">741,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,217,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">519,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,392,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">293,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,231,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Myriad Genetic Laboratories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">499,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,954,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">296,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,760,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">499,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,314,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,069,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">466,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,392,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">260,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,138,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,954,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">254,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,645,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,314,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,985,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,914,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,685,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,628,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,377,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,095,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,814,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,914,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,667,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, General</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,628,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,367,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counsel and Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,095,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,822,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown reflect the aggregate grant date fair value of restricted stock unit awards granted in each year
presented calculated in accordance with FASB ASC Topic 718. Amounts reflect the maximum potential value of each award assuming the highest level of performance associated with the award and are based on the closing price of our common stock on the
Nasdaq Global Market on the date of grant of the award. For fiscal year 2019, based on our achievement of the applicable performance criteria established on the grant date for these restricted stock unit awards were awarded at 95&nbsp;percent of the
prior grant level. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For Mr.&nbsp;Capone, for fiscal years 2017-2018, the amounts reported in this column reflect the actual cash
awards paid under our 2013 Executive Incentive Plan to Mr.&nbsp;Capone pursuant to his annual cash incentive bonus award, calculated based on measurement against plan metrics and performance results for fiscal years 2016-2017. For fiscal year 2019,
the amounts reported in this column reflect the actual annual cash incentive awards paid. For all other NEOs, for fiscal years 2017-2019, the amounts reported in this column reflect the actual annual cash incentive awards paid. No payment was made
under our long-term, three-year cash incentive bonus plan which concluded in fiscal years 2017-2018 as our performance goals for that plan were not achieved. For fiscal year 2019 cash payments under the three-year cash incentive bonus plan were paid
out at 34&nbsp;percent of the target. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All amounts shown for fiscal year 2019 consist of an average of $307.87 per year of premiums paid by us with
respect to term life insurance for the benefit of each NEO for their respective periods served and the balance of the amount shown for matching contributions made under our 401(k) plan on behalf of each NEO. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2019 Fiscal Year Grants of Plan-Based Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables show information regarding grants of <FONT STYLE="white-space:nowrap">non-equity</FONT> and equity awards that we made
during the fiscal year ended June&nbsp;30, 2019<B> </B>to each of the executive officers named in the Summary Compensation Table. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future Payouts Under<BR><FONT STYLE="white-space:nowrap">Non-Equity&nbsp;Incentive&nbsp;Plan&nbsp;Awards&nbsp;($)&nbsp;(1)</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future<BR>Payouts Under Equity<BR>Incentive Plan<BR>Awards (#)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date<BR>Fair Value<BR>of Stock<BR>and Option<BR>Awards<BR>($)(3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/19/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,177,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">FY21&nbsp;3-YR&nbsp;Award</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/19/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,392,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY21 <FONT STYLE="white-space:nowrap">3-YR</FONT> Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/19/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,392,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY21 <FONT STYLE="white-space:nowrap">3-YR</FONT> Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/19/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,914,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY21 <FONT STYLE="white-space:nowrap">3-YR</FONT> Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/19/2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,914,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY21 <FONT STYLE="white-space:nowrap">3-YR</FONT> Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts represent the threshold, target, and maximum amounts awarded to our NEOs under our Three-Year Cash
Incentive Bonus Plan for fiscal years 2019-2021. The metrics against which performance is to be measured are discussed in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2019 Named Executive Officer Compensation- Long
Term Incentive Awards Three Year Cash Incentive Bonus Plan.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts represent the threshold and target (which is the maximum) number of our shares that may be awarded
with respect to the restricted stock unit awards made to our NEOs on September&nbsp;19, 2018. Based on our achievement of the revenue performance criteria established on the grant date for these awards, the number of shares underlying these
restricted stock units were awarded at the 95&nbsp;percent threshold. These shares vest <FONT STYLE="white-space:nowrap">one-fourth</FONT> per year beginning September&nbsp;26, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts represent the grant date fair value calculated in accordance with FASB ASC Topic 718 and are based
on the closing price of our common stock on the Nasdaq Global Market on September 19, 2018 of $47.85. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Richard Marsh retired from the Company effective July&nbsp;1, 2019. As such, (a)&nbsp;he will not receive any
payment under the FY21 <FONT STYLE="white-space:nowrap">3-YR</FONT> Award (or any subsequent <FONT STYLE="white-space:nowrap">3-YR</FONT> Awards) and (b)&nbsp;no further shares granted to him under any equity incentive plan awards will vest after
December&nbsp;31, 2019. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative Disclosure to Summary Compensation Table and 2019 Fiscal Year Grants of Plan-Based Awards Table
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into standard form employment agreements with no defined term with each of our NEOs. Pursuant to these agreements,
either party may terminate employment without cause at any time upon a specified period of written notice to the other party or immediately with cause upon written notice to the other party. Each employment agreement also provides that the employee
will not disclose confidential information of ours during and after employment and will not compete with us during the term of employment. Since the dates of these agreements entered into with our NEOs, the compensation paid to each NEO has been
increased and equity awards have been granted, the most recent of which are as discussed below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Previously, we have entered into an Executive Retention Agreement with each of our NEOs under
which they are entitled to certain benefits upon a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> as discussed below under &#147;Executive Compensation &#151; Potential Payments Upon Termination or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control.&#148;</FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Capone was appointed to
the position of President and CEO of the Company beginning July&nbsp;1, 2015. He had previously entered into the Company&#146;s standard form of employment agreement when he was initially hired by the Company in October 2002 as the Vice President of
Sales for MGL. Thereafter, in September 2005, he was appointed to the position of Senior Vice President of Sales for MGL. In February 2006, he was appointed to the position of Chief Operating Officer for MGL, and then in March 2010 he was appointed
President of MGL. As determined by our Compensation Committee, he received an annual salary of $887,000 for the fiscal year ended June&nbsp;30, 2019. Mr.&nbsp;Capone will be paid an annual base salary of $918,045 as our President and CEO for the
fiscal year ending June&nbsp;30, 2020. His annual cash incentive bonus for fiscal 2019 was $742,419 as approved by our Compensation Committee based on the level of achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> performance
goals. Additionally, in September 2018, the Compensation Committee approved a three-year cash incentive award under our 2013 Executive Incentive Plan pursuant to which Mr.&nbsp;Capone will be entitled to receive up to $266,100 as of the end of
fiscal 2021 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2019 Named Executive Officer Compensation &#151; Long-Term Incentive Awards &#151; Three-Year Cash
Incentive Bonus.&#148;<I> </I>On September&nbsp;19, 2018, Mr.&nbsp;Capone was granted a restricted stock unit award of 150,000 shares of the Company, subject to time-based and performance-based vesting requirements. Based on the level of
accomplishment of the performance-based metric for fiscal 2019, the restricted stock unit award was reduced to 95&nbsp;percent of the original grant or 142,500 shares. On September&nbsp;25, 2019, he was granted a restricted stock unit award of
150,000 shares of the Company, subject to time-based and performance-based vesting requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Ford was appointed President of
Myriad Women&#146;s Health, Inc. beginning August&nbsp;1, 2018. He had previously entered into the Company&#146;s standard form of employment agreement when he was initially hired by the Company in June 2010 as the Vice President of Sales for MGL.
Thereafter, in July 2011, he was appointed to the position of GM Preventative Care, and thereafter as MGL&#146;s Chief Commercial Officer in January 2013. Thereafter he was appointed as President of MGL until 2018. As determined by our Compensation
Committee, Mr.&nbsp;Ford received an annual salary of $519,168 for the fiscal year ended June&nbsp;30, 2019, and will be paid an annual base salary of $537,000 for the fiscal year ending June&nbsp;30, 2020. His annual cash incentive bonus for fiscal
2019 was $257,923 as determined by our Compensation Committee. Additionally, in September 2018, the Compensation Committee approved a three-year cash incentive award under our 2013 Executive Incentive Plan pursuant to which Mr.&nbsp;Ford will be
entitled to receive up to $116,812 as of the end of fiscal 2021 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2019 Named Executive Officer Compensation &#151;
Long-Term Incentive Awards &#151; Three-Year Cash Incentive Bonus.&#148; On September&nbsp;19, 2018, he was granted a restricted stock unit award of 50,000 shares of the Company, subject to time-based and performance-based vesting requirements.
Based on the level of accomplishment of the performance-based metric for fiscal 2019, the restricted stock unit award was reduced to 95&nbsp;percent of the original grant or 47,500 shares. On September&nbsp;25, 2019, Mr.&nbsp;Ford was granted a
restricted stock unit award of 50,000 shares of the Company, subject to time-based and performance-based vesting requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Riggsbee was appointed to the position of Chief Financial Officer and Treasurer in October, 2014, and entered into the Company&#146;s
standard form of employment agreement at that time. As determined by our Compensation Committee, he received an annual salary of $466,650 for the fiscal year ended June&nbsp;30, 2019. Mr.&nbsp;Riggsbee will be paid an annual base salary of $483,000
for the fiscal year ending June&nbsp;30, 2020. His annual cash incentive bonus for fiscal 2019 was $236,872 as determined by our Compensation Committee. Additionally, in September 2018, the Compensation Committee approved a three-year cash incentive
award under our 2013 Executive Incentive Plan pursuant to which Mr.&nbsp;Riggsbee will be entitled to receive up to $104,996 as of the end of fiscal 2021 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis
under the heading &#147;Fiscal Year 2019 Named Executive Officer Compensation &#151; Long-Term Incentive Awards &#151; Three-Year Cash Incentive Bonus.&#148; On September&nbsp;19, 2018, he was granted a restricted stock unit award of 50,000 shares
of the Company, subject to time-based and performance-based vesting requirements. Based on the level of accomplishment of the performance-based metric for fiscal 2019, the restricted stock unit award was reduced to 95&nbsp;percent of the original
grant or 47,500 shares. On September&nbsp;25, 2019, Mr.&nbsp;Riggsbee was granted a restricted stock unit award of 50,000 shares of the Company, subject to time-based and performance-based vesting requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Lanchbury was appointed to the position of Senior Vice President, Research in November
2002 and entered into the Company&#146;s standard form of employment agreement at that time. In September 2005, he was promoted to Executive Vice President, Research. In February 2010, Dr.&nbsp;Lanchbury was appointed Chief Scientific Officer. As
determined by our Compensation Committee, he received an annual salary of $508,595 for the fiscal year ended June&nbsp;30, 2019. Dr.&nbsp;Lanchbury will be paid an annual base salary of $526,000 for the fiscal year ending June&nbsp;30, 2020<I>.</I>
His annual cash incentive bonus for fiscal 2019 was $224,290 as determined by our Compensation Committee. Additionally, in September 2018, the Compensation Committee approved a three-year cash incentive award under our 2013 Executive Incentive Plan
pursuant to which Dr.&nbsp;Lanchbury will be entitled to receive up to $114,434 as of the end of fiscal 2021 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2019
Named Executive Officer Compensation &#151; Long-Term Incentive Awards &#151; Three-Year Cash Incentive Bonus.&#148;<I> </I>On September&nbsp;19, 2018, he was granted a restricted stock unit award of 40,000 shares of the Company, subject to
time-based and performance-based vesting requirements. Based on the level of accomplishment of the performance-based metric for fiscal 2019, the restricted stock unit award was reduced to 95&nbsp;percent of the original grant or 38,000 shares. On
September&nbsp;25, 2019, Dr.&nbsp;Lanchbury was granted a restricted stock unit award of 40,000 shares of the Company, subject to time-based and performance-based vesting requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Marsh was appointed to the position of Executive Vice President, General Counsel and Secretary in November 2002 and entered into the
Company&#146;s standard form of employment agreement at that time. In September 2005, he was promoted to Executive Vice President, General Counsel and Secretary. As determined by our Compensation Committee, Mr.&nbsp;Marsh received an annual salary
of $508,595 for the fiscal year ended June&nbsp;30, 2019. Mr.&nbsp;Marsh retired from Myriad Genetics effective July&nbsp;1, 2019 and consequently will not receive a salary as EVP General Counsel and Secretary in fiscal year 2020. On July&nbsp;1,
2019, the Company entered a <FONT STYLE="white-space:nowrap">six-month</FONT> agreement with Mr.&nbsp;Marsh under which Mr.&nbsp;Marsh agreed not to compete with the Company and will provide consultation to the Company on an <FONT
STYLE="white-space:nowrap">as-needed</FONT> basis, in return for which the Company will pay Mr.&nbsp;Marsh $20,000 per month. His annual cash incentive bonus for fiscal 2019 was $205,981 as determined by our Compensation Committee. Additionally, in
September 2018, the Compensation Committee approved a three-year cash incentive award under our 2013 Executive Incentive Plan pursuant to which Mr.&nbsp;Marsh, but for his retirement effective July&nbsp;1, 2019, would have been entitled to receive
up to $114,434 as of the end of fiscal 2021 if the Company achieves the performance goals discussed above in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2019 Named Executive Officer Compensation &#151; Long-Term
Incentive Awards &#151; Three-Year Cash Incentive Bonus.&#148;<I> </I>On September&nbsp;19, 2018, he was granted a restricted stock unit award of 40,000 shares of the Company, subject to time-based and performance-based vesting requirements. Based
on the level of accomplishment of the performance-based metric for fiscal 2019, the restricted stock unit award reduced to 95&nbsp;percent of the original grant or 38,000 shares.<I> </I>Due to his retirement from the Company effective July&nbsp;1,
2019, Mr.&nbsp;Marsh will not be eligible for any further salary, bonus, or Long-Term Incentive Awards, including the award scheduled for the end of fiscal 2021 mentioned above, and did not receive an equity grant on September&nbsp;25, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All annual restricted stock unit awards granted to our NEOs are subject to a predetermined, formula-based financial performance metric that
must be met in order for these awards to vest annually over a four-plus year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2019, the Compensation Committee
approved a three-year cash incentive award pursuant to which our executive officers and other key management members may be entitled to receive compensation at the end of fiscal year 2022 if certain predetermined performance goals are achieved.
Following are the amounts that may be earned for our NEOs for the awards under our three-year cash incentive awards: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future Payouts Under</B><br><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT> Incentive Plan Awards ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Award</B><br><B>Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">FY20-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">FY20-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">FY20-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">FY20-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">FY20-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Richard Marsh retired from the Company effective July&nbsp;1, 2019. As such, he will not receive any further
payments under any <FONT STYLE="white-space:nowrap">non-equity</FONT> incentive plan awards. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at 2019 Fiscal Year End </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the grants of stock options and restricted stock units outstanding on the last day of the fiscal year ended
June&nbsp;30, 2019, to each of our NEOs. We have not granted any stock options that are subject to performance conditions. The annual restricted stock units granted to our NEOs are subject to time and performance conditions. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="16" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option Awards&nbsp;(1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date of<BR>Grant</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B><br><B>or Units<BR>of&nbsp;Stock&nbsp;that<BR>Have not<BR>Vested<BR>(#)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;Value<BR>of Shares</B><br><B>or Units</B><br><B>of&nbsp;Stock&nbsp;that<BR>Have not<BR>Vested</B><br><B>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity&nbsp;Incentive<BR>Plan Awards:<BR>Number of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or Other<BR>Rights that Have<BR>not
Vested</B><br><B>(#)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity&nbsp;Incentive<BR>Plan Awards:<BR>Market&nbsp;or&nbsp;Payout<BR>Value&nbsp;of&nbsp;Unearned<BR>Shares, Units</B><br><B>or Other
Rights<BR>that&nbsp;Have&nbsp;not&nbsp;Vested</B><br><B>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2009</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2010</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2010</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">330,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">546,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/14/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,291,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,437,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/19/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,167,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/22/2010</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/22/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/14/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/19/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,389,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/17/2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">331,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/14/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/19/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,389,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Jerry&nbsp;S.&nbsp;Lanchbury,&nbsp;Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2010</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">322,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/14/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">694,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/19/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,111,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Richard&nbsp;M.&nbsp;Marsh,&nbsp;Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/14/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">694,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/19/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,111,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Stock Option Vesting Schedules: </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Options granted on and between September&nbsp;14, 2005 through and including September&nbsp;15, 2010 were granted
pursuant to our 2003 Employee, Director and Consultant Stock Option Plan, as amended (the &#147;2003 Plan&#148;) and vest 25&nbsp;percent of the shares per year on each anniversary of the date of grant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Options granted beginning on and after February&nbsp;23, 2011 were granted pursuant to our 2010 Plan and vest
25&nbsp;percent of the shares per year on each anniversary date of the grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restricted stock units vest
<SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> per year beginning no earlier that at least the annual anniversary of the grant date on which the restricted stock units were granted. Restricted stock units
awarded to Mr.&nbsp;Riggsbee in connection with commencement of employment vest <SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> per year from the date of grant. The vesting of unvested restricted stock unit
awards held by our NEOs will accelerate upon a change of control of Myriad in accordance with the Executive Retention Agreements described below under &#147;Potential Payments Upon Termination or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Change-in-Control.&#148;</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The market value of stock awards is determined by multiplying the number of shares by $27.78, the closing price
of our common stock on the Nasdaq Global Market on June&nbsp;30, 2019, the last day of our fiscal year. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On September&nbsp;25, 2019, based on the degree of accomplishment of the revenue performance criteria for our
fiscal year 2019, the number of shares actually earned was at 95% of the award. The restricted stock units will vest <SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> per year beginning on September&nbsp;26,
2020. </P></TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2019 Fiscal-Year Option Exercises and Stock Vested </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows information regarding exercises of options to purchase our common stock and vesting of restricted stock unit awards
by our NEOs during the fiscal year ended June&nbsp;30, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired on<BR>Exercise (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized&nbsp;on<BR>Exercise ($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired on<BR>Vesting (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized<BR>on Vesting<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">870,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,879,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">None</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,770,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">None</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,271,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,373,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,396,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,336,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column do not necessarily represent the actual value realized from the sale of the shares
acquired upon exercise of the options because the shares may not be sold on exercise but continue to be held by the executive officer exercising the option. The amounts shown represent the difference between the option exercise price and the market
price on the date of exercise, which is the amount that would have been realized if the shares had been sold immediately upon exercise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column represent the market value of stock awards upon vesting as determined by
multiplying the number of shares by $46.35, the closing price of our common stock on the Nasdaq Global Market on September&nbsp;17, 2018, for shares which vested on that date, by $46.65, the closing price of our common stock on the Nasdaq Global
Market on September&nbsp;25, 2018, for shares which vested on that date, by $46.00, the closing price of our common stock on the Nasdaq Global Market on September&nbsp;30, 2018, for shares which vested on that date, and by $44.45, the closing price
of our common stock on the Nasdaq Global Market on October&nbsp;17, 2018, for shares which vested on that date. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pension Benefits
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have any qualified or <FONT STYLE="white-space:nowrap">non-qualified</FONT> defined pension benefit plans. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nonqualified Deferred Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do
not have any nonqualified defined contribution plans or other deferred compensation plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments Upon Termination or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;17, 2005 (and
thereafter for subsequently appointed executive officers), we entered into Executive Retention Agreements, or the Retention Agreements, with our executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the Retention Agreements, if the employment of an executive officer is terminated without &#147;Cause&#148; or if the
executive officer separates from Myriad for &#147;Good Reason&#148; within 24 months of a &#147;Change in Control&#148; (each is defined in the agreement and set forth below), the executive officer will receive: (i)&nbsp;all salary earned through
the date of termination, as well as a prorated bonus and any compensation previously deferred; (ii)&nbsp;an amount equal to three times the executive&#146;s highest annual base salary and three times the executive&#146;s highest annual bonus at
Myriad during the three-year period prior to the Change in Control; (iii)&nbsp;continued benefits for 36 months after the date of termination; and (iv)&nbsp;outplacement services in an aggregate amount of up to $25,000. If the employment of an
executive officer is terminated by the executive officer for no reason, during the <FONT STYLE="white-space:nowrap">90-day</FONT> period beginning on the first anniversary of the &#147;Change in Control Date&#148; (as defined in the agreement and
set forth below), then the termination shall be deemed to be termination for Good Reason for all purposes of the Retention Agreement except that the payment of an amount equal to three times the executive&#146;s highest annual base salary and bonus
shall be reduced by <FONT STYLE="white-space:nowrap">one-half.</FONT> In addition, upon the occurrence of a Change in Control, all of the executive&#146;s unvested equity incentive compensation shall become fully vested, whether or not the executive
is terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;12, 2007, the Retention Agreements were amended to provide that all payments under the agreement are to be
made in a lump sum, in cash, six months following the date of termination of employment, unless an earlier payment, in whole or in part, following the date of termination of employment is permitted under Section&nbsp;409A of the Internal Revenue
Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;29, 2015, the Retention Agreements were amended to delete the tax
<FONT STYLE="white-space:nowrap">gross-up</FONT> provision that previously allowed for a payment to be made by the Company to an executive officer in connection with a change in control of the Company to offset any excise taxes or penalties incurred
by the executive officer under Section&nbsp;4999 of the Internal Revenue Code in connection with a &#147;parachute payment&#148; within the meaning of Section&nbsp;280G of the Internal Revenue Code. No such payment is now permitted under the
Retention Agreements and any excise taxes due shall be borne solely by the executive officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the terms of the Retention Agreement
are either satisfied or expire on a date that is 24 months after a Change in Control, the Retention Agreement will renew annually for <FONT STYLE="white-space:nowrap">one-year</FONT> terms unless we provide notice of
<FONT STYLE="white-space:nowrap">non-renewal</FONT> at least 90 days prior to the end of each term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As defined in the Retention
Agreements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<I>Cause</I>&#148; means (a)&nbsp;the Executive&#146;s willful and continued failure to substantially
perform his or her reasonable assigned duties (other than any such failure resulting from incapacity due to physical or mental illness or any failure after the Executive gives notice of termination for Good Reason) that is not cured within
30&nbsp;days after a written demand for substantial performance is received by the Executive from the board of directors, which specifically identifies the manner in which the board believes the Executive has not substantially performed the
Executive&#146;s duties; or (b)&nbsp;the Executive&#146;s willful engagement in illegal conduct or gross misconduct that is materially and demonstrably injurious to the Company. No act or failure to act by the Executive shall be considered
&#147;willful&#148; unless it is done, or omitted, in bad faith and without reasonable belief that the Executive&#146;s action or omission was in the best interests of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<I>Good Reason</I>&#148; means the occurrence, without the Executive&#146;s written consent, of any of the
following events or circumstances: (a)&nbsp;The assignment to the Executive of duties inconsistent in any material respect with the Executive&#146;s position (including status, offices, titles and reporting requirements), authority or
responsibilities in effect immediately prior to the earliest to occur of (i)&nbsp;the Change in Control Date; (ii)&nbsp;the date of the execution by the Company of the initial written agreement or instrument providing for the Change in Control; or
(iii)&nbsp;the date of the adoption by the board of directors of a resolution providing for the Change in Control (with the earliest of such dates referred to herein as the &#147;Measurement Date&#148;), or any other action or omission by the
Company that results in a material diminution in the Executive&#146;s position, authority or responsibilities. (b)&nbsp;A reduction in the Executive&#146;s annual base salary that was in effect on the Measurement Date. (c)&nbsp;The failure by the
Company to (i)&nbsp;continue in effect any material compensation, pension, retirement or benefit plan or program (including without limitation any 401(k), life insurance, medical, health and accident or disability plan and any vacation program or
policy) (a &#147;Benefit Plan&#148;) in which the Executive participates or that is applicable to the Executive immediately prior to the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Measurement Date, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to such plan or program; (ii)&nbsp;continue the
Executive&#146;s participation therein (or in a substitute or alternative plan) on a basis not materially less favorable, both in terms of the amount of benefits provided and the level of the Executive&#146;s participation relative to other
participants, than the basis that existed immediately prior to the Measurement Date; or (iii)&nbsp;award cash bonuses to the Executive in amounts and in a manner substantially consistent with past practice. (d)&nbsp;A change by the Company in the
location at which the Executive performs his or her principal duties for the Company to a new location that is both (i)&nbsp;outside a radius of 50 miles from the Executive&#146;s principal residence immediately prior to the Measurement Date and
(ii)&nbsp;more than 50 miles from the location at which the Executive performed his or her principal duties for the Company immediately prior to the Measurement Date; or (iii)&nbsp;a requirement by the Company that the Executive travel on Company
business to a substantially greater extent than required immediately prior to the Measurement Date. (e)&nbsp;The failure by the Company to obtain the agreement from any successor to the Company to assume and agree to perform the Retention
Agreement.; Or (f)&nbsp;any failure of the Company to pay or provide to the Executive any portion of the Executive&#146;s compensation or benefits due under any Benefit Plan within seven days of the date such compensation or benefits are due, any
material breach by the Company of the Retention Agreement, or any employment agreement with the Executive. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<I>Change in Control</I>&#148; means an event or occurrence set forth in any one or more of the following
events (including an event or occurrence that constitutes a Change in Control under one of such subsections but is specifically exempted from another subsection): (a)&nbsp;The acquisition by an individual, entity or group [within the meaning of
Section&nbsp;13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)] (a &#147;Person&#148;) of beneficial ownership of any capital stock of the Company if, after such acquisition, that Person beneficially
owns (within the meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> promulgated under the Exchange Act) 20&nbsp;percent or more of either (i)&nbsp;the then-outstanding shares of common stock of the Company (the &#147;Outstanding
Company Common Stock&#148;) or (ii)&nbsp;the combined voting power of the then-outstanding securities of the Company entitled to vote generally in the election of directors (the &#147;Outstanding Company Voting Securities&#148;); <I>provided</I>,
however, that for purposes of this subsection (a), the following acquisitions shall not constitute a Change in Control: (i)&nbsp;any acquisition directly from the Company (excluding an acquisition pursuant to the exercise, conversion or exchange of
any security exercisable for, convertible into or exchangeable for common stock or voting securities of the Company, unless the Person exercising, converting or exchanging such security acquired such security directly from the Company or an
underwriter or agent of the Company); (ii)&nbsp;any acquisition by the Company; or (iii)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company. Or
(b)&nbsp;such time as the Continuing Directors (as defined below) do not constitute a majority of the board (or, if applicable, the board of directors of a successor corporation to the Company), where the term &#147;Continuing Director&#148; means
at any date a member of the board (i)&nbsp;who was a member of the board on the date of the execution of the Retention Agreement or (ii)&nbsp;who was nominated or elected subsequent to such date by at least a majority of the directors who were
Continuing Directors at the time of such nomination or election or whose election to the board was recommended or endorsed by at least a majority of the directors who were Continuing Directors at the time of such nomination or election;
<I>provided</I>, <I>however</I>, that excluded from this clause&nbsp;(ii) is any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or
other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the board. (c)&nbsp;The consummation of a merger, consolidation, reorganization, recapitalization or share exchange involving the Company or a
sale or other disposition of all or substantially all of the assets of the Company in one or a series of transactions (a &#147;Business Combination&#148;), unless, immediately following such Business Combination, the following condition is
satisfied: all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own,
directly or indirectly, more than 50&nbsp;percent of the then-outstanding shares of common stock and the combined voting power of the then-outstanding securities entitled to vote generally in the election of directors, respectively, of the resulting
or acquiring corporation in such Business Combination (which shall include, without limitation, a corporation that, as a result of the transaction, owns the Company or substantially all of the Company&#146;s assets either directly or through one or
more subsidiaries) in substantially the same proportions as their ownership, immediately prior to the Business Combination, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively, or (d)&nbsp;approval by the
stockholders of the Company of a complete liquidation or dissolution of the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<I>Change in Control Date</I>&#148; means the first date during the Term (as defined in the Retention
Agreement) on which a Change in Control occurs. Anything in the Retention Agreement to the contrary notwithstanding, if (a)&nbsp;a Change in Control occurs, (b)&nbsp;the Executive&#146;s employment with the Company is terminated prior to the date on
which the Change in Control occurs, and (c)&nbsp;it is reasonably demonstrated by the Executive that such termination of employment (i)&nbsp;was at the request of a third party who has taken steps reasonably calculated to effect a Change in Control
or (ii)&nbsp;otherwise arose in connection with or in anticipation of a Change in Control, then for all purposes of the Retention Agreement the &#147;Change in Control Date&#148; shall mean the date immediately prior to the date of the termination
of employment. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Retention Agreements is qualified in its entirety by the full text of the
agreements, which has been filed as an exhibit to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
addition, under the terms of the award agreements for options and restricted stock units granted to our NEOs, all of the NEO&#146;s stock options and restricted stock units shall become fully vested upon the occurrence of a Change in Control, as
defined in the Retention Agreements, whether or not the executive is terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the potential payments to
each of our NEOs upon either a change in control or termination following a change in control, assuming the occurrence of the different triggers of the Retention Agreement, as of the close of business on June&nbsp;30, 2019, the last business day of
our most recent fiscal year<B>. </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Executive Benefits and Payments Upon Termination</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change in<BR>Control ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change&nbsp;in&nbsp;Control<BR>and Involuntary<BR>Termination&nbsp;Without<BR>Cause or for Good<BR>Reason ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change in<BR>Control and<BR>Voluntary<BR>Termination&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark&nbsp;C.&nbsp;Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,661,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,330,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,227,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock option and RSU acceleration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,443,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,443,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,443,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cobra benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outplacement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,443,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,424,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,980,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,557,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">778,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bonus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">773,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">386,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock option and RSU acceleration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,587,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,587,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,587,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cobra benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outplacement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,587,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,011,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,845,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R.&nbsp;Bryan&nbsp;Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,399,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">699,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">710,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock option and RSU acceleration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,803,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,803,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,803,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cobra benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outplacement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,803,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,007,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,951,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry&nbsp;S.&nbsp;Lanchbury,&nbsp;Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,525,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">762,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">672,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">336,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock option and RSU acceleration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,170,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,170,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,170,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cobra benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outplacement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,170,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,461,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,362,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard&nbsp;M.&nbsp;Marsh,&nbsp;Esq.(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,525,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">762,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">695,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">347,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock option and RSU acceleration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,160,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,160,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,160,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cobra benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outplacement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,160,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,474,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,364,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Richard Marsh retired from the Company effective July&nbsp;1, 2019. As such, he is not eligible to receive any
payments, equity acceleration, or any other benefits under any Retention Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of
the assumptions that were used in creating the above table. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Vesting Acceleration Calculation &#150; The value of the vesting acceleration was calculated by multiplying the
number of unvested restricted stock units by the closing price of our common stock on the Nasdaq Global Market on June&nbsp;30, 2019 which was $27.78. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the total compensation paid or accrued during the fiscal year ended June&nbsp;30, 2019 to each of our nonemployee
directors who served during fiscal year 2019. Directors who are employed by Myriad are not compensated for their service on our board of directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned&nbsp;or<BR>Paid&nbsp;in&nbsp;Cash&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted&nbsp;Stock<BR>Unit&nbsp;Awards&nbsp;($)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">380,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">369,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">392,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">399,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lee N. Newcomer, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown reflect the aggregate grant date fair value of 9,360 restricted stock units awarded to each
nonemployee director who served during fiscal year 2019 calculated in accordance with FASB ASC Topic 718 and are determined by multiplying the number of shares by $32.05, the closing price of our common stock on the Nasdaq Global Market on
November&nbsp;29, 2018, the date of the grant. RSUs awarded to our nonemployee directors vest in full one year from date of grant at the Company&#146;s next annual meeting of shareholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows outstanding and vested options and unvested RSUs for each nonemployee director as of June&nbsp;30, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options</B><br><B>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested</B><br><B>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested</B><br><B>RSUs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lee N. Newcomer, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the grant date fair value for restricted stock unit awards granted to each
nonemployee director in our fiscal year ended June&nbsp;30, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Granted&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date<BR>Fair&nbsp;Value&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/29/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lee N. Newcomer, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director Compensation Policy </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nonemployee directors are compensated on a role-based model and are paid cash fees based on the annual retainers (25&nbsp;percent paid
following each quarter of service). The following is a description of the standard compensation arrangements under which our nonemployee directors are compensated for their service as directors, including as members of the various board committees:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman; ">Annual retainer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">All members</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$60,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$100,000 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chair of the Audit Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$28,000 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Compensation Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$20,000 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Nominating and Governance Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$15,000 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Members of the Audit Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$13,500 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Members of the Compensation Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$10,000 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Members of the Nominating and Governance Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$7,500 additional</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Members of the Strategic Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$5,000 additional</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Attendance </I></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board Meetings: In addition to the annual retainer amounts, we pay each nonemployee director a <FONT
STYLE="white-space:nowrap">per-meeting</FONT> cash fee of $2,000 for attendance at board meetings in excess of five <FONT STYLE="white-space:nowrap">in-person</FONT> meetings and four telephonic meetings per fiscal year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Committee Meetings other than Strategic Committee: We also pay each nonemployee director a <FONT
STYLE="white-space:nowrap">per-meeting</FONT> cash fee of $2,000 for attendance at committee meetings in excess of four meetings (per each committee), whether in person or telephonic, per fiscal year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Strategic Committee: No per meeting fee will be paid for meetings of the Strategic Committee.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All directors are also reimbursed for their
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in attending meetings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted and
Unrestricted Stock Grants and Other Stock-Based Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our 2017 Plan, our nonemployee directors may be awarded restricted and
unrestricted stock grants and/or other stock-based awards. Beginning in fiscal year 2017, as recommended and determined by our Compensation Committee, and approved by our Board of Directors, on each date of our annual meeting of stockholders, the
Company shall grant to each <FONT STYLE="white-space:nowrap">non-employee</FONT> director, other than new nonemployee directors appointed within six months of the annual meeting, a restricted stock unit award equal to $300,000 divided by the closing
price of the Company&#146;s common stock on the applicable date of our annual meeting of stockholders. In addition, depending on the proximity to our annual meeting of stockholders, it is our policy to grant a restricted stock unit award for shares
of our common stock to each new nonemployee director upon initial appointment to the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock units granted to our nonemployee directors vest in full upon completion of one
year of service on the Board at the Company&#146;s next annual meeting of shareholders. Options granted to our nonemployee directors are exercisable after the termination of the director&#146;s service on the Board to the extent exercisable on the
date of such termination for the remainder of the life of the option.<B> </B>All options or restricted stock units granted to our nonemployee directors will become fully exercisable upon a change of control of Myriad or upon their death as provided
for under the forms of award agreement for directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Compensation Policies and Practices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended June&nbsp;30, 2019, the Compensation Committee conducted a risk assessment of our compensation policies and
practices for our employees and concluded that our policies and practices do not create risks that are reasonably likely to have a material adverse effect on the Company. For this purpose, we considered the compensation structure of the Company for
its employees including executive officers, which is based on an annual salary, annual bonus (for bonus-eligible employees), three-year cash incentive bonuses for executive officers, sales commissions and bonuses (for sales staff and managers), and
equity incentive compensation in the form of stock option or restricted stock unit grants. We do not believe we offer any short-term incentives that might result in high-risk actions or conduct by our employees. For example, incentive compensation
for executive officers in the form of an annual cash bonus or long-term three-year cash incentive bonus is based on a predetermined formula and management objectives approved by the Compensation Committee and is subject to a cap. There is no unique
operational division or group of employees who are specially compensated, or who, as a group, are responsible for a material portion of our revenues or profits. We do not believe that the awarding of long-term incentive compensation under our
three-year cash incentive bonus or equity incentive compensation in the form of stock options or restricted stock units creates any undue compensation risks to the Company. Additionally, we believe that we have appropriate internal controls that
support the accurate and timely recognition of Company revenues. Accordingly, we believe that we have a balanced pay and performance program that does not promote undue or excessive risk taking. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax Deductibility of Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based
on changes to U.S. tax laws, incentive compensation for our executive officers will no longer be determined under a section 162 (m) plan since the exception to the $1&nbsp;million deduction limitation for qualified performance-based compensation has
been eliminated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation Plan Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain aggregate information with respect to all of the Company&#146;s equity compensation plans in effect as of
June&nbsp;30, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(a)</B><br><B>Number of<BR>securities<BR>to be issued<BR>upon<BR>exercise of<BR>outstanding<BR>options,<BR>warrants<BR>and rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(b)</B><br><B>Weighted-<BR>average<BR>exercise<BR>price of<BR>outstanding<BR>options,<BR>warrants<BR>and rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(c)</B><br><B>Number of securities<BR>remaining&nbsp;available&nbsp;for<BR>future issuance under<BR>equity compensation<BR>plans (excluding<BR>securities
reflected in<BR>column (a))</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,529,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,129,014</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,529,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,129,014&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These plans consist of our 2003 Employee, Director and Consultant Stock Option Plan, as amended (the &#147;2003
Plan&#148;), our 2010 Employee, Director and Consultant Equity Plan, as amended (the &#147;2010 Plan&#148;), our 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#147;2017 Plan&#148;), and our Employee Stock Purchase
Plan, as amended. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Column (c)&nbsp;includes 554,674 shares available for future issuance under our Employee Stock Purchase Plan.
No shares are available for issuance under the 2003 Plan or the 2010 Plan. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee of our Board of Directors has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation
<FONT STYLE="white-space:nowrap">S-K,</FONT> which appears elsewhere in this proxy statement, with our management. Based on this review and discussion, the Compensation Committee has recommended to the Board that the Compensation Discussion and
Analysis be included in this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEMBERS OF THE COMPENSATION COMMITTEE: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D., Chair </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lee N. Newcomer, M.D. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors, which consists entirely of directors who meet the independence and experience requirements of
the Nasdaq Stock Market LLC, has furnished the following report: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee assists the Board in overseeing and monitoring the
integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of internal and external audit processes. This committee&#146;s role and responsibilities are set forth in the Audit Committee Charter
adopted by the Board, which is available in the Investors &#151; Understanding Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>. This committee reviews and reassesses the Audit Committee Charter annually and recommends any
changes to the Board for approval. The Audit Committee is responsible for overseeing our overall financial reporting process and for the appointment, compensation, retention, and oversight of the work of our independent registered public accounting
firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In fulfilling its responsibilities for the financial statements for the fiscal year ended June&nbsp;30, 2019, the Audit Committee
took the following actions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed and discussed the audited financial statements for the fiscal year ended June&nbsp;30, 2019 with
management and Ernst&nbsp;&amp; Young LLP, our independent registered public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Discussed with Ernst&nbsp;&amp; Young LLP the matters required to be discussed in accordance with Statement on
Auditing Standards No.&nbsp;16, <I>Communications with Audit Committees</I>; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Received written disclosures and letters from Ernst&nbsp;&amp; Young LLP regarding its independence as required
by PCAOB Ethics and Independence Rule 3526, <I>Communication with Audit Committees Concerning Independence, </I>and has discussed with the independent auditors, the independent auditors&#146; independence; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Audit Committee also considered the status of pending litigation, taxation matters and other areas of
oversight relating to the financial reporting and audit process that the committee determined appropriate. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the
Audit Committee&#146;s review of the audited financial statements and discussions with management and Ernst&nbsp;&amp; Young LLP, the Audit Committee recommended to the Board that the audited financial statements be included in our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2019 for filing with the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEMBERS OF THE AUDIT COMMITTEE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel, Chair </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lawrence C. Best </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our records reflect that all reports that were required to be filed pursuant to Section&nbsp;16(a) of the Securities Exchange Act of 1934, as
amended, were filed on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Annual Statement of Beneficial Ownership on Form 5 is not required to be filed if there are no
previously unreported transactions or holdings to report. Nevertheless, we are required to disclose the names of directors, officers and 10&nbsp;percent stockholders who did not file a Form 5 unless we have obtained a written statement that no
filing is required or if we otherwise know that no Form 5 is required. We received either a written statement from our directors, officers and 10&nbsp;percent stockholders or know from other means that no Forms 5 filings were required. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were not a party to any transactions with related persons since July&nbsp;1, 2019 that would be required to be disclosed pursuant to Item
404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Policy on Approval of Related Person Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Policy on Related Person Transactions (the &#147;Policy&#148;) under which the Audit Committee reviews, approves or ratifies
all related person transactions. Under our Policy, a related person transaction is one in which Myriad is a participant, and the amount involved exceeds $120,000, and in which any of the following persons have or will have a direct or indirect
material interest: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Executive officers of the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Members of the Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Beneficial holders of 5&nbsp;percent or more of Myriad&#146;s securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Immediate family members, as defined by Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under
the Securities Act, of any of the foregoing persons; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any firm, corporation or other entity in which any of the foregoing persons is employed or is a partner or
principal, is in a similar position or in which the person has a 5&nbsp;percent or greater beneficial ownership interest; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any other persons whom the Board determines may be considered to be related persons as defined by Item 404 of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Policy, the Audit Committee
will approve only those related person transactions that are determined to be in, or not inconsistent with, the best interests of Myriad and its stockholders, taking into account all available facts and circumstances as the Audit Committee,
determines in good faith to be necessary. These facts and circumstances will typically include, but not be limited to, the benefits of the transaction to Myriad; the impact on a director&#146;s independence in the event the related person is a
director, an immediate family member of a director or an entity in which a director is a partner, stockholder or executive officer; the availability of other sources for comparable products or services; the terms of the transaction; and the terms of
comparable transactions that would be available to unrelated third parties or to employees generally. No member of the Audit Committee shall participate in any review, consideration or approval of any related person transaction with respect to which
the member or any of his or her immediate family members is the related person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In reviewing and approving these transactions, the Audit
Committee will obtain, or will direct management to obtain on its behalf, all information that the Audit Committee believes to be relevant and important to a review of the transaction prior to its approval. Following receipt of the necessary
information, a discussion of the relevant factors will be held if it is deemed to be necessary by the Audit Committee prior to approval. If a discussion is not deemed to be necessary, approval may be given by written consent of the Audit Committee.
This approval authority may also be delegated to the Chairperson of the Audit Committee in some circumstances. It is contemplated that no related person transaction will be entered into prior to the completion of these procedures; however, where
permitted, a related person transaction may be ratified upon completion of these procedures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee may adopt any further policies and procedures relating to the approval of
related person transactions that it deems necessary or advisable from time to time. A copy of our Policy on Related Person Transactions is publicly available in the Investor Information &#151; Understanding Myriad/Corporate Governance section of our
website at <I>www.myriad.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 1: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board of Directors currently consists of nine members, classified as follows: John T. Henderson, M.D. and S. Louise Phanstiel constitute a class with a term ending at the 2021 Annual Meeting (the &#147;Class&nbsp;I Directors&#148;); Mark C. Capone,
Heiner Dreismann, Ph.D. and Colleen F. Reitan constitute a class with a term ending at the 2019 Annual Meeting (the &#147;Class&nbsp;II Directors&#148;); and Walter Gilbert, Ph.D., Dennis H. Langer, M.D., J.D. Lawrence C. Best, and Lee N. Newcomer,
M.D. constitute a class with a term ending at the 2020 Annual Meeting (the &#147;Class&nbsp;III Directors&#148;). At each Annual Meeting, directors are elected for a term of three years to succeed those directors whose terms are expiring. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;25, 2019, the Board of Directors accepted the recommendation of the Nominating and Governance Committee and voted to
nominate Mark C. Capone, Heiner Dreismann, Ph.D. and Collen F. Reitan for election at the Annual Meeting for a term of three years to serve until the 2022 Annual Meeting, and until their successors have been elected and qualified, or until their
earlier death, resignation, retirement or removal. Unless the authority to vote for any of these nominees is withheld, the shares represented by a valid proxy will be voted FOR the election of Mark C. Capone, Heiner Dreismann, Ph.D. and Collen F.
Reitan as directors. In the event that any nominee should become unable or unwilling to serve, the shares represented by a valid proxy will be voted for the election of another person who the Board of Directors recommends, unless the Board chooses
to reduce the number of directors serving on the Board. We have no reason to believe that any nominee will be unable or unwilling to serve as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An affirmative vote of the plurality of the shares voted affirmatively or negatively at the Annual Meeting is required to elect each nominee
as a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a policy on plurality votes for the election of directors. Under this policy, in <FONT
STYLE="white-space:nowrap">non-contested</FONT> elections, if a director receives a greater number of WITHHOLD votes than FOR votes, the Board will decide, through a process managed by the Nominating and Governance Committee and excluding the
nominee in question, whether it should request that the director submit his or her resignation, maintain the director but address what the Nominating and Governance Committee believes is the underlying cause of the WITHHOLD votes, or resolve not to <FONT
STYLE="white-space:nowrap">re-nominate</FONT> the director in the future for election. A copy of this policy is publicly available in the Investor Information &#151; Understanding Myriad/Corporate Governance section of our website at
<I><U>www.myriad.com</U></I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS THE ELECTION OF MARK C. CAPONE, HEINER DREISMANN PH.D. AND COLLEEN
REITMAN AS DIRECTORS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 2: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL TO AMEND OUR 2017 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October&nbsp;8, 2019, we
had 514,267 remaining shares of common stock available for issuance under our 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#147;2017 Plan&#148;).&nbsp;Accordingly, we are seeking an approval to be able to award up
to 1,200,000 additional restricted stock units by increasing the aggregate number of shares of common stock available for the grant of awards under the 2017 Plan by an additional 1,200,000 shares.&nbsp;An approval of an additional 1,200,000 shares
will allow us to award up to 1,200,000 additional restricted stock units which we expect will provide us with enough shares to grant restricted stock units to our employees, executive officers and directors pursuant to our fiscal year 2020
compensation programs.&nbsp;Without approval of this amendment to increase the shares authorized under the 2017 Plan, we will not have enough authorized shares under the 2017 Plan to compensate our employees with equity and we will need to
substantially revise our compensation programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2017 Plan was approved by our Board of Directors and stockholders in 2017 and amended
by our Board of Directors and stockholders in 2018.&nbsp;We anticipate the need to continue requesting each year additional shares for authorization under the 2017 Plan to fund our equity compensation programs. As of October&nbsp;8, 2019, restricted
stock units representing 2,005,323 shares of common stock are outstanding under the 2017 plan. As of October&nbsp;8, 2019, options to purchase 4,604,172 shares of common stock and restricted stock units representing 664,422 shares of common stock
are outstanding under the 2010 Plan.&nbsp;As of October&nbsp;8, 2019, options to purchase 360,239 shares of common stock are outstanding under the 2003 Plan.&nbsp;No further shares are available for issuance under the 2003 Plan or the 2010
Plan.&nbsp;Shares may be transferred back into the 2017 Plan from previously issued options and RSUs which are cancelled or expire under the 2003 Plan and the 2010 Plan.&nbsp;By its terms, the 2017 Plan may be amended by the Board of Directors,
provided that any amendment that the Board determines requires stockholder approval is subject to receiving such approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
September&nbsp;26, 2019, the Board of Directors voted to approve an amendment to the 2017 Plan to allow for the award of up to 1,200,000 additional RSUs by increasing the aggregate number of shares of common stock available for the grant of awards
under the 2017 Plan by an additional 1,200,000 shares.&nbsp;This amendment to increase the number of shares available for grant under the 2017 Plan is being submitted for approval at the Annual Meeting in order to ensure that we have an adequate
number of shares available for issuance in order to grant equity incentive compensation awards to our employees, executive officers and directors pursuant to our compensation programs. Approval by our stockholders of this amendment to the 2017 Plan
is also required by the listing rules of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board, the Compensation Committee and management believe that the effective use of
stock-based, long-term incentive compensation is vital to our ability to achieve strong performance in the future. The 2017 Plan maintains and enhances the key policies and practices adopted by our management and Board of Directors to align employee
and stockholder interests. In addition, our future success depends, in large part, upon our ability to maintain a competitive position in attracting, retaining and motivating key personnel. We believe the authorization of an additional 1,200,000
shares for issuance under our 2017 Plan is essential to permit our management to continue to provide long-term, equity-based incentives to present and future key employees, consultants and directors.&nbsp;Additionally, in continued response to
recommendations from our stockholders, we intend to continue to issue restricted stock unit awards to reduce the dilutive effect on stockholders from our equity incentive compensation program.&nbsp;Accordingly, our Board of Directors believes
approval of the amendment to our 2017 Plan is in our best interests and those of the stockholders and recommends a vote &#147;FOR&#148; the approval of the amendment to the 2017 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2017 Plan includes the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Types of Awards &#151;</I> any stock right awarded under the 2017 Plan must be in the form of a restricted
stock unit or a restricted stock grant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>No Liberal Share Recycling &#151;</I> shares that are withheld to satisfy any tax withholding obligation
related to any award will not again become available for issuance under the 2017 Plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Cap on the number of shares to be issued per year &#151;</I> no participant may receive awards for more than
500,000 shares of common stock in any fiscal year and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors may not receive awards that exceed $500,000 in aggregate grant date fair value in any calendar year (other than pursuant to an
election to receive equity in lieu of cash for all or a portion of fees received for service on the Board of Directors or any committee thereof); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Minimum Vesting Period &#151;</I> all stock rights awarded must have a minimum vesting period of at least one
year (we have historically provided for a four year vesting period for our equity incentive awards, and intend to continue that practice); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Limited Acceleration of Vesting &#151;</I> the vesting of any stock right awarded under the 2017 Plan cannot
be accelerated from the original grant vesting schedule except in connection with death, disability or a change in control; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>No Dividends </I>&#151; we may not pay dividends or dividend equivalents before the vesting of the underlying
award; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-SIZE:95%">&#9675;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Clawback Policy </I>&#151; awards will be subject to recoupment in accordance with the Company&#146;s clawback
policy then in effect.</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A complete copy of the 2017 Plan, as it is proposed to be amended, is attached as Appendix
B.&nbsp;The following summary description of the 2017 Plan is qualified in its entirety by reference to Appendix B. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Equity Plan Information
for Stock Options Previously Issued </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October&nbsp;8, 2019, there were 4,964,411 stock options outstanding with a weighted average
exercise price of $24.39 and a weighted average remaining life of 2.15 years. All options granted vested 25&nbsp;percent per year on the anniversary of the grant date. The following table provides additional information regarding vested stock
options outstanding as of that date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested&nbsp;Options<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average<BR>Exercise Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted Average<BR>Remaining&nbsp;Years&nbsp;of<BR>Contractual Life</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Substantially
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> options outstanding in excess of four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,954,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other options outstanding in excess of four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All options outstanding less than four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total vested options outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,964,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material Features of the 2017 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Eligibility. </B>The 2017 Plan allows us, under the direction of our Compensation Committee, to make grants of restricted stock units and
restricted stock awards, to employees, consultants and directors who, in the opinion of the Compensation Committee, are in a position to make a significant contribution to our long-term success. The purpose of these awards is to attract and retain
key individuals, further align employee and stockholder interests and to closely link compensation with Company performance. The 2017 Plan provides an essential component of the total compensation package, reflecting the importance that we place on
aligning the interests of key individuals with those of our stockholders. All employees, members of the Board of Directors and consultants of the Company and its affiliates are eligible to participate in the 2017 Plan. As of October&nbsp;8, 2019 we
had approximately 2,663 individuals eligible to participate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Limitations on Grants. </B>As of October&nbsp;8, 2019, we had 514,267
remaining shares of Common Stock available for issuance under the 2017 Plan. If this Proposal 2 is approved by our stockholders, the 2017 Plan will provide for the issuance of up to 1,200,000 additional shares. Additionally, up to 360,239 additional
shares may be issued under the 2017 Plan if options outstanding under our 2003 Plan are cancelled or expire in the future without the issuance of shares of common stock, and up to 5,268,594 additional shares may be issued under the 2017 Plan if
options and RSUs outstanding under our 2010 Plan are cancelled or expire in the future without the issuance of shares of common stock. No additional shares may be issued under our 2003 Plan or 2010 Plan. Under the 2017 Plan, each share of common
stock issued as a restricted stock unit, counts against the number of total shares available for issuance under the 2017 Plan as one share. In addition, shares of common stock reserved for awards under the 2017 Plan that lapse or are canceled will
be added back to the share reserve available for future awards on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-to-one</FONT></FONT> basis. However, shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock tendered in payment for an award or shares of common stock withheld for taxes will not be available again for grant. The 2017 Plan provides that no participant may receive awards for
more than 500,000 shares of common stock in any fiscal year. Additionally, for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, the 2017 Plan provides that the aggregate grant date fair value of any stock rights granted in any
calendar year cannot exceed $500,000 other than pursuant to an election to receive equity in lieu of cash for all or a portion of fees received for service on the Board of Directors or any committee thereof. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Units and Restricted Stock.</B> Restricted stock is common stock, and a restricted stock unit is a right to receive common
stock, that is subject to restrictions, including a prohibition against transfer and a substantial risk of forfeiture, until the end of a &#147;restricted period&#148; during which the grantee must satisfy certain vesting conditions. If the grantee
does not satisfy the vesting conditions by the end of the restricted period, the restricted stock is forfeited. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the restricted
period, the holder of restricted stock has the rights and privileges of a regular stockholder, except that the restrictions set forth in the applicable award agreement apply. For example, the holder of restricted stock may vote; but he or she may
not sell the shares until the restrictions are lifted. During the restricted period, the holder of a restricted stock unit does not have the rights and privileges of a regular stockholder until all restrictions set forth in the applicable award
agreement have lapsed and the RSU is converted into common stock. With respect to any dividends which the Company may pay, no dividend payment will be made with respect to any restricted stock or restricted stock unit until the end of the applicable
restricted period when the underlying vesting conditions have been met. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Plan Administration</B>. In accordance with the terms of the
2017 Plan, our Board of Directors has authorized our Compensation Committee to administer the 2017 Plan. The Compensation Committee may delegate part of its authority and powers under the 2017 Plan to one or more of our directors and/or officers,
but only the Compensation Committee can make awards to participants who are directors or executive officers of the Company. In accordance with the provisions of the 2017 Plan, our Compensation Committee determines the terms of awards, including:
</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Which employees, directors and consultants will be granted awards; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The number of shares subject to each award; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The vesting provisions of each award with a minimum one year vesting; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The termination or cancellation provisions applicable to awards; and </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All other terms and conditions upon which each award may be granted in accordance with the 2017 Plan.
</P></TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All equity grants must have a minimum of a one year vesting period. Historically, our equity grants have been granted
under a four-year plus vesting schedule. The 2017 Plan specifically prohibits the acceleration of vesting except in the case of death, disability or a change in control. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Stock Dividends and Stock Splits</B>. If our common stock is subdivided or combined into a greater or smaller number of shares or if we
issue any shares of common stock as a stock dividend, the number of shares of our common stock deliverable upon issuance of an award will be appropriately increased or decreased proportionately, and adjustments will be made, including in the
purchase price per share, if any, to reflect the subdivision, combination or stock dividend. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Corporate Transactions</B>. Upon a merger
or other reorganization event, our Board of Directors or an authorized committee, may, in its sole discretion, take any one or more of the following actions pursuant to the 2017 Plan, as to some or all outstanding awards: </P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide that all outstanding awards will be assumed or substituted by the successor corporation, become
realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon the merger or reorganization event; and </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">With respect to stock grants and in lieu of any of the foregoing policy, the Board of Directors or an authorized
committee may provide that, upon consummation of the transaction, each outstanding stock grant will be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such transaction to a holder of the number
of shares of common stock comprising such award (to the extent the stock grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Board of Directors or an authorized committee, all forfeiture and
repurchase rights being waived upon such transaction). </P></TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Amendments and Termination</B>. The 2017 Plan may be amended
by our stockholders. It may also be amended by our Board of Directors or Compensation Committee, provided that any amendment that is of a scope that requires stockholder approval as required by the rules of Nasdaq, or for any other reason is subject
to obtaining such stockholder approval. However, no such action may adversely affect any rights under an outstanding award without the holder&#146;s consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Duration of 2017 Stock Plan</B>. The 2017 Plan will expire on September&nbsp;14, 2027. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than grants to
our nonemployee directors as described above under &#147;Executive Compensation, Director Compensation, Restricted and Unrestricted Stock Grants,&#148; the amounts of future awards under the 2017 Plan are not determinable and will be granted at the
sole discretion of the Board of Directors or authorized committee, including grants to our named executive officers, our current executive officers, our current directors who are not executive officers, associates of directors and executive officers
and employees who are not executive officers although we anticipate that most of our grants will be in the form of RSUs and we will use most of the additional 1,200,000 shares proposed to be authorized to make grants in fiscal year 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Existing Plan Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is
a list of restricted stock unit awards issued as of October&nbsp;8, 2019 to our executives, directors and employees since the initial approval of the 2017 Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Position, or Group</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Underlying&nbsp;RSUs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named Executive Officers:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone, President and CEO*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee, CFO and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D., Chief Scientific Officer*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Executive Vice President, General Counsel and Secretary*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexander Ford, President, President, Myriad Women&#146;s Health, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers as a group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">958,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors who are not executive officers as a group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominees for Director:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Colleen F. Reitan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each associate of directors, executive officers, or nominees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All employees, including all current officers who are not executive officers, as a group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,395,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Capone has received greater than 5&nbsp;percent of the total awards granted to date under the 2017
Plan. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of October&nbsp;8, 2019 the closing price per share of our common stock was $28.29 as reported on the Nasdaq Global Select
Market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Federal Income Tax Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The material Federal income tax consequences of the issuance and vesting of restricted stock and restricted stock units under the 2017 Plan,
based on the current provisions of the Code and regulations, are as follows. Changes to these laws could alter the tax consequences described below. This summary assumes that all awards granted under the 2017 Plan are exempt from or comply with, the
rules under Section&nbsp;409A of the Code related to nonqualified deferred compensation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Stock Grants:</B> </P></TD>
<TD>With respect to stock grants involving the issuance of shares that are restricted as to transferability and subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair market value of the
shares received at the first time the shares become transferable or are not subject to a substantial risk of forfeiture, whichever occurs earlier. A grantee may elect to be taxed at the time of receipt of shares rather than upon lapse of
restrictions on transferability or substantial risk of forfeiture, but if the grantee subsequently forfeits the shares, the grantee would not be entitled to any tax deduction, including as a capital loss, for the value of the shares on which he or
she previously paid tax. The grantee must file such election with the Internal Revenue Service within 30 days of the receipt of the shares. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the
grantee. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Stock Units:</B> </P></TD>
<TD>The grantee recognizes no income until the issuance of unrestricted shares. At that time, the grantee must generally recognize ordinary income equal to the fair market value of the shares received. We generally will be entitled to a deduction in
an amount equal to the ordinary income recognized by the grantee. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the shares voted
affirmatively or negatively for the proposal at the Annual Meeting is required to approve the amendment of the 2017 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF
DIRECTORS RECOMMENDS APPROVAL OF THE AMENDMENT OF THE 2017 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED. PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF THE APPROVAL OF THE AMENDMENT OF THE 2017 PLAN UNLESS A
STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 3: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has appointed Ernst&nbsp;&amp; Young LLP (&#147;EY&#148;) as our independent registered public accounting firm, to audit
our financial statements for the fiscal year ending June&nbsp;30, 2020. The Board proposes that the stockholders ratify this selection, although such ratification is not required under Delaware law or our Restated Certificate of Incorporation, as
amended, or our Restated <FONT STYLE="white-space:nowrap">By-Laws.</FONT> EY has audited our financial statements since our fiscal year ended June&nbsp;30, 2007. We expect that representatives of EY will be present at the Annual Meeting, will be
able to make a statement if they so desire, and will be available to respond to appropriate questions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In deciding to appoint EY, the
Audit Committee reviewed auditor independence issues and existing commercial relationships with EY and concluded that EY has no commercial relationship with Myriad that would impair its independence for the fiscal year ending June&nbsp;30, 2020.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents fees for professional audit services provided by EY with respect to the last two fiscal years: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Type of Fee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;Year&nbsp;Ended<BR>June&nbsp;30,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;Year&nbsp;Ended<BR>June&nbsp;30, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,605,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,336,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,605,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,336,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit Fees &#151;</I> Fees include audits of consolidated financial statements, quarterly reviews, reviews
of registration statement filings, and consents related to SEC filings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit-Related Fees &#151;</I> Fees include services for
assurance and related services that are reasonably related to the performance of the audit or review of our financial statements that are not reported under &#147;audit fees.&#148; We did not engage Ernst and Young to perform any audit-related
services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Tax Fees &#151;</I> We did not engage EY to perform any tax related services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>All Other Fees &#151;</I> We did not engage EY to perform any other services other than those listed separately above for the fiscal years
indicated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policy on Audit Committee Preapproval of Audit and Permissible <FONT STYLE="white-space:nowrap">Non-Audit</FONT> Services of Independent
Public Accountant </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with SEC policies regarding auditor independence, the Audit Committee has responsibility for appointing,
setting compensation and overseeing the work of the independent public accounting firm. In recognition of this responsibility, the Audit Committee has established a policy to preapprove all audit and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services provided by our independent public accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to engagement of an
independent registered public accounting firm for the next year&#146;s audit, management will submit an aggregate of services expected to be rendered during that year for each of four categories of services to the Audit Committee for approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Audit services include audit work performed in the preparation of financial statements, as
well as work that generally only an independent registered public accounting firm can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or
reporting standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Audit-Related services are for assurance and related services that are traditionally performed by an independent
registered public accounting firm, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Tax services include all services performed by an independent registered public accounting firm&#146;s tax personnel except those services
specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Other Fees are those associated with services not captured in the other categories. The Company generally does not request such services
from our independent registered public accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to engagement of the independent registered public accounting firm,
engagement letters describing the scope of service and the anticipated fees are negotiated and approved by the Audit Committee. During the year, circumstances may arise in which it may become necessary to engage our independent registered public
accounting firm for additional services not contemplated in the original preapproval. In those instances, the Audit Committee requires specific preapproval before engaging our independent registered public accounting firm. The Audit Committee may
delegate preapproval authority to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any <FONT STYLE="white-space:nowrap">pre-approval</FONT> decisions to the Audit Committee at
its next scheduled meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the shares voted affirmatively or negatively at the Annual Meeting is
required to ratify the selection of our independent registered public accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our stockholders ratify the selection of EY,
the Audit Committee may still, in its discretion, decide to select a different independent auditor at any time during the fiscal year ending June&nbsp;30, 2020, if it concludes that such a change would be in the best interests of Myriad and our
stockholders. If our stockholders fail to ratify the selection, the Audit Committee will reconsider, but not necessarily rescind, the selection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE TO RATIFY THE SELECTION OF ERNST&nbsp;&amp; YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF SUCH RATIFICATION UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 4: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DISCLOSED IN THIS PROXY STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are seeking your approval, on advisory basis, as required by Section&nbsp;14A of the Securities Exchange Act of 1934, as amended, of the
compensation of our named executive officers, as disclosed in this proxy statement. More specifically, we ask that you support the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis section, the
compensation tables and any related material contained in this proxy statement with respect to our executive officers named in the Summary Compensation Table. Because your vote is advisory, it will not be binding on our Compensation Committee or our
Board of Directors. However, the Compensation Committee and our Board will review the voting results and take them into consideration when making future decisions regarding the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation philosophy is designed to align each executive&#146;s compensation with our short- and long-term performance and to provide
the compensation and incentives needed to attract, motivate and retain key executives who are crucial to our long-term success. Consistent with this philosophy, a significant portion of the total compensation opportunity for each of our named
executive officers is directly related to performance factors that measure our progress against the goals of our strategic and operating plans, as well as our performance against that of our peer companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders are urged to read the Compensation Discussion and Analysis section of this proxy statement, which discusses how our compensation
policies and procedures implement our compensation philosophy. The Compensation Committee and the Board of Directors believe that these policies and procedures are effective in implementing our compensation philosophy and in achieving its goals.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed in the Compensation Discussion and Analysis section, we believe the compensation paid to our President and CEO and other
named executive officers is appropriate as supported by our accomplishments in fiscal 2019. This is evidenced by our financial and operational performance where, among other accomplishments, delivered our third consecutive year of top line growth in
fiscal year 2019 with revenues up 14&nbsp;percent to $851&nbsp;million. From a profitability perspective, our adjusted earnings per share grew 18&nbsp;percent year-over-year to $1.67 per share. We have made substantial progress on our strategic
objectives that we believe position the Company for long-term growth, as well as progress on our five strategic imperatives to: i) build upon a solid hereditary cancer foundation, ii) grow new product volume, iii) expand reimbursement coverage for
new products, iv) increase RNA kit revenue internationally, and v) improve profitability with Elevate 2020. For example, we returned our hereditary cancer business to year-over-year revenue growth for the first time since fiscal year 2014.
Additionally, we received new guidelines from the American Society of Breast Surgeons recommending hereditary cancer testing for all patients with breast cancer. New product volumes increased on a year-over-year basis and now represent greater than
75&nbsp;percent of total test volume and has grown at a 34&nbsp;percent CAGR since fiscal year 2013. We made significant progress on reimbursement coverage with our efforts leading to a $1.2&nbsp;billion increase in reimbursed addressable market and
a commercial coverage plan for GeneSight from UnitedHealthcare in August of 2019. In international markets we received coverage for EndoPredict in the United Kingdom, Greece, and the first region in Italy. We also received approval for two new
companion diagnostic indications in Japan for ovarian and metastatic breast cancer with our BRACAnalysis CDx test. Finally we continued to make progress on the Elevate 2020 program with significant lab efficiency programs leading to a 300 basis
point improvement in year-over-year organic gross margins. We ended the year with $192&nbsp;million in cash, cash equivalents, and marketable investment securities and plan to continue to exercise a balanced approach to capital deployment, including
investing for future growth, business development activities and returning cash to stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on this performance, we believe
that the salary and annual cash incentive bonus paid to our President and CEO and our other named executive officers are in line with our compensation philosophy and goals. Similarly, we believe that the equity compensation awarded to our President
and CEO and our other named executive officers is consistent with our multi-year growth in revenue, operating income and stock performance, and provides the appropriate incentives to reward and foster long-term growth and stockholder value. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As evidence of our pay for performance philosophy, fiscal year 2019 total compensation paid in
aggregate to our five NEOs, including our President and CEO, was between the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles of total compensation of our peer group
as determined by Mercer under the 2019 Mercer Executive Compensation Review. With respect to the annual cash incentive bonus paid to our NEOs for fiscal year 2019, we paid between 81&nbsp;percent and 88&nbsp;percent, respectively, of the target
awards, based on the level of accomplishment of the <FONT STYLE="white-space:nowrap">pre-determined</FONT> incentive goals. We made cash payments under our long-term incentive program at 34&nbsp;percent of target based upon the achievement of
certain <FONT STYLE="white-space:nowrap">pre-established</FONT> performance targets. For long-term incentive compensation, because the <FONT STYLE="white-space:nowrap">pre-established</FONT> performance target was not fully met, we awarded
95&nbsp;percent of the RSUs granted to our NEOs. We believe these actions are demonstrative of our pay for performance practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
accordance with the rules of the SEC, the following resolution, commonly known as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Say-on-Pay&#148;</FONT></FONT> vote, is being submitted for a stockholder vote at the Annual
Meeting: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the compensation paid to the named executive officers of Myriad Genetics, Inc., as disclosed pursuant to
the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables and any related material disclosed in this proxy statement, is hereby APPROVED.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the shares voted affirmatively or negatively at the Annual Meeting is required to approve, on an
advisory basis, this resolution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR
NAMED EXECUTIVE OFFICERS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF SUCH APPROVAL UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE CODE OF CONDUCT AND ETHICS AND WHISTLEBLOWER POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Corporate Code of Conduct and Ethics and Whistleblower Policy that applies to all of our employees, including our Chief
Executive Officer and Chief Financial Officer, and every member of our Board of Directors. A copy of the Corporate Code of Conduct and Ethics and Whistleblower Policy is publicly available in the Investor Information &#150; Understanding
Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>. Disclosure regarding any amendments to, or waivers from, provisions of our Corporate Code of Conduct and Ethics and Whistleblower Policy that apply to our directors and
principal executive and financial officers will be included in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days following the date of the amendment or waiver, unless website posting or the issuance of a
press release of such amendments or waivers is then permitted by the rules of Nasdaq. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors knows of no other business that will be presented at the Annual Meeting. If any other business is properly brought
before the Annual Meeting, proxies will be voted in accordance with the judgment of the persons voting the proxies. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDER
PROPOSALS AND NOMINATIONS FOR DIRECTOR </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered for inclusion in the proxy statement relating to our Annual Meeting of
Stockholders being held in 2020 (the &#147;2020 Meeting&#148;), we must receive stockholder proposals (other than for director nominations) no later than June&nbsp;18, 2020. To be considered for presentation at the 2020 Meeting, although not
included in the proxy statement, proposals (including director nominations that are not requested to be included in our proxy statement) must be received no earlier than September&nbsp;6, 2020 and no later than October&nbsp;6, 2020. Notwithstanding
the foregoing, in the event that the number of directors is to be increased at the 2020 Meeting and we do not issue a public announcement naming the nominees and specifying the size of the increase by September&nbsp;26, 2026, to be considered for
presentation at the 2020 Meeting, although not included in the proxy statement, nominations must be received no later than the tenth day following the day on which such public announcement is made. Proposals not received in a timely manner will not
be voted on at the 2020 Meeting. If a proposal is received in a timely manner, the proxies that management solicits for the 2020 Meeting may still exercise discretionary voting authority on the proposal under circumstances consistent with the proxy
rules of the SEC. All stockholder proposals must also comply with our Restated <FONT STYLE="white-space:nowrap">By-Laws,</FONT> a copy of which is available by contacting our Secretary, and the corporate governance policies applicable to
recommendations for the nomination of directors, copies of which are available in the Investor Information &#151; Understanding Myriad/Corporate Governance section of our website at <I><U>www.myriad.com</U></I>. All stockholder proposals should be
marked for the attention of: Secretary, Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHETHER OR NOT YOU INTEND
TO BE PRESENT AT THE ANNUAL MEETING, YOU ARE URGED TO VOTE YOUR SHARES AT YOUR EARLIEST CONVENIENCE. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Salt Lake City, Utah </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;16, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>OUR ANNUAL REPORT ON
FORM <FONT STYLE="white-space:nowrap">10-K</FONT> FOR THE FISCAL YEAR ENDED JUNE&nbsp;30, 2019, AS AMENDED, (OTHER THAN EXHIBITS THERETO) FILED WITH THE SECURITIES AND EXCHANGE COMMISSION, WHICH PROVIDES ADDITIONAL INFORMATION ABOUT US, IS AVAILABLE
ON THE INTERNET AT </B><B><I><U>WWW.MYRIAD.COM</U></I></B><B> AND IS AVAILABLE IN PAPER FORM TO BENEFICIAL OWNERS OF OUR COMMON STOCK WITHOUT CHARGE UPON WRITTEN REQUEST TO: BENJAMIN G. JACKSON, SECRETARY, MYRIAD GENETICS, INC., 320 WAKARA WAY, SALT
LAKE CITY, UTAH 84108 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(801-584-3600).</FONT></FONT> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPENDIX A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>GAAP to <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Reconciliation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Condensed Consolidated Statements of Income &#151; Operating Basis </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>(Unaudited data in millions, except per share amount) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GAAP Net Income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">133.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#151; Integration related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#151; amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Recurring</FONT> Legal Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elevate 2020 costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Potential future consideration related to acquisitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of hereditary cancer Qui Tam complaint</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax reform impact</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax impact of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax expense associated with <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Net Income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">126.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">102.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GAAP Diluted EPS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to net income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.43</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Diluted EPS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GAAP Operating Income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">121.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#151; Integration related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#151; amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Recurring</FONT> Legal Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elevate 2020 costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Potential future consideration related to acquisitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of hereditary cancer Qui Tam complaint</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Operating Income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">145.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">138.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GAAP Free Cash Flow</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elevate 2020 costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#151; Integration related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for contingent consideration in operating cash flows</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#151; Integration related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Free Cash Flow</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">130.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We supplement our consolidated financial statements presented on a GAAP basis by providing additional measures which may be considered <FONT
STYLE="white-space:nowrap">&#147;non-GAAP&#148;</FONT> financial measures under applicable SEC rules. We believe that the disclosure of these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures provides additional insight into the
ongoing economics of our business and reflects how we manage our business internally, set operational goals and forms the basis of our management incentive programs. These <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures are not
in accordance with generally accepted accounting principles in the United States and should not be viewed in isolation or as a substitute for reported, or GAAP, net income and diluted earnings per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">&#147;Non-GAAP</FONT> Net Income&#148; and <FONT STYLE="white-space:nowrap">&#147;Non-GAAP</FONT> diluted EPS&#148;
financial measures exclude the following items from GAAP net income and diluted earnings per share: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>1. Acquisitions &#151; integration related
costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Costs related to closing and integration of acquired companies </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2. Acquisitions &#151; amortization of intangible assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recurring amortization charges resulting from the acquisition of intangible assets, including developed technology and database rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>3. Equity compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equity compensation
expense for the period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>4. <FONT STYLE="white-space:nowrap">Non-recurring</FONT> legal expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">One-time</FONT> <FONT STYLE="white-space:nowrap">non-recurring</FONT> legal settlements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>5. Elevate 2020 costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expenses tied to the
Elevate 2020 program. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>6. Potential future consideration for acquisitions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expenses related to valuation adjustments of <FONT STYLE="white-space:nowrap">earn-out</FONT> and milestone
payments tied to recent acquisitions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>7. Settlement of hereditary cancer Qui Tam complaint </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expenses associated with the settlement of the hereditary cancer Qui Tam complaint. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>8. Tax reform effect</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">One-time</FONT> <FONT STYLE="white-space:nowrap">non-cash</FONT> charges associated with change in value of our deferred tax assets due to tax reform. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>9. <FONT STYLE="white-space:nowrap">One-time</FONT> <FONT STYLE="white-space:nowrap">non-deductible</FONT> costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">One-time</FONT> <FONT STYLE="white-space:nowrap">non-deductible</FONT> tax items. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>10. Tax reform effect </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">One-time</FONT> <FONT STYLE="white-space:nowrap">non-cash</FONT> charges associated with change in value of our deferred tax assets due to tax reform. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>11. Deferred tax impact of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax impact associated with <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>12. Accrual of legal expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accruals made
associated with a <FONT STYLE="white-space:nowrap">one-time</FONT> legal settlement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Appendix B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2017 EMPLOYEE,
DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED (as proposed to be amended on December&nbsp;5, 2019) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>DEFINITIONS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Myriad Genetics, Inc. 2017 Employee,
Director and Consultant Equity Incentive Plan, as amended, have the following meanings: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Administrator</U> means the Board of
Directors, unless it has delegated power to act on its behalf to the Committee, in which case the term Administrator means the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Affiliate</U> means a corporation which, for purposes of Section&nbsp;424 of the Code, is a parent or subsidiary of the Company, direct or
indirect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Agreement</U> means an agreement between the Company and a Participant delivered pursuant to the Plan and pertaining to a
Stock Right, in such form as the Administrator shall approve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Board of Directors</U> means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Cause</U> means, with respect to a Participant (a)&nbsp;dishonesty with respect to the Company or any Affiliate, (b)&nbsp;insubordination,
substantial malfeasance or <FONT STYLE="white-space:nowrap">non-feasance</FONT> of duty, (c)&nbsp;unauthorized disclosure of confidential information, (d)&nbsp;breach by a Participant of any provision of any employment, consulting, advisory,
nondisclosure, <FONT STYLE="white-space:nowrap">non-competition</FONT> or similar agreement between the Participant and the Company or any Affiliate, and (e)&nbsp;conduct substantially prejudicial to the business of the Company or any Affiliate;
provided, however, that any provision in an agreement between a Participant and the Company or an Affiliate, which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede
this definition with respect to that Participant. The determination of the Administrator as to the existence of Cause will be conclusive on the Participant and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Change of Control</U> means the occurrence of any of the following events: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Ownership</I>. Any &#147;Person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act)
becomes the &#147;Beneficial Owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented
by the Company&#146;s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company or its Affiliates or by any employee benefit plan of the Company) pursuant to a transaction or a series of related
transactions which the Board of Directors does not approve; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Merger/Sale of Assets</I>. (A)&nbsp;A merger or consolidation of the Company whether or not approved by the
Board of Directors, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity or the parent of such corporation) more than 50% of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation, as the case may be, outstanding
immediately after such merger or consolidation; or (B)&nbsp;the sale or disposition by the Company of all or substantially all of the Company&#146;s assets in a transaction requiring stockholder approval; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Change of Control&#148; shall be interpreted, if applicable, in a manner, and limited to the extent
necessary, so that it will not cause adverse tax consequences under Section&nbsp;409A. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Code</U> means the United
States Internal Revenue Code of 1986, as amended including any successor statute, regulation and guidance thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Committee</U> means
the committee of the Board of Directors to which the Board of Directors has delegated power to act under or pursuant to the provisions of the Plan, the composition of which shall at all times satisfy the provisions of Section&nbsp;162(m) of the
Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Common Stock</U> means shares of the Company&#146;s common stock, $.01 par value per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Company</U> means Myriad Genetics, Inc., a Delaware corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Consultant</U> means any natural person who is an advisor or consultant that provides bona fide services to the Company or its Affiliates,
provided that such services are not in connection with the offer or sale of securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market for the Company&#146;s or its Affiliates&#146; securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Disability</U> or <U>Disabled</U> means permanent and total disability as defined in Section&nbsp;22(e)(3) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Employee</U> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an
officer or director of the Company or of an Affiliate), designated by the Administrator to be eligible to be granted one or more Stock Rights under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Exchange Act</U> means the Securities Exchange Act of 1934, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Fair Market Value</U> of a Share of Common Stock means: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) If the Common Stock is listed on a national securities exchange or traded in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market and sales prices are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting
system for the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) If the Common Stock is not traded on a national securities exchange but is traded on the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in clause&nbsp;(1), and if bid and asked prices for the Common Stock are regularly
reported, the mean between the bid and the asked price for the Common Stock at the close of trading in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market for the trading day on which Common
Stock was traded on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) If the Common Stock is neither listed on a national securities exchange nor traded in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, such value as the Administrator, in good faith, shall determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Participant</U> means an Employee, director or Consultant of the Company or an Affiliate to whom one or more Stock Rights are granted under
the Plan.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>As used herein, &#147;Participant&#148; shall include &#147;Participant&#146;s Survivors&#148; where the context requires. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Plan</U> means this Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Restricted Stock Grant</U> means a grant by the Company of Shares under the Plan that are subject to a lapsing forfeiture or repurchase
right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Restricted Stock Unit Award</U> means a grant by the Company under the Plan of an unfunded, unsecured commitment by the Company
to deliver a <FONT STYLE="white-space:nowrap">pre-determined</FONT> number of Shares to a Participant at a future time in accordance with the terms and conditions of the award agreement and the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Securities Act</U> means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Shares</U> means shares of the Common Stock as to which Stock Rights have been or may be granted under the Plan or any shares of capital
stock into which the Shares are changed or for which they are exchanged within the provisions of Paragraph&nbsp;3 of the Plan. The Shares issued under the Plan may be authorized and unissued shares or shares held by the Company in its treasury, or
both. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Stock Right</U> means a right to Shares or the value of Shares of the Company granted pursuant to the Plan &#151; a Restricted
Stock Grant or a Restricted Stock Unit Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Survivor</U> means a deceased Participant&#146;s legal representatives and/or any person or
persons who acquired the Participant&#146;s rights to a Stock Right by will or by the laws of descent and distribution. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>PURPOSES OF THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is intended to encourage ownership of Shares by Employees and directors of and certain Consultants to the Company and its Affiliates
in order to attract and retain such people, to induce them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to promote the success of the Company or of an Affiliate. The Plan provides for the
granting of Restricted Stock Grants and Restricted Stock Unit Awards and shall not allow for the grant of stock options. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SHARES SUBJECT TO THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Commencing on December&nbsp;5, 2019, the number of Shares which may be issued from time to time pursuant to this Plan shall not exceed
1,714,267<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> Shares of Common Stock, plus (i)&nbsp;any Shares of Common Stock that are represented by options previously granted under the Company&#146;s 2003 Employee, Director and Consultant Stock
Option Plan, as amended, and (ii)&nbsp;any Shares of Common Stock that are represented by options or restricted stock units previously granted under the 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, that are forfeited,
expire or are cancelled without delivery of Shares of Common Stock, or the equivalent of such number of Shares after the Administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination,
recapitalization or similar transaction in accordance with Paragraph 18 of this Plan; provided, however, that as of December&nbsp;5, 2019 no more than 5,628,833<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> shares shall be added to the plan
pursuant to subsections (i)&nbsp;and (ii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any Restricted Stock Unit Award expires or is forfeited, cancelled, or otherwise
terminated or results in any Shares not being issued or the Company shall reacquire (at not more than its original issuance price) any Shares issued pursuant to a Restricted Stock Grant, the unissued or reacquired Shares which were subject to such
Stock Right shall again be available for issuance from time to time pursuant to this Plan. Notwithstanding the foregoing, if the Company or an Affiliate&#146;s tax withholding obligation is satisfied by withholding Shares, the number of Shares
deemed to have been issued under the Plan for purposes of the limitation set forth in Paragraph 3(a) above shall be the number of Shares that were subject to the Stock Right or portion thereof, and not the net number of Shares actually issued.<SUP
STYLE="font-size:85%; vertical-align:top">3 </SUP> </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Balance consists of 514,267 remaining shares available for issuance under the 2017 Plan as of October&nbsp;8,
2019 and 1,200,000 additional shares subject to stockholder approval at the annual meeting of stockholders to be held on December&nbsp;5, 2019. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This number consists of options to purchase 360,239 shares of common stock that are outstanding under the 2003
Plan, and options to purchase 4,604,172 shares of common stock and unvested restricted stock units representing 664,422 shares of common stock under the 2010 Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of October&nbsp;8, 2019, unvested restricted stock units representing 2,005,323 shares of common stock are
outstanding under the 2017 Plan. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ADMINISTRATION OF THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator of the Plan will be the Board of Directors, except to the extent the Board of Directors delegates its authority to the
Committee, in which case the Committee shall be the Administrator. Subject to the provisions of the Plan, the Administrator is authorized to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interpret the provisions of the Plan and all Stock Rights and to make all rules and determinations which it deems necessary
or advisable for the administration of the Plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Determine which Employees, directors and Consultants shall be granted
Stock Rights; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Determine the number of Shares for which a Stock Right or Stock Rights shall be granted, provided,
however, that in no event shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Stock Rights with respect to more than 500,000 Shares be granted to any Participant
in any fiscal year; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the aggregate grant date fair value of Shares to be granted to any <FONT
STYLE="white-space:nowrap">non-employee</FONT> director under the Plan in any calendar year may not exceed $500,000; provided however that the foregoing limitation shall not apply to Stock Rights made pursuant to an election to receive equity in
lieu of cash for all or a portion of fees received for service on the Board of Directors or any Committee thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)
Specify the terms and conditions upon which a Stock Right or Stock Rights may be granted; provided, however, that except in the case of death, disability or Change of Control, Stock Rights shall not vest, and any right of the Company to restrict or
require Shares subject to a Stock Grant shall not lapse, less than one year from the date of grant and no dividends or dividend equivalents shall be paid on any Stock Right prior to the vesting of the underlying Shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Amend any term or condition of any outstanding Stock Right, provided that no such change shall impair the rights of a
Participant under any grant previously made without such Participant&#146;s consent; provided however, the Administrator is not authorized to accelerate the vesting schedule of an outstanding Stock Right except in the case of death, disability or
Change of Control; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Adopt any <FONT STYLE="white-space:nowrap">sub-plans</FONT> applicable to residents of any
specified jurisdiction as it deems necessary or appropriate in order to comply with or take advantage of any tax or other laws applicable to the Company, any Affiliate or to Participants or to otherwise facilitate the administration of the Plan,
which <FONT STYLE="white-space:nowrap">sub-plans</FONT> may include additional restrictions or conditions applicable to Stock Rights or Shares issuable pursuant to a Stock Right; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that all such interpretations, rules, determinations, terms and conditions shall be made and prescribed in the context of potential tax
consequences under Section&nbsp;409A of the Code. Subject to the foregoing, the interpretation and construction by the Administrator of any provisions of the Plan or of any Stock Right granted under it shall be final, unless otherwise determined by
the Board of Directors, if the Administrator is the Committee. In addition, if the Administrator is the Committee, the Board of Directors may take any action under the Plan that would otherwise be the responsibility of the Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent permitted under applicable law, the Board of Directors or the Committee may
allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any portion of its responsibilities and powers to any other person selected by it. The Board of Directors or the Committee may
revoke any such allocation or delegation at any time. Notwithstanding the foregoing, only the Board of Directors or the Committee shall be authorized to grant a Stock Right to any director of the Company or to any &#147;officer&#148; of the Company
(as defined by Rule <FONT STYLE="white-space:nowrap">16a-1</FONT> under the Exchange Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ELIGIBILITY FOR PARTICIPATION.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator will, in its sole discretion, name the Participants in the Plan; provided, however, that each Participant must be an
Employee, director or Consultant of the Company or of an Affiliate at the time a Stock Right is granted. Notwithstanding the foregoing, the Administrator may authorize the grant of a Stock Right to a person not then an Employee, director or
Consultant of the Company or of an Affiliate; provided, however, that the actual grant of such Stock Right shall be conditioned upon such person becoming eligible to become a Participant at or prior to the time of the execution of the Agreement
evidencing such Stock Right. The granting of any Stock Right to any individual shall neither entitle that individual to, nor disqualify him or her from, participation in any other grant of Stock Rights or any grant under any other benefit plan
established by the Company or any Affiliate for Employees, directors or Consultants. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>TERMS AND CONDITIONS OF RESTRICTED STOCK GRANTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Restricted Stock Grant to a Participant shall state the principal terms in an Agreement duly executed by the Company and, to the extent
required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of
the Company, subject to the following minimum standards: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Agreement shall state the purchase price per share, if
any, of the Shares covered by each Restricted Stock Grant, which purchase price shall be determined by the Administrator but shall not be less than the minimum consideration required by the<B> </B>Delaware General Corporation Law, if any, on the
date of grant of the Restricted Stock Grant; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Agreement shall state the number of Shares to which the Restricted
Stock Grant pertains; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Agreement shall include the terms of any right of the Company to restrict or reacquire the
Shares subject to the Restricted Stock Grant, including the time and events upon which such rights shall accrue and the purchase price therefor, if any within the parameters set forth in the Plan; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Dividends (other than stock dividends to be issued pursuant to Section&nbsp;18 of the Plan) may accrue but shall not be
paid prior to the time, and only to the extent that, the restrictions or rights to reacquire the Shares subject to the Restricted Stock Grant lapse. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS. </U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Restricted Stock Unit Award to a Participant shall state the principal terms in an Agreement duly executed by the Company and, to the
extent required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best
interest of the Company. Each Agreement shall include the terms of any right of the Company including the right to terminate the Restricted Stock Unit Award without the issuance of Shares, the terms of any vesting conditions within the parameters
set forth in the Plan, or events upon which Shares shall be issued provided that dividends (other than stock dividends to be issued pursuant to Section&nbsp;18 of the Plan) or dividend equivalents may accrue but shall not be paid prior to and only
to the extent that, the Shares subject to the Restricted Stock Unit Award vest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the Plan and any Restricted
Stock Unit Awards granted hereunder be exempt from the application of Section&nbsp;409A of the Code or meet the requirements of paragraphs (2), (3) and (4)&nbsp;of subsection (a)&nbsp;of Section&nbsp;409A of the Code, to the extent applicable, and
be operated in accordance with Section&nbsp;409A so that any compensation deferred under any Restricted Stock Unit Award (and applicable investment earnings) shall not be included in income under Section&nbsp;409A of the Code. Any ambiguities in the
Plan shall be construed to effect the intent as described in this Paragraph 7. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>PAYMENT IN CONNECTION WITH THE ISSUANCE OF RESTRICTED STOCK GRANTS AND ISSUE OF SHARES FOR STOCK RIGHTS.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Restricted Stock Grant requiring payment of a purchase price for the Shares as to which such Restricted Stock Grant
is being granted shall be made (a)&nbsp;in United States dollars in cash or by check, or (b)&nbsp;at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six months (if required to avoid negative
accounting treatment) and having a Fair Market Value equal as of the date of payment to the purchase price of the Restricted Stock Grant, or (c)&nbsp;at the discretion of the Administrator, by any combination of (a)&nbsp;and (b) above; or
(d)&nbsp;at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company shall when required by the applicable Agreement, reasonably promptly deliver the Shares as to which such Stock Right was made to the Participant (or to the Participant&#146;s Survivors, as the case may be), subject to any escrow provision
set forth in the applicable Agreement. In determining what constitutes &#147;reasonably promptly,&#148; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or
regulation (including, without limitation, state securities or &#147;blue sky&#148; laws) which requires the Company to take any action with respect to the Shares prior to their issuance. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>RIGHTS AS A SHAREHOLDER.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Participant to whom a Stock Right has been granted shall have rights as a shareholder with respect to any Shares covered by such Stock
Right, except after issuance of Shares as set forth in any Agreement and tender of the aggregate purchase price, if any, for the Shares being purchased, and registration of the Shares in the Company&#146;s share register in the name of the
Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ASSIGNABILITY AND TRANSFERABILITY OF STOCK RIGHTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By its terms, a Stock Right granted to a Participant shall not be transferable by the Participant other than (i)&nbsp;by will or by the laws of
descent and distribution, or (ii)&nbsp;as approved by the Administrator in its discretion and set forth in the applicable Agreement provided that no Stock Right may be transferred by a Participant for value. The designation of a beneficiary of a
Stock Right by a Participant, with the prior approval of the Administrator and in such form as the Administrator shall prescribe, shall not be deemed a transfer prohibited by this Paragraph. Except as provided above during the Participant&#146;s
lifetime, a Stock Right shall only be exercisable by or issued to such Participant (or his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject
to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of any Stock Right or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of any attachment
or similar process upon a Stock Right, shall be null and void. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT OF TERMINATION OF SERVICE ON UNACCEPTED RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a termination of service (whether as an Employee, director or Consultant) with the Company or an
Affiliate for any reason before the Participant has accepted a Restricted Stock Grant or a Restricted Stock Unit Award and paid the purchase price, if required, such grant shall terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Paragraph 11 and Paragraph 12 below, a Participant to whom a Stock Right has been issued under the Plan who is absent
from work with the Company or with an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such
absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#146;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, for purposes of this Paragraph 11 and Paragraph 12 below, any change of employment or other service within or among the Company
and any Affiliates shall not be treated as a termination of employment, director status or consultancy so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF TERMINATION OF SERVICE OTHER THAN FOR
CAUSE OR DEATH OR DISABILITY.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, in the event of a
termination of service for any reason (whether as an Employee, director or Consultant), other than termination for Cause, Disability, or death for which events there are special rules in Paragraphs 13, 14, and 15, below, before all forfeiture
provisions or Company rights of repurchase shall have lapsed, then the Company shall have the right to cancel or repurchase that number of Shares subject to a Restricted Stock Grant as to which the Company&#146;s forfeiture or repurchase rights have
not lapsed or cancel a Restricted Stock Unit Award without the issuance of any additional Shares thereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF TERMINATION OF SERVICE FOR CAUSE.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, the following rules apply if the Participant&#146;s
service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All Shares subject
to any Restricted Stock Grant that remain subject to forfeiture provisions or as to which the Company shall have a repurchase right and Restricted Stock Unit Awards for which Shares have not been issued shall be immediately forfeited to the Company
as of the time the Participant is notified his or her service is terminated for Cause. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Cause is not limited to events which have
occurred prior to a Participant&#146;s termination of service, nor is it necessary that the Administrator&#146;s finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant&#146;s termination of service,
that either prior or subsequent to the Participant&#146;s termination the Participant engaged in conduct which would constitute Cause, then all Shares subject to any Restricted Stock Grant that remained subject to forfeiture provisions or as to
which the Company had a repurchase right and Restricted Stock Unit Awards for which Shares have not been issued on the date of termination shall be immediately forfeited to the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF TERMINATION OF SERVICE FOR
DISABILITY.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, the following rules apply if a
Participant ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability: to the extent the forfeiture provisions or the Company&#146;s rights of repurchase have not lapsed on the date of the
Participant&#146;s termination due to Disability, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro
rata portion of the Shares subject to such Stock Right through the date of the Participant&#146;s termination due to Disability as would have lapsed had the Participant not been terminated due to Disability. The proration shall be based upon the
number of days accrued prior to the date of the Participant&#146;s termination due to Disability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall make the
determination both as to whether Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used
for such determination). If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR
CONSULTANT.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, the following rules apply in the event
of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate: to the extent the forfeiture provisions or the Company&#146;s rights of repurchase have not lapsed on the date of death,
they shall lapse in full on the Participant&#146;s date of death. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>PURCHASE FOR INVESTMENT.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the offering and sale of the Shares shall have been effectively registered under the Securities Act, the Company shall be under no
obligation to issue the Shares under the Plan unless and until the following conditions have been fulfilled: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The person who receives a
Stock Right shall warrant to the Company, prior to the receipt of such Shares, that such person is acquiring such Shares for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such
Shares, in which event the person acquiring such Shares shall be bound by the provisions of the following legend (or a legend in substantially similar form) which shall be endorsed upon the certificate evidencing the Shares issued pursuant to such
Stock Right: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise
transferred by any person, including a pledgee, unless (1)&nbsp;either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&nbsp;the Company shall have received an opinion
of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2)&nbsp;there shall have been compliance with all applicable state securities laws.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At the discretion of the Administrator, the Company shall have received an opinion of its counsel that the Shares may be issued in
compliance with the Securities Act without registration thereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>DISSOLUTION OR LIQUIDATION OF THE COMPANY.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the rights of a Participant or a Participant&#146;s Survivors have not otherwise terminated and expired, the Participant or the
Participant&#146;s Survivors will have the right immediately prior to such dissolution or liquidation to accept any Stock Right to the extent that the Stock Right is exercisable or subject to acceptance as of the date immediately prior to such
dissolution or liquidation. Upon the dissolution or liquidation of the Company, all Restricted Stock Grants and Restricted Stock Unit Awards which have not been accepted, to the extent required under the applicable Agreement, will terminate and
become null and void and any outstanding Restricted Stock Unit Awards shall immediately terminate unless otherwise determined by the Administrator or specifically provided in the applicable Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ADJUSTMENTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of any of the following events, a Participant&#146;s rights with respect to any Stock Right granted to him or her hereunder
shall be adjusted as hereinafter provided, unless otherwise specifically provided in a Participant&#146;s Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<U>Stock Dividends and Stock Splits</U>. If (i)&nbsp;the shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its
outstanding Common Stock, or (ii)&nbsp;additional shares or new or different shares or other securities of the Company or other <FONT STYLE="white-space:nowrap">non-cash</FONT> assets are distributed with respect to such shares of Common Stock, each
Stock Right and the number of shares of Common Stock deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made including, in the purchase price per share, to reflect such events.
The number of Shares subject to the limitations in Paragraph 3(a) and 4(c)<B> </B>shall also be proportionately adjusted upon the occurrence of such events. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Corporate Transactions</U>. If the Company is to be consolidated with or acquired by another entity in a merger,
consolidation, or sale of all or substantially all of the Company&#146;s assets other than a transaction to merely change the state of incorporation (a &#147;Corporate Transaction&#148;), the Administrator or the board of directors of any entity
assuming the obligations of the Company hereunder (the &#147;Successor Board&#148;), shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) as to outstanding
Restricted Stock Unit Awards, either (a)&nbsp;make appropriate provision for the continuation of such Restricted Stock Unit Awards by substituting on an equitable basis for the Shares then subject to such Restricted Stock Unit Awards either the
consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (b)&nbsp;terminate such Restricted Stock Unit Awards in exchange for
payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock which would have been issued pursuant to such Restricted Stock Unit Award. For purposes of
determining the payments to be made in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith
by the Board of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) as to outstanding Restricted Stock Grants either, (a)&nbsp;make appropriate provision for
the continuation of such Restricted Stock Grants on the same terms and conditions by substituting on an equitable basis for the Shares then subject to such Restricted Stock Grants either the consideration payable with respect to the outstanding
Shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (b)&nbsp;terminate such Restricted Stock Grants in exchange for payment of an amount equal to the consideration payable upon
consummation of such Corporate Transaction to a holder of the number of shares of Common Stock comprising such Restricted Stock Grant; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">In taking any of the actions permitted under this Paragraph 18(b), the
Administrator shall not be obligated by the Plan to treat all Stock Rights, all Stock Rights held by a Participant, or all Stock Rights of the same type, identically. The Administrator or the Successor Board shall determine the specific adjustments
to be made under this Paragraph 18, including, but not limited to the effect of any, Corporate Transaction or Change of Control and, subject to Paragraph 4, its determination shall be conclusive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Recapitalization or Reorganization</U>. In the event of a recapitalization or reorganization of the Company other than a
Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, a Participant shall be entitled to receive after the recapitalization or reorganization
for the price paid, if any, the number of replacement securities which would have been received if such Shares had been issued prior to such recapitalization or reorganization. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ISSUANCES OF SECURITIES.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock
of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Stock Rights. Except as expressly provided herein, no adjustments shall be made for dividends paid in cash or in
property (including without limitation, securities) of the Company prior to any issuance of Shares pursuant to a Stock Right. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>FRACTIONAL SHARES.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares shall be issued under the Plan and the Participant shall receive from the Company cash in lieu of such fractional shares
equal to the Fair Market Value thereof. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>WITHHOLDING.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any federal, state, or local income taxes, employment taxes, Federal Insurance Contributions Act withholdings or other
amounts are required by applicable law or governmental regulation to be withheld from the Participant&#146;s salary, wages or other remuneration in connection with the issuance of a Stock Right or Shares under the Plan or for any other reason
required by law, the Company may withhold from the Participant&#146;s compensation, if any, or may require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs or employed the Participant, the
statutory minimum amount of such withholdings unless a different withholding arrangement, including the use of shares of the Company&#146;s Common Stock or a promissory note, is authorized by the Administrator (and permitted by law). For purposes
hereof, the fair market value of the shares withheld for purposes of payroll withholding shall be determined in the manner set forth under the definition of Fair Market Value provided in Paragraph 1 above, as of the most recent practicable date. If
the Fair Market Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the difference in cash to the Company or the Affiliate employer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>TERMINATION OF THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan will terminate on September&nbsp;14, 2027, the date which is ten years from the <U>earlier</U> of the date of its adoption by the
Board of Directors and the date of its approval by the shareholders of the Company. The Plan may be terminated at an earlier date by vote of the shareholders or the Board of Directors of the Company; provided, however, that any such earlier
termination shall not affect any Agreements executed prior to the effective date of such termination. Termination of the Plan shall not affect any Stock Rights theretofore granted. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>AMENDMENT OF THE PLAN AND AGREEMENTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan may be amended by the shareholders of the Company. The Plan may also be amended by the Administrator; provided that any amendment
approved by the Administrator which the Administrator determines is of a scope that requires shareholder approval shall be subject to obtaining such shareholder approval. Any modification or amendment of the Plan shall not, without the consent of a
Participant, adversely affect his or her rights under a Stock Right previously granted to him or her. With the consent of the Participant affected, the Administrator may amend outstanding Agreements in a manner which may be adverse to the
Participant but which is not inconsistent with the Plan. In the discretion of the Administrator, outstanding Agreements may be amended by the Administrator in a manner which is not adverse to the Participant. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EMPLOYMENT OR OTHER RELATIONSHIP.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Plan or any Agreement shall be deemed to prevent the Company or an Affiliate from terminating the employment, consultancy or
director status of a Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any Participant a right to be retained in employment or other service by the Company or any
Affiliate for any period of time. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SECTION 409A.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Participant is a &#147;specified employee&#148; as defined in Section&nbsp;409A of the Code (and as applied according to procedures of the
Company and its Affiliates) as of his separation from service, to the extent any payment under this Plan or pursuant to the grant of a Restricted Stock Unit Award constitutes deferred compensation (after taking into account any applicable exemptions
from Section&nbsp;409A of the Code), and to the extent required by Section&nbsp;409A of the Code, no payments due under this Plan or pursuant to a Restricted Stock Unit Award may be made until the earlier of: (i)&nbsp;the first day of the seventh
month following the Participant&#146;s separation from service, or (ii)&nbsp;the Participant&#146;s date of death; provided, however, that any payments delayed during this <FONT STYLE="white-space:nowrap">six-month</FONT> period shall be paid in the
aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant&#146;s separation from service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall administer the Plan with a view toward ensuring that Stock Rights under the Plan that are subject to Section&nbsp;409A
of the Code comply with the requirements thereof, but neither the Administrator nor any member of the Board, nor the Company nor any of its Affiliates, nor any other person acting hereunder on behalf of the Company, the Administrator or the Board
shall be liable to a Participant or any Survivor by reason of the acceleration of any income, or the imposition of any additional tax or penalty, with respect to a Stock Right, whether by reason of a failure to satisfy the requirements of
Section&nbsp;409A of the Code or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>INDEMNITY.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the Board nor the Administrator, nor any members of either, nor any employees of the Company or any parent, subsidiary, or other
Affiliate, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with their responsibilities with respect to this Plan, and the Company hereby agrees to indemnify the members of the
Board, the members of the Committee, and the employees of the Company and its parent or subsidiaries in respect of any claim, loss, damage, or expense (including reasonable counsel fees) arising from any such act, omission, interpretation,
construction or determination to the full extent permitted by law. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CLAWBACK.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in this Plan, the Company may recover from a Participant any compensation received from any
Stock Right (whether or not settled) or cause a Participant to forfeit any Stock Right (whether or not vested) in the event that the Company&#146;s Clawback Policy then in effect is triggered. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>GOVERNING LAW.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Plan shall be construed and enforced in accordance with the law of the State of Delaware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp-088.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">VOTE BY INTERNET&#151;www.proxyvote.com MYRIAD GENETICS, INC. Use the Internet to transmit your voting instructions and for electronic
delivery of information up until 11:59 P.M. Eastern Time on December 4, 2019. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. ATTN:
CORPORATE SECRETARY 320 WAKARA WAY SALT LAKE CITY, UT 84108 ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future notices of
availability of proxy materials or proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted,
indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE&#151;1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on December 4, 2019.
Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes
Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: E85557-P29118 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY MYRIAD GENETICS, INC. For
Withhold For All To withhold authority to vote for any individual All All Except nominee(s), mark &#147;For All Except&#148; and write the The Board of Directors recommends you vote FOR number(s) of the nominee(s) on the line below. the following:
1. Election of three Class II Directors (or if any nominee is not available for election, such substitute as the Board of Directors may designate) for a three-year term. Nominees: 01) Mark C. Capone 02) Heiner Dreismann Ph.D. 03) Colleen F. Reitan
The Board of Directors recommends you vote FOR the following proposals: For Against Abstain 2. To approve a proposed amendment to our 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. 3. To ratify the selection of Ernst &amp;
Young LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2020. 4. To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. In their discretion,
the proxies are authorized to vote upon such other matters as may properly come before the meeting or any adjournments or postponementsthere of. This Proxy, when executed, will be voted in the manner directed herein. If no direction is made, this
proxy will be voted in accordance with the Board of Directors&#146; recommendations. PLEASE MARK, SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. NOTE: Please sign exactly as name(s) appear(s) hereon. Joint owners should each sign. When
signing as attorney, executor, administrator, trustee or guardian, please give full title as such. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>

<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805243dsp-089.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Annual Report
are available at www.proxyvote.com. E85558-P29118 MYRIAD GENETICS, INC. 320 Wakara Way Salt Lake City, Utah 84108 ANNUAL MEETING OF STOCKHOLDERS DECEMBER 5, 2019 THIS PROXY IS BEING SOLICITED BY MYRIAD GENETICS, INC.&#145;S BOARD OF DIRECTORS The
undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice Regarding the Availability of Proxy Materials in connection with the 2019 Annual Meeting of Stockholders to be held at 8:00 a.m., MST, on
Thursday, December&nbsp;5, 2019, at the offices of Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108 and hereby appoints Mark C. Capone and R. Bryan Riggsbee, and each of them (with full power to act alone) the attorneys and proxies
of the undersigned, with power of substitution to each, and authorizes each of them to represent the undersigned and to vote all shares of the Common Stock of MYRIAD GENETICS, INC. registered in the name provided herein which the undersigned is/are
entitled to vote at the 2019 Annual Meeting of Stockholders, and at any adjournments or postponements thereof, with all the powers the undersigned would have if personally present. Without limiting the general authorization hereby given, said
proxies are, and each of them is, instructed to vote or act on the proposals set forth in said Proxy as specified by the undersigned. SEE REVERSE SIDE FOR ALL PROPOSALS. The proxies will vote in accordance with the Board of Directors&#146;
recommendations where a choice is not specified and in their discretion on any other matters as may properly come before the meeting or any adjournments or postponements thereof. Continued and to be signed on reverse side </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g805243dsp-088.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp-088.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
M   !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P/_P  1" .$ LH# 1$  A$! Q$!_\0 M0 !  (" P$! 0            8'
M!0@$"0H# @$! 0$! 0                 ! @,0  $$ P$   0# P01 P
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M64U!%N_4_#E2;9=N>^JZ_$'K;OGIRZ=6JO2N, N5,^;?PXQW"<U*,RV3OJ^
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ME%2*&D&4,C]-)U)>W%7)G27E#DWPPR8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M%@NM7#VXW> %"K%PJ;=G.BNE!(4F_! =P]%G"D\8D&1D6.%7304O1(DEI_\
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MN>XA7VZ[:W>>6NSCK]8 RA+%0LE=LO2U3/4MWY,GG'/1\:R3X0>W<HYF(&6
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MU^A1ZQ467#CSGQS[:M.M)9?VI49VV<<=\NMNSB_N"7JU_;;O_ICG_KVD6OF
MSV;Z)N?5/,'C?FMUO52Z7T.T(XMYVI]SY@S2^@<NC7_? 1TXD9?EC93\1PDA
MM+K*_DJ0;^W63';K5E>L_/?L+?I#T!]QCF/%.O=4[7X>M/AV@>4PI"J0Q-X]
M#<E"<MN<;U?JL5X' %B);%U/>CY:IR!\6-"3.K#J&64I92E)-MVXFV]+G/\
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M_2-)D.F;MX_-NUADP& P& P& P& P& P& P& P& P*1NOG'B?139FP76@#;
M0L8I\186IDTR@.=8?K1BF_6F:[&),5\F?BU*P3!L8H_%62B09"F67VV_P3HL
MMG1A'O)_G^0$9KTGGS4H:U^I/CW*LEPDDIWZL@5X8:T6./V!PV:2N%4 Z8VI
M<A_4#88>J+\E<&(ID<JRH;S1PX KY@SGX]$E3Q>4].ED3Q0E,F'T=(0;GD"9
M0K,($B!?][]F5)D/N.//.&'UJ5M>TJ2.5?JQ<#I5EM?$#DZ)#T"X"W8GZ'5-
MBXDF)'+&Z1,YM%EO$9FY$O8\32#1&(B'K7RWW93;SJE+CM:T,_Y1I_Q[YQE
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MQ7A>I?US4@8$/09DA"F]*9BS6'5ZTV\VI1,5'XG9^/3Z:8Z-!ZOS6;SVO2Y
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M)T79 4QR'(<B2VXI<-*FCY"XLIE;3FD.;VAQ.TJ_#>MZP=$EP& P& P& P&
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M^3;W2&;2FQV&PW"^GYY ].G6"[DC!'31@@0)N2OI1S$;3C"6U_$2V]U/\O\
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M,.OWCD 2_P PD7LDCX7:]&<(K+3=L*DDYJQC\Z4I;#:5EO*=>[L6PP8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8&H=^\N4*P7T]U"S'1$1XY>@%G<V8KX1UJ/,C\*OOG@('T5(
MR$+=VX[TU<^-^/X+^LUJ.VG?SMKPUFXPJ>#X,*Q3,(Y,[@0/3JU5JY6J1^H*
MA-)1 K-4O_ ^A@8Y0-N^-5V:$&$."Q8:(XR$$ER(1)[<N9*EH3*V.3-47P53
MZ99!EA<LC9R17KQ:K6!G$Q%@)6#8VRB.Z1& 1N?8K[8@#S]>,=W(38<T2)"+
MWMG:7FW7)#CVA=S!!/ C\"PT\P9[48LL&A@Z=6ZT,)5B1MM@#4;5Y^M<<%)A
MKN3]4;#Z?X(S'93!$092F"KRILB>\TV[L<EGUWS[7W."7WRV2ZQ$,I-Q;*/@
MPZZQ&A-\TK4K\MT(IU<J1JR7,TBDU+3L5"(!4C/0J-*^D^-J$N/&9&=<LYR_
MS!%HO6RG;CUF%V2]GX=\:+)#4J-4JW"E7I7)XTIVI"G#ED(5V*D3R <B6VN=
M,>)37GI3[_X[0VD6YF%&](\=N=,M_>)O1[O5:E1>H]'+$*A"9JP619BA2[>4
M:KYF3^<6R:9B;(B)"99=**XN&IZ9(:C*U+^1OZ78F[&/%([OX1$7B9:QLOH*
MQE"LUBZ;8TA!5-@1;C >[0&$U;HXS]?H,I6^)36(TIJO)0.8?!3%0)/S96Q,
M%IL<OJR7GOS3(YMV:S7%\RR6J]2YE2.5TYAE(-F.1N(X0("=&Z.L((D34UHX
M;I%%I%?D,J6TMQZO29"&([,M*%BW,20GY5)2>C&K^%Z/$J[$SJ=:ZJ'J@FD+
MD5\99QU8OU.M-HEQ#%O)L2K_ &X#>M)=)0FQ@[4D5#D21DUWZE4@<M,*>@_;
MT4X&M0^S]K-V(G>QMQ V^Q+KY5)B>&O'!X/$#<H:0-7ZQ$@UI?0'B%_JFY"Q
MK;^GHS(YF,XTB.7EY)O7O"U1%OMDB9@),-/E>3'B\B%4R[T,B;Y;W1KMBR;/
MZ]OO1;'#?M;\.+ EIV5>:9W'U(90G?X,I)R4J;\,\2@'"U*L?:ZJDK>:HV"@
M5>U//-V0>8G"KC2A!.E5;731-76*EU6U21BA\ROE%R%[D*CR6/GK;27E5]V7
MQE ,&[H8@VH%IJ[JZ.Y.$6.CD28\?)O%RYC?0Y$1*JE]H1X86IMJYNF=&EQY
MK3ZYDE$A"F'X^G'"3<N*M5Z]_NVOG-K1<0%\/AZ\BF 3##R8]G)CU<U!#&#7
M3--(:@0+E;+/^8$G=0XS$)F%+CH;2O;:W7"=\M4^:^ &(U+K,;IEQBO6A/%5
M\F,LTFHBJP/!09W Z_PS<FM+T0,M0[2("P9FW2K2$-SM/MLHBQHL=IC"W=JS
MLGPHDG;ZYT>U7\8<LM2ME?NT0'6^7 :S3C$VL4NM\S9"S:P0LIEET8:YR*G0
MY++DU+&RTN"11\G804Q&')+>/\''<P\IFN3=AN2@1+JT2RUNXV6;9A44N/<Z
M)#3SF@U*!9'TLC)]EI/.V0-7@/M(5J=)%-.-H6IS6E"W.[,[(Q?_ !/;NHLT
MB%<>XQ61%+ C T>OT[FTVHUK<@2)N0%!B!6HO2Y=?CSS@>ULL$]38I)OX1C"
M1J1;;DE#PF[#X77Q+6')#,N==Z$,YU$-A['/JURY@,GCY=@C^<)/E4>&D6-B
MYU>0.H$VMS8DE(B)J+,T22M#!!MJ1\I F[ZK_F\3NDK@X'D6NSV1=G$.UM9#
MI4R#-42L<,'9XAZ8"*M"[,'M+88P+C;%./QS[)SZ3>G%DG96W7W29URUQ#?;
MIIX[E*.7R^@$YJE[2B?;6:R+BV";"1Y;(>9$#W)#\T@XY"1 G?FWRWW)#;BD
M?2.)6TM3FS7+7+82C\0.42D][A3^F#X-J[39+)=YUYIM&%44=02Q+EU-YQ%)
MUZND#-KC.+ ,4ADGIXE,EJ>DK5I[:F]:UAG/10-&\&!!CA.SRNIJM!6SS1MA
M8/1@,Z8TPI-SX1?-20A6T7J\V1R,3E<,A*VX\6E*VN9MU"_P89;T6[F=%^.!
ME:+4U= ZF* WKF->J6AZ)5)%EXFVVI_H.*Y8+#5H-D!3GT62)VH\U%<^J82V
M0@_/^.1KZF.L9SU0:O>(!DRTT5W?HZ9;HW(:M0ZD$KK8V.])%#N?$.*C9<&3
M!@7-=:&#YUH\\25;TR&C$&2!&:U(F2]1&&F2\O)L7Z!\M5[T!**3#-CG@9,S
MD=HY;!DCH*%S!NK%=^?7O1=L@U-@D/I$E.=1&)D%EV/J?$<6C;[2M)7HDW8:
M\_[!LHA=2\&=8J^"YL6I')V;',JU>,_K6QW:H]L[IV4[,J=KMU]N5RYRB78.
MAPWI;K\\ZN=J1(2SN*O\7,+RT\TOK_C"LU>QUNW7SHX0@3'4^/R (V-HX&AA
MW0^^<S>5U?4 <\;--)Z X),S4R)C"](GMN,Q&(D6+'0RHG*U;'$_.A;D-K:L
M:[[ )0U\LIW/C8"NU"?5!UP/TL+5JT)Z1:69]WMT)VU0*S5FQD50^.-_]@[\
MF6N;J-!W$);F*-,?;NJ!YCHD A?"[4>]VF]&VCD!BRZO L'T8CU$]8ZLZ:+W
MTU6'(L6P]0?D#I X&(>8;B-HD:EK6X[LO)(:)Y5 <_N0Z(*Z314W4Q0[2,Z3
M6G*T=*3[;3+ =$IEW.J#+?UZV6ZC6#4H?'@3"BIA8/+VW'0N E4>/I N[,\F
M.JGDD!670PL%UFD3.OT^P<NM3$F?0Q)*%(_=%P.+P>'"M//F;M'.D!*J?;$D
MF_A*Q7!A0C'D,N);6EIT<OHXX/[>E0KE.14A5\(IVF0:?=-2:N'<)RVS?&N>
M<B=AR]QY,1IP?$3SUB?'CITAEE*FHJ$):C-*P<KG+\]#\7EC/*7^:S._-5#E
MP&7T0L\XW3Y8><]7+42G65PAT.SC^D H]JL=+D2I#D<G+98%R$//O$QLZ3MN
M4R)NUSW8L]X>D*N/-'Q%CEEP2^C0+%TDL_$$#V'^:@Y=WN)'FDB'N=*F&Q?2
M;L; _4H;;2VTP!^8MS7QZ:=+RT=DN&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# T:Z90_4D_J
MMK?I5@?7S%N7SF\U%M=NCCGI5CFW/F ._<_(P9,>4['IU9H=",FF5;2M,HA;
M'&VD[7%2C#4NW&O5&N8U+V9KF'IR/8)VJAT*XUAN9PV,=L^[>-I'0R%$(1#C
M0\I.O'1BFZG"NR8ZX#DF7&;<9U\](L?\;D1(^W,\'.@<O]4N<*>K,;IUE@&B
MIA"G!MDB0XG7:\)G]%K,J7$#=<'=HZ6-9'A:7&*::W,<-$Y:)24:EQE(;9;&
M9E!C')/6M9''!E8-WVZ"K1.N0LBHUV(K-L=8 0NXVJ5RTQ37]W[GA'9>!QE0
MJ).1^H1:YZ5.2"+I @QMF67.VI]YGY;Z+!]"@WKO3T<F9UR")49IG9H04=T?
M>"\;EEXK,<7IG284BX 3\G:DZ2C:W/BU^&G482V=D+YQR7UI)O',-WZU=&$4
MX,5K)'MJG>MQ)^NB7L'7>QO%[-1&PI!\A5N.'[+/K"55Q"0^W6VVD*',-Q9;
MLXN=N/-*^Z>=KOT+N<JS"6;BJKV%KR>Y.,#.GD00T(WQ?M]ZM][BCZ_^HHSX
M(Z4JUFA*BD1,-$I:&YB$RHTA;>WB2XCA<-YQZ\$]?JAKL%[L\RG!::#'[A0"
M (S6RS$*A/U\F$NRG+Y"E+NCU]3H]^<0JQ.?E-?*CK)L-;?B;%NW&C@L<,]#
MB^G6NS #!L#6WNM[O <(#O;0H$>8L?>*)-N1&T@XC[*#;TGB(\K&:CSOF-M+
M>WMI")NH[S1<S"H*=Y]]DTT</JE=MG0JT JG++N#IS3=\'6V++O"VNY(D2+<
M>LW4U$?H[H6L-6(@IZ@9J<(U"0RO\H2W)1(&=JR;=Q#UX*'7%_EO3KNJPO0Y
M=4J3MSZ8_8A$>K_[,H:)^;O"R<SY&[G/]%0I+S9-?X3(^W_C2XV.WMG0SM[I
MCR#D_8J/U&J]+ML?I]\V]R"V49]BP7D5%FU9R;VMNR 0UAK+_7KP /2!-.++
MU%-?FQXH]$';:E2=/J9;62V686OW+DMRN/2N<WN@0*M%L5.YWW<2*MY^(.E;
MK5TMU=K,7G9%R+(BRILZ##.C%NO::0OY;;>_Q3OX]:V)=,5$.3TGO,7G79A-
MJ(=2J^C].##.>PRU_J?2.N@+LB@NC;[;:_;"A@A5FHIRVK9E H4\@U$C2&'7
M5,#8\A,1@7&6DO9&_6U'Y^7EVXK?0A>Q<^N%>Y32>9=BDQ[V]VEOGM0$<VL<
M@G.L-D.6>'&,P2;Q("X6LFDE"K?PZ,1HZ9;99Q;]\<H'<*OU O8[O:;*:J]I
M3W&08%F[BD\'$2M]GBS.%QZJ VXN/7(D;DDN8S)3#2W\:DM)F;=?;;5HELQH
MU4N<'UZ(W11-HA]8( V[YS*C&MT/IP(98.F1D]*[$=MQ8 8&'!TVJA"'.E &
ME2BLVO3'%-[A_,B*;;DN%^U?EHXKVF[\@\KC;.;=F]=Y;<ZQ=;;8$6J?!AQS
MP?F]\$0B=@_)9(F->VQMH,#OKV-LJ9([0\XEK2%[3A,R6XZ(=Q_EGI_]XW-B
M5\.]-!<UKD$>0N=<L/8(EG+V;J4"D*@6.Q/SP)2<]*Y59;5(CR!H'Y\:.R_!
M>=<&P(TC4%0MF/-Q>Q\8]-W_ *YTUQ%B+SN6$9G/)=%K#,D&BC2ZT&>YG--5
M^PL$K]'GB+B+NP,P<8GQ:R\[+BK8B**H95N$@2S'FCU)Y=[&',A9'4;+U&]C
MW>A;D=0J=,NU?HI RAD'<F(MNY;;T]>_-(E!FV4@+D3:^N33?E18;.HX[^QE
MQIQ;=O9P*EY[],T^IS0P8WTR!"JPV6/%UUOM;LJ5<4&_4UNN71R @X3L!"3$
ML]JX),CP*_/+28NQ$N3M*=0)#>I;+Y&96>&<A]?+_.#S]OO<)Z!/I[',JH4Z
MI&(I$46?U7L2[@$Z,EJ>0#W>Z#>1'J]'61F2"B]28C.XLMZ5&=FODSM7OYVJ
MG;*],M:>PIN$ZU/"A; .X2+W!-\P4&;KE88' 1M!@V)AT5;@A6/,T5GK$)_,
MGM.O((NM2&H\<7';HTD3P3VU]5--0R/2:^5+5/A=5Z<>5T^MW"\76P4T#Z37
M<[+S%>ND4%FK45CIO0JZ:BAY1P.P_";=9T-::;>&RC6=OQ^BT=</]@UMPSND
MV=V'LG:S\62INQA T$G ZWU_OZ+YU%\3"T['B6RFU6]5FWPHB-_ Y,%J'-?V
M2EZV3.WNY-=X?ZN(%IT7I?8.I"ZL]UJ9*M\^N72!6(<GFHV#WB0#/TJRP;_8
M[4+86P7IL0F-0+JZ/FC]/:8DJU+ER(9G@NSR!<^N'::"D]B@VHI9NA0K)<8]
MAU"D-T<%5*2_4>9TUEM^=J#(@&^R"QKEX:@IBZ4SLE-2[MO33"5U-V,Z-78W
M-_5742<TV%?M\"*&[?V$BT3ZK=8!RISY]0],6!'$;)0Z,X\^0J8/G-&$26IS
M.X<+9B+(B:1HE\*)+9<[?\?[.8/YM[Q'5;F@R.7N\\S%MU=M%B.'KN+9*UY^
M <Y-#N=6D,M=RL@>VT"T !EF)0I)1%A>;FS=PVP@>-].MH9VI11.8^SV^@\N
M59;9?Q7.*L8VAV4]90=EM]B9'7G\V-GNTC)'8W:Y'3T:EN(%-1 GZIA!U,.R
MQXX*[);9BC.U9G7.+]3>[?;NJ4EN\SZW9P_GNNW(#3>K3:C:+53:,0[_ "[?
M6Z.HA9P 6FDXQRWU8@[):F!GI\)J?&:FMN2'].DEF,->A/G3UN.LT2^EMR2%
MAEAPD/H!&MWL**O]LK+S7E:';*F"M*9 !L;=R-<Y>5@N&$OBFY4B$MQJ3!^M
M8D-%SMQA(IO/ON#B(L"94[#-GZ#3(O1P->M?0@<^;)DIN=EY_ X;?#*DO-&Q
M8WA-CA6&>4:<=;EW,&E6GI&W52'1G:M7U1YWZ-T"J\V#U"7:[H4K''^^\O)E
M7KWNOJ)F>B\**4FNVVZ"9ID> M;<FSQVOJ-OL3W8K\W3R&%-Z>4@DJ,2^-^M
M!W3:B,"=(OS'&Z[>)SXB<U98%OM3 UPAQXVF7>W[+T2H/V2H38\.W"DQI+-B
MD#FI6E1QN_\ V+T09F/-V489,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#KYZWZ"[)2.G=9!4&
MJ IPRE5&X]!FS+1%OAY!X?SGEG/K@FK5>"-,#Q00Q:R%ID042&-.-M.,?/5%
MEO:<:4:DG=7=I];]KCEW" E^@MP*1T'NU>L]:&58I8:_;6P'$[OT3C=2$=2A
MVV2P];"<VM-I,--C1Y*&1VH>L:GX67IL7C&<M7LWJ-#&R:X9J-/L_6QQ%;TZ
MN5D/=XD-RDN>:1O6U=!CC5O'32:J%Z++EAGY&E.JF,"9+,=O4_\ M**<?I_V
MQA[TGV +=CSL,[2>^5Q@!QZS\Z <? 6.H_JR03A^@TVZ:#+P;Y>%6<80.T$6
M*5&>5-A1)C[6EZVZI"'28GR<9KV1W29LRNMA.5WP#3:/9NE&;Y6*UT)%;NL.
MK@>1&BO,*5#>L$M\=>Q,GH$V#*FR9,UMIYACXQ[<E,V%&+QC:[D/="5O$=RF
MW"..<F\=O%O#3&^?!R5E!O  \-9D,S7SXXP>WT&S*!;;_,8L>**(02BUP'1S
M2VVW9!FSIAU^(]S=A,GQUMAN4\5! U?N+ 8,2!V'=;[5/AUSRGT"@U0$.I]]
MNXL5U<FY?#%?@+_.RJF93<M.AZY"9,)@UQBU)/N;K0C<DY.YN!.AA[9Y^[TJ
MMA[<OH7&"SMY*<MYQSN^._6D1IBX7JY$ LG3T>- :CB6R,E$=Z$B,0='&+X\
MX]]Z_P!3Z7TNE]"I--K$&@NFPTML4:AHM RQ5RUR*S&>GUUVTFC\NK=%%PW#
MP8A('AVVX"VFD;(:<U*T2R29BACGK3M]!D]-&F)?/3Q*M=!]#N5N,3I5G$RK
M%$H!>C*Y3YXK\4+8Y#[G5.DUJVKG#"KJ).Y<9M#C N:C4AQ@N(VN[KV7H/,3
MO*Q%4H[5E_>R0D4@,E^,0>6'Z,Y-KQD=&/RQTKZ ?6]<X@VL@_)<4VC4L,PP
MEW\92<))*T[C>RNZGB'."0N%1G0CD^M'+T#K].LKI#1FV\A[]88_E,F5/V1"
M 790EZY\"@.$4L-./3S,1ET5%^8W'GM5XR-H?/?=.I=8X1;^EGJI456<=%)2
MJ@+IQ2&5B'GVJ*%L;0,J*#VNY2@1\7:B,D-(ANS]37-14ON1X3KVXC!+)+CL
MUXE>Y;8=@L3@PFH2:K/FM51QT,FRSKB8LY;@_.>@(&50/%/ 2[@L#=K>1&'C
M8S15^L?0MZE04_#.F0"\7*3ZU[L*'JDR*33XP">Y/!@B9 /?IRZ%!K%G\_5H
M[T?II22<2]8JR/%=<*EI3$=(]YN-7MJ<G*2_(>A#C%D3>^=6MGB7K?9Z8:H\
M/I=3=[F.KMJ 5(Z>I$V/R3J-QIL6U0JB7-:+OQC-:JGUFVG)SS++SVUH<D,)
M3MPF/NPI]WTWWOF(KHI.0,"]' &.B=AD44XY!,JU3:Q7O0/)^>;LUE)$[6(K
MT_G4"K]6D&83#4T4S$% _P"S(N,NNRHD7$K8RV=3Z?+\U\QZ6Y"A5Z\F[YPI
MP\/HQ6':PDP(7[!41IYH:5%OFH<FO6FJ/NJ=VS)DZC19:D:E.;;^>JLXF<=F
MNL_U?Z4A N>V0D"I;<MM=2MMEJ=>I%I3OH _HGE/K'5*UQ\#./V5Z2!N#/5Z
M5$!QRFDO;(RR$%OZ!AQ3D.2:Q/CYOJ.]A^D2M,DV<?2.2$$0.7]'OL8@+>*V
M(=:R(0SS.NU &PU2[M;(E/D,&+L227C/D29'305"DQXZIBT0AQC-3?5WHIWH
MHWDPVBT..9W-O !^Y%HSH /=)]?Z3>*,LKSJN6#H,0S+G5"N5X?8)P**JPRB
M"23<5$B(TI,]1,3&5TB^]V(#XUYCV>T'@U@O5CHO*4&+$*J*?TO^NKL[7@A.
M68 2+S6!E8#"SQ1U!)R?8!<,9MIS;SS.D?*T,?=AKF$]L^AB="5TO?(JS)&J
M")%1:7"#W95JDW/7G.Q=J?L*B+4R?$138YNLK&[@1X<R8MJ4G;4QQ]I+4DO&
M9PV-\I=>FWXCV>#:ND52\%G>RV5'/YE624&UT_0:IS+AC1<O0 IPJ<F;J@RT
MVWX9;L6>2@MDYZ])E+V[K6$L5Q;/7?6ZYULUS%GE4&8T(O[7)5'DPK2Y"=O7
M52< ]Y](-/L-+B/4U/,(Q*3;Y:%_"/*HCLH6UIS:,&)C*BQGK;TKS'F7.Q1B
MO5BY&;'5*4>B]$MS),"(K<6S1NYKA!^HF[?>:L*D'S1+E8N"@EJ<+:8DG](U
M"DN,QVY\7C+6XO&NW==NG4)=:OE0K "LE==K; 1PD:POF:_+XS<N<51QFQ6.
M=+V#L+=NU?'WHCD.%!0A O:T;DH?W]-4LF-%"W7V7V ??^G4JC@^8V0C5^GE
M^8C*XL7>)!^HPXS7(%A^H]"E#R?T\RH%B'19 [4:'&B?C*1'VU-=4B;'C%FV
M8S61+>L^W-7C=$"5[GI$Y-Z5.YO.%KK%YV5Y+#&]PYWR@/TKH\5JQ;03K?5Z
MY:Y=BK\-A8WX(Z8[:9T]E$V9&&)C**O^T>W!1M,U>(?'*&[>+)21WZT/USH3
M=+I8NP2?2@DILW%=LT.88(:E\(@3&%;F"X[#)_Y#VU:CMS98XQ'G_9_I /$(
MDYM6H[92X6/F3X"I6\:FFCN0!+5Y<K_46P5UM-DO-19(IOO5DD@ PK)W#<A2
MXLMO<.9)::&:&(M/E'IBYW'T@,'='-U>C5Z-0.QABO-(RCT.=1[XUZ%Y3R_F
M8+H1DG+>KE@NETA2%R "HS0UV3'++3%CRHSC4QX7;IHN/O'5ND4KJO-ZCST,
M+DRKL/@"G#UC8MYBMU_1GIM#K<XE-K0 P%'E98X*6DRF/F2(K^U-?*U(98<>
M5A))AH]T3V3VX^,ILE0\/3B0\F4E%>8@V>D#;M>A0[RCUJ]$+M&."IK#X_E$
MSI@]H1%9U'3+CDAJ=_F.YOR8JC4VQ<'2_<EUH?/KW;6H-.E78->>B@ W&T5<
ML_9Z[!YGJ]S&Q'1K"1Z16H<2P]6!U2/,KBX<!3DGZS38V"=UK3N$FW-?"!ZN
M]!!KL$H,H50;H0.=R[177R92+#YM$@5JL]GJU8IO+(CYR^14[Z,OEUJW8HLE
MM@I)+P68^FAJT.OSFAB.T?#!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:5](]7V*E]GUR@1QF
MWV5D=<><@99<1+JLV5;H70>5]NONV:>.FVP#H21KI#E+34E\RY%AN1W7_@5\
M>F-N&I-,L1?_ 'SS2KC8ZZG5K/T6P&.:UGJE6K@8M1!DT[6K'*Y_M;$I@I;6
MC%3+BPG1X!!;)F# ;DL:6F,X\O6]:'&K6Z=ZKY=R$V6KMX;M$ N($"[ ["B!
MF23\T"3K5_LGYP*8AD'7R4$?KFQ&!)4TA6VB2XK'X*^J84LDEK#*]@\VA2;D
M)L%>Z!5[1SP;))7:HF X1\U7D-$:!#BL/20-E-5X@Z5A],$3HRX4Z5'7$?7\
M3B'FG&4CC7)Z_P"ON2<0N3-(NRS*BTH%,+P_R%=8-ORI[ <P;@UC].Q+/^M(
M9L_#"/)@.R1; N0^I#7UB5KTG!-MO1"2GO#F%>W9VK31NLU672?SMFXQ386G
M-(KA$;:JC1Q J84AWJ:!ER[K;+T+AB'(<N3%>U)W(?>CQ67WVR\;>C+\Y]Q<
M3ZCT"L\UJ^K8JR61M;*TS!0Q$6OGD";,>W7#OTAR;.T^X%J<J2V3AL3*\\AR
M*ELBI<R*AXG&QCV/:]8AQKB_:>8](!KHU@[1^HFH":A8M!N8<3N[-'L/8BRX
M%I:VW6),]_;C8^*F8=VB-)4W"=:CK=V7BDO4O8G,.1V:R5:RB+G(EUM?/8"B
M4")6(H S9.GHL$RJU(*9L=K 0W3:P=3)$I;DC<<?"AQ/Q>DI=>C-/";;4;D^
M[./LT[70HX._RZ1,L%?I0"R.CJK7X=FZ">$1#SE#&1+?<*X6@G  A]]TC()Q
MQXF.Y!DL:F+DM?)4.-Z/E ]U\73$L)8N0L48-#8KIT-)>I1 .](K1NL4JRE-
M_33RL@@0(T0+;VBI[\8T)< :YK6H[BV5*<'&I=5?7W,[ES172@0>ZRF7>@5W
MEPJIZ'U]=G/W>VLUV77! 62Q9GZ9*:(C[1%D.2UEVX<!"9")KL9Z+)::)QLN
M$@Y9Z8I/73MT!5P!=AF^<B&9EZ*V@8&"!JR?V9L8$C19TMRP/.R+6 (U$CJ=
MN,V^,8;CI<^L4A^.IX66*^JON7CUS2857QUN((J,2U&NC28FZ.0%\XI]/AA"
M)2[V(\*O$^OF*](&GV'XB $HT1E(0_I$7:X[Z&R\:Q=T];<?G2*WR[HE)ZP#
M*=-KP0^W5OHQWZJB5FU%YXRB%Y$+GMY)VYMRXG ,EB+'%)DE(+D9>R3$!O\
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M4%YR7KV_Y^-7J(PXF P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M@_'3SBFR3L G^$=C\(F]386Y XUCWO>-,59P28U(Z"ND_H.^W>[SWZK\%CI
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MRMW"VP.5IN7/Y4"[P':#S=TE??I)T8/)@!U0'G?BCK91M.BZU9]=Y]Y<7^G
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M= 2Y32$,+A2OD[:8DN/[2ULO&N,CU,++]4YIS.NTRXI7:;W/HUR-6  ^/%5
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M%#I$G:&83:W4CC]&[>&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M*D0*I,+O$%B(']C&&QV]Q65.Z94YLEN5/4_Q!SJC6WFAS5N!SPO*N9\HYF1
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MR&J[]*$#*C.(C:EO24(>^<3.9JW4PR8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&F1OE=M@^JA
MW1J)7+-'@6R2&1V"S6/]T4SGLZG .>VVOC8%-6A+W=0E^9/$("=:87%".1MR
M5O;<WM*%&LZ:L7#\^F@WB3L_GH-3 D2=90?K"NU"D,RA;0&2$Z??.L$J.(=D
M?._+(L(O7+3"T^EY>ODZ>4E_\%I7^ S]V6MA+S5ZI@3XYRIMCX=NXIR;N'GW
M@5LDV(/,D.\XGO4(M1+*]'=GQ%C[K<A0Q 23IY3*&)U8B3)#S;3^EI+F=^ZS
MH?+O6D:M'R&KQU,I-B\^I(VL5TA9ZG5K MLCWR\GNK@F](O72A.^EPN#_E02
MO6$M82#:7ULON269FI,EHF9Y,;:^>>S9ULO4VA6GHM5JG[MH$3EE?-G*D<F(
MA*H4$>=J-VMA+JI_<#L7Z[^O(#[ @(=8U\<)MTNF*F0PDLNWNB='XOZT#= @
M3@\OI'.N:'^SW:\S(!&R4GH-ZC,2[!RA >7TZ;KK(88< E^?5TL)0WMVW31V
MW=O.1GY>HTML9F/->PKF?;;+Y<Z'2;A#/R^HA+)*M7)R]VM(N=:[?8*"5KO0
MN8V&U['VBWU:CSR-_ HCO0AI)P7'C-:DL,P6W_R^*3,SY*$KOGCT919Q$\&H
M@HG(ET2U]]?'1KP-#RM^R>[Q(M*ZV/'S81,;*^12J4Z5E#)R)HZ/.ED],HF1
M/Q7(:+F?'@RW.2?J.DWZJU_HAV\6<!5*%U3L_2:V+?C6&\Q G/[UU,)Q3GL:
M$..7%),SVNEW(/+^E</D9KDVAO,NRGUR77EC3#8/T!0KS<^I^8.@ :4;, Z4
M_>UW.!"&<H-&@B+;#I6X$>7 Z18A8YACXP\AN5-$.RB$3:-?)2M*][PDN)6H
MEEH_I"F7$MUCI!"ZAP@80Q6>DW1WL%&!Q[>$,>C8Q^<'X<^[8QDSF(LKSY@6
MQI,V17E;9C*BHVR06HA(+I9B.3R6E>X>A :8;(=)ZA40QCD$U^J%"CM;)DHY
M:5#ZMH?!ZHY,N=>?_44PE/JQ!@I#J9=3D2&B/J3#;<FI>%XRK"&TKWE/AG9U
MJ*G(,0M$JW1Y=7K%\J>K'$E],Z!2IO5_/],.K>@0!SG%.<4XK"KYMZ3'8(2[
M1I34UIR/J5''VN2/HWM9!(,M1.\M+9+UMSFLHE?*A,!T2HL]JN9*VB?1XV,>
MW,ZA9B'"I(8;%D#$G-)(,*^&5&DI=+2A]J4>9Z[V7F_1C)CK=/ZR3*]0I? ^
M<3;)8+54;\Q^OJ"&[];^IW+<FOF)/Z+Y/)*%HS8AN1],M<LHQ'CC8FE*9;%Q
M9HC?1O-?6=]UN?4*-71T\-U/U!YK*])$RCHB$V4Y1R(+P8J/Z=$9E2$I_4]$
MLU%/B78"M)E%1)/XDZ7N+#2H2S&/)L%YKX&]Q\UUB>49ENLOVS](\?\ S$C"
M*?H_SV#A0R]-Y[7?IOQ>$UL';#YOY+$C:INV-1VW5K9C1$MDMRIZQ^5R,S@G
MI7F0Z@5]3MU] F^L\X JFBD#Y4B4<I%GA6A]QV1]+$,*L@R;/WN6KY^IB=/;
M_MFT*P9UE\E^D>/IMGI%/1;%40+%5I',IX2J%DQQ?YU:+QTA]T7>"TV1"<T8
MC,U.B5N"+A+?VC;J#L]*=?"VA6R9Q%# /,)A? /.W 3/.ZG$KM<OZW.@H6W6
MI\:I<MJUML'0!-6KR4.+6IJ[$@P -(:A:_!D7)E;7M*FD:V7.MK?T;,E36I#
MDL3-#K9(DH;3$YX:^Y+BPIK\:(694,G$&40B\=I,AA#JFY*&G$I>::=TIM)E
MD<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,"D?0_3+5QWE%EZ34ZM7[E*JC3) B"L-I(U!B0*4YJ.^J"5&U2X+V01(
M>:^!IR*AI2-KWMQ.]:THLF;A5+?I>Y1C<I93F03= J_6:+P:_6X1?)<HJ-Z;
M>'*>(1-K%5(4L9JP<]"W*^#!,B?)G#B2UJD2&QZF(Z5/EQ]66O?J85SPU>Z[
M8:K,;,4^ZTX7$C,$-NZ/<YL5&(]%-]-C[_+M.,1*K6:/<?F0M)=5(EUE;*7D
M_4MJ023*MK)ZUZG5Z793Y?B=5'6&)P<KZ3J0"1U<B_ -\ZK+<-=OKI\Y!YH^
MNM]*KVSHE*HK$4F(DJ(;^217J.YO9>/^JT.:=]L=Q[7?>+V,/S*OF^;00'Z@
MA".DF3UH(SSE-JMPT1 5J;S^OZ?IT1%J1#5.D2F'U26%?^WTG>L)9IE]+GZ?
M!\][T1X];J^^+KD/A+O96>CZ)ID19)*"4O&B5!W7T0-/M%M5*A3S$1_ZI29;
M,22WIM"F-*<$F9F*JI7N-NRL>;E&^73:Q)[1%8>Z/%7:6":N%RK+:B7..9P#
MRVP<75C>Z#U(8X!C[9U$2Q(;<7OXT(_E+=O7R5J"^Y=7W0<FR6*@0-B$]4I'
M*HZZ->OU;)8M/0E]6A5VDFM$JI51X;I;97G@U$P<[*T-A1;3 E/D6F4N[T7B
MNGTCZPL7FZC\SL-HY]6WK)=(EJE6"ONWHXV* RJ?1"5V)  ]@#<ZL,D^5G;'
M;@Q'GH ^#MW>W7GFF]:_$DF:E<CTL1EA-?IOGBIUU-=\*< I];,6B,+%RS@<
M(4M12P6BQCQ)S0(0*JE>)2WT0XI5UQV(EAC;VWD+T3'^C"53TM?>@6J?S&G\
MLK>NGT=ZP(ZY"LO1R NE5-L19-  JJS9AG/CAJY.7J*APB.TX(&)CPFEZF[C
MR?@CK+COV1I'M D>WWO5 Y"5N&_.=PM-"Z&J.<E?,8LXZU"Q%>8&"!58-V<P
M/74)SEG.2(0^5^6#&M,0D%2"G8L<<>F>[-=D];IY/Q'E_7&!W.[>GHQEX4F8
M$O\ 9"'/6&H?..A]&?G!;97N9V.QGVYK'/UP(R4@6=_52T[>^4EI?XB3-PPM
M:]H[L=@L4%%2J<6&#O/!:+NO[Z.F7TQA_N.N&K9L)BKP:M( 0J_74]HTW\V.
M7F:FOCOP;4E#^EM#BEMM]-VH*;NTFO<MAV3G="Z=6.)%[*[=UB;/,Z;=&*G"
M Z$4_=4G19-*C7&_A0\Z>X4:G-+?E268+[,5.Y(FV?J@8/W<+LQ+4$'SF<_'
M,U7@TZC$)5GAQF;9>^O&:%"M?/?@2*>4-G\E$=;J\\D_^+^WFR$A/R6=PG%+
M'%+KY[!AT#N8?DA2@RWZ\_<X55L_0VK#&:B4V 6HU>L(FU%@CHS2W 2[5;!P
M:6YJ6C4%$GZYS?R&G=($VYF4#ZK[MWS?D_"NH)YX-D:['2+)>G !FX%QCPIB
MLUD58G:P*GAJ#9DE;(8453&B.3&18U#B-JDR6&]_%H3;FX7]7O0*#TKG,;])
M/P5= [CVGB^M.F8[S@9SCS'8'G+ ]IB$IF;H[^Z?:?IFW-:C;G:WI][37XND
MPKSDOK1?5^N:YK'K],K+4>MR3\ADQT&4Y>2NF[WV6CHW5:C'IVH98;%=Y)N3
M+D.D8VV$3MHTA>V=;>+=N)E^CGJTX$F%;"OF,=_DD7IUWXN+MGZS4W;R/0*/
M%LL*7+D4G56=@#Z03O=3F5^/-T8>GZD;:E+@IB.*<:''ZHC2_;RK7Y:ZGZ1U
M2:W(9YNTVJ-&K%_EV*CVEQ^J4^QOH'7;]$CR:-UDA:W!!E* SZHI,7*::T_M
M.M8..N%B\"]3Q>T2"4:?68-6:"T\O:2)QFR/$@+S0/K'3N73'X*R]>JY>.&?
MWS99)IXC$@2DL2](=C-_+TXX+,(71/9\KIE?"LU+F/R.EV_J$BD5&E6:X(%"
MW*=/Y\_VBE]4LMCA5TK-" +3QI<4EJ$P-FS&2\A0O7S%1Y$IL<<=4W$>E#13
MOS_FI-!&.])KM/Y_T._2H-Q?<JM;HUK:/Q2QT>1(U442L#L.R!$#!T1J(B1,
M<D?.E:'QV_F.#&F4<N'LF%2N\[XZ5H$O0%@S9*^5Z,FQ1TC@12#1>%6>H*,!
MU"OG11=ULW<(M>1*U(4B&11&4YI3<S>XPXZ9??@'KS_:$N9&G5KGZQCU.#4"
MQ],(3K.VMBIB^H\;HW4J)#'L;"Q95E.')MOD0]ML)1#BQ!#\E^2V^]&@NB[<
M3++6WU8U7.OW?E0SG1RV+J_/+,6!% 9..J9>>R52HP>D$.!@0KL/7X6Z5S0Z
M-,19*Y/RGD2'6OEZ5'5M0QIEC;#ZMV!\]5;M>HW+B$FSWVGT)Q,?I1V)SZMS
M[;>HE+==L]N,<W%V8+-J[TK:2D"57X\R)/:7%<0A2=KT..N&/D^M+%"AD+F[
MS0+.Y*&Z*QQTE<A/07I)J1?G40PFRX6L/4QB*0YIOI,]H V2629)N)VJ?H=]
M*G7QCC]4RC^I@C(G5A/5>>-!1/*L3U,:D0B#12;!"*C/SB-7B0=Q(*2$^'#B
MK4W(VZREY?X)^6C\?QT3'^J)*]6VFGVRG53LW+!-#7<(U6L.RX+H:K>(K%0M
M"C8-4BRRI%.K.V+%7+]H"(G1V$OP'$V!J1&FO?(>9T7&>BO(/O0L9YW MP[C
M+T$Y!<LL?J(@[;YB O%?RGJ:N>!S/0#0&E'B[=7+!X<L\_,BBWMCQ[;;CR/I
ME/2XXX^;?6K61BSC4SF$(4E#8S:IT%4B972NR((4=00J1]Z)"8M-;6R62AD@
MPVEIUQM:?P2M"T),I+@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"*7FE5WHU3.4BV0W)]<
ML4/Z$M#9ERH+LB-\YI_X$2X3K$IC?S64[_%"T[_D_#!T5L1\Y\O*="WT>7"L
M'YD]: E\(5QFVV1B@E^@UH;!$5V^EZ(T2162%M"CQ4-+,IR/O^VP8CZTJD1(
MSK1<Z82,WQCFUCZ4)ZV<K3!2[A:/8><PYTR1,>'.5.SS(LPI G@%O[!DG_Q8
M=:8D/QW)$:-.FLM+0U,DH<&;C"O0/D[C0 !<:TV.M!@5<^?.\DE)L]ZMUFE@
MN6.,38[?/J@0-&)DVK5IA$]>](B.-O.*0SMUQSZ>/\H9K-FN!B)=GN]RK-XZ
M/1+%T216)-I=K5IDZ$RGZXU51*IT2OD431(\N2J-49$.2FFTN(C.+<1K3_X.
M8,LE?O/_ "KIQUJQW:MK,E69_+B3;VRI:(VF3QZT6FVTA*H\*;'8<BL%+J4;
MG,*3M@I!FN1)B'HRMM8,V(&]XQ\VRXY5LES$.8($FPK<>R&ER2UNKB:V<G6F
MN[IMKGO/GJ<L%;"DDM$4-?C*9)2').M_-5M6#E643Y.X1\0[4FEH(Q!T$<-4
M*+$R94(5A"F^DQX,<^&GRY TZTU#ZY8(ZDRFG=.1YWREZ4AEE+8S7UMOE[F%
MVI]$HYV1?' G.X1@0 ?B]$M\0\_7K  F54U7#EF:*Z/G1)*MS50G?J9#DC;2
M4JT[IU.G,&;G+@N>3N3;U8&8^[H.'F[3!O0X2)NQ\6/H]X':AHAVSGB(,IA^
MF%VX\+4=6H;B([L1Y^,XTN/(>:6,URF/+/*Q[%?4 7>*N> /6-Y=UK?0;<+N
M]F_61QNS6UN[V=LJHC=&C]@:3+<T25(W&=UKZ3<=.OPP9KGO>:>8(+D[(":L
M].M1EVZ.%;53+<?KM@)(OED5<#44B0@S4[(P8EG<<F#F)"76A;C\A,5+3<J2
MAX9K\$_,_,9]!I?.HJKD #4&RE[A72M:O5I#6]NS62#<AUK-3K?%)Z/D2-L8
MZ"940>=?4X\_/<>TI+ND+0,WJCB?('(H@XV#!O7RKUHQ.Y^89K%:OEA% :\?
MY>USZ/1[!5X3<I>PA8+&Y>&;TMM?P/(CKTZA>WG=K'*L^WYBY?\ JP=<9?ZQ
M)$89BJVL@-(7FSO5>T7RDBAH6K]%MM301:KU@O0F &A?#/>C;6Y(@Q9#B5R(
MD9UD9KC5_P G<'J\RC3PE+W#D\XZCT?L=25^>'GD#[WU5JPLV^<^T^2<:(C'
M&K(ZF"/D:=@C-1H?TC3/T47Y0Y5)S?G[E%CMEANAVM;*&[4*- [#]63*+'%!
M%BJ0VCF8$D5J7H?N/.K(EF.O6F]?^FUZ_!:E*V,W&$(,>0^,&N?<NY?(AW"+
M3>14R7SFKP1M_M\&=.H92NCZH;JEJ.,E]'+0-/@A;+,Y<R0Y)D;3M:G?C4M2
MARN<N3_LI\Q1'(Q81'H0J.]>B?2JXV'Z!8A>^>70Y+M$H\6YVY"E,O55HXBZ
M%(\N&RI4)^',7'4S\GX4:&:SM(\Y<YYO9Q5GHR[97%C*H%IKX.);SLBMGA=>
M>M4L7+LPHC+FZ.GD$+H1EO$'UJF2Y<C;TAQUS6E:&;>K@3_+G("=L*VV8,L+
MBC!8_9I%73<;0U1&+K:*Y.J5@O<"E-%$5Z!<28 G):7-:82I+\EZ4G29CKDA
M0S60>\W<J<H]^YVT+,0JMTH?7X%HAPK,>CO..5BJ5ZE!RHR7J=N0(-,UZIC&
MG)4=2''UPFW'=K<TI2AF]4'<\9\;6DDAN1T2-JRUZQ5>^JC]'M;;W2A5L,'3
MMA3?9.YZI)V61(62;_;_ (VG68[NH[6VV&F6VQRK,/\ D+SZU.EE:MS\?S4K
M);J:F"/)W7N8R!9*CM6N'6#XE-+4&C03T />"HQR2EO:I@F:N!)^=$_!G0Y5
M(4^<N8_J()=)$6PS;S7Y5.FC[Q,M9]VV;D4L81"1/JS&IR'YD8\%+R8AF.YI
M48PP[\,IMS:&MH&:_-I\U<<NA;H1JS5=PI-ZE6K34KK\TR9;8)A+C7^<5@XU
M'CL3FFA<M8KDX+Y$F+IF1$?A_.96V\XXM0S8^-,\R<@Y\7J]@J(,F(/5)#,4
M89;LA]\E*$-<_J/-5UXY*E$'G+!7)%=H0=UR%,^<PHH/9(?#J:GY^QFWJX$S
MR=P2697:VZ$/&WU=^/=,UTP,Z^)Z:W<+)$+BRD]N_P %QFT)B+ FGA;</ZG<
M-D7IN(AI+#3:$C-2 %Y\YH K4*L,P#)&/%Z0.Z]++&[&:*V,[T<66A&HMIL!
MV5,5.+3-3!T=.VG%?3:CL-L:;TRA*-#-8LIYCY(8N)"Y3Q9U;A:P+N1*JMVV
MR,4"9>U M5O5]>HS))%<W;FQ*4_#+TQK\);:)OP_7-HDI&:CH+R+RX"NN?++
M='*1:Y2E\S0-L%\,G11SFJM1T-T"TC2*GXEBJ[#;&T)9DI6YM#KB5.*2O>L&
M:^4CQIPLC3KE1K +M]J"WBN5FF%)-IZ+>3Q\?2J68U8*I4JW99YYT[7 @0UK
MZI&HDAI^0_I+DAQY:$*2.53![SES=$[JY<!^K:4<[58JS:>@G:/=+)6"Q(M4
MZT+J O<"2.(-I!1' (EMN2Q"2PU)=4X^YK<AQ;NQF_19%'HM<YR @U2HQI(V
MLB((02  K(39HVN!:[70]7$!034U^0L>+BC C2OE)5O2Y"W7E[4ZZXI1.J88
M# 8# 8# 8# 8# 8# 8# 8# 8# Q9 X%$O0(Q4P+&2"LC406P0(1(3Q*5M3:-
M1H#4EYM<R1M;J=? WI2OQ5K7X?RZP.'*MM5A19<Z;9J_$A0""Q$Z9*,C8\6$
M6;U\2QDN0[)0U&((3O\ ';*]I<UK_P#=P/TY:JNU)GPW;(!;EBH.B9.*X8'H
MDCANT-.:(3V%2-.PX.VY#:OFN:2W^"T[_'\-Z_$..S=:;)?&QH]MK,B281IP
M1'9/"G7RK>WWHNG!K2):G)R-R8[C?XM:5KXT*3_ZZWK09)XV%C3_ ,JD%Q;!
M/Z%TG^7/3XC4_P#+65;2\0^C6ZF1]"TI.]*=^'Y:=Z_EW@?-NP@'6!4IHX'=
MC'74L!)#9.$M@P^IMQU+(IU+^VR#JFF5JTEG:][2G>__ $UO YRIL)")3JY<
M5#4%6TS7%2&DHAJ2TW(4F4O:])CJ2PZE>]+_  _!"M;_ /3>L#YZ)C=D5"-$
M(.RR(FB"Q>I;&R*8"G?D)FJA:<^I3$4_KX-.;3\&U_R?C^.!SL!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:;=RY_=S
M/H[SQT,#49%DK-/K'2@)V=' \\L.@I>RW7B9D$],1=K"%+5X>Y#IL]QPJ#9G
MD8OR-)0SM3C>E&I9C#0/G7C[K-5I5H58^;](GV<8YS0S1(X>/Y8EOP.G5ZF=
MTJ$T0V)M,PM2+YPNLP^F_#%LEK;=Z23=G:=GNO[B-*CFK9E?QGSG>#![J P_
M1+G+K'5*&^9[[)K,;@/R[1U- GCC0>)YM)V)>[HD!J;29B9PZ]N_D_TS#:6V
MMK4C6R9B?U'AW0[=,X GI'/JL,A\TMG3NE+L)>O<TBV]ANO64NSYRI=EA<TW
M"KC-@98MJK*<57],"$%0C2&U[5)<_$EL[,):/-W2#/8[AW;I(,+U0G2N7465
M5:5SX!4J9"[)>ZT*] B9E)_,.@V>T&JG590?I,6++AS2S8PB_(^8^XN.AZ-L
M9F,11-B\B]1LG.J+%JU,FTWI=FF]"U9M&J=S230.,F[[URG=,,73F34#KRIO
M,WJXX)^0$F"81^<28@-N3(D::KY^S4W3.O1LYT'S)+/\D]ZT,=0Q,E'=+L=O
MU!"J(#V8EKM4_B7*8+1TFMZ<AB)+=ZK5I2MZ(*0C2HR%[3J/\K#,NLJ*B^"=
M38]Y3>U2ZS/537K:9(I([?Y[NFL5J;P0'0X=E@6!J:CN4CHS]C"MBY%9ELJH
MK W;A)AE)32);Q<SCAV3X8,!@,!@,!@,!@:C>RBW;@_/J*[Y^3*>Z%+[)0Q^
MHK&U:CS*W)_-OU+'F[<4T*5_]BD+7#03>C"72B(K<U]F,IUQ)K;C.O1HW=.C
MVMM'>DTJV]AD)'^.!Q7CDFZ],[55NF?K*/2^P_JZ7OF8ZL;K9^^-'A;>BTY]
M3)(%,8;U!B:2S$;V733YKLJH_KG0NU\PD\\MY,)S.L<\H5K-%6>V]GZ)5Y*F
M>R]3:N]8'_K.N#8W73-SK8J.+DRK'N'*K,93+\!#GRV/B)I)KU93L(GIE:Z;
MVRQ<Y)=4GDX^_%TNG R/3>L;YXHC>?1QX3UF)#%?46JNB!1"G"X;)7<01)2(
M&;4XVPTAU?S!,?ZJ>LUK] S+#T]N\7@WRX2*L=^G[CHL_3]\YGCPO1>(?I^B
M0>D5>HUR]UT?;@LPA%9,B![4Z!M^3\IJ2REYMYE9C"Y.HI[7UD?Y*@<Q_>)R
M9^Z<YNAVP)L=ZZ !*<Z+-52B.UHI?7PD$B[T>S5*80D+; V)<:"=D:>U.6VK
M2TZ),3.5 '[OV55!LCE5M?=Y?H!?+O4SOH"K2UWQFMT<J/I5Q?YT_1X:HTBO
MTDD.Z)'!PJ<_6$_5'04B1-<T06VJ4T:Q,Z]$^IX#JDFQ\U8M9[N TR ZGZ<
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M[&,WBS5&#;1A%D(3G?4I_.I<P:Q(7I,1A(L__I&/-Y+TDGMW+I?3Y74X=:G
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MV<]T3G_1PJ@,Q<Y+[J6X+4G;T9K:7DITM*RRX:D_[ /4/^IS]Q/_ !H\M?\
MT*F3"\IX1MC/XV?F\'1Q9OO?;!]A161U>WZ!@D.?)[DN5 DQI#MI61D<\D\[
M_4A),?;4A>JYJ)MMU?P,(5\*DU,ZY:G?[ /4/^IS]Q/_ !H\M?\ T*F3"\IX
M1MER3CA_E_,R7/#/>NU]B*SY)^0UU+JQ#G\WI Q)N.EB/&'2Z7SRDU-,>O*3
M\R!IT0ZI+F]_.4]K^3*EN6I:/M_]12E*=_<[^XJO:4Z3M:[1Y9^)7X:UKXE?
M#Y33KXE?^N_PUK7XY,+RGA&R_GS@=GX:U:VK)Z9]#>C=V5T.[#>[X4Y>2=J*
M139!#[-7WS7E?,D,M&=SDJE_6)FJ4J,U\O;6M+TNI;GMA1%I\-=(LEGL=BB?
M<:][U.(?/%S46JUBR>:V:U68Y2>_-9K]>:+^93!9H&&;?U'B)E2Y4C3#:=./
M.+_%>YA>7E%C\+\LW3C5TD6VP>S/6??8+X*:%31^W&N*$*='D3)4"2W8&&.>
M\0YV=T<@HA*:94J>J/IJ0[\;*U;0I%2W/:,/V#R)>^J=!-7D)[G]E<7&EV1;
M3'.>2'N#0J$#4-&11[SP>-=^ WFRMO%G8^Y4KYY.0G<EU>V]-H^%M)9<=HQ/
M-O&'0:!>ZO="GO\ ]P=.'UPE^82^?]$L/GF51[6U]-(C_E=FCU;SI5;$\.^-
M_3OX1",-WYC:/[9\/Q)5#/E%A]^\UV_MYX ;KGK;T_YWCA!$@7(KW""_'QP*
MPO/S=RTF3K?2..=*(N%HR-_(;5&DQF-,_P BFE*_LLJ2X[11T/P1TZ)-A2W/
MN8?<+FMQ)D26N#,L_E]4.<B-(;?7"F)8\LL/JARTM[;=TVXVYMM6_A4E7X*U
M,+RGA&T'?N*6+MP $#KGH3NGG>2&-*+R+%P@CSH<>/L*@286@9MSI'-^E#7
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M1;1V2H6:O=7KL6N]DM7Z%)P;N<BQ^V]QZF5=J\;]1R*\$+6\/V'Z"5->3)3
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MF_G/^1>.^3IJR.7\Y\Y\Z31I=M(4O5(K/.:OJI3K]'&P[S,K7Y+$A?DDJXQ
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M.K2A.MJ5K6V#WO4^(Y?]6$^T)_D9Z?\ Q!]@_:O&#WO4^(?U83[0G^1GI_\
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M$$)2+EA>_B8\=:-J6J9#F)4A*$LK=&[=R^/D[3,,--O0/GZ\],OD"YUF?69
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M:.%]<K4SU!8B]9.6'HKUGM76Z551QYXRQ-'LE#L5Y&X$/;WS-G2[]MU[Z_\
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M4*LZN>!I;!0K/9E.5=%R)-L3'$JG+8D?*<>6VVTEL6V]5ZX0P& P& P& P&
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M<G^N?CSS%M&R93R-18 UM3C:2\Y9BS5W3Y7,P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MV ^7MD8"N59K%S,Q%'NAWC+,AJ+]6A2HCK#SPXWNY!OVUS&JB"ANV5?HX06
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M*I?+C NQ<T@GQT*FA[3:0]'/ 1\R+&)%Y2),B PJ;]5\*M*-\[X3+LNPP8#
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M^U=[L_Z5O4?XKO(W_P DX,;?$_VKO=G_ $K>H_Q7>1O_ ))P8V^)_M7>[/\
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M5289*8,EO_-V^I]*1NS+BMW<,F P& P& P& P& P& P& P& P& P& P& P&
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MW^K8)AUW?U;?G7HTPY/.5_24O]W3PI_W0_)G]UNN2]'7T?W7^->C7*Y& P&
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M7N>RER.>\\[%Q;G.XEB3S<94=HZ!%\N2(("OE(@TOTY%M,&^F%TEIA.*^(C
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M>-O]6P3#KN_JV_.O1IAR><K^DI?[NGA3_NA^3/[K=<EZ.OH_NO\ &O1KE<C
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M,_NMUR7HZ^C^Z_QKT:Y7(P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P&!YR_"/_ )"/WI?\U'C;_5L$PZ[OZMOS
MKT:8<GG*_I*7^[IX4_[H?DS^ZW7)>CKZ/[K_ !KT:Y7(P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!YR_"/\
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M6ZY+T=?1_=?XUZ-<KD8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M99;K2IZV&Z:TF<?-V*S&'6^>7>;T>D)E'+&6*F)NJQ=R#Q")\Y]SY;J_A_\
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MS>B*@?-?#*Q.V1!\X!PIB9#[T1[YA&3^4L2 ]O J$ &YDZ0U7:VT*OYIID5
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MSSI3MI%NL$FYM0LP^[<YC%$2PK@]UXE)>F/;<E;2[HO*X2*-YJY$ "P1]$J
MFDDJ_(25IYH6W.=>K=CB5NQ5889U'<(MI+MQ1%JG,OPY2W(L]F2XW(0XE>\)
MF]W*J_G+DE8XUSWA&JI!+<\YJ"#!*\*)-Z^'7Y,(D!TDY"8?TK6R,YB;(6^I
M"4H4Y(<WI.OQUK0S<Y9"=Y^X\0,P+"[2(+!X:0B$8Q@9.,AR2EPP-=JZ8$R:
M()0I!$!+ 5$7%EC)"G1TUJ QJ0P[MM.]#-?"#YVXS  ?I=JD19%>37[;48PD
MF5L!F(.J5YA@!UGJ8=!<M.V%JT\?5A["!T3;,**S$0B.TTG\=;&:XASS-P>S
M,6R+8>:@C4.\OFY-HA$EDI4$D[9+!5[98-IA.SE11[9FTTL82DHC(90]/C?4
M*UMUQU:QFIW7N:TNIV2SVRN"'!!BXRED+&F(5-)#3R;_ ,C<PPBLK(KK4 T3
M5%;5,FQHC,J:M&E/N.*_EPF47->?^-V&JU6DEJ$'DUFC#T#*:-0X0B;JT5K8
MY<58"="F1R(J= >$178TIEY$J*_';=:<0XA*M%S6)9\T\:'A)P:OU%NKN2UN
MS8YX%.GLV42>VBZ?2VL6:FR)TIJTCIG0S,MB:Y\UU,R<X\KXE_AO0S63MOG_
M )+?8-4@7:J:M**:!=JX>26,'5SGZ_*6 ?GASTV.3CR+.,)SJJ-ERHQ%4IB1
M-@L2%HV\TA:1FSH^BN!\F77;-5W:I]0,N%N&WZQR91VRR["2NH.0"DU^T[MT
MDR[;(IRM.5<;H7(8FMN#6X$=N+MIMEM*1FOQ7_/G&*K$AP*_ST$,BCY^RD1M
MG4QS;1)57LE+7.VZ_*===E.U>X%(:UK4I2VIKNU?BK?Q:&:_@3SYQZN;<0$I
M44="<)5$TD,P3._IR.<HLP(1K!V#67"BZ\..P9]<@O.S6(S<J8[&0J2X]O\
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M>EO)TTTYM)9,KRPA@:IS/6%6K/1+[2.DULES0/1'@\==[LA^HR@5BD62 :-
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MH%'X?8.!5.=5S;40R'IA]SFBG)#965"ES'BT9GE8YCXUJVR_'>DMOMN:=UM
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M-Z/T>:8%W>KWF>8F)I#%B/SZC6J]5(4$G:1=.@6/<*RBJTSJS*1*T_9E//\
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M";^9,7&D6$Y#A_-TC;:7Y+:5*U\6L"5X# 8# 8'$GSX(J#,)E)L0:-'17YQ
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MC+HU<ZM58]>!RC+55VU;[%8+NVZ6,6=R$;<BUV !ISGS&F!\J3MU6MMH7O\
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M-"%'!]JVU26J28KD@C+AUX(X07VB/(!$IVV8C2M$%N[:U&DZP8MU4I$]*>:
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MTW[@L#C;_O5/W":5M0J\D>J$ND5.@5,-S?FIV4N/#KE*IS=UJ3,D\5'[*D2
M1UX>RQ'^>X]LO+;COG&%%UC[-_>Z)R?LG,1?J*OWMKT7YWH]1ZW,NU*@ ?\
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M,AS8KC3K;B-*2M&__77X;PEF-$KP& P& P& P& P& P& P/.7X1_\A'[TO\
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MN&#]/ZE1Z"4+"4.7.$LH,'VHZ*ESQR)L=;.WVD+:TZC:-J^+6]87%LTCZ_\
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MX[O"G_,$\&?\;/DG^(WC_P"V.#CN\*?\P3P9_P ;/DG^(WC_ .V.#CN\*?\
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M;*N(?94=ER$R7-..2OFK7IQ7X[W\6_Q:GM_E$3@_>R\^0*S"IZ/LO?<AEUN
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MUB<%_P!*_P"Z[_#(S^U6-3V_RA_6)P7_ $K_ +KO\,C/[58U/;_*']8G!?\
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= 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g805243dsp-089.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp-089.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M;4AT;5_0QMMDUFLD:L=(W#,:*GVI##)5#])K#@FT6I"E9!2AI:@R=B*VX%_
MZM_U#<J]=_"</VB]"V6=4ZX0P& P& P& P& P& P& P& P& P& P& P& P&
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MHRQ:Y<K]".JBT)?T2Z%V0K<JA!!#BFIKD#:U-*=J9K)"68.7-B(@LA^!]IH
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MEKI'@^BNG:=>^D'5JM"8U99%FSI97<XD30O2,#(A%$&!O4FOX6C:0#4DVA
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M*W?1/D,A=95G$ZUYC@DCG=4$\^A@%91JUH/8C-$"W%( ^1];2!"K YN(2QA
MA-&A+V @6B\O9=IKK9B?1^O^%S/&7VK9_D]Z]JNZHK9<[:>?.8_'[4B>ZX"S
M/SBTPF<=P="_5J9@U32/)CBF^0J:CBT05?3EJ0&[0+' LT&@"'K#.^LTF.]O
M]D-^='FW77O??%O.J<G8Y%8O$7DA+@"DOTTH:K1C=>Q*6U@\I#-_:2J;ITQ(
M!Z&'T%H'NUK?VX7V[C6WXQQDZ]OM=Y/N>K+[DDZ1>%OX^YY\=/+C:E=$BDCZ
M7K"Y[^KV:]9N"8"@&B]+8^F8$+,,P/VB(4@W_ +(W)X7Q];?Z.V_E/Z$GLQN
MOLN/\WV5W3&Y5PKS?%IA;4FJWJ>H.9.9:4E4HB,JL6 /SO&)>RNTMZ!E$B;A
M)]N;686)K-2)2D*<12PWWBK&DXF<8M].5:38:Z]9^0?P-7Q:M\=!12?]4\&V
M+:\V=:^N!VKQ#&)C#Z0J5^<VRI4*!.417K%:;B8>;+FM#_$OH!^TP(  R+]N
MNTF,2M5AO0/E@Z<?NA^FZ*_6?<+3I_N:=5PSQ,OJ+EJN.(X#5E36JWQ191%H
M\XV+*8Y/%LBD=?D'C/DBP!;FL=ER<]"HT2'?O+C28EQC'[KJ4J\]-V[UEYH9
M\_=A]!M%8<.VO:"6EZ-CDQVCABM^F'*>U&]2U0L2+GHR%P(X)#C'6-M4MZ)&
M_C.<1_(=[-:,7$FLQ,U"58]1V5>O#_B H4RSN\[/Z^Z#YDFMY/15 ]*POGMW
MG<5AH4;;))]?'1=F)75_VDCRM2'Z!O:1&+EZHT0E&A$E  86ZXVVO'C*K92/
M1%P]'?\ VD=YN^>NEH2VK_,GUC2#7/']_C\ODLAAM;P>8(HD=)9O%4+;')X\
M(6I8%(-]1D%D.Q9 %0=;^3W;K5DGEC^*^O&-H=04?Y+V"F?)%8G6[C<?2$ZZ
M4=^5Y-#+VALLX MVM(VA<WQJBB2BH\D3/=:2&!0G8#TYZT@*@;@$OYSM^[T%
M.[&TETSIC$_JD?SV46AL:T_%&]J+3O>%G2GR)492HF^M;4>84SQY')V^P78^
MS(FW("#"V&[&0:4*=JDQ6_JT"09A00[T/UU3V[C/3HAPQWNGJ+I#REP2;>0S
MICD:-^,V,U]!*!BU>V:Q1%6O9T%-&3 WIGH==(F)P=+P*F;VBT-0%>8!O&1L
M8-Z":8 >%XUDXER@"A^D^VO(Y=WB>ADHZENOF5OZB\;%LVIT,91+J5"'28N5
M67F!E;9M"FUQ;W6.P>4V8E8V]1MX3H!*DC&X*DR+9(% =@BV:ZS:R2XKL%Y_
MJZ(F7B,[!//EM@L>ZUJ=\L E-$96M8$LW41]H6-Y<3LM*D*&7-*_=/O7:AP:
M#]!(5J$Q!@MZV4'*Q[?WR7I7*:Z.>7 J?_NWU05_TC?38=/-=)/YMT.EA)K%
MMR)LDMYAK222>-5S,)4UO*".(BF Q0T, OI% &!(H 8F#L9)6]&Y?ON$4SGM
MCM&@^;.R>=H_T/==CFUKYFZZX4B-]2R90?\ 6,BW/-EQU-+%[65<EA$-D':Y
MRN<4@6)KE,@"6E;#7?Y3#"M 3Z*AXZVR^NN79OQ:-O><&N7I.N>CF&]T/.&X
MS6$SH,'571E$=&]"1"5K]/C/8\;>9E4DH>WYR@,@,;DSBR&O17JG&6J().'K
M0@ZKGOXXF,9<]?+O<D:Z"\G?-7(<GH;H/I[GCDNKI[?/3M<\UU6OM^4"LJ](
M!*JTHY'(XXG7MR%$DBK,X'O)*A0<'81N(/8$0OM";TF-+<R6J4Q'MWH5E\"+
MK3</LVV*#ZQX7[.Y^XX?7Q3]]0:VH_ G"[XLCJT^;Q\Q0!>B*<*W>"F=R:3Q
MC(4_="E.9\A>][$:\=?R9ZZV+L6W->G>/>@/*CS.V]F=+W+$&KPRSGLR%RFX
M)JA=K"K"^6YYF4*/?ZPDT=9XX*#,RC23ZXAM;RB$B!1HKX A^$.]QF8VDN)/
MJP_/-4NZNHV_/!3-I5VOT;?:?R-4S8A/1==6[)VQ]JTH^/\ .47M&&.==Q=,
MS(38D^1]>[ED*7':A2X/ B!'K#S!J#M"I?&S;B3"O$S[?OUA\,7:$^6=3VBU
M7VQ>7">4A 9<;9[ZGL]DBZ'K&$@25='G3;CI^;6))5Q+@$#:7L!(&?1VM T3
MO>3LOC/.<<>/^$H>5'JZUW*1^0^U>3[9[HB[GP RQ1@G,[:.GZ>I3D^K;?10
MEJDS;$&FA)"PN<TZ,52D:XG3N4O#\:Y8L"C;1!$$&S+W-).)M)B_U6XX FSQ
M9?FDZ>L:0Z3!?Y_XJO'S-GP*(KX$87B5 >GUSTD)]=_"FTM7C^,/_P H?36&
M=N-)/C5=_.=S@;UIY"^8*&;"1CF$M\=?D"=JP5$:_P![:K>@Z*%S>K'5"/UT
M(E4FF[ C#[P[T+19@]:_A],+[=\=<_&.177%]J/)Y4,Y\@+ZC6A9N:H5XO.3
MH@G<4!Z4*'HNU+O@EJ]=K4@#PA %8PN!;<PB-#]IJ80=Z_)WZ9*WK/"^/KF_
M].G?1]S^2#I[M'R5P7GQUZS:)/QV_0F"\XQZA^DN;*'INN#%%9H)RU6?T;6U
MTO;(_7G'+)D:P9J@\T*AH2,A0TQ BU(=; 9DUFLSCEZ]Q7SY*>J.OK@H)L!U
M/%+ H/CGEN9QVN.->G>:Z'8V"Z;DJL,OGUPV.MLR4EI[^KQFLHS[E1(6I4XQ
MY.B;S='[^9448,2:S7/&,]WYG5)V_<GD@\'DKZWMR[*PZ)N;F#HE=<NJ?Z$0
MM46A]A5!5L%$N_,<\P!<\Q")L-SJ$PEDJ2L:Q0CD"=0$H7M 7Z82637;'3AI
M%\]7=>%\:^0!\AW3]Q1&PHW^\$D\]5I.DTS>E;A7=4N5J0-A;Z[8R3U@BM5N
MVE.@_<P;_P#JY01L9(R]EF"UN]EUD\IF<>*?[&Z#ZY\>?0/EBIZ"=&WKU,T5
M%XO8_P!G5.'HUX:;)E,&NA9)Y+#'IT852%@94B>$)RDPGDQC*2EMA.DP2BR@
ME@%[R8UVFMLDYPB6LK0LBN^@/! *#^4SHGI\':,A<Y_TE6DONIAES&YJS*2$
M_'K$S!&4+<ZP^O44N>5+7J,N!AS<6N0%C**+5I%.]ELEFV=9,/I@XNAL;@U6
MREIBW6,T[';U=P6>]*+.G5EQZU7>,.;K(!*'"I$DAC8S$+<RUJ?ZH$C69OZA
MO+U\9FM;^S#C<YYF%NL(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# ]-Q;T+NWKFES2D+FUS1JF]P0J0:-3+$*T@:96E4%"]0F$*$YH@##
MO[-AWO6!72*<:\JP5'0J"'4!5T:1<MF2XWG5*T11M1DTP9/B3TTT'7H"BM:C
M@I.0J, MV1[?G"/>A>OKA<UX'3BSDQ[@MEUD[\]54XU]<EI&W=:D.5Q)M.8)
M_;I[XT24ZQ90W"*V0ZRPR0,")9M89K9NU"4L?KZAU@\KZN=IOAFHVX.R.Z>A
M>PZ[ISH2O.DY5SU)J>B;RTO_ .*JU-J:I]5[,4CZ[%F-@#VV8K4Z8X:%,H.0
MJR$Q6E10A%@UHUYV:R:\6+\7SP=QMTQ 8'6=Z<ZU?/(-5)"=/6+,L80,WYMT
M*-M(:"D$%=(X:S.\0:]-*0E.-,@4)TYA!)8!@$$L&@DFVTN9658.)^18S7]/
M5;'.=:D9ZYH&=M%ITO$6Z'-*=DKJR6/:\;58$:3EDZ^EF*<;JI'MRWL:LTP\
MP8S!"%O>R>6W7/->_?W'G,/4SI6CWT)2<&M9ZIR2;EM8O$H;C#76&/PS$9QZ
MIG<4:A(L+3+#FY.-0E&,:10).5LTH>RP;T)M9T0LL\5WCI<9[-;.<N.:+<YQ
M84K13N5O;G#4KC];-4+\DE ):@;%HSV>/2-5(D!*U6M;DZ10N4%A&H&;O6%\
M]L8SPL(9R[SL<9?QIM,U\89U0D(0='#%'$.Q74B2Q8Z$)TMB;^/_ .R0DF(J
M3&X(3_=K20>R_P#R[PF;_1'UJ\$\;7=#*9KVU.<ZQF4,YX-:1T@P.+%HA'6!
M3&W(6EM01$;<<B4MC.6V-:4@Q"$>T:@I,4$TH>BP>A9MM.9>J:;;I.I+ZC3=
M#;GKN*69%6F51J<MC!,6A,\M:&80UR+>(K(TR54$993LP.A03TIVM>XHT.MZ
M^W"2XZ-<F_,?/5E6Y6=^3ZFJ\EUU4T6M)JJTGV,MJ^<0(EQ^H^M(C4A-)VX-
MI!_UAV]@ /VZV<9O6M;&+U&;C'9 ;SXP/'S(+ZWTX]<C4JY7B.2IYJ?.%,4)
M&)9-TFPB33=PCNC=1)QFI)H-&A=ST!CCH[7R?-\GY6%\]L8SPERQ>.^8+:NZ
MKNDK&I.#2R]Z6 $JL;3<FTP,MBA!2PUR2IDK@E/3_7)$#DH,4I2585!250:,
MTD(!C$+9)M9,3HCZ8^./A6?4DBYQE?+%/.=)-4P>+"9:^+BJ=L:8].Y"YKGE
M]F,:4M(T#K&Y,[N;FH.4+4"A.H-$>9H0]Z%O6RS;:7,O+%3;QF<%V+3U5T+-
M>8:V?ZLHX"TNH&!4F=B7&N .AYREW#$9@D=4\T9M/*@\0UOQ..OK!>FS_D]H
M?0>6V<YY69IFF*GY]K*+4_2$%CE;U;#DBM+%H9%$FD;&U$.3BL>7 :<OWFF'
M'N3JXGJE!Q@QFJ%!XS!B$,6][);;<WJB([A?CI1123F,_FRH#>?4$H_&Z"H!
MPQJW!4,P_$9\OU)D3'\/TR1\U)U1J[2DO03=*#!"]WJ+?J/+;.<\M'O_ ,:'
M!G4L]36C?W+M76781+0@CZJ6O#8M1O#^PM>O:VL<P/97!K#-V=O+_()2O 5Q
M!9>M "'0=:UA9MM.)>%$/(9X_>E^B[44O%%T/XMG)K%4R6M:YOGHNLYR[](\
M_K%;4\,;V]Q'[AB[W%I<B8D+@4HC"4]0W_=*\ S-B&$6M9,-:[23G*S, \2?
M&Z'DWDWE:\*IB70[7R/"&>-P.93II-2O^GH"$@$N>D:EK<"'!M:YHYA&<M:=
MJCT*@G99*@)X2P[RI=]O*[3NL=%^%>.(01"4L.YGIJ+(ZUMQXOJOD4?@S(T(
M87<L@;0L[S9$91(4Q"5FE3@U "G,4D  +X0Z!KT#K6L,W:WJU6Z_'#PIT=;;
M;>MZ<M5#9]LMC0E80S.5QHM<N=&=!H86UNDZ/1I33+TS5H?^YZ=4ZWZ3VA^'
MV>P/H6;;28EX2;&^1N8X>LI)PB]%UJPKN;8G*()0BMLC#>F/J2&S9K)99=&H
M*867H3 T2)I3%IU9)/M"<4#01>NM83RVYYZO01<8<H-U75C2:'GVK$E24O/V
MFU*GKLB)MI<3KZQV)Y=Y$S36*M&BOI6F1-CZ_+59*DO6C 'JC!:WZBWA?+;.
M<\N.WD/\7?4/8]K7>3"JH\8,-C-UQM'7"7L&45?.WCMFN*O=XVSL$_;D9),>
M.ATGFZU.!Q2-#P)W0#0M:DM/Z!$6$T)O7>:R=?EV=X:CK=DINJ:RJ&,FJCXY
M5=?0RN6 ]<( UI[+"(XVQEK.6#+" L:LU$V $9L.M:V/>_36'.W-RJ\Q>-+@
M>-*ITK8^4*;;QV5:<1NZ:)RXL28VO%L0)W=9!#9T!H/--:FI\C;Z^K5J4:(E
M. M4J--T'WC$+9?+:]:GU5SM1*^PI]:[A4< <;&M6O4-365+W&,MC@\3NLFX
M:P:*!2LY8G/ ^10C;@?_ +DH",C>CAZV'>A;UA,U!O.GCCX=Y)G+K97./-E=
MU-.7=C71@^11M,Z"5HHPYN"%U<(TP%.CFX)(O'5KBV)SC$+86D2C,(+WLO\
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MV*^-S@^$T\&@8WRI3:*G13QEM%= E$43.S._6+'%(%C#-)6-X&O7R^1M*HH
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M5EDCTVZT0<H3@!L1.M!UZ!UK6$NUO5JU*^./ASG:VGB]Z8YJK>#6^]A?P*;
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M#.(O4\RC+TX%ICCBBEQKJE+V82@"J/)XYZ<\M^W*NAKZX7636ND#+272EO\
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MCK&,>0>0.\),XHMGENMF1*W/@+!3=#538MC.+LZFJ6P4=/BRF#SZ&$-2)(D
MK"K H H&:885L @:"+0A/'_;*I/YM_/)^U)XT?\ VPW]_P"N6%S[?I5YN46#
MLU@BLI3]IV-S_9$S/DA9\-<>?*\FU=,#=$]-*(LU _M\WF$R6N+V)Z"H,">0
M<23I., /9[@[%LS?'_56>YX+YA7.TYLOH+H3@R*4TJ=BC*]CMG4!<TIG[2RZ
M;D(#DTID,?MQB975Q$Z@4F!,3(TY>B!EA]ON#L6S4NF.9<HQ_-OYY/VI/&C_
M .V&_O\ URP9]OTKIK!&^[4E*L#98\EKMXZ!)@8$DEE<3C;ZT5<MLG34,L;R
MT15R>G&1(XCMZV$S2,U>8JTGUL'S>[\K#-QGCHYCEUMYY]%@T;U+XSQ&Z '1
M@@<OW^$&S/;KW[!K=Y[WH.Q?P:WO^##6?;]*V:'5[YN4TOB:F=]+>.QT@R>3
MQ\^:M<:YOO-KD;E$"7=&9)V^/.:^Z%R!N?5K($\I&H/(.))4B ,98PAV'8S[
M?I5[>EFCII[JY4@Y)FE/P&XA/;(:CD-Y0V43R!%QXI5L4A2'Q^'R2*/)CJK1
M^@4INE>BRC/M& >OLPS,9^KHYW_FW\\G[4GC1_\ ;#?W_KEAK/M^E6)YAB'D
M^8K)/6]?W9QS8-3;B[J0F8:(I>TX!. 3$Q:TB9G Y]F5ERUH&PIF\M:!0GTE
MT<8::4()@= %H1+X8^G.6P=717R,/\HB9_%EO\H5O#D[ M*FK?T'4EDV*_N4
MF$XZ&@6QYPA%A0U$W,Y37^0:2>2<:,[\K0]!_)P:^/\ MG*JWYM_/)^U)XT?
M_;#?W_KEA<^WZ5>_E5B["8(5(4O9]@T-8U@'2DT^+NW/T F=>1A%#=M+462W
M/+5-I=,7!:_A>RUAHE!1Y1&TQA0-%^X A",WQ_UZ*IVU _,FXV;.5U)=$<"1
MJH54A5G5U'[$Y[NF23IHBX@E:1(I6_L=OLS.[O)8]#V8>F2)RA:WKT!KTPU/
M#',N4>;K?SR>GV=2>-'U_P!GKS!?W_KECDS[?I732/M]WDT<W-<GDM<K>B05
MH%$Z2YGC;ZBJD^V_PX(D3^BB2I[4R0B#;E7H?] -P$L^B_BOG^3\O#/&?@YD
M@K;SSZ #1G4OC0V9[0_)L',%_P"@;'Z:]VPZW>>]Z#L7\'_PPUGV_2MO@-?^
M:Y'.H6KLOI'QYO5<II7'U$_9XCSE>+-+'6%DNJ4R3MT8=W.YG%M:Y"M90G%H
MU"A.>02H$ 8RQAUL.QGV^TN5V>GF;J=\K4I#Q_.*7KZVM25H/.?[XA,LG\'%
M$2REVGQ 6Q0V3Q)W"^JCA)MIC]JMDE! 9H18MB#O1G7QS]71SY_-OYY/VI/&
MC_[8;^_]<L-9]OTJR?+<2\F3#8+HL['N?D"Q*P,BBU.S,M!TW:%?3)--!.C0
M8WN2]ZFED2]J41XIG+7%FI@)@'C/-)&$S00""(E\,?3G+W.JXIY(W^:QQ3QA
M<7)-<U^3%_@E35T#4%F6)*%\Q^]EQGW@RNL)L6'-R%@^Y1)B_IS4YI_U #!_
M)[1!"$3PQ]6<JP?FW\\G[4GC1_\ ;#?W_KEA<^WZ5?GEEDZV88 [(^R9]1MB
M689*URAD>J!@<PKV()H4-L: -S:XLTUE<P=%,A)=RUQAJDM2 @9!I(-%Z$ 8
MA&;XY^GHJ!9\!\SR^QYTMI_HSQ^QZJ54I>#ZY8IWSO=C_-6>&F*QB8FZ6/C/
M<32TN[^F1>T*E0F2IR#3-;V L.OLPU+ICF7+1!5OYY?;OV]2^-'0O3?MWOF"
M_MZUOT^SUUJ\O7>O7')GV_2NFP&^[M48%K,DM=;Z,_-9I .7@C;]JI]W)^%?
MI]R(,1V][DVH!N9_[S]W_>/UOW?_ !7U'R?QF&>,_!S)#6_GF]H??U+XT-C]
MNO=L/,%_Z#L7I^5L.MWEO>M>O\&&L^WZ5N]:P'S1(;$@RRVNCO'T_P!6I96Q
MJ+%8X/SM=K#,W>%E.!(Y$W11[=[C=6IHD*MLT8!(I4I5!!)VPB&6,.MAV+^/
M'$N5QNI&7K-^KUM1\<3RCZ\M $J;E#L]W[!9?8,./A@$#J!T;D++"Y7$'0B0
M'N9B(9*@:D9 "2S0B+$(81!,SQS]710/\V_GD_:D\:/_ +8;^_\ 7+#6?;]*
ML[RK$_),P3B0*NSKCY'L:NSHJ81&&CG^G[-KR5H9G][MIA3B\.TUL:8-JV/Z
M9 *RA)RDY9^U)A0]&:"$01$OACZ9<O7ZEB7DP?I^TJ^-[GY!KNLBXJD3O;+?
ME.6A8,Q53,+FZF+G%O>879$0:DT?,:#$192<:89X3RS1[,V$80A$\,?5G*M7
MYM_/)^U)XT?_ &PW]_ZY87/M^E= N7F;JMBK=4B[#G5*6%:XI2['HGZA8/+:
M_A)<-,2-@65N4,4SE,N=C) F6@6"4* J@D&%F%:"6'8!;$9N,_3T4KG]?^:U
M9.IFKK/I'QYLM<*94_GP%GEW.=X/,L:H8:Z*3(TW2=W;+F;FUTD")G$26L4)
MTY!!QX1# 6 .]!T:S[>.9<M/'6WGFV 7Q]2^-#0_:+V;%S!?^PZ'Z;]NQ:U>
M6M[#K?\ #@S[?I731Y;[Q-HQ6UL,FKA+T:*L@H4,O<XT_JJF*M[\-@(%(%$1
M3OA$F-@GXL]Q^D 7$*SZ'T*^H^3\O#/&?@YFZK?SR>FO7J3QH^O^WTYAO[T]
M?]OI_P#CRPUGV_2M_JJ!>9AOLJ"KKFZ*X D=2I9*VGV,P0#GFZX[.'B(@-]7
M9!$WUZN%X:&A]/)^P@]2E4$EB^T18M?9CDOACB7*V'53%V$_PN/I>,;!H:N9
M^3*"CY.[= P"9V'&%L.TU.99S<S-4)ET.<$3\)Z,1F!4&GFDZ3EF@^/W#"()
MF>/^W11#\V_GD_:D\:/_ +8;^_\ 7+#6?;]*M+RG%?(XP2V4*.T;@Y-L>$'Q
MP@F'MO/M1677<C;I4%S*&I7/SE-K#F*!P9!M&AEA()().T?L(MC]NMAV2^/^
MN<L'T]$/)\^V0G6\@77QQ7U3AC#60I8KWI>TY_.#)@!8Z">' I]AMEQ)G PJ
M$!B,"=/M)LXLTLT0C!:&'01/#'U2Y5V_-OYY/VI/&C_[8;^_]<L+GV_2NA7,
MC/U"QUD%#UY-J:G]NZD+R<*043"I7 H+N+FB3[8$6F"8R:6O&GI*'1NE1_U?
MPF^X/L 'TWZF;XY^GHHQ,*]\W2F72M3!>EO'6UP=1)GX^%MDCYNO1SD3;$37
M569&D$@<D-THD+B^HV41!:P\@DDDY0$8P%@#O0=&L^WWERUHRMO//L ]%]2^
M,_1FP"^/8^8+_P!@T/TW[-BUJ\];V'0OX=:WK[,<F?;]*Z931NO-31[PUP"3
M5LU=$&U^%(Q2V3QE_=:I2V=]T%%C>G*)M[X@DJJ'??FAFZ1%N %7TVP@V=[M
M;%LSQGX.9_YM_/)^U)XT?_;#?W_KEAK/M^E233T$\QC;:$(7WMT-P1**>2O8
M#;#CU;<^W1&9Z[Q[Z52$Q)%9 _6\]LS2Z[6")%HU2D4%: $6M@WO>MZ%NF.)
M<K.=7,'9[_%XJGXLL;GZN)B1(CCIFX]"5W-K%87&*[:E99"&/M\(F,-6-ST%
MY$08(\\XXK:<(P:!H6]"T37Q_P!LJ-?FW\\G[4GC1_\ ;#?W_KEA<^WZ5:_E
M"+^1"/R&8'=J6YRK9$74LS87!47/=3617+TUOY:Y0)W521;-[!F21S:U#<(H
M!!1!1!A9H1"$,0=ZUHE\?]<Y7@PR8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'B./
M)3@V8H.*(+UO6MF'& *!K>_X-;&/80^N\!H\D6RM!.*WL\.QD:T8#>S@!T$0
MAE:UO^,"$(M;WO7KK6MZP/'I8D$,TL*I-LP@(A'@T>5L9(0_8(1H="]Q80[_
M (=[]/3 _/UZ'X=J?K4GT^A_'L_Z@GX=#_\ O-F^_P!FA_\ P]?7 \^CB=[*
MUHTO>S@[&3K0P[V: .@[$,K7KZF!#H>M[WKUUK6]8 PXHKV?*:67\@PE%_(,
M(/D,'OT"6#W;U[QBW_!K7V[P/UH8-CV7H8=F!"$8B]"U[P@'L80#V'U]V@C$
M6+6M_P &]AW_ .&!_ &%F>[XQ@'[!B+'[!!%[# ?^8 O;O?M&'U^W6_MU@?K
MUUZ:WZZ]-^GIOUUZ;]?X/3?\'V^N!^?D+^3X?D!\OL^3XO<'Y/CT+0=F>SU]
MWLT+?IZ^GIZX'[P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!SE\C!C&2T\
MJG2=)2RV.E=1EB=D_1*L*&FA%;YQZ+ DW,U9S6\I"/1R&1]W[.3C+VY_3ZWL
M.]Z%HUKW^3GU<06\[K*./+0?3VF)'*.$#8I#&1I/=+RE"!(KC:G3IX^YLC)1
MM$9YN1A6%$RM&2B5:<$C9( FGM!2DL\R-3I_7]5M#=754)F>[^;V6V.6Y#"Y
MO5MOR:VNH(E3J%JE-+N!E[1Y^2PGHR2E6,Y,\\;IN?)'!,! L<8^N""/'F&$
M&$"V--3GKRV9S25-.JM;'*33/B:K:YH;I6>&UQ,EM I-<J].GN%#&-ZQT;*K
M5V4RIES]'7*9N#88M;'QZ M<XX8-%L>][(3CF>O,0++)&^3&\*LLJ01*%56^
M^W@%S'SX],#N5U$!0$$<?UC5Q"[C0MFH!3+<MD&FN9M(VY2<X$,KZF6&,>C?
MF$7C&/G^JNAU5"[;Z+LSG.$RND:DCKRO!U0S-S/;3VHM2%IF$4'@*)JLY+N(
M,S<<BF*$]Q.&VHA'(%)7Q&[ O3C&$>C,Q)GGLT_[AIV:=()ZRJVW8/ [EYWJ
MR>UY:70B]X8FJ^;IN9ZY\' T3.O; .;?)IW':P8#")O(EA_SMZ:1(&LE$/9Z
M5S$E+SC-Z5K?*D!23V37#$8W$ZNC5 :Y$BM=6D[\S6])Y3#;6N1$_.:D$E-L
M-A8X5]9+72%!6A=3B52V1F-[F06]*=#,2EZ3J7^^4U/\*02#QX<'NSD0_;=(
M$I\;;\S($;J_-J4EW,LKGQC4JGYE0*DY#X%K:W%5LLEP+/)2G;^?V!-* ,!/
M]KCXJW'ISM^1D;DI414U07V(A"AAPF1P!VJ4VF4<2SFRI).=F"2&<-:%L2TQ
ME D"3\&C!"=/F]6G9?\ 7]OV_P#Y=]L.9@,!@,!@:/.+.K6L42=RLFPH/7K<
MK,$2E7SB6,,31*30^WW%)U3\X("#C ^[7J$(M[UZZP8MZ(M_6_Y+_:BYU_39
M6G]IL+X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^
M2_VHN=?TV5I_:;!X[>E/UO\ DO\ :BYU_396G]IL'CMZ4_6_Y+_:BYU_396G
M]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_P"2
M_P!J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VF
MP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_ )+_ &HN=?TV5I_:;!X[>E/UO^2_
MVHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X
M[>E/UO\ DO\ :BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:B
MYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_P"2_P!J+G7]-E:?VFP>
M.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7
M]-E:?VFP>.WI3];_ )+_ &HN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>
ME/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO\ DO\ :BYU
M_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_
M6_Y+_:BYU_396G]IL'CMZ4_6_P"2_P!J+G7]-E:?VFP>.WI3];_DO]J+G7]-
ME:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_
M )+_ &HN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I
M_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO\ DO\ :BYU_396G]IL'CMZ4_6_
MY+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]I
ML'CMZ4_6_P"2_P!J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO
M]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_ )+_ &HN=?TV5I_:
M;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VH
MN=?TV5I_:;!X[>E/UO\ DO\ :BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'
MCMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_P"2_P!J
M+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.W
MI3];_DO]J+G7]-E:?VFP>.WI3];_ )+_ &HN=?TV5I_:;!X[>E/UO^2_VHN=
M?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/
MUO\ DO\ :BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_3
M96G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_P"2_P!J+G7]-E:?VFP>.WI3
M];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:
M?VFP>.WI3];_ )+_ &HN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO
M^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO\ DO\ :BYU_396
MG]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+
M_:BYU_396G]IL'CMZ4_6_P"2_P!J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?V
MFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_ )+_
M &HN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!X[>E/UO^2_VHN=?TV5I_:;!
MX[>E/UO^2_VHN=?TV5I_:;!X[>E/UO\ DO\ :BYU_396G]IL'CMZ4_6_Y+_:
MBYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CMZ4_6_Y+_:BYU_396G]IL'CM
MZ4_6_P"2_P!J+G7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_DO]J+G
M7]-E:?VFP>.WI3];_DO]J+G7]-E:?VFP>.WI3];_ )+_ &HN=?TV5I_:;!X[
M>E?P77O)(M;"+J'G00=_PA%==:;UO_;]NMR;TW]N#QV]*:Z]Y)UZ>G4/.FO;
MKVA]+KK37IK?IZZU_P#9-]FOLU_]S!X[>E-=?<DZ]?3J'G37NWZB]+KK3\K?
MIK7KO_[)OMWZ:P>.WI3];WDGTT']:'G3VZ]OIK\]=:>FO;O6P^FOQ-Z:]N]?
M9_X8/';TI^M_R5Z^OZT7.GKK6]:W^>RM/76M^GKKU_$W\&_37_W,'CMZ5_?U
MO^2_VHN=?TV5I_:;!X[>E?G?7G)&Q:'OI_G/8]:]-#W==9^[6OM^S0OQ+Z^G
MVX/';TK^ZZ^Y)#KT#U#SH'6OX-:NRM-:U_M_@U)O3!X[>E?W];_DO]J+G7]-
ME:?VFP>.WI7\_6_Y*]?7]:+G3U]/3U_/96GKZ?\ AZ_B;^#!X[>E?W];_DO]
MJ+G7]-E:?VFP>.WI3];_ )+_ &HN=?TV5I_:;!X[>E;'%>C^>)T\IHY"+YIB
M8R%;OVHV**VC!Y"\JQ?_ 'J9K:'Q8M/W_P#  -X++.J9\(8%4.Z>E2N.N/.C
MNGA-13ZJI>J93,V9D4;,"D>)*E1;2Q5K7#)&6<!O<)(K2E*! %H821BV'[=:
MPUK/+:1\IOCH\(3#Y7Z;8O([Y2KVNJ[+$Z1.>Y;"(/'IA^%F"(P<M]<FAGV<
MIVWN*MN2N.FX9S<S,VVQL:VT2<O83C=F;#'7;W/"^.G2.CG^E.\17]1KO_3=
M(OY)C#/YMS_2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]-TB_DF,'YMS_ $IW
MB*_J-=_Z;I%_),8/S;G^E.\17]1KO_3=(OY)C!^;<_TIWB*_J-=_Z;I%_),8
M/S;G^E.\17]1KO\ TW2+^28P?FW/]*=XBOZC7?\ IND7\DQ@_-N?Z4[Q%?U&
MN_\ 3=(OY)C!^;<_TIWB*_J-=_Z;I%_),8/S;G^E.\17]1KO_3=(OY)C!^;<
M_P!*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_TW2+^28P?FW/]*=XBOZC7?^FZ
M1?R3&#\VY_I3O$5_4:[_ --TB_DF,'YMS_2G>(K^HUW_ *;I%_),8/S;G^E.
M\17]1KO_ $W2+^28P?FW/]*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_TW2+^2
M8P?FW/\ 2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]-TB_DF,'YMS_2G>(K^H
MUW_IND7\DQ@_-N?Z4[Q%?U&N_P#3=(OY)C!^;<_TIWB*_J-=_P"FZ1?R3&#\
MVY_I3O$5_4:[_P!-TB_DF,'YMS_2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]
M-TB_DF,'YMS_ $IWB*_J-=_Z;I%_),8/S;G^E.\17]1KO_3=(OY)C!^;<_TI
MWB*_J-=_Z;I%_),8/S;G^E.\17]1KO\ TW2+^28P?FW/]*=XBOZC7?\ IND7
M\DQ@_-N?Z4[Q%?U&N_\ 3=(OY)C!^;<_TIWB*_J-=_Z;I%_),8/S;G^E.\17
M]1KO_3=(OY)C!^;<_P!*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_TW2+^28P?
MFW/]*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_ --TB_DF,'YMS_2G>(K^HUW_
M *;I%_),8/S;G^E.\17]1KO_ $W2+^28P?FW/]*=XBOZC7?^FZ1?R3&#\VY_
MI3O$5_4:[_TW2+^28P?FW/\ 2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]-TB
M_DF,'YMS_2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_P#3=(OY)C!^;<_TIWB*
M_J-=_P"FZ1?R3&#\VY_I3O$5_4:[_P!-TB_DF,'YMS_2G>(K^HUW_IND7\DQ
M@_-N?Z4[Q%?U&N_]-TB_DF,'YMS_ $IWB*_J-=_Z;I%_),8/S;G^E.\17]1K
MO_3=(OY)C!^;<_TIWB*_J-=_Z;I%_),8/S;G^E.\17]1KO\ TW2+^28P?FW/
M]*=XBOZC7?\ IND7\DQ@_-N?Z4[Q%?U&N_\ 3=(OY)C!^;<_TIWB*_J-=_Z;
MI%_),8/S;G^E.\17]1KO_3=(OY)C!^;<_P!*=XBOZC7?^FZ1?R3&#\VY_I3O
M$5_4:[_TW2+^28P?FW/]*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_ --TB_DF
M,'YMS_2G>(K^HUW_ *;I%_),8/S;G^E.\17]1KO_ $W2+^28P?FW/]*=XBOZ
MC7?^FZ1?R3&#\VY_I3O$5_4:[_TW2+^28P?FW/\ 2G>(K^HUW_IND7\DQ@_-
MN?Z4[Q%?U&N_]-TB_DF,'YMS_2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_P#3
M=(OY)C!^;<_TIWB*_J-=_P"FZ1?R3&#\VY_I3O$5_4:[_P!-TB_DF,'YMS_2
MG>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]-TB_DF,'YMS_ $IWB*_J-=_Z;I%_
M),8/S;G^E.\17]1KO_3=(OY)C!^;<_TIWB*_J-=_Z;I%_),8/S;G^E.\17]1
MKO\ TW2+^28P?FW/]*=XBOZC7?\ IND7\DQ@_-N?Z4[Q%?U&N_\ 3=(OY)C!
M^;<_TIWB*_J-=_Z;I%_),8/S;G^E.\17]1KO_3=(OY)C!^;<_P!*=XBOZC7?
M^FZ1?R3&#\VY_I3O$5_4:[_TW2+^28P?FW/]*=XBOZC7?^FZ1?R3&#\VY_I3
MO$5_4:[_ --TB_DF,'YMS_2G>(K^HUW_ *;I%_),8/S;G^E.\17]1KO_ $W2
M+^28P?FW/]*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_TW2+^28P?FW/\ 2G>(
MK^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]-TB_DF,'YMS_2G>(K^HUW_IND7\DQ@_
M-N?Z4[Q%?U&N_P#3=(OY)C!^;<_TIWB*_J-=_P"FZ1?R3&#\VY_I3O$5_4:[
M_P!-TB_DF,'YMS_2G>(K^HUW_IND7\DQ@_-N?Z4[Q%?U&N_]-TB_DF,'YMS_
M $IWB*_J-=_Z;I%_),8/S;G^E.\17]1KO_3=(OY)C!^;<_TIWB*_J-=_Z;I%
M_),8/S;G^E.\17]1KO\ TW2+^28P?FW/]*=XBOZC7?\ IND7\DQ@_-N?Z4[Q
M%?U&N_\ 3=(OY)C!^;<_TIWB*_J-=_Z;I%_),8/S;G^E.\17]1KO_3=(OY)C
M!^;<_P!*=XBOZC7?^FZ1?R3&#\VY_I3O$5_4:[_TW2+^28P?FW1Q:W[IOXY'
MB$/A5%/]ZTM;2=$>J@4_W9*B7-K))TX/E:%3TPNK9]0M:@*P!^;2)4@6A!O8
MB3P#UK>,$][;//1,/[NAV=?%_P!#] <P=3OKC+;_ .$+A.I:0S)Z7&.;])(F
M8:_-L?#('91_OC\]1M^AKPVB<#O4]8B3I##]B/$88.GNZR66=*^BO#DY%^>?
M_*"[N_N>)_XTBF2M^W]\97P8?Y1G!']PC'_2KSE/<^^_-U?PP8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'R<?N[W_ %Z>>#_O!_YM]+8=_=^W
M7Y/K'PX.1?GG_P H+N[^YXG_ (TBF2M^W]\97P8?Y1G!']PK)_2KSE/<^^_-
MU?PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'R<?N[W_7IYW_
M /O!_P";?2V'?W?MU^3ZQ\.#D7YY_P#*"[N_N>)_XTBF2M^W]\97P8?Y1G!'
M]PK)_2KSE/<^^_-U?PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8'R<?N[W_7IYW_^\'_FWTMAW]W[=?D^L?#@Y%^>?_*"[N_N>)_XTBF2M^W]
M\97P8?Y1G!']PK)_2KSE/<^^_-U?PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M7<G4:/BGDJ]NJG"%JK$14A!U$U4PE"^$1I7(RTZ] AVWD/RIM=T[8,7UWO\
ME$F.UK0?3V_;A=9Y;857\5_E,AGDVIBTK0*J]UH&24[/Q0V=5S*Y8BE"]H:5
ML199I&9D<])V.-DELTD9G0X16AI@^SZ,S?O$'TWAK?3PN.JI?CQ\\*'R-="7
M90-6\HR***:^IFQKDK&7RNVFO31<C3$K!:Z^B9!*8B!EFP]OG2YU"=I>(QQ+
M;]%F V6?L.]X:V]OPF;>Z>>5O,[1E[\C=2=.V["WSF61<42*=Q7IZCIH_H)!
M-*W>XCM6%G1 7D-S 0\'SI2E$@:PZ3$;.>"CD8?<(K1@R;>W9M).<JUSWSIV
MK!J!\?\ ;0_'9.G2Q?(Q.);%J0H?\_479Y:4U(0Q<RNWUY?7FO4C*G4VBFDY
M2I(D,T2!&C$2::H%L[8"B_CF;,]$P\]>:0BS+)Z4YVOOC^X>3>I^<^?Y7T@?
M35B2F)2=ML"OHFU!<%1T5L"+EB0".4&*4P2S-HAIQE'#,+,,$0<4 E]O$EES
M+5S^ N[8SW%PU6W<*Z&&4E%)VPSZ2.L8?Y2EE'X-9Z^E\LB[JN<I.E:&)*K3
M;31,Q:(>DI6B2C/;OW;#L6S.VN-O%3CQ7>;2M/)_9US58STM+:.?:]C#195=
M;E\F2OPKFJ!VE#W%-6(Q)B8ZP":$B)R0H0G$:&N!H;B$ 3Q;*'AK?V_"2YR_
M?7?EPM>A.[$?!%!\%SGKJTU5#M-_[.B%V0>MC0116_/K"[E ;9I'3D1HV,YJ
M(%L7W@$:@2P 0%Z]HM[&NDNOE;B)4X(\M]2]L6M97,\JJ.W>4.O*A;MO<YYP
MOAJ0M\H%'@'(2#Y#$7IL4&MLH:D8W1(([>@)C_@6$J"RS$QFCL)MI=9GKJN3
MV'US2W#//5@=+WZ^J&2NZ_1)AJ"6Q,!PD,D?'144W1Z)19K&>F"YR.1.AY:=
M,4(PHH&Q"-.,*(+-- 9UEVN)U<HZJ\G?E$N1KA=N1#PMS5)SM.5\</9GF5=5
MUE&;EW!Y$M1%DS\VIG2,$.86TIG6Z<=)?D^<Y.'^*V8$03!1NZ:3B[<_)('7
MGENMFA>ZT' U \&3;KJUE]#M-^@-BEWP>LM@BZM_?6!U)VAFD;4(=_<BAJ($
M,SZ_0SOK A 5^0+>Z:Z2Z^5N)EIW8?F=M/A;B^H^I.BO'_.X-85HWB[TX=SH
MLO*$+Y%&4J-@F,B9IB;.8Y%G^/NR>0H(GK92(H@LTGZK7O,]0;T*9-?;FVUD
MO&$T])^7^K*3X_XW[+KVO5]VUWV3<%(U1%4+;,$$36105R-K\K.=GE4>R2 E
M6X09QCY[>XMH %&?6%F ^4&R]^MO!/;MVNMZR(\ZG\NMPTWWD\\!\\\ 3GKJ
MT&2D(Y>ZQ;%+S@E9Z#$GIS.:' 6VZ:QLU($+(X#2%C'I?LPX2L/L*UH(MY":
M2Z^5N&-O'RG=W4+2S9>$N\.ULAC#-6,YLV[ [ZFI8O\ ,HWP>22E(I1O)J9E
M7GRG:R$,">0Z-;2#/C3K@I]@$<4/UI--;<>7]FEU#YJ.@K"Y>M3LZ9>,BQ:N
MYIA7+DZZ4@MI.?1E:R)JM444$UC98"V-+3%RI/'%LN1*59Y*]8A$2F"A%HPK
M>S 9%OMR;>.><I]M+S-4927CSYR[NLJ!3$EZZJB\&54MS;"U:.8V;-I]/6@M
MV;H"Q+0I&=&NTV%&:VM<A)RBB@;!H!1B@Y.G.K,TMVNL[/;YT[H\@TRFS6X]
M7>,1;R?SB[0V;39SN5=TU7]COU9ML1B;A+$Q%EUDQQUND3:I>RF_:4.BM^Y*
M>/6C@A%KV8+KKCBYOR07QWY;^PNZ)% [0H7QE2)7PI/+;W7"+I"5]%U_')LE
MBR*2CC4@M<5,'L9KLX1N.G$FC4I4:U2;LT@P@!PAEC$$NVFNO%OU.^F'-S?Z
MT\AS;RMUWP3R@KJARFZSN>9S^'M\Y22]&Q(ZT'!$,<7&."]A/87-1* .>I#H
M(2RE2+97Q;WL0O=KT-:ZYEOHJQ4OG"JNP?*C:?B\EE1O%;26&2"5PR"7"Y3I
ML=HW9DXBS T2S<4*CFH\U*8RY/,;5+CT>AKEFSC6_9.@^\XO#5]NS2;K&TQY
M-8-9O5'D1YSED&%5<;\>#?!7R=7(_P S1N$>E,=EL-<IJZOHF0EB0J8HABC6
MUF[/^54MV<'6Q!]OI[=DNEQ+ZJ*UUYE^T.M6R1VSX_?$_8=_\P1]Z>FMCN*S
MN@:\Y_=K;)CZH]$XJZO@TI9G14Y%;5IAE%B,5"#HT.RCOA4 ,(!&OQZSC;;%
M?07''%P>(\PNSLS'QUT=&9K<7*/JCRU2IB<%J$A2L9E*HD("5)[8H-$0,P&M
M!&(&]ZUK6\KDS. P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P/DX_=WO^O3SO_P#>#_S;Z6P[^[]NOR?6/AP<B_//_E!=
MW?W/$_\ &D4R5OV_OC*^##_*,X(_N%9/Z5><I[GWWYNK^&# 8# 8# 8# 8#
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M=2%U?5JC0C=BWHU48+^$>_46V\562XO$5XRK_GRVT+?XAY[FL^=%9C@]299
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M'\DI*B1)P%%AU]@0!UK#FR^ P& P& P& P& P& P& P& P& P& P& P& P&
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M_-U?PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# H+Y(J.LR_.=4$8K*,M%FG12X*BM&<4%(9 GBD>Z6K2NI@CD<QH5YD3
M@ UE;D\W1I0#) Y@$SK%B0E(XZT@/4"T:TLEY8_DBW>7[&B%R'\QU3#N:+MA
M3<A9+HIZPJ;:Z5L:KY4D97A9 4]TQ./IV=2]0HL)RE0UN[:X+F1Q0;4C:W >
MOE$$;2]^8@+G?N23.O8M?\R/W6')/83;;E66U,_O?FR/EQ1]IB;5&N@8E;!(
MT*"YKD;WV#S%HF"O2!4>>B<$BYI&69\X3OXDMU^G.+% "UG2#?Q'Q*91EE0"
M M3MY89_&'Q/*8C/'UR>),]^1^\BXN%:NAUH0$A76Q6RC-/K&>08<[E[ $M8
MD]N_>:XS<^G^'TK *D!, "3+5K.Y2HJ'Z*DSC'FU:S1]?( ,OL>5C&SN3J^N
M#4SJG'1@TR8]<L.()$$ SS1!V8(Y*+^(@(0>,'A (0Z"$/,=5:"$.M:#K6HT
MD]-:UK[-:UAK?[JKF\]V3JJ.I:+K*3==<7] %W3T(*@YASM3T>''[<ID4A9I
MDOBDJ2OH;PL-QD)L6=X^A025(ZL;9[P+AJ"/I-E!(,->,LMQ9PB_E;HB>)K@
M[GYBYFCD?FO0#EY%+RFMA2"8DNA]3\X5([H:Y3(YY:WW*O:G=ZD\YTS+TL.B
MB!6F7OJI*>I.4(FU&I5ZA9,2WIA-UY=QS-9TS<W/5==0\;<JI>;HU7^Y/)NG
MQM[X^6_;5B10N>ML,C,/-N*JE,4K*,Q!Q:S'=]":Z+E*YUTF2$E[1'C.J37C
M.+<KP\3]*)>ON6:<Z*3M+<PJ;%CJP;\RLSR1)&)IF$6D#Q"INWQ^1)M!(D$=
M23"-K@-ZX.@_6(M%'>T.Q^FC.T\;A23D*EJSZ[L'I3KWH^%QFYILGZ;O_GNF
M&"S&5OF48H:F>>;%=Z?;X[ (A(T[BQQ62SV00]?(I [$$ <W,US*(-.VE2IB
M@&K;K)K.F,K =9FUWRGSG'15I1%'[C#AU'RJQ#KQ?7C(D@"9UMKJ:I8:ZSQ'
M&&$AI;B)['5$AV]M3C[-F$/J-.J'HP1>];),V\YZ7_A4)I<^]4GD)\@I4&L>
MAI9^$.6Z)DU>UG(*YM8#4L/>3^P#J8CJ-0&\M-,<D9\F9DI4S>248BWY)HC2
M9*WC3A%CLU]/A/G_ -+-1?NASMM'XY 5 Q1]2\]HM#E:<_0OI3JNU6%,UY5_
MXCMPXL#<O0&I9<R6M(HY#R-J_E3%+G(W9A1FRO31GQQG/9TCPRYH>+X(0U]U
MO[0A#Z^2?O\ %OVZUKU$+HV8;$+?I_"+>_X=X;WZSY1RFLI7?#/QOWF[4A/H
M97Y)'F:F:&9J7V-S)SD3F5(NS.<6&/IXR]P^PH/MB;_O5PV%_)4DN&GAE,/1
M%[2B-V?HWQY3/\?\.Q?1=C7!4M;58?/.S>.N87U4G=DEAV59M:+A1R:RM.6W
MFM#54L+F71,1^YD 2AJ35Y*MX?EVP:)T5LO7O,PYR2WI;'->?]2VQU/1WBNN
M:#-]22.YU7DOG=4%NS&O?CJ(>I#6U8=K4X[VXPB+7J),X5HX,\<-E:)M+7;6
M*4PRT&EVA"^LT;DDNT[8_P"G2KG^WK]9.HK2Y(Z)EE<6B],=*UWT-7%I5S7K
MQ56W&(S&:SNO9+#9E!W.<V(D3/,7DD-*/0KT3GLM<@<- -(+.3C&<8LF/*>J
M!?+/^;.,-/)ERW.F;;-K"H.C"71[Y06MBF5O73CY+8#+8;$&>MJT3('8NV+:
MJY]=P2EDCZI,)$J WJ31G)322%)1=,\R=<=4(<9VWS3 YMY#NWXPPI>7Z:9F
M>L(7.>5 1;\!6VT3>K-SH)EQ6ASHD3(5M?VO?_XN;6"*-)23[RDS:S-YQ@C5
M:L*9*7:;636\W]=V-INLK)1^4GE7HF_6Y2U]!](<C]IR&5Q(:\;BVTE64=GW
M).J@YZ91E_\ U?\ -6[/)%2B0K$^O8[2YW<U01;3C2@+%L\+K.DL_P IJZJI
M&%L7DX\9U[;42I[L.:79>T/ KD<L?'AAA<,:^(KO.-BE>1,]7J-0]L?GMM+<
MW0U,E^N<E_H(]0,HH@HH:V^%G;_Y;M.H3#NBO*@"O+AB[#8==\T\5Q.TX% 9
MJTH9%#R;7OZX;%A;U8ID:=4ZIH<9-'X/3@&MN5J"C#&XAW7:(]FU)@MDEQIQ
MUM4+M2 PZ)TKY<.5$DPA-2\V\[=$\WWBP1&:R!;"Z>!6=CQFEK^MGEL]8QI5
M2V)5?<DN:W]I):VI*> G<NVE3(SB1Z1CC6<W6];9^JD?CN4<X]%=]UE:= 42
MNX7<:?Y?E::95/8%5(^;+EZ4CUNF093%"DU.)D#1N8TE0I[$8=J4#TI 5('4
MI&B"41I2:HJ;9FO-SR^@/#F8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8'R<?N[W_ %Z>=_\ [P?^;?2V'?W?MU^3ZQ\.
M#D7YY_\ *"[N_N>)_P"-(IDK?M_?&5\&'^49P1_<*R?TJ\Y3W/OOS=7\,& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P(BN
MQQO1IA87#GF*U?-I^F>VL9T8MJ:2:OHRZQKWFZ?"$<MBL,L!>TR'1>P"1B-:
ME*40M"";[=;T+19CNY56[P%T]ULU=?6+=4AIVE[:OSF>#<PUC6]9R":V#7T<
M@D&L=YMIR)NBQ%T8KB13\5H2!Z.8G,EM94!#5&#E!2?ZE0J/%LW-M=<8SC*8
MJ[YKZ<DW4'+E\V1!^:.?JTYJK:]:[;*,I23R2<G+5MMM%?MY4H0RA15M5,3:
MS-?X# G2LA347],F.&:-4<8()!!+9BR9MK5'/A.\8UQM5E4PQYK*4W+1W;2[
ML&,MST]R6,5[-TI?7<^O]' '25)XJ_/T77KH3-?H!+P-"\E,[%:W\1J;U'L>
M4\L]L.IS/N4/D(0?B]H9XS,':-EAD+&R/JF4,;&^K6_VKVUMDBECC:M];T"L
MP19:L;<B&H '0]D%[W[-&'*?E?G/R)TSS75''$Q'R,VU;"::_,>Z7+65HW>.
MX6UH(ACA&$$]B$3?:;:HP&7HUQI"LM,>\$IRQAW[3OR0ZV;MTM\N<HWK'A'K
M)'7O"%'/$.Y&IFM^(;HI:QI(_P!5R&;2%[Z,_-/&W^*J) G85=80\BLG>3B?
M3'UP+7+Y(L7O MEF+@%_*I4%NVO-YS4IMGCLM&"RN[^@ZBL>%0+JQ]ZEMNZJ
MQEQ:-]50.>TU8R>&;4<W=,,Y"1$XR:&.JR-''E*T7U"^*.@R7-H-V/2I(K)Y
M=K]N&=F/+-^0'I2W.AZKI[EV_67IF/5<X6K5ET2UUA+O6EQ5Q#$M?;EM:681
M2UFAE,"E$.:FQ*X-:]G:U9*MI+6)S/\ >U"<L>4QCF8=)ZV:WIF@,1;9*P0F
M+21,PM_XCCU;B5&0)GD!Q 5#VAB)Z]H8%ZIA*=#3?ISST*,X\'H8826,6P:,
M*$&T)U5S);=QSSD!-3-JT_T#.EUP3OGNZII+:H<H%<[X@;V^;S.HK6BL#M)-
MN-6:>VDN;Q'W=BV%.]_4K4:X&EAR71K,L^K.6Y712W174?-D9AEEMM/59:J/
MHCG>V%S-$9K,+"A#?#:2Z.K:W5+07+7.OX2\NLK>(K"3TX=Z9TJ(#@<6'W_#
MH1N#,EXZ8_P]H-0W97G>,]Z%BS364FI&]:4IFN[.7R.>/D0GM4NE#/=U/:-]
MCL>(@TBCL_8Y8@M<!1I:AV9#F\Y",S8S2QZ#@S+KCOES#H-N>.<'3RM]B5>E
M_/Q#*'>[5I;A6OXNT.3BB/=98^BZ(NBN&+4<"M5O+$]=@6D"-'+$.O8B31C:
M?UUI"+8(W>?&7KW_ %\GT$PTR6&Q"*&STED33DR-L1DS3QK:O<<(E@VM**1$
ML&UYRA=MD*>-G!2_,88;\&@^\0A>N]UR<W&&E>U^6)]?R;F&/<[W73-^7#,[
M[8F:Y[-GM.S&DK,M,:5SLQN-61&J;7:[-K5WF9*A\1E "R.R$YQ4)-F*"@D&
M -YULF<YC67OQ^6H1P#:5#MU@0F9=-VM=J?K.<39Y;WB'U;*K\WT9#^CG*.(
MT#<"22")5H-7#DL80&Z O7I6LDI2: X_W@$7RGGGMT>Y,*#ZS<.HH%V:W4OS
M'-IZX\VHJ(?*JLFY)A]W<\25!9,GFID_J"S4E#O@Y4VSEL?4B24)OP_'W%1M
MD;]$*3"RQ T3.N,9O5BZ@X NR%0/DMBG%C5O)9=1OD!O_L6QWUB;9"RL\J8K
MH)ZF/+9(BSGI%9K4]H72_$7N3J3A)2DZ(_05)HM%[,%VEMQWF/\ A<5)04G3
M]RR#J,3RPBACMR?$*"(CP?O#\3E2>.V_.+#5/)NMI--7W">U2@D@OT/VH^H+
M'ZEZ![1;)GZ<=\H^ZXY\N>;VOS+TQSTMK1SM?F);;"-+6MR*W]EKZQ(9=,89
M8Y,$J:9QAEE+W7=@- 8TD&SO);0Z$_ <M1*"/@6#,+&MF++TJOB/@&3=57-9
MU[]_PBJFM'+JSJ"JX91%%69:3@0QI*<M)]N6-V/.KO;6NE9;([#:YT[EB92F
MUO;T3(E3BV$Q0<J-$67RQ,:OP;XCJ2:.PN>^@867,D$#J*!6NA?X^_\ 2G4\
MGECG8L@E=.R&M'EG62*TGPC44828*[@>&HY46WNHE:72I(L"2#X!YWQL7!OC
MGZ46KT#Q/;C(],#<Q<S6I:D\F#8Z;<?O9_;)YSY9M1-B.-?2)%"/:Y&^S9,J
M/^J,(+^D),]@A&>T&R2XEGJCCH"C;[9>E(3V%RXCK&7SM)4#OS];=0VY+)'7
MD=L6MQRXJ?P9\C5BQF'6$JB<XKB7'N?QEJF1>A<FU\5E"$G.*(,V)9CQVZ*V
M/?CPO&<TY8\PEMA58E[,L?L2I>WCS"VF2R#GINEU CA#/3M"NY)X&29RBK6.
M!5\B;U;S],C<Q/*@YX(1EC+)2:+-I+C_ %QA*S%1_7-[]1<W7[TS%>?Z5C'*
M)=K.L/BM-V+,[DFEDSBU($HK1Q-?9G)ZMJ%)"JQ;X^Y*%OW.0D<U3FZ$HC%!
MI040-&C.LEDSRZ=88,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,#Y./W=[_KT\[__ '@_\V^EL._N_;K\GUCX<'(OSS_Y
M07=W]SQ/_&D4R5OV_OC*^##_ "C."/[A63^E7G*>Y]]^;J_A@P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P&!CG=H:9 TNC"_-C>]L;VW+6AZ9G=$F<FIW:7),:B<6QS;EA9R1>WKT
M9PRCB30#+-+&((M;#O>L#$0N$0NMHLRP:NXA&(%"HVD^@CL/A; U1>+L*'Y3
M#_HF:/L:1"TM:3YSAC^,@H />/>_3UWO>#KU;1@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M?)Q^[O?]>GG?_P"\'_FWTMAW]W[=?D^L?#@Y%^>?_*"[N_N>)_XTBF2M^W]\
M97P8?Y1G!']PK)_2KSE/<^^_-U?PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8'R<?N[W_ %Z>=_\ [P?^;?2V'?W?MU^3ZQ\.#D7YY_\ *"[N
M_N>)_P"-(IDK?M_?&5\&'^49P1_<*R?TJ\Y3W/OOS=7\,& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P&!\G'[N]_UZ>=_P#[P?\ FWTMAW]W[=?D
M^L?#@Y%^>?\ R@N[O[GB?^-(IDK?M_?&5\&'^49P1_<*R?TJ\Y3W/OOS=7\,
M& P& P& P& P& P& P& P& P& P& P& P.%WFB\FM^\.IZ J+C6NX);_ %3>
MJNT)BDA<Z;GQ]:FBF*2KYYFMB2<UGC<FB;H)=_NY6D8]J]%C+2*PZ+,,T#6C
MIII-N=NBQ<?\A K7\1;WY'*B11M1) <?3V\VV.NQ2Y?&&JT(# GYPD4.>$J-
MS1.JAI8; CJIO/ %62H,()WO1@1"T+1/'&_C?5SX\;?FNM;K_A3LZR[9A->0
M+K_E>E9Q>[5"6IEDS5 9U5[G5C]8-+6(WL3U*G21K8V[.;&>W.>T[E[1:)+&
M TG:H 0&MO;DVDGVVJS])^=/N*L/'1XM.J:MJ6C9Q=O;BRP")_ CHA/US"<=
M#]*5"%JK9K;;"3OC<N<4Z001;5*G,6Q;]0 WOT#LU/;UNUEZ1?;I/R_/K?77
MB&NGE=!7\EK/R,=*U?5<R%.6Y[=G:*1&8DIR92UL1K)(8\0V3V(OH53:H&J+
M6)BU20>MD"UK[3&NG-FW:)PY([XN2]_*)Y(N+9@PUZAJKD-JI-;6;S'VE^2S
MAV-L:-)WA\#,G-=)'%F<2TZHW>DVDB!#L /L'L>_MPFVLFDV[U^N(^][DZ.\
MB7D\Y.G+#7K=6_&4FI]FJQUC+2_(I>\)9\R/SB\CF[@XR1U:7(X@]L+TGVC1
M(- #L6AZ'O>MZ&VLFLOJY^=I>=JV^<O(\?2D&K>O)+PYS_8G-U/=IW2Y-TA7
MRNO9_P!%'2(Y"%A>&Z5-S VI(LT)"1GE*6U:+:I L)&,O8R?::GMRZYOW7HZ
M ^8GOFX> ZDYCGM)LE=R)SN?L.GJ"DH+!:WUY;4T(L!!*53NY,0(])(V:1("
MA,I/TQYIBA.$(A>XD?KKT5G36;6R^CK_ (8?,[YO_+YV'X[.@J2K#F6M*;L5
M@EM!V7>U@I;$C\Q=I(2Q54]_/*11Q7&YQ&$B4A'#DJE2/1R94,(B]F>NPAV#
M<=?;TUVF;ZK0>4'RI3#F?C7F:Z^0F"#67<?8\LKA#0T7GJ5W=H\Y0^20=7:$
MID:Y%'7Z-N!Q;%#TI8!#"K*+3J%A8S-""'8-U--)=K-ND44L3S7=C-7B!X([
MDA,.YZ,Z ZWZ=34._,\AC$\'5#4@>)A=449G%I:D,_)DZ \!D";!J#37%8'0
M3%&PE;V(L(#7X]?.ZW.)'4FLIMY8JKKGIVS.V3.$W)DKN@IQ.:D2\W-UVA<C
M[#B+$]/^BIX38CF6G41(](WEA]B$TE4(S8M>\.MZWHQ?"V>.5&_&SUMYN^\*
M>YTZP,2>-A@YQMA[.62=C"Q]#MMOI89&)X\PN9@94_XGD$332(XV.*QMWSJ3
MD^PB*$;Z>H@Z-;ZZ:VSG*&KQ[R\[M"]?\J\7RIN\8#C978!5AJJS?F..])'P
MUC3UPV&/#N&:+%TP0/"0U4B!K2?Z-$KT,S[!>S7VX6:^W=;MSB+@C[U[NIWO
M_P 9'"71K-S"XR;J2L.AYAT1(*A9+)$RMSU7>[#>( 54KA+)0F6MS<?&F1J"
MZA=4"TPQ9M3\(BR]E["9\=;K=IGA '('G!MVR/+%T#PET5!ZWBM+)+WO/GGF
MVU8FQRAH7.EK5&_KE[57T]>WN6O; X2&7URD,4D:2)4 QKR2P%EB"HT$LUM[
M<FDVG7"P-*>7I]2._FDF'3C1#6>F/&1<YL-A!U>,KREF,LBH$\K @;9"8]R9
MU;'>9R%Z:D*!&-,4V)/J%7Y8 AW[@F;I]N.M0Q0=U_O!?<=6,?5E3E\!<EU1
M8[=^+J4I*YHE;=ASR3P-P")5%'N=RV/.*4MC+DK<(H\@U,E),.(-"=](0 8-
M;+9[6M\;FU]$\%%,APB'#L8MA)L(<5CPIV3%1+!Q<J9":$>Y.7&Q..Q. F$#
MWL_2/9^]G;3Z![_RO7#D^?5Q[[\C?>O7?3_/'C 1\TU/2O&<K*K2UNENDV28
M3L4]MTHQ>G=(;7\0B+@WDIVIL<&E60:H-TH%\2?2D1I6E"9.9'7QUUUEWSFI
M7X@\GO0M@RGM_C_LFKZ\K;NKB* .-BK3*Y4/JVGKEKT^.B=(Q8L50O*H3\V(
M#CUC8-6F&KWLPAT($#Z<SYDY%3;2<;:_;4'^++LSS0>0.L^?.K'=!XZH]R]8
M,X6HK 8T+%?[7=A$-ATU<HA.-Q0@Z4R2&IY"H-95 VS:I2:1L(B]G:UZ[#J+
MOK[>MLYRZB>4[MY9X[>&KJZN:(6GL&2P))&FJ(11P.6)F1PELVE3-#F$^1JF
M_P!%Q,>;%ST%4KT2(LXXHG9)9A8S F!K&FOEMA5KC!Y\S5@U^MN&Y;=\>T^B
M=M\T/\ZHYBK2(V>@!#+QDK*SN]3-4QDZ5\=&V758C$L4%/Y[>:)?L9>@I!CU
M_&B-;>$N)GJY]G]Y>>)/W\A\<9C=XO=W<OY_,Z+*E((YTGNM PXI\41\36-P
MW,-234BVN3[%HK3=LCXMZW\OK]F&O'V_'RYQ^RV'6/D3[FB5Y<G>-'F."\]3
M'R*W#2S?:_0UD20V:?JS4,Q-K>>FE$F:&,M21-7IO<GYG<!MA"L_YRDNDA8R
M5*A: )9G777%VVSXL;5?D [YY+[KH7AGR@,W/TYC_7*-[2<W=3\XM$OAS$ML
M1A+),65O/85+%KGM,O5'*DR8@U*(GXSUZ3?JH <:)(+KKMK=M,\=GZN#R*=U
M]2=RW1P;XLX31C*FY:3M:3ISK'I)++'Z#Q";/(#!):_A$-B*I"K>'Q.<G/3#
M$H$=\ZI&KU\:<A-I0?%FNNNLVWSRPO3/<7DSX A'#L9Z/<>0;3M;I3R%PSG2
M1S&N(79++#C>?I@UQ\9+ZB97F7M"J-6DC>3',!IA@UK46F+(%HH>]CW@FNFU
MN,XD331'D=Z"[M[]FU6<6QBL3/'_ ,QKSXGT1U3-V*32)=:ULIC!#5UESD<T
M2N/1XTIM] %JGA22Y)BR/>KT$19S<!94NLUUSM]U27X[^\[CZPZ[\IU#6.Q5
M\U0WB?H2*535"^(-+\WR!YCKYJP]JU4Z5NLD>D#F[@_":?XS$29O*U[C/4O?
MJ'VDVUDDL[Q!G.GEUE#BM\T<RZ:9X.R5#XQ[QED*AAM?,[VAE4IA4<W.@HT4
MD->Y*]-[M-7Y;'42)*-*4W)1*E7H(L(=ZV$MT^W'6Q6& =;?O -^\RC\B%5U
M]PW$:<=HLYVM6W&LK9+2>[CGE0MI1[DB6'V2C>6UK3S"3Q]*)4VDA+2%K F%
MB^(C9A9&S5U]N;>'.?5NW27G1E.O$YS-Y%^5H7!R)+<W159T=.J]M9*]RE!
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MRG??Y-"[.IJP.(_)SQ7PHV1Q8HY2DOE#J'N[E)Z()5&(H TVO+FR)7/2*30
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M,24 I.204#199!1( A++)++#H(0ZUH.M:]-:],#]EE%$@T626 HL/KZ + $
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MF+&'[0C 04 8=[UO6]A$$&MZ^S>!Z#Y'F"3H1-<E8V>0M@QA,&W/C8B=D(C
M:WH)@DB\A0G$,.A;]-[#ZZ]<#]HF)D;$*9L;6=J;VU&'8$;>B;TB1"D +?J(
M*9(02600$6_X=!#K6\#W0I$@ &%@2IP%FZUHT 22P@,UK^#1@=!UH>M>O^W
M_>R"-Z*#LDK82-A$2'98-Z)$#7H 16O3T+V'7V:WKT],#^_$5HW9VBB]';#[
M-F^P/R[!ZZW[-F>GNV'UU_!Z^F!XBT:0D>C"DJ8HS7KZ#+(* /7N^P7H((="
MUZZ_AP/T:F3'[#L].0=L.MZ#LTHLS8=;^W>@[&'>]:WO6!^=(T>BQ%:2IM%#
M%H0BM$%:+$+7IZ"$#V^W8M>G\.]8'D,((.T$)I)1H0"T(&C"P#T 0?X!!T+6
M]!%K_9O6!XUB)&XI3T+@D3+D2HL1*E&L(*5)5!0O_,4>G/ ,HXL7^T(M;UO
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MDE;,"=LHO9P0[ $W8 [,"#?KZA"9Z>[0=^N_L]?3 P:F)15:]I),LC,?5R-
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M^O3SO_\ >#_S;Z6P[^[]NOR?6/AP<B_//_E!=W?W/$_\:13)6_;^^,KX,/\
M*,X(_N%9/Z5><I[GWWYNK^&# 8# 8# 8# 8# 8# 8# 8# 8# 8# ;UK>MZWK
MUUO[-ZW]NMZW_#K>L#Y5O)[2E,L'FA\&478JBJ]FC4PEO2VI='FJOXDWLDJT
MFBL;-2ZDC4D:"D+[I(:8(9.E19NBABV('H+>][G=VTM_'LP?G-0RFGN[_!:7
MRY3<'DT[BMU=#.-54J0YLU20>3RI0GJ95]R*'U(VB9XBF<CU1Z@Y7],,.S=;
MV((MCWZCV^=-LH/Z#M3N2T/--X4#^V>4*\Y9=&6P+X*KM% +Z:;T+FR!?"D
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M;UI1'75QU-1$L=5)BS2^J6U'%']J2-AX][!IG3.<@5'IRR_XH@*OXB]!+
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M/!#V068W0]8YB6+&Y<$\PL>A$^\Q6:(SWZ]F@EN\NOC)B95OYU\#-V\GQU+
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M@M>WQ_?5J=,C3J'B0/[HJ6J=E$DDA-/V$HLLL(0!,;6[7-ZK'X0P& P& P&
MP& P& P& P& P& P& P&!\G'[N]_UZ>=_P#[P?\ FWTMAW]W[=?D^L?#@Y%^
M>?\ R@N[O[GB?^-(IDK?M_?&5\&'^49P1_<*R?TJ\Y3W/OOS=7\,& P& P&
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ME M!^2<0E,)*-#K01!WK6M86[[;=:NQADP& P& P& P& P& P& P& P& P&
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M86S6?#:=<'(XF?3Z'SR>1=I"W.!J==&:U=(*SR]<:Z%)AMB(UN<+':  ).-
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MJ"0T.\D00RG$+M6M701\Z7E3<V4NDL#4,AS3:$UCM6HV->_OCFL4"^J,.0E
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MX5;2_P <?T![6\L[BF'^2>B<6]4848'[/4(M_;K>&.G*OC_Q1S5)XK7<1?(
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MSVR8H1I4>T3Z_J6QP<T:9R)2#,-V13Q[2\Q%5Q]16KT'Q7U99M=4OJ,<YO\
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M9:YBT:(THC7R%FTF/6/++N-[\;P='5S1UZ06!4=U7+IM-YL5)JW>)/:M2O\
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M&5<(;H,[S$A\D+:UCB[39DB<HE7SF_;6*"@M2"8R9G5H6\X[8"U*E,8 &][
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MXY/P6X2S1*C:0*W:#XMF:+,^/0O=[1>GILDYN'/F(=M]#Q>LZ*OOI"A*N8:
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M+HY4H/(3%1QS=U"TI(TO8C517JF5")."$T MAT$8=[&+G'=X)KT+#&WF.?\
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M*),)1HL!AA,7.)U8K]<WE#1%?J!="U. %JC4!KP!DR:"U$KTC?11=6:V)#%
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MOI2'T^K,1_QX2]E?EX9Q<9[*XU?W762VR+NK"Z[+J&MY;$>H9#1U51Q?)4K
M^RZ/HH;6#LP+7!(]O)XCGQ\DTV4H$YA84J=:<64G3EB/T+0BW6XEGHM?=-H-
M-(T]:US/S4]OK'4M<3:RGADC20*^0N[7!XVY29>V,:(9A):IV7)6P12< A@
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MC=$AA8%1 3$BD.M&$&F%B"/895\?6.,M2U]DCRU1]C;BPG.#R^.*1I:D!(C
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M; 0F)-/.$$ S-A*) (PP6BRPC,'O0 [^P.MBW_!K6]X1IL9LF#2]H@CTQR1
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M\7J8H5*##![V(6]X1D&1]9),TH'Z-O#5(&)T("J;'ID<$CJTN*46]A"I0.*
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MHL MZ+)GHD?"& P/DX_=WO\ KT\[_P#W@_\ -OI;#O[OVZ_)]8^'!R+\\_\
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M6 ?H,3/PE=0>D)_&*+YY<54JD=L"TI!!:DC3A6PVMUNV63ZQ9"PUG FF&JI
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MN*(3)IP&ZN#&6W&F)RE&@*S>V.<=<1],6')\QMQ%W5NFO+*8O752'CG]>"P
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MSBP#[&=7*GFJ7%L=)5JG(D$MAQ=,#K-L;R$:YVJP+=I Y.+H8J>SY"@4'F*
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M94..WORDUQCEN&;.3Z9(ITY ;&:JH:6")MFB0E)2IJBZ BJTU*#W!VFBJHX
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M,+#IO$\IUPD8 A 5L -:#HF;)CL_DXY*YUL:R4EP2^KF5PLE,"/%J96B7/K
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MZ6BQ)\?:06P:_P#WFI,/<%#@J4-^R )R"%8D3QELD]%R[1Z#FS'<[]S_ %Q
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M;&M?$VJ;1D3VO8'X]&:X11S;5*QKE# Y+D)IK>K,CCZUJTHU)(MD'Z(^4'Y
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M5<KMZ4V]=\-HN,1%)*$L/])!.F>4K6EW7OBUI>4R-C;ED>#MQ-$3L29 (Y0
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MT"C\@(Y2N7K.LXQ ^A(M;"]ZCM(,S&\32M;.W'XP@W6MEMZ:7,YFPHP2%F.
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MOZ@*0U&69M.;Z>W"Z[>+\QKD 3!VQ-NJS9P4OB3_  DXJ,U**/:)#$[AE#3
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M[$=9R_R!.]7I-#TRL\;$R[2)&-"A7FJ$Q?U:0(2W$ULQC*X46XC=(YSWQ#2
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MMRQ-'Q+!MP9,\EC'O\.Q43@6,C3HX;3-_P Q8P?-[@"UH36WF16^Y^SFV/\
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M"?*4LI_7RGR34/=R5,KKI_=*^G](2/I7EJ1N3S'Y8%"?$Y.C9(Q&W8Y^;BE
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M4HEY\)F]@%D.1I/Y+8W[CE?.(MJ#/R-'!++_ /,8'"R9;$XS-@:I;&(.M-<
MR*8-DG=V(DAC?%C::AB&V,+X)P?T;<>PLB@K<C2_3DK5*<Y;[C/I@&_"=\9,
M=VTX&BUM9<&N"%M%B5K(DDLA3^8[%LDB0%+"D#KID>G&/.!Z':Y,D.4H@NK4
M> I0$&R%)8=&DC,)& P0LQQ6]8# 8# P[I(6!C4,:1Z?&AH5R9WU'XVE=')&
M@42!^VVN+SIE9"%1Q1KJ[;:&=6K^F(T8=],E.-]OL*&((:HCM: *D\G6'R$E
MD0P^>)JS>U\K2.,/;PS9>='TC6S-:^4I&=(__?3C*4"1 H0#4I5RU2%,088?
MH182XKUVBV8>]VW.:30GN IU7D'KNPY(G-;CRFPJ-VB[V$QQ,U&Z"_W=:L.7
MU@ZZ/)!^6G" H0OL-#@QQGLDO"(T>+9A[%;,#I5P/< SFQX78T^C*<IN/-;#
M8[5CI7S1+35KH'_=T2LE;9K5H@D?Y2@(S=A^PH6%QQGLW,R0L!+^DBAKXT%2
MAP:'"0(8V8Y(P/RUA:5C8W.KVD9Q':<%#0V.#TC(4*0%[)).5D@&+0C0:$1F
M,!@,##/4BC\;*0'R)]9V$AU>6F.M9SRYHFLIRD#\M*;F-B0&+3B K'AY<#@$
M)4Q>Q'*#A: 6$0MZU@9G 8&&D,CCT197&22M]9XS'6@CZIU?I YHF9F;$WO
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M?4M3QQIMJ?-426+XG<',;*A9 0Y&_$QG\/O)3ELUR;MIMH7)<6G5*BC#R"C
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MK'(RQJG%L2-[8I'%6]'IN,,((*+-.3&&;#H0Q83><SMQ%%55G7"9Q'(O(O\
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M(_++>JB)V&^1E,G1-9TG2GN"$;>D<_OI(VN[*-1IDD;6E=_]Z*3.*=406?\
MEA!H6_7!+9T>:LJ.25Y:705M*)2\R:0WU*H4ZFI5^AIVJ$1*O:_8X3%H+&T
M5:E.!O3KTKH\*%.@E&J5ST?[P^TLO!;F2>C6;'XRY6MV7/L[LNB*[F<KE+*0
MP2AV>F0!^Y.WHT)C8VCD:,!A;>^NC,VF[3H%ZLHY<@)UH"<XH(0ZT)MM.E2D
MIIZL%A-LIU4(83R;U+V5<!9B3W!L,O<(;*VV"2_E_P"_:W V9*U?[/\ ="
M_P!GK@S?Z-!L#DOFNU-0/\X=+P25[K)G+C<(&Z- !FLD6+ @ *(?*4,HURAJ
MG36FVH:%>U#:I$06(T@>P!WH3:SI4B1FI:QAM9HJ9C,#BS34S=&U,.1UR2SH
MS8<7$UJ=0D61H3"I*/;SF)4D5&$F)3 ")&4,0-AV'?I@S<Y[HZJ7DOFZB7LB
M2U'3T-@TD31]UB1$@:$1PGPJ)O*Y@<ED6"[+5"MP_#0%L6;QID'R?2(OI0!3
MEE!]VMBVWJW6J:1J>C6R0,M105BK]ED\G=9D\LT<)-1-!TC>S-'.B]&U_,-
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M0RQB<*<9"47M05TMC,1>(&P*8R3[]_0FM,.D"UN)WZB]J52,/^WUPN;_ %>
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M_D'ZES5@D34A:FA(R-28E VMK<0U-J,@/L3HD*-,!(C3$@UZ^PE,06$ =?[
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M_.L5VH)\<ER1F;6Q=2//HZ-$8G;=*]N#A*/J+)L4QZ7/9YI)FB"!(DB$10M
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M1*IC9\76U5J76/!WVR6I*T6\JHVPMSMB98K^<D!)RW>GM@D'W,\K5*U+[@F
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MXVN6G-R*4S,]&G5)(+$UJ],:22ZO)B!O-,(-"$[>RC/:6:V]%=K9[()0]O\
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M)F*%6;:$?C<RD:(#JU1(('-\DPF,:_[K!)%[#'$#NZLT6$YZVG^]%I2=O^<
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M2QJ8SP)$^S2_J%&P%:%K8]832R;2WHKXEFDHJOJFR^I72@.@[!K?I/GFBX[
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M.7T1:]?37NUK0O37KK6][UK?I]NM;WK6]Z]?_AK#D_N P/DX_=WO^O3SO_\
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M.Q^OIU'RIC/?^66+>@^A9;.B0<(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M.>D%+&J=PUO=R83%D*W[T+0AE)SF8-Q&N$E-$3N+.-L3IC_#Z2 FE#&86$P
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M1:A,48$^*PZ^1;MC9Q;3)O=_]&5OVZ^S"9O1N6 P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P/DX_=WO^O3SO_P#>#_S;
MZ6P[^[]NOR?6/AP<B_//_E!=W?W/$_\ &D4R5OV_OC*^##_*,X(_N%9/Z5><
MI[GWWYNK^&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQ<#GR2]457#XU:MGUNH;]E!9T\=15I*S=(%(!B4&/45?4X]>A!>&O'Z<]_\
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MD-R=$W92S'S#S1V&94=*VVRC3H(HY52]QF&+H,H62)&Z/2>:/<D>Y0 A(>C
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M76Z]6INGD/XK8Z<NGH!YZ#A;54'.MF.U-W;,W F0)$]<VBQO;-'7.$O[4>S
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M;$0HIPTI&A>\EQ1\6,A<M9"4;FZ 5P^5!2?6M"H8RC5*$TLP9)0A;!HYN2]
M41<<:\WWD#Z!?ZYDC32EE\K<K0Z V6K3IPQB62F&Z<?Q0QM"D"D:DU<Q[.#\
MX1% T'U^S>_LR=V[9^.3OEQ^DWCUZ-.\0'D+K-%RQ*#^B[7\ITSNJ&1HN.L0
MK!F5=E]55N^1B?-*TQ;HP;.FKI&O/2F;4%C*0_4:"#7R#T.M^<\Y>V&7ZHY+
MOF']A>31':T;\D<HY^[U,A+]&%W"5)\_WM';2A8*E1UZ^TO<!]HPF52NK)#"
ME:$Y.SGB6M3)M&H^J"<4>'1HHLVEUF,9GJLUYS*U_-[X7.<ZA0LDDFFH9;_
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MQ,42&!)2GM)B@S6RMC+*W%N\NTW]+T;?8W*75-(],M%O2U@[Y;*AO3QO\GT
MO=.&Z=I2_P"<PV6U- RXW8] W'7]I0BP'>.1)^6N)CBG7M!9#:>N..+6FC]F
MAD"668F,YO5J5S<G6WR;"^79;XW*L\IT7[GA7(=84[ EDKIFHK(I.?U2Z6<_
M3%OH'L%^WHRNJ]?ZN3N0RW(:$Q$2E2%H2RQJC #-+$VFV?+'CG]8=YO*;S+:
M_5/CQ?F6+,*53U94?YJ^EJA:HLJ]"BNB:+=6B>)F&**U9A0AAD9B%R8T8C#
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M$TE4IDTY3/QZ)NVR#=!(R&[>UB891>C2MC'L$C=\=K+;,21)'._C2OOD2UO
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M+X@_3E,P6]JW23!#"+#0+W)@2S^&R"OI>2G;GIR85&GJ'2E$WO[(<)<U&[+
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M.J>:J?JF?7/;%*2-[\SW/-*T1.W7HR =!WA%Z#M^NIA]Z5M>DTK9V4M5B.<
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MFUY67>)Y!CW:.JX.; -YJ<9NV_ZH SU)8O\ > F%Z:>4DS:HY".NNP^HN?\
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MZ.8*;L"+5"TI(_5C6\0QL*U7D=0HDS:FCL.6MQ:)PCT= WHB2=H$QQ:0990
MB+WH(?0LVVG2I$AO*_-E=N54O,%HFJHD\47!W:M*:=F"$,#:Y5A7[]L@3Y#H
M0O3(BU4=CSR-*6)6E3#+*4#!H1FA;^W">5]447;XY>$ND;)1W!>W*%(VC9R,
MAM2"FLL@[4O?'1(SB#MH22-1HHH,J2->BPA3E.858"0!T$&M!UK6BS;:3$MP
MG.[^?Z3Z3K9TI^^ZNA=L5B\F(#E\*FK&C>602IJ."H:UZ5.>#WMSDV'!T),I
M3B*4$;_^C&'UWA);+F=6NTER?S+S:<Y*J H6J*<6/3!&HL^+ZZ@[!%7%^8(>
M!:&,MS\XM*),M>RV;;DI$2-48<9HQ08/8MC,$+8NUO5H%E<,\365?,%Z9LWG
M:FG[H:'O4;7PFVW>-MB6>%/\25)W*)*@O!&TBE^=(VI0%&-XE7U)B3X ?%[=
M #K19MM)B7ANN^0>6!5D=2PN>*;W4:B>;M(^M=U[&=P@ZR!2<,T%.C(WMN^Z
MARO<N!IS^NV5]1]=KYO=\GY6$\MLYSRT;H#Q\<0]53-@L3HSEJEKBG4:2D(&
MF5SB$-+N^::TI_U25G<EXR0'/K(F4[V,M$NVI2 $(6PEZ]V_4LVVG$J<"J+I
M<B?0VU$]4U\FLBNX,LK&!3A-$F-/)X77+@8E-6P6+NY"(M8Q1)28A)V-O3"+
M2[^('Y'Y.O0F;T[()KOQW\,U)9=@V_6?*E)0BQ+58))%;%D$>@S0@!+HU,3T
MBJ7,3NS%D_<!K5*5"$D3B0%*$M;LO7S:'A;OM9BVX>?GOQ]<3<H3)^L+F_F*
MH::FTE:E+"[R>#1-&TNQD?6+TKJKCR)2'Y!,\?4N2 @\:%'\"01I)8ME^H ^
M@NVUF+>&_6!R5S):JVTW.QJ(JZ8.MX0=EK2WWA[A[.J>;'K^.+!.$>A\O>/I
M@N;TP,:\>ST:8XT1:8W?O+T$7VX2;6=*_O.G)W-?(T6=85S12=>TM&WYTT^2
M!!!(^E:3I"\!)^G+<Y"YZT8ZORXA/_%EFJSSAE%[V$&]:WO6"VWJ]Q7RWS<N
M8;JBRVBJI51OI!U6OM_L1\&CQK5<STY(4S6X.MEH1H-IYDO6MR,H@TU>$X8R
MBPAWO>M:U@S>.>B,KV\>W$'3:2!(K\Y:I>TB*N9DL:KW<HA+4H41*+HBRBDL
M59UB<I,K3Q0DL@.M-FQ[0>FOM*^W?J6;;3I4CV-RIS9;=)$\VV/1E7RR@TJ%
ME;6^HG*',P8&SHXV,HR/$L4?2I4Z%AVQC)#](-&$@:?T]"]AUO?J26RYG5@K
M0XOY4NBDXESA:-#UW,J+@/X;W"*P=&0 (M$11!I4L48,CB)&8E&S&L;,L.2I
MQIQEB+(-&#6_:+>MB;67,O*DW5/BBJRX&'@NKJ9B%*U%S_R/U0SWC,*6%7:4
MZ$6# PQ281R5P9+'FXDMG,<94.5",5J'$I06I]3-G>\0O7#4WLS;UL7(J'A?
MCFA:MG%)U#S33<&J:SC5QMD0%K@[*='9_MQ3"1*RYHB<4RW4H3B1#V2 I;L\
MHHG>P%A"'?IAF[;6YMY8&C_'APWS8DL!!1W+%+5TBM:/BB5D)6:%-AY,TB ]
MJ]BA[^6Z%KPKXAOZX[7W4+_</0P6OA]-X6[;7K6$KSQF>/ZJ(;.*\K_D*B8[
M [)E$,FLYAQ,$:ET:D<IKIT5/4!>5S,ZEKD 54+=UIJEKT66 "$\P0R0@%OU
MP>>UYS<K-HZ9J5OLF67(AK:$I+8G<49X+-+'3QMJ*FDJAD?-4GL<6?Y&!-IT
M=&%H.6&C3I3C!DDB,%L(=>N\)F].R&I=PGQI/*-8^:)9S%2CQ046<3WB*5.;
M &!-#(B\JG-Q>5+S$FI$C3 BSP>Z.ZL\:MOVG4",5&[V/^,'ZCRVSG/+6E'C
MCX15\^AY54\HTF=SR"2F34NJC(2V"C94U/'L9\T*_(^\"I@?K>PF.H3]+QEB
MV 1NP;V'9?/;.<\I6HSE/FGF0EX(YXHBJ:5!(FZ--,B%6L(8(B?(4$.2*T48
M*?U+.B2J'H;*F<% 23%0S3=;/,%L6Q#%O9+;>M1A87CJX1MJT91=-H<D4'8-
MHS:/&1683&85M&Y"Y2AE-0::1E/Q3FA4H'5;]TZTD"L.)&M D_B0FZ*_)PLV
MVDQ+PF9BYSH.,/\ +I5':;K5DDL^@D:JZ;OS7#F-$[2RN(:U',<3@TA7IT0%
M+M%8XS*3$J)"<(:=,0,0 !T'>]83-J%K'\<W"-N5Q5U0V-R914IK*DOD!4,)
M65\QIF"MTQXPF*VZ'(V],CTQ-#@, =JD1&P)%7M#\I8_:'T+Y;2YSRGVHZ,I
MF@8^YQ*CJJKZH8L]2)PESK&ZWB3'#&)?)W8A$E<WY2TQ]$@0#=%R9M3EFG?'
M[Q ) '>_0.M:);;U:25R)RV1'D<2)YZITJ+MUSBZ+01\NOHR%G1WV-P4.HKC
M3-^F[28FR1.:HU1MX"'2[9Q@A_)Z[WO!Y;>O9(C/3]5Q^RYC<S'7<-:+:L)D
MCL:G5DMT>;$DVE\?B(3P1=ED<D)3 =7=LCP51FD9)YHRT^AB]FM>N\&;C'9H
M$WY-YILFZZZZ0GE'UO*KYJ1,8CK>V7B,H%4XB*08U1H$[4^B+TK"2E.7'F)P
MF;'I,8>8,KV",'L0S9,3H\1'(G+2:M(K3*?GJG2*E@TY1V;#*W*KZ,@A46L1
MN?UDK03=AC@6[34URA')7$]>6M)* H K.&;H6ABWO!Y7.<\HTN?QQ\(=$6<D
MNB[^3Z0LRTT@&LH<WE,&:ESXZE,8BQ,I4D/T467*BVCX0!3!<P*]$  $(-!"
M'6M%FVTF)>$M27ECFR9"N<4LHBJ)&+HQLCC+?>WJ"QUQW<C1$&\+3%6RR?JD
M!GXP0QUK#I.B*7?,!.3KV UH/V83RLQST3 QI(ZB:4\>CA+00R1Y,1'$S.TZ
M2:;V9(UI2D2=D C2^I"(I C+ 4%/[0_&7K0?;K7IA%+H/XPO'?6TT5V+!>+N
M<HU.%4W:+(+DS=5D7TZ-4Y87 YW9I)&SCD!NHJX-SJ>)25]V:2 "?Z&>WW:U
MO1KSVO&;AMUH\ \572Q3F-6?S'3TM9K,LI!<E@IE</;D9TQM=L8E48;[%D+@
MU 0.+E,4L<7'( +S#=J-)#1%>[V"V'!-MITKVY!P=QA*N?FGE60<PTHY<Z1\
MXI6P4^; & N%,+D2<H4@>F1L3I"?NB0[4+#S!N*<1:XP9YHA&[V:/8B>6V<Y
MY;!4_'7+%%'UVLJ&@JN@#E4L&?ZSK1Y8(FVIWZ%5]*Y,JF<FAS _FE'/**/R
M"6K37)8FT?\ &I6F".,T(>_7!=MKUJ,[C\=O 5TVLAO>[>5Z%F]L@5L>M3^6
MPQD->GI>QF%&QS[^., 2FEBUJ$D+TCVXEJS"0E!"7Z! '6BS;:3$MPE6?\C<
MQVK<=?\ 0EC456DRNZJT*IKKZT7Z+MRZ9Q9N5_6?*A;GDPKZG:0L3BH$269L
MP*<:@T16@",'L1)M9,2\-;F/"G&U@45'>8YAS)2KWS]#C]*X;4A\!8"(5#%N
MEJUQTOAS2B1IBXHX_6N2DSZAOVF.]5!OY7H8/6QY;9SGEYHYP[QW$J:9^>8[
MS+2;72##*VF>-E7DUY&S(>3.F)T3/3/-CFE0A.)72]N=T1*DIS4?*N"<2 7R
M^H ^@\MLYSRF--456HK3=+Q25[#DUR/<+05P\6B1'VPN=N<!:W8U^;H:NDX$
M^G=3&D+T<-64C&;L@"@6QZ#H6_7!FXQV0=T?P9QIU\ZQE^Z;YJJ*ZWZ'$&(H
MV^SN(M[J]MC8<H^K.90.^@%.*A@.5;V8-O.-,1#&(0ME;V(6]EFVVO2I43<]
M40C?JEE"*G*S0R&A6)[B])/"&%1]$NJ6-R1J2L3^PUT>E0%"A[.\LJ$E*I3(
M/@*-3E +$'80ZUA,WIZL] :CJZJE$Y5UI7L/@:JS9P\678BB)Q]L8CIO84A"
MG ^S:4&-R=.)[D[N!(5I2M4;&H.T6'W"WZ:P6V]58U_C2\?CM/YW:3OQOSL\
M6!9CPAD4YD[O5L6=%[_(FYX1R%/(#@+V]0D2/QCZW$+#UJ<LE2J5$@,.&8,.
MMX7RVQC-PFM3S!SFL:KL8E5'58H9NDUBEPZ":SH1'S$%TKUC24PJEEFI1(=D
MS-2H92 )!C7Z/$).'0-_DZ],)F^O1SJZY\=5D]>="\?QZ5E\VQ7@CCRR:^N^
M(PEAC$N/OF0S2MXTXLL?K$SY@)ZTB]-!5F(C#P(O>K4)4):;90=:"8$WKO-9
M;SY5V!6(TCBD5-[@E3+D"Y,>C6HEA!2E(L2*2A$J4JI,<$9*A,H)&( P##L(
MP[WK>MZWAS4]HWQW\,\SV*\VY0/*=(5+9;Z2X)5DSA4#9FA\3(W8P1KJ@8U)
M1&]1IN<QCW]0F;@I2#M;]!@WK[,-7;:S%MPS3EPEQJ\6%<-KNW,M,.=A]!0I
M;7-WRE?!&-6OM6#.86\#K&9R ]*-)(&QX TI=+0J"QB6:3%?-L?QA]!Y;8QG
MB)6W0=);D-2RW=3U]N44*PNL6I.0?A1F^^*HC;ZQH8T\L5?N'TGU,5:G2/-B
M=$H(1B*+-2D +%K80ZUHF;_5 3#XW^#(M>H.F8UR91S#>Y4@5RTBR6F"M*!\
M22YP)4IU\M1%)BBVQ#*UQ2P[1SD2G N-V:/8C=[%O>R^>V,9N%DJPI^JZ48G
M.,5#7<-K..O4ID4X=V.#QYLC36YS&7+Q.LIE"Y"U)DJ=2^R%R'L]8J&'9R@W
M>Q#%O?VX2VWJP*_GBB'606S+'*GZX7R>^8>@KZZW]7$&0]WM:#-3.NC[;$;
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M[KN\Q_2?(E*T@GO"6O#=;-ZN,J1[=;-E=AV86^F5=#E*-&8X.+<W)CFUKT6
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M?G"%ZBMIW(5</<\VW0#;&@Q) 8FLA+:U:QBN3Y2Y.>WH)T;5,A,:TK E)*5
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M&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# ^3C]W>_Z]/._P#]
MX/\ S;Z6P[^[]NOR?6/AP<B_//\ Y07=W]SQ/_&D4R5OV_OC*^##_*,X(_N%
M9/Z5><I[GWWYNK^&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M\2AY7?"8<6< D!)11 =;,;7-XS^Z\6&3 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MB7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\
MY[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$.
M/_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80
MX_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_
M &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K][
M'_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K
M]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]
M9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]
MC]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_
MK]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_
M*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^
MQ_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')
MX^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G
M')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^
M*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B
M7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y
M[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__
M )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X
M_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_8
M0X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['
M_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]
M['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9
MK]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C
M]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q_*_K
M]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X^Q_*
M_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G')X^Q
M_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*G')X
M^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7^*G'
M)X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[B7^*
MG')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\ Y[B7
M^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$./_Y[
MB7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80X_\
MY[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_ &$.
M/_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K]['_80
MX_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K]['_
M &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]9K][
M'_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]C]9K
M]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_K]C]
M9K]['_80X_\ Y[B7^*G')X^Q_*_K]C]9K]['_80X_P#Y[B7^*G')X^Q_*_K]
MC]9K]['_ &$./_Y[B7^*G')X^Q_*_K]C]9K]['_80X__ )[B7^*G')X^Q_*_
MK]FNRF0?O9/2+*LJ<ZJ>6>36B5DFL[[<4;DL00/\>:7(L25:H:G%-:-S/[8M
M*3C%L"EK9A+R1>@B32C-!,#5_P#TSGFNU?B;\9T'\7G,H:=9Y,.Q;-F\B.L.
M\+3/1#;]S6>KD29!\+2B4'K%J**1MN2@2-Y2@\Y09_&JCA?.I-#HY[[^=SV=
M/\,& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
K& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g805243dsp03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp03.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M!2N;O4] 9+F^O([S2MZI(YAV31;C@.2#M*@XSA1@$GMR =!0 4 % !0 4 %
M%"66VTQA#;6ZFYNI&=8H\*7;^)S[#C)^@Y) (!S?C>2_;1S:M*BM,CMY48X8
MC"QIN/7,KQ#H,C(Q0!U-G8Q65I!;QE]L**@RY[#'K0!.(E!)Y_%B: %,8(QE
MOP8T ,, Q\KR*?4.3_.@!A@F!RMW)GT95(_D#^M %6]L+F]L9[*X>WGMIXVB
MD1HRNY6&",Y/8^E &+HGB9K3PU;SZXLB"VW6US> ;T$D3&-V?'*@E2<D8]Z
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1!B@ H * "@ H * "@ H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g805243dsp26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp26.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG'_WV?\*
M#=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL_P"% !NG_P"><?\
MWV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG
M'_WV?\* #=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL_P"% !NG
M_P"><?\ WV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X
M4 &Z?_GG'_WV?\* #=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL
M_P"% !NG_P"><?\ WV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \
MX_\ OL_X4 &Z?_GG'_WV?\* &33RP1-(T2$#T<_X4 /W3_\ /./_ +[/^% !
MNG_YYQ_]]G_"@ W3_P#/./\ [[/^% !NG_YYQ_\ ?9_PH -T_P#SSC_[[/\
MA0 ;I_\ GG'_ -]G_"@ W3_\\X_^^S_A0 ;I_P#GG'_WV?\ "@ W3_\ /./_
M +[/^% !NG_YYQ_]]G_"@ W3_P#/./\ [[/^% !NG_YYQ_\ ?9_PH -T_P#S
MSC_[[/\ A0 ;I_\ GG'_ -]G_"@ W3_\\X_^^S_A0 ;I_P#GG'_WV?\ "@ W
M3_\ /./_ +[/^% !NG_YYQ_]]G_"@ W3_P#/./\ [[/^% !NG_YYQ_\ ?9_P
MH -T_P#SSC_[[/\ A0 ;I_\ GG'_ -]G_"@ W3_\\X_^^S_A0 ;I_P#GG'_W
MV?\ "@ W3_\ /./_ +[/^% !NG_YYQ_]]G_"@ W3_P#/./\ [[/^% !NG_YY
MQ_\ ?9_PH -T_P#SSC_[[/\ A0 ;I_\ GG'_ -]G_"@ W3_\\X_^^S_A0 ;I
M_P#GG'_WV?\ "@ W3_\ /./_ +[/^% !NG_YYQ_]]G_"@ W3_P#/./\ [[/^
M% !NG_YYQ_\ ?9_PH -T_P#SSC_[[/\ A0 ;I_\ GG'_ -]G_"@!\;^9$CXQ
MN .* &2_ZR#_ '__ &4T 2T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 5=0_X\9/P_F*
M +5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MG'7(YI6T38WHVNQ?H * "@ H * "@ H * "@ H JZA_QXR?A_,4 6J "@ H
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M""*<_=U6O;SOL**<G8S+?Q8\OAYM4DTXQ2)="V: RY()<+G./?IBG;6*[_\
M!_R%?23[?Y)_J7;CQ!#8WM[;WT?D"WA\^-]V1,G0XXZ@\8YZCUJ;^ZVMUT]=
MOO*MJET?],T+&::XL89KBW^SRNH9HMV[9GL3@<U35G8E.ZN6*0PH * "@ H
M* "@ H * "@ H * (K;_ (]8?]P?RH )?]9!_O\ _LIH EH * "@ H * "@
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M/_EYZ?HBYKNF7FO:F6AC,*Z6!);M(F!-/P<<]4  ''<^U*+<?WG7:WEU_P"
M-V:Y'UW_ $_X/W'16%TU[807#P20/(H+12*59#W!!JI))Z$J]M2S2&% !0 4
M % !0 4 % !0 4 % !0!%;?\>L/^X/Y4 $O^L@_W_P#V4T 2T % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MT3[CV;78NV5[;ZA:I<VLF^)L@'!4@@X((/(((P0>13:L!8I % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 5=0_X\9/P_F* +5
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M 4 % !0 4 % !0 4 % !0 4 5=0_X\9/P_F* +5 !0 4 % !0 4 % !0 =*
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M.I60.#=1#'JV*DHLJRNH92"IZ$=Z %H * "@ H * "@ H * "@ H * "@ H
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M H JW.I6-G_Q\WD$/L\@7^= &;+XPT"$X;44/^XK-_(4 0?\)UX?_P"?M_\
MOTW^% "IXX\/L<&^*_6)_P#"@#3M-:TV^BEDMKV)TB&7.<;1ZG/3I0!=CD25
M \;JZGH5.10 Z@ H * "@ H * "@ H * "@ H * "@ H * *NH?\>,GX?S%
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MAL>S#'ZYH [[1/B=HFI[8[PMI\Y[2G*?]]?XXH [-'61%=&#(PR"#D$4 .H
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M//2A;7\[?E_F*ZO;RO\ G_D7*!A0 4 % &9K>NVFA6?G7+9=N(XE^\Y_P]Z
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M * )[*W-W?6]L#@S2*F?3)Q0 ?$JZ^T>-KM!]VW1(EY_V03^I- ')4 % !0
M4 % !0!Z)\/_ !XVG/%H^JRYLF.V&9C_ *D^A_V?Y?3H >Q?2@ H * "@ H
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MNS4;"3R\?0?ET_*@#O: "@ H * "@ H * "@"*V_X]8?]P?RH )?]9!_O_\
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M % !0 4 % !0 4 % '9?#?7SH_B-+65\6M]B)\] W\)_/C\: /=* "@ H *
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M] '*T % !0 4 % &WKC"R^%UG&I^:^O2[#V4$?S5: //J "@ H * "@ H *
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MN+5[*^B$UJ_!4]O<4 <!XC\+SZ(_GPDSV#GY)1_#[-0!S] !0 4 % !0!O\
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MMK9^:TOD1+'O;JV!C)JYRYI-DQ5E8LU(S"OY/,O']%^4?A0!6H * "@ H *
M"@":*8"-X)D$MO(,/&W((H XGQ-X3;3U:_T[,M@>2.K1>Q]O>@#E: "@ H *
M .@U>;_A'?AZENIVWNM-N;'40C_$$?\ ?1H \YH * "@ H * "@ H * "@#L
M/AIJ1L/&,$1;$=VC0MSQGJ/U 'XT >[4 % !0 4 % !0 4 16W_'K#_N#^5
M!+_K(/\ ?_\ 930!+0 4 % !0 4 % %:_?99R8ZGB@#"H * "@ H * "@ H
M569&#*2".A% $&K:-9>(XL38M[\#"3@?>]F]?\_2@#SC4]*O-(NS;7D11QT/
M56'J#WH I4 200O<7$4$>-\C!%SZDXH G^)UR)O&<L*]+:&.(?EN_P#9J ..
MH * "@ H * "@ H * "@ H ZSX;WILO&UFI.$N T+?B,C]0* />J "@ H *
M"@ H JZA_P >,GX?S% %J@ H * "@ H * $9@JECT S0!S9)9B3U/- "4 %
M!0 4 % !0 4 2P7#0,<8*GAE/0B@#EO$GA%3&^I:,F8NLMN.J>ZCT]J .)H
M* -/0-+.KZU;6>#Y;-ND/H@Y/^'XT 97CG6AK7B>X>)@;6W_ '$..FU>X^IR
M?IB@#FZ "@ H * "@ H * "@ H L6-TUCJ%M=I]Z"59!]00?Z4 ?3B.LB*Z'
M*L,@^HH =0 4 % !0 4 % $5M_QZP_[@_E0 2_ZR#_?_ /930!+0 4 % !0
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MT ^H- '&4 % !0 4 % !0 4 % !0 4 % 'T+X%8MX)THDY/E8_(F@#H: "@
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M23DDT )0 4 % !0 4 % !0 4 % !0 4 ?0O@52G@G2@>OE9_,DT =#0 4 %
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MM !0 4 % !0 4 <YX\LOMW@K4T ^:./SA[;2&/Z T ?/E !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!U_PSLC=^-;9\96VC>8_EM'
MZL* /=Z "@ H * "@ H JZA_QXR?A_,4 6J "@ H * "@ H 9-$LT,D3C*.I
M4CV- 'S%=VSV=Y/:R?ZR&1HV^H.#0!#0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0!:TRS;4=4M+)<YN)5CX[9.* /IM5"J%48 & * %
MH * "@ H * "@"*V_P"/6'_<'\J "7_60?[_ /[*: ): "@ H * "@ H 9+$
MDT+Q2#*.I5AZ@T ?,^IV+Z9JEU8R9WV\K1G/?!ZT 5* "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * /6OA#IACL;_ %-UQYKB%"?1>3^I
M'Y4 >F4 % !0 4 % !0!5U#_ (\9/P_F* +5 !0 4 % !0 4 % '@_Q)TPZ=
MXQN'5<1W:B=>.YX;]03^- '(T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 =I\+],^W>+DN64F.SC:4GMN/R@?J3^% 'N5 !0 4 % !0
M 4 % $5M_P >L/\ N#^5 !+_ *R#_?\ _930!+0 4 % !0 4 % !0!XW\6-&
M-KK4.JQK^ZNUVN0.CJ,?J,?D: //: "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H ='&\LBQQJ6=B%4#J2: /I#P[I*Z'X?LM/ &Z*,;R.[G
MEC^9- &I0 4 % !0 4 % %74/^/&3\/YB@"U0 4 % !0 4 % !0!P7Q5T8WW
MA^+48ES+8OEO]QN#^N/UH \6H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H ]O^%^BG3?#/VR5<37S>9TYV#A?ZG\: .WH * "@ H * "
M@ H BMO^/6'_ '!_*@ E_P!9!_O_ /LIH EH * "@ H * "@ H Q?%>AKXA\
M/7-C@>=C?"3V<=/\/H: /G62-XI&CD4HZ$JRD8(([4 -H * "@ H * "@ H
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MD@#F2/J1]1U'X^M 'B5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0![G\._"YT'1OM5RF+Z[ 9@1RB=E^O<__ %J .SH * "@ H * "@ H *
M(K;_ (]8?]P?RH )?]9!_O\ _LIH EH * "@ H * "@ H * (+RS@O[.6TNH
MQ)!*I5U/<4 ?/OBOPS<>&-6:VDW/;/\ -!*1]]?\1W_^O0!A4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0![1\.?!IT>U&JW\>+^=<(C#F%#_ .S'
M].GK0!WU !0 4 % !0 4 % !0!5U#_CQD_#^8H M4 % !0 4 % !0 4 % !0
M!XK\1?!QT:\.JV,?^@3M\ZJ/]2Y_H>WY>E '!T % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!Z%\-_!QU*Z36K^/\ T.%LPHP_UKCO]!^I_&@#V2@
MH * "@ H * "@ H * (K;_CUA_W!_*@ E_UD'^__ .RF@"6@ H * "@ H *
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M]H=OJ/UH \EUOPSJWA^79J%HR)G"RK\R-]&_IUH R* "@ H * "@ H * "@
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M2>Y/2G?1+^OEY ]9.7]?U_P#;I % !0 4 5=0_X\9/P_F* +5 !0 4 % !0
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M0 4 5=0_X\9/P_F* +5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 <7K<6J0>)KFZLC=B66"%+98[821289MR
MR,5.P<@]5_'&**>]GW_"R_+7_+4)[779_?\ \'0I+HDMQ?"V,ER=.LEN&+K8
M/%*K,P8*&;(E.X9!5<<#.<THZ1OV22^5K:?+\1O5\O=MOYIIZ_,M:7#JVAZC
M80+:-*MT!YKO$SF-"Q.W>N%0C)8Y&&+$#&!5QWY.B7Y+\E9)==;]R);<R[_F
MU^=V_DD=O4E!0 4 % !0!%;?\>L/^X/Y4 $O^L@_W_\ V4T 2T % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 5=0_X\9/P_F* +5 !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!%;
M?\>L/^X/Y4 $O^L@_P!__P!E- $M !0 4 % !0 4 % !0 4 % !0 4 % !0
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M]9/^_C?XT 'D)ZR?]_&_QH 1K6)U*MO(]"[?XT +Y">LG_?QO\: #R$]9/\
MOXW^- !Y">LG_?QO\: #R$]9/^_C?XT 'D)ZR?\ ?QO\: #R$]9/^_C?XT '
MD)ZR?]_&_P : #R$]9/^_C?XT 'D)ZR?]_&_QH /(3UD_P"_C?XT 'D)ZR?]
M_&_QH /(3UD_[^-_C0 >0GK)_P!_&_QH /(3UD_[^-_C0 >0GK)_W\;_ !H
M/(3UD_[^-_C0 >0GK)_W\;_&@ \A/63_ +^-_C0 >0GK)_W\;_&@ \A/63_O
MXW^- !Y">LG_ '\;_&@ \A/63_OXW^- !Y">LG_?QO\ &@ \A/63_OXW^- !
MY">LG_?QO\: #R$]9/\ OXW^- !Y">LG_?QO\: #R$]9/^_C?XT 'D)ZR?\
M?QO\: #R$]9/^_C?XT 'D)ZR?]_&_P : #R$]9/^_C?XT 'D)ZR?]_&_QH /
M(3UD_P"_C?XT 'D)ZR?]_&_QH /(3UD_[^-_C0 >0GK)_P!_&_QH /(3UD_[
0^-_C0!(JA%"J, # % '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g805243dsp27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp27.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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ML36FGG;U?^0R3PB9X#:S:@3:1^8;=5BPT;.<Y+9.[&3C@>^:A75GU5E]UO\
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M ?9H/^>,?_?(H /LT'_/&/\ [Y% !]F@_P">,?\ WR* #[-!_P \8_\ OD4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H RM?M[^73I9=.O+B"XAC9D2%4/F'' .Y3^F*EZ:E*ST,K0KRYGU=$C
MU'4;VW$+>=]JM!"L;Y&,'8N3UXYK1=?P,]=.YU524% !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 175S%9VLMS,VV*)2
MS'&< 4 8/_"=>'_^?M_^_3?X4 :^FZI::M:_:;.0O%N*Y*D<CZT 7* "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * *NI+<OI=TMFX2Y,3"-B<8;'%)[%1W.<\-MJ+:@()H
MKN&*W$I<75P)&8,P*=&). #R?7BK6U_ZW_R(?;^MM?Q.MJ1A0 4 % !0 4 %
M !0 4 % !0 4 % !0 A( R3@"@!OG1?\]4_[Z% #E96&5((]10 M !0 4 %
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M?Q_R(+GQ#?V]H^L)="6W^TRP+;!%V%55L,#C=G*YZXP>E2[I)=6G\BHKF?\
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MSQ'_ ,BWJ7_7N_\ *@#Q*@#UGP#_ ,BM%_UT?^= '3T % !0 4 % !0 4 %
M!0 4 % &9XC_ .1;U+_KW?\ E0!X0U_$FH?8SG<L7FNW&U!G S]>?RH ]?\
MA[_R+)_Z[M_(4 =70 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M)YD;+M9R@;(Z%AR/J*F2NK%1=G<YO0X)=.UN*UGMQ%YD#&/;J<MP/E*\;6
MZ]:T3O<AJUCK*D84 % !0 4 % !0 4 % !0 4 % !0 4 9GB/_D6]2_Z]W_E
M0!XE0!ZSX!_Y%:+_ *Z/_.@#IZ "@ H * "@ H * "@ H * "@#+\1\>&M2X
M_P"7=_Y4 >"VD,MWII74H4WS@[XB!PI)PI]<"@#TKX<Z@-,L;30WMKDQ3%S!
M=L=ZLRC)C8]00HR">O/<4 >B4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 !Z4GL!RFDV5U=06"I
M?6K:;;R^9&1$RSL03PV3@'DYXYYZ52TLWV_0):N27?\ 6_YG5T@*.M2B#0[Z
M5H8YE2!V,<OW& '0^U3+8J"O(Y'P_J6CZ5JT<*:AH;K=1DF2UA6!D((PI^8Y
MSGIP>*T6MX_TS-[*3.\J2@H * "@ H * "@ H * "@ H * "@ H S/$?_(MZ
ME_U[O_*@#Q*@#UGP#_R*T7_71_YT =/0 4 % !0 4 % !0 4 % !0 4 <?XZ
M$&KZ7=:+'J/DS01K>W,**27B!.U2?X<NH]<A2,<Y !Y?0!Z?X'MQ=^#;BV:2
M6-9GD0O$Y1URH&58<@^A'2@#5TN[.D_8=#UC55NM3E5S#*T>PSHI[]BX4C..
MO)Q0!N4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4GL!Y_9Z380^(+2?3X[R687&9!+IBQ*%YR=_E
M+C'UYIT]+6VM^@5-;WWO^IZ!0!4U03MI5TMK(L=P8F$;,< -CCK294=&<WX<
M2^748X+BVN;>.(3'%W.KM(&8%<#<2<<\^_O5K;^N[_0A_P!?=K^.IU]2,* "
M@ H * "@ H * "@ H * "@ H * ,SQ'_ ,BWJ7_7N_\ *@#Q*@#UGP#_ ,BM
M%_UT?^= '3T % !0 4 % !0 4 % !0 4 1SS);6\D\IQ'&I=CC. !DT <H%B
MO?!^HZ^^EFPOM4L_,F1V)?:%/EAL]"%/3L2?K0!Y=0!ZK\/?^19/_7=OY"@#
MH[JRM[SRC/#'(\+B2)G0-Y;CHP]#0!1T*ZU22T,.N00P7\<C1AH6^2X4 $2(
M,Y .>0>00>V"0#6H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "D]M .$MK?5+2>WN$TG57ODES<2F\1D
ME3G/R&3 SQ@8&/PIQ=K=K?I_F$]6_73TO_D=Q$[21([1M&S*"4;&5]CCBF]&
M)&1XCTNYU2"U2WAM+A8I=\D-VQ$;C:0,X!S@D'IVJ;:W*OI8I>&-$O\ 2)"+
MNST\$H0UQ%*[RMSP"64?*![]A5WTM_7J2UK?^D=/4C"@ H * "@ H * "@ H
M * "@ H * "@#,\1_P#(MZE_U[O_ "H \2H ]9\ _P#(K1?]='_G0!T] !0
M4 % !0 4 % !0 4 % &1JZZG<WNFV^F7,<$2W"RWK;AO$(!(4 @_>8 $^F['
M- $GB/\ Y%O4O^O=_P"5 'B5 'JOP]_Y%D_]=V_D* .KH S=6T.TUA[.68RQ
M7%G*)8)X6VNA[C/HPX(/44 -T?61JC7D,EI-:7-G,8I8I5ZC^%E/1E88((^G
M44 :E !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % $<\T5O \TTBQ1(,L[G 4>I-)[#2N<!I$/E:O;Q+=Z<\5
MS,DR3Q7!>2<INRVT#JV<$DX'(JH::=K_ (I+_@DSU;DNMOSO_P  ]#I#*FJO
M)'I-V\,Z6\BQ,5E?[J''4TF[:E15W8Y_0=1N[_48+F6[;9<K-FV((6/85  R
MH.>22?>K2LG]_P"+_+8C_.WX?KNO(ZNI&% !0 4 % !0 4 % !0 4 % !0 4
M % &9XC_ .1;U+_KW?\ E0!XE0!ZSX!_Y%:+_KH_\Z .GH * "@ H * "@ H
M * "@"*YN(;.UEN;B01PPH7=V. J@9)- &1X?M+25[GQ# T[R:PL4H,Z[6CC
M"#8@'8#).#W8T 6?$?\ R+>I?]>[_P J /$J /5?A[_R+)_Z[M_(4 =70 4
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M_GG'_P!]G_"@ W3_ //./_OL_P"% !NG_P"><?\ WV?\* ,WQ$9O^$<U',:
M?9WSASZ?2@#PN:YGCO(8XK;S8&)6617&8SVR/3_ZU 'L'@-I?^$7BV(A7S'Y
M+X[_ $H Z;=/_P \X_\ OL_X4 &Z?_GG'_WV?\* #=/_ ,\X_P#OL_X4 &Z?
M_GG'_P!]G_"@ W3_ //./_OL_P"% !NG_P"><?\ WV?\* #=/_SSC_[[/^%
M!NG_ .><?_?9_P * #=/_P \X_\ OL_X4 8VLSWD]]8Z,-*BN[2^$GVQI=S1
M)"%Y!.,;F+* #U&[TH V%\Y%"K#$% P '/'Z4 9WB(S?\(YJ.8T ^SOG#GT^
ME 'BU 'J7P_,H\-G8B$>>W5B.P]J .IW3_\ /./_ +[/^% !NG_YYQ_]]G_"
M@#GO%'B:Y\/?9-MI%)Y^_JYXQCV]Z .0O?'$UT)I8+"&TOWB,2WD0!EC&<\%
M@<C(!P>* .Q&NW&@P:;:>(YH#=W+&(7<2.D#/GY0QP0A;L"<$Y [4 ;^Z?\
MYYQ_]]G_  H -T__ #SC_P"^S_A0 ;I_^><?_?9_PH -T_\ SSC_ .^S_A0
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MYI:\CO\ %T[[]/G^'D&EXVVTO^.YKW%Q&VBZ!#JTJ&)&C&H+*P(7,3;?,!Z
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MBOK7S!%(.!)&492#@@J>00: +E !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 ,EBCFB:*5%>-QM96&01Z$4!L/Z<"@-@H AGM8;DQ&9-_E.)$!/ 8=
M#CO1L[ATL34 % $45M#!+-)&@#S-ND;.2QQC^0HV5@ZW): "@ [4GL!Q>B0Z
M0=1BF>PU&"]+_P"J:.<P(PS@C(V@<G'IGM50T6G;]/Z03W=^_P"O],[2D!C^
M(3>R6/V.Q%N)+M6B#2W!B8$CC;A3DXR>W2DU=V*3MJ9'A=;)-7GAAT[2+>YA
MC*R-9SEY,Y&1@H.,]>3S5IWBVMC-JS2>YU]24% !0 4 % !0 4 % !0 4 %
M!0 4 % ')>)'O+YM6M9].C_LJSLO,6:9,E[@\C9SP%4')QU88/!H \LH ]9\
M _\ (K1?]='_ )T 2"0^%'OKK5=8>72;BX4P>>I9K9G)RI?_ )YY(QG[N<9Q
MC !T8((!!R* //\ XF_\PO\ [:_^R4 >?T ?0% !0 4 >*>)?^1FU'_KNW\Z
M &^&8[35/$)\/W23/'J%K()?*;&V,%2=Q]#PO_ J /;$18T5$4*JC  Z 4 +
M0!F>(_\ D6]2_P"O=_Y4 >)4 >J_#W_D63_UW;^0H ZN@ H \_\ B;_S"_\
MMK_[)0!Y_0!] 4 % &7JNB_VE<VEU%?W5E=6K91X)/E921N5T/RL#CN,CL10
M VRUB:?6+S3;K3+BT:#YXIR-T,\><9#C@-ZJ<'ZCF@#6H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * #M2>P' V-I'!XAM$
M_M>TFNO,4RYU$L^X;MP\LGG<"..V/:JI^7]:?H];A4Z_UUO^6AWU(#*UFTAN
M_(!U%K&YAW2QR(5R%QACA@1C#=>W%*UW^'W_ /##Z?UN%GH5M936+P,PCLX7
MB1>N[<02Q/<_+^M5?5OT7W$]$O.YJTAA0 4 % !0 4 % !0 4 % !0 4 % %
M/4KZ&QMT#W,4$UPX@MS)T:5L[1CO0!D3Z=)I/@">QFNI+N:*T?S)Y#EI'()9
MO;))X[=* /(J /6? /\ R*T7_71_YT ='/!#<V\EO<1)+#(I5T<95@>H([B@
M#(2:^TK59ENOLD?A]85,,VX1&W8878V3@@]01C'2@#FOB;_S"O\ MK_[)0!Y
M_0!] 4 % !0!XIXE_P"1FU'_ *[M_.@"Y\+3<R>([F:[B6-C'((U Y6,,H&3
M[XS^- 'K] !0!F>(_P#D6]2_Z]W_ )4 >)4 >J_#W_D63_UW;^0H ZN@ H \
M_P#B;_S"_P#MK_[)0!Y_0!] 4 % !0!C:S-H.IZ=>Z1J5]:^3<1M#-&TZJP!
M&#WR#0!%X;UK3;J)M(M]6%_>:<J0S.Q >3"@[^.H.>HXSF@#>H * "@ H *
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MBNY+F $R-]ED$2D ''F$!2>>QH K6]UXFU*PN]VG6VC7!"_9FGE^TG_:WHF
M,=L.?\0#R#Q'I<UQJ=W;:G?27$JS-YLD(, D.?[H.0/;- '5?#L8\2./^G=O
MYK0!ZI0 4 9GB/\ Y%O4O^O=_P"5 'B5 'JOP]_Y%D_]=V_D* .KH * //\
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MJ7_7N_\ *@#Q*@#U7X>_\BR?^N[?R% '5T % 'G_ ,3?^87_ -M?_9* //Z
M/H"@ H * /%/$O\ R,VH_P#7=OYT :WP^4/XBE4D@&V<<'!ZB@#NO#2W%A8)
MHNHZG'?:C9+\S[R9&A+,(W?/.XJO)[D&@#;H * "@ H * "@ H * "@ H *
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M*D@!AGN,BA:JXWH[$8\0:7YTT1N@IA5F9F1E3"_>PQ&&QWP3BE?2X[:V&?\
M"2Z5Y)D\^3AMGE_9Y/,SC/W-N[&.<XQBF]!+4TH)XKF".>%P\4BAD9>A!Z&F
MTT[,2=R2D,* /%/$O_(S:C_UW;^= &Q\._\ D9'_ .O=OYK0!V&EQZ;XAUI/
M$]O+-,MO'+96P< 1C#XDD3UW%5&?1>.O(!T= &9XC_Y%O4O^O=_Y4 >)4 >L
M^ ?^16B_ZZ/_ #H Z>@ H \_^)O_ #"_^VO_ +)0!Y_0!] 4 % !0!XIXE_Y
M&;4?^N[?SH V/AW_ ,C(_P#U[M_-: /4Z "@#,\1_P#(MZE_U[O_ "H \2H
M]5^'O_(LG_KNW\A0!U= !0!Y_P#$W_F%_P#;7_V2@#S^@#Z H * "@#Q3Q+_
M ,C-J/\ UW;^= &Q\._^1D?_ *]V_FM '9^(/L&AR'Q7-;2O+9P>3*T38_<L
MZEF8=PF"WL-V.M &^K*Z!E(*D9!'0B@!: "@ H * "@ H * "@ H * "@ H
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M<E>\>[;^]/\ S+/V+5AXD_X2 :7)@H8?LGFQ^9C:/GSNV]>.N<?E22LI+O\
MAM_D#UMY6_7_ #.@T.RET[1+.TF(\V*,!MIX![@>U7*U]!;MONV_O9>=2V,2
M,F/3'/YBI&,\I_\ GXD_)?\ "@#QCQ(,>)-1!)/[]N3]: '^&;G48-<@BTNW
M\VXN"(F9ERD<>X%V;V"@X]R!0!Z_:V$5E:Q6MJ?(MX5"1QQHJJBCH  .!0!+
MY3_\_$GY+_A0!F^(HV'AS429G/\ H[\$+Z?2@#Q:@#U;P'&S>%XB)74>8_
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MI_\ GXD_)?\ "@ \I_\ GXD_)?\ "@ \I_\ GXD_)?\ "@ \I_\ GXD_)?\
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MMI"2O(8HRYEA*_.A4<GE5;CG*B@#8M[B&[MHKFWD62&5 Z.O1E(R"/PH EH
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M2_\ (S:C_P!=V_G0!L?#O_D9'_Z]V_FM 'J= !0!F>(_^1;U+_KW?^5 'B5
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M !0!'-#%<1&*:))8SC*NH(..1P: '@!0   !T [4 +0 4 % !0 4 % !0 4
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MZG0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 >*>)?^1FU'_KNW\Z -CX=_\C(__7NW\UH ]3H * ,SQ'_R+>I?]>[_ ,J
M/$J /6? /_(K1?\ 71_YT =/0 4 >?\ Q-_YA?\ VU_]DH \_H ^@* "@ H
M\4\2_P#(S:C_ -=V_G0!L?#O_D9'_P"O=OYK0!ZG0 4 9GB/_D6]2_Z]W_E0
M!XE0!ZK\/?\ D63_ -=V_D* .KH * //_B;_ ,PO_MK_ .R4 >?T ?0% !0
M4 >*>)?^1FU'_KNW\Z -CX=_\C(__7NW\UH ]3H * ,SQ'_R+>I?]>[_ ,J
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MXQ_]\B@ ^S0?\\8_^^10 ?9H/^>,?_?(H /LT'_/&/\ [Y% !]F@_P">,?\
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MC_[Y% !]F@_YXQ_]\B@ ^S0?\\8_^^10 ?9H/^>,?_?(H /LT'_/&/\ [Y%
M!]F@_P">,?\ WR* 'HB1C"*%'H!B@"MJ45Y+9.MA-%'<CE?.3<C?[+#K@^W-
M(:L8D?A2:VC!M=12"9TD28BWRA5VW'8NX;<'IR>O.:&DUR]-%]U_\Q)N_-U_
MX;_)'0VUNEI:PVT0Q'$@1?H!@5<GS-MDQCRI(EJ2@H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M"EK%Y)I^BWMY$%,D$+R*&&02!GFDW8J"N[& _B/4+*UBNYT6Y@E)B4)8RV[B
M4@%!AV.03D9Z9(JFM>5;O;_@_G\F1%W7,]NOH7+G4]5TZZM1="TECD5M\<*,
M'4+'N9\DXQD8QCN.:F34>9]DW_E]XXIM+U2^_P#R([36-6D 22.S::>S%W
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MC'F)TVDA,XQQQ@^]-OF=V)>[L;**L:*B@!5& !V%#=]02LK(6D,* "@ H *
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M % !0 4 % !0 4 % !0 4 % !0 4 % !0 R2&*8*)8U<*P8!ES@CH?K1YAY
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MHPI'0@=L47UN*VEAS0Q/*DK1J9$SM8KRN>N#VH&4X=$TFW>1X=+LXGD4J[)
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@2H)W8!(5L#_ &3Z4 !\:>%5MTN&\2Z2('9D20WT>UF4 L =V"0&7([;AZT
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
, !0 4 % !0 4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g805243dsp28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp28.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@".*"* ,(HDCWL7;:H&6/4GWH\@)* "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH 9--';PO-,X2.-2S,QP !U-)NPTFW9&;'XAL6M/M+I=0H9/+19+:0/(>Q5<
M98$<\#I3>@M]A7\1Z5&D+FZRLRAU*QLP52<9; ^09XRV*=M;?UY!>RO_ %IO
M]Q+;ZS875ZUG#.6F&[^!@K;3AMK$8;!ZX)Q26JN@>FC+] !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % %>^C\VPN(_LZW&Z,KY+-M#\=,]LU,MAQ=G='+16>
MH36@F%KJB10RJ]E&9(?M$/RE6R7)!7G&&)/-7KOUU^[3?_@$I+5=/U3Z%:/P
M]JUE8W=FMO\ :6U"T\EI/,7$+EW)+9QD8D_A';I1II'LU^"2_30=[/G]=/7;
M_@FAH^E:A;SZ;;3VQ2+3FF8W!=2)MV0N #GHV3D#D=Z$^K[)?E_D3RV7*N]_
MS_S.JI%!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M3,;@NI$V[(7 !ST;)R!R.]"?5]DOR_R)Y;+E7>_Y_P"9U5(H* "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Y/5DU'
M4-9N#>R-8^&]+7S9BN2;T[-S C',8!((YSR.3]T S;?_ (G5N=;UO_B6^%;5
M!]EL#\JRJ"-KR*.HR!M3G/&./O@!;_\ $ZMSK>M_\2WPK:H/LM@?E6501M>1
M1U&0-J<YXQQ]\ +?_B=6YUO6_P#B6^%;5!]EL#\JRJ"-KR*.HR!M3G/&./O@
M#$NVO;*3Q%K$+6?A>TBVVFF",$3J<!6=.A&=NT=!P<@#+ '7:!<ZE>Z6MUJE
ML+6>9BZP=XT_A!]\<GZ]!T !IT % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MYSR.3]T S;?_ (G5N=;UO_B6^%;5!]EL#\JRJ"-KR*.HR!M3G/&./O@!;_\
M$ZMSK>M_\2WPK:H/LM@?E6501M>11U&0-J<YXQQ]\ +?_B=6YUO6_P#B6^%;
M5!]EL#\JRJ"-KR*.HR!M3G/&./O@#$NVO;*3Q%K$+6?A>TBVVFF",$3J<!6=
M.A&=NT=!P<@#+ '7:!<ZE>Z6MUJEL+6>9BZP=XT_A!]\<GZ]!T !IT % !0
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M&\)V+B/RX_D:[90"%P/NH!CCCMW^X %O_P 5_<&WM_\ 1O"=BXC\N/Y&NV4
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M!Z*&X&/PX"T $O\ Q2GD>'-"_P!)\1ZIF26\N/QS*Q.<XPV%YZ$G)^\ $O\
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M& =SX]<9).X CB_XD5P^MZ[_ ,3'Q5<I_HUA;_,T*D'"(HS@8#9?GH<9).X
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M "@#*\3?\BIK'_7E-_Z : /FZ@ H * "@"YI'_(:L?\ KX3_ -"% 'TU0 4
M% !0 4 % !0!Y3\8F83:2H8A2LF1G@\K0!YDTLC($9V*CH">!0 /-+(,/([#
MT+$T #S2R##R.P]"Q-  \TL@P\CL/0L30!Z=\'Y9)+G5M[LV$CQN.<<M0!ZK
M0 4 % !0 4 % !0!PMV8O!R75W$IU?Q3J3$A!\SX.2 %'S"-0O8<X'08V@$<
MG_%&6DMRW_$Y\7:C]X+\SG()X0?,(UVGH.<#H,;0 D_XHRTEN6_XG/B[4?O!
M?F<Y!/"#YA&NT]!S@=!C: #V-[X=MS]DFCU#Q=JCJL]P_P Q@1CC>% R(U(
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MZ  TZ "@ H * "@ H * "@ H * "@ H * "@#*\3?\BIK'_7E-_Z : /FZ@
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M_IWB&_?-U=O\[1$D9EE R0/G& >.23GG< =M8V\EII]M;2SM<20Q*C3-UD(
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ML4 % !0 4 97B;_D5-8_Z\IO_0#0!\W4 % !0 4 7-(_Y#5C_P!?"?\ H0H
M^FJ "@ H * "@ H * /*/C'_ ,?&D?[LO\UH \PH * "@ H ]/\ @Y_Q\:O_
M +L7\VH ]7H * "@ H * "@ H \N;Q3H7AB/4KVVNCJOB2YD99'DC=0G/"Y(
M'R+@# Y.!T&-H!!:>+-$\/:9=:C!>_VSXFO/];,\3JH)[#(&$&!P.3@=!C:
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M"1D]>2P Q(KS2K*3Q/J*+?\ BF\B_P!#LB"#"IQ\B1_>)4-EL<]1GDL0#KM
MT^[TW2UCU"\-W>R,99Y>Q8]A[#@#Z=!T !IT % !0 4 % !0!5U*..;2[J*:
M*26)XF5DB^\P(Y ]ZF5K:E1;3NCEX9S?Z>#-<WYLK>6-[*[ALF\UB%.<IL.0
M/7: <U3N[2ZZ_=;_ ()"5KQ6VGRL_P#@(J7$6J36UZ+^QGFN[^P6&!DA)PX=
M_O8X0X*,<X''M379:.Z?X+\G<=[6;U2NOZ]47-#M;E+K2[>2UFCN+)[@W,SQ
M%58,3C#=&W$@\9Z<T1:W_NI?/3_)DM-*SWO?Y:_YI'8TB@H * "@#*\3?\BI
MK'_7E-_Z : /FZ@ H * "@"YI'_(:L?^OA/_ $(4 ?35 !0 4 % !0 4 % '
ME'QC_P"/C2/]V7^:T >84 % !0 4 >G_  <_X^-7_P!V+^;4 >KT % !0 4
M% !0 4 ?,NK_ /(:OO\ KX?_ -"- %.@ H * "@#Z1\,_P#(J:/_ ->4/_H
MH U: "@ H * "@ H Q_$NG/JFD-:F_-C:LV;N4$ ^2 2P!/3/&2>,9SGH0#F
M9/\ B?Z9#INA_P#$L\)0H?M-]_JS*HY9$#<XZ[G/4[LYP0P!%/!::O81D2QV
M'@2Q0."C%6O"#R"/O !@1@\L>1DD%0"74/\ BH+=9KW_ (E?@JS17 ^XUX <
M+\HY5.!@8!.1@9(V@!J'_%06ZS7O_$K\%6:*X'W&O #A?E'*IP,# )R,#)&T
M UM)N=2U;5;:YM(!8^&[:/\ T=2NUKK(*J=O54 Y .,\''/R@'44 % !0 4
M% !0 4 <=K-K;67B1=7U>Y6[G+"+1M/)P/,VCGI]XOQN/"Y4D], %*V_XD^I
M+J6N?\3'Q;?(?LMC#R(5Z!%/(0<G+GL&QGYBP 6W_$GU)=2US_B8^+;Y#]EL
M8>1"O0(IY"#DY<]@V,_,6 "V_P")/J2ZEKG_ !,?%M\A^RV,/(A7H$4\A!R<
MN>P;&?F+ #(X[G3+TZAJ!AU#QI?1$V=D6PENG]U>P &XDDC." 2220#K/#]C
M<Z?IGE7U]]MOF<R7$O;><' ] !@#IQC@=  :M !0 4 % !0 4 % !0 4 % !
M0 4 % !0!E>)O^14UC_KRF_] - 'S=0 4 % !0!<TC_D-6/_ %\)_P"A"@#Z
M:H * "@ H * "@ H \H^,?\ Q\:1_NR_S6@#S"@ H * "@#T_P"#G_'QJ_\
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M0!<TC_D-6/\ U\)_Z$* /IJ@ H * "@ H * "@#RCXQ_\?&D?[LO\UH \PH
M* "@ H ]/^#G_'QJ_P#NQ?S:@#U>@ H * "@ H * "@#YEU?_D-7W_7P_P#Z
M$: *= !0 4 % 'TCX9_Y%31_^O*'_P! % &K0 4 % !0 4 % '$?%7_D3O\
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MO^N<G_H)H ]UH * "@ H * "@ H \#^(_P#R/NI_]LO_ $4M '*T % !0 4
M>Z?"_P#Y$F#_ *ZR?SH [*@ H * "@ H * "@!D44<,:QQ(L<:C 51@#\* '
MT % !0 4 % !0!E>)O\ D5-8_P"O*;_T T ?-U !0 4 % %S2/\ D-6/_7PG
M_H0H ^FJ "@ H * "@ H * /*/C'_P ?&D?[LO\ -: /,* "@ H * /3_@Y_
MQ\:O_NQ?S:@#U>@ H * "@ H * "@#YEU?\ Y#5]_P!?#_\ H1H IT % !0
M4 ?2/AG_ )%31_\ KRA_] % &K0 4 % !0 4 % '$?%7_D3O^WA/Y&@#Q"@
MH * "@#L?AC_ ,CO;?\ 7.3_ -!- 'NM !0 4 % !0 4 % '@?Q'_P"1]U/_
M +9?^BEH Y6@ H * "@#W3X7_P#(DP?]=9/YT =E0 4 % !0 4 % !0 R.6.
M4$QR*X5BI*G."."/K0 ^@ H * "@ H * ,KQ-_R*FL?]>4W_ * : /FZ@ H
M* "@"YI'_(:L?^OA/_0A0!]-4 8VOZO/IHM8;1+?[3=.4C>ZE,<2D#."0"<G
ML.])7<N5?UZ>8/2-_P"O^&()O$HBUV/20MDLX">:)KP1G+=HUVY<@<_P]137
MO-VZ?>)^ZDW_ ,#[RHGC-B+P&R@=X&C1?(NQ(H=WV!)& PC ]0-V!ZT17,E;
MK]VURI6BW?97]=/+\C:TC4VU**X$L*PW-M,T$T:2;U#  \-@9&"#T%/HI+K_
M )V)V;3-&D,* /*/C'_Q\:1_NR_S6@#S"@ H * "@#T_X.?\?&K_ .[%_-J
M/5Z *5QJ^G6FH6]A<7L,5W<?ZJ)F 9OPH6KL@>BNQZ:E827DMG'>V[W40W20
MK*I=!ZE<Y'6CI?H&SL13ZYI%M;17$^J6<4$V?+D>=55\=<$G!HZV#S+RL&4,
MI!4C(([T; G?86@ H ^9=7_Y#5]_U\/_ .A&@"G0 4 % !0!](^&?^14T?\
MZ\H?_0!0!JT % !0 4 % !0!Q'Q5_P"1._[>$_D: /$* "@ H * .Q^&/_([
MVW_7.3_T$T >ZT % !0 4 % !0 4 >!_$?\ Y'W4_P#ME_Z*6@#E: "@ H *
M /=/A?\ \B3!_P!=9/YT =E0 4 % !0 4 % %35 C:5=K),\"&)@TJ ED&.H
MQZ5,MBHNSN<?#)I+Z1/9M_8\-O%*FV[6'=:SL5/WE! W#'=B <=ZJ>JOMO\
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M^RWL5W/9JDYO89K'*!B^1Y95,R;N2?O?ATI+X%?HE;O?^NOXA+XG;JW]VO\
MP%;Y6([50OA[3WC_ +7LM1M#.L*Q:<YR6.<,&C( (*\\=^>#@?,DG'?E2_+]
M4"2U3VYF_P 7^C.XLFN&L;=KM52Y,:F55Z!L<@?C5SLI/EV)A=Q7-N3U)04
M?,NK_P#(:OO^OA__ $(T 4Z "@ H * /I'PS_P BIH__ %Y0_P#H H U: "@
M H * "@ H XCXJ_\B=_V\)_(T >(4 % !0 4 =C\,?\ D=[;_KG)_P"@F@#W
M6@ H * "@ H * "@#P/XC_\ (^ZG_P!LO_12T <K0 4 % !0![I\+_\ D28/
M^NLG\Z .RH * "@ H * "@ H 9%%'#&L<2+'&HP%48 _"@!] !0 4 % !0 4
M 97B;_D5-8_Z\IO_ $ T ?-U !0 4 % %S2/^0U8_P#7PG_H0H ^FJ "@ H
M* "@ H * /*/C'_Q\:1_NR_S6@#S"@ H * "@#T_X.?\?&K_ .[%_-J /5Z
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M&YH%D!=1ZE>HI+75 ]-RS0 4 % !0 4 % !0 4 % !0!E>)O^14UC_KRF_\
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M@ H * ,KQ-_R*FL?]>4W_H!H ^;J "@ H * +FD?\AJQ_P"OA/\ T(4 ?35
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MY_Q\:O\ [L7\VH ]7H * "@ H * "@ H ^9=7_Y#5]_U\/\ ^A&@"G0 4 %
M!0!](^&?^14T?_KRA_\ 0!0!JT % !0 4 % !0!Q'Q5_Y$[_ +>$_D: /$*
M"@ H * .Q^&/_([VW_7.3_T$T >ZT % !0 4 % !0 4 >!_$?_D?=3_[9?\
MHI: .5H * "@ H ]T^%__(DP?]=9/YT =E0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 97B;_D5-8_Z\IO_0#0!\W4 % !0 4 7-(_Y#5C_P!?"?\ H0H ^FJ
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M,NK_ /(:OO\ KX?_ -"- %.@ H * "@#Z1\,_P#(J:/_ ->4/_H H U: "@
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M ^9=7_Y#5]_U\/\ ^A&@"G0 4 % !0!](^&?^14T?_KRA_\ 0!0!JT % !0
M4 % !0!Q'Q5_Y$[_ +>$_D: /$* "@ H * .Q^&/_([VW_7.3_T$T >ZT %
M!0 4 % !0 4 >!_$?_D?=3_[9?\ HI: .5H * "@ H ]T^%__(DP?]=9/YT
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MTLO^_I_^)H ['P#X3U/PK+?M?+%(+A4"^2^<8SG.<>M ';>:_P#S[R?FO^-
M!YK_ //O)^:_XT 'FO\ \^\GYK_C0 >:_P#S[R?FO^- !YK_ //O)^:_XT '
MFO\ \^\GYK_C0 >:_P#S[R?FO^- 'C]]\+O$%SJ%S<(]F$EE9P#*<@$Y]* (
M/^%3^(O^>EE_W]/_ ,30 ?\ "I_$7_/2R_[^G_XF@ _X5/XB_P">EE_W]/\
M\30 ?\*G\1?\]++_ +^G_P")H ]:T>"?3]$L+*6%C);V\<3%2,$JH!QSTXH
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M?#=N?EX[M6CTJMKIK_E_78QC_"M\O\_N5_F=<!@8%07L% !0 4 % !0 4 %
M!0!E>)_^15U7_KUD_P#034RUMZK\RZ?Q(YV^T233M.LYK1K.UN9I5MF>TM?)
M!CEPIR-QRP."#[=*T:3GR/9WO\KO]+?,RB[0Y^JLU^7ZEB1]*TWQA;P03QK(
MEA)$85FRX(,>U0I/!P"0!C/)J'+FC4?I^M_ZZ%VMR+S*_@CR$OI$B:!RUJA9
MK8\ [C_KO^FO/)[X/ K3H_EZ;=/Z[$-WDGZ^N_7]/F=O4%!0 4 % !0 4 %
M!0 4 <OX@T_^TO$NEP;+-\6\[8N[;STZQ_P[AS[YHA\4GZ?FQR?NKU_0AM-.
MA@U[4(+B=8]-L4,T2[O+$1E!W'=G@#:V,8QN-$7[K;]/EH_U2^0G\22]?GM_
MP?4RK>33I?#MKMN]-EMK>]N-UO=7&(Y,N^T$@-DX((&#FD]HO^[;YZ;>?3YA
MUDEW_#_+_(Z[PTMPGARP6Z#"81#(;.0.P.>>F*N>_P#6_4F/7U?YZ&K4E!0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 0W:3O9S);2"
M*<H1&Y&0K8X./K2:;6@U9/4\WUBTU2SFT+2KS6OMNK3&8+'_ &M-8^:NT$<1
MX+D'ID<^HHBE*?+_ '=?O6OW7]=^A,KQC?\ O:?<_P!;=[;(TM2LH+#Q-9:2
M=;NE36(]KQRZK,LJF,ALQ#=D;^AVXZ?44X^])Q_[>_2WIU^3\K#O&,9?+\-_
M56MZM?.Y'=P1>(/$FG6^MK!)%9P,/M%RTPMF(<;MK/Q_ 3R,\'J<T-\U-O\
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MT=[7[)G4R:I)9:/OT6TO-8B:*22&Y$R.@(7*@LS!F![%0V?6IGS).^G]=O\
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M Q4D'W'(I-7&G8BT_3K?3+?R;?S2,Y+33/,[?5W)8_B:INY-K%ND,* "@ H
M* "@ H * "@ H * "@ H * "@ H * "@"E'I5I%J\^JHL@NYXUB=C,Y4JI)
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M3]XFGU37WM,4/=<>T;?A?_,K1>!=<LV%P=9L;HQ*2(4TXQF0_9_)"[FF8 8
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M.!HQ(5  <@R,H.U0/E S@9.  +<V[WZ_U_7SZCE>3OYO\6W;\?\ ACJ:@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
G"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g805243dsp28a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp28a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MO3]0>CM_6AJT@"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M:?AY_P!#K_Y=<_\ \?H /M/P\_Z'7_RZY_\ X_0 ?:?AY_T.O_EUS_\ Q^@
M^T_#S_H=?_+KG_\ C] !]I^'G_0Z_P#EUS__ !^@ ^T_#S_H=?\ RZY__C]
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M 4 % !0 4 % !0 4 % !0!S_ ([_ .2>>)?^P7<_^BFH Z"@ H * "@ H *
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M "'/%G_843_TCMJ .@H * "@#G_&7_(#MO\ L*:?_P"ED- '04 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S_CO_DGG
MB7_L%W/_ **:@#H* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@#G[S_DH>C?]@N^_]&VM '04 % !0 4
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M_P"BFH Z"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M"2Q>:2>>&%Y905CEBC4DL6"G 8  \'EB*:]Y*ZZMO[E^NJ\A-<K:79)?-O\
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M //O)^:_XT 'FO\ \^\GYK_C0 >:_P#S[R?FO^- !YK_ //O)^:_XT 'FO\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!S]Y_R4/1O^P7??\ HVUH Z"@ H * "@ H * "@#G_#W_ "'/
M%G_843_TCMJ .@H * "@#G_&7_(#MO\ L*:?_P"ED- '04 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S_CO_DGGB7_L
M%W/_ **:@#H* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@=Z2UM;J#TO?H+?:Q+:ZO;Z?#:I*TJ>9EYA'D9P0@(^9AUQD<=Z(ZMKM_7W
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M H * "@#G_#W_(<\6?\ 843_ -([:@#H* "@ H Y_P 9?\@.V_["FG_^ED-
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MTFX4NW5L0MR?>AN[N**LK'1TAA0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MUZ-_X'Q?_%4 '_"=^#_^AKT;_P #XO\ XJ@ _P"$[\'_ /0UZ-_X'Q?_ !5
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M3L[>GZ@]';^M#5I <_X>_P"0YXL_["B?^D=M0!T% !0 4 % !0 4 % !0 4
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M^-_C0 >0GK)_W\;_ !H /(3UD_[^-_C0 >0GK)_W\;_&@ \A/63_ +^-_C0
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M\;_&@ \A/63_ +^-_C0 >0GK)_W\;_&@ \A/63_OXW^- !Y">LG_ '\;_&@
M\A/63_OXW^- !Y">LG_?QO\ &@ \A/63_OXW^- !Y">LG_?QO\: #R$]9/\
MOXW^- !Y">LG_?QO\: #R$]9/^_C?XT 'D)ZR?\ ?QO\: #R$]9/^_C?XT '
MD)ZR?]_&_P : #R$]9/^_C?XT 'D)ZR?]_&_QH /(3UD_P"_C?XT 'D)ZR?]
M_&_QH /(3UD_[^-_C0 >0GK)_P!_&_QH /(3UD_[^-_C0 >0GK)_W\;_ !H
M/(3UD_[^-_C0 >0GK)_W\;_&@ \A/63_ +^-_C0 >0GK)_W\;_&@ \A/63_O
MXW^- !Y">LG_ '\;_&@ \A/63_OXW^- !Y">LG_?QO\ &@ \A/63_OXW^- &
M%<QB/XAZ/@L<Z7>]6)_Y:VOK0!T5 !0 4 % !0 4 % '/^'O^0YXL_["B?\
MI';4 =!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S]Y_R4/1O^P7??\ HVUH Z"@
M H * "@ H * "@#G_#W_ "'/%G_843_TCMJ .@H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H Y^\_Y*'HW_8+OO_1MK0!T% !0 4 % !0 4 % '/\ A[_D.>+/^PHG
M_I';4 =!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S]Y_P E#T;_ +!=]_Z-M: .
M@H * "@ H * "@ H Y_P]_R'/%G_ &%$_P#2.VH Z"@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@#G[S_DH>C?]@N^_P#1MK0!T% !0 4 % !0 4 % '/^'O\ D.>+
M/^PHG_I';4 =!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S]Y_R4/1O^P7??^C;6
M@#H* *.K>0+!C<W$T,0(R87*.WHH*\\GTYI,:.4N&OH;:6"^U"Y@EM--:YCV
MSD'?O;&X@_/M 4$'(.?>FVU=K5KE7^?WL<4FXI[-O[M+?<F2V%[=37-G>R74
MPNI=0>VDM_-.P(%/&SH",!LXS[\U223275/\'_2,[WBV^G+^-K_FQVH7ERE[
M?7274PN+6_AMX8%D(1D8)D%.ASN8Y(SQ[5FG:*:Z\WX7_P DS1I-M/HE^?\
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M&!Y3F1HXPI<^I(ZTEHK(>[N6* .?\/?\ASQ9_P!A1/\ TCMJ .@H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H .
ME $37$"?>FC7ZL!0!"VJ6$?WKVW'MY@H @N->T^W@>47"R;1P$YR: %T?5H]
M6MC(J&.1#AUZ@?0T :- !0 4 % '/WG_ "4/1O\ L%WW_HVUH Z"@ H * "@
M H * "@#G_#W_(<\6?\ 843_ -([:@#H* "@ H * "@ H * "@ H * "@ H
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M H * "@#G[S_ )*'HW_8+OO_ $;:T =!0 4 % !0 4 % !0!S_A[_D.>+/\
ML*)_Z1VU '04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MMXIW2-RCG<H8@'(;!XH ]'T/7+;5=*LYS=6YN984>6.-Q\K%02,9R.: -:@
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M 5[RQL]0B$5[:PW,8;<$FC#@'UP>_)H BL]'TS3Y3+9:=:VTA7:7AA5"1Z9
MZ<"@"[0 4 % !0!S]Y_R4/1O^P7??^C;6@#H* *U_>II]E)=21RR+&,E8D+,
M?P_J>*F4N578TKNQGW/B2UMH8I1;W,RM;BY<1JI,41_B;)'Y#)X/%6U:3B^F
MA,7S13778?%XAM9;]+9(IS&\IA2YVCRVD R5'.<X!YQCCK0E?^NP7TOZ?CL$
M_B"UM[\VS0SE$D6&2< >7&[#*J><\Y'0$<BDM?Q_#<;T%T[7K?4KA88X)XO,
MC\Z%Y5 $R9QN7!)[CK@\BG9V]/U!Z.W]:&K2 Y_P]_R'/%G_ &%$_P#2.VH
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M 4 :OV*[_P"@I/\ ]^X__B: %^R7@X_M)_QB7_"@ ^RWHZ:B?QA6@ ^SW_\
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M@RNML@*D="#C@T :5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M\;_&@ \A/63_ +^-_C0 >0GK)_W\;_&@ \A/63_OXW^- !Y">LG_ '\;_&@
M\A/63_OXW^- !Y">LG_?QO\ &@ \A/63_OXW^- '#?\ "HM _P"?S4?^_B?_
M !% '<^0GK)_W\;_ !H /(3UD_[^-_C0 >0GK)_W\;_&@ \A/63_ +^-_C0
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MCL+&WM8U& L$2H /H!0!;H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#$\6>%=.\8^'Y]'U(.(I,%9(R \; Y!!- &7X"^'>D_#^TNXM.EGN);ME:
M6:<C)"YVJ, 8 R?SH Z^@ H * "@#G[S_DH>C?\ 8+OO_1MK0!T% !0 4 %
M!0 4 % '/^'O^0YXL_["B?\ I';4 =!0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!
MS]Y_R4/1O^P7??\ HVUH Z"@ H * "@ H * "@#G_#W_ "'/%G_843_TCMJ
M.@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H Y^\_Y*'HW_8+OO_1MK0!T% !0 4 %
M !0 4 % '/\ A[_D.>+/^PHG_I';4 =!0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M!S]Y_P E#T;_ +!=]_Z-M: .@H * "@ H KW=Q+;JABLIKHL<$1%!M]SN8<?
M2A;V#H6* "@#&TNSGL=4UZ9T\Q+V]6>/81PHMX8\'..<QGUX(H U/-?_ )]Y
M/S7_ !H /-?_ )]Y/S7_ !H /-?_ )]Y/S7_ !H /-?_ )]Y/S7_ !H /-?_
M )]Y/S7_ !H /-?_ )]Y/S7_ !H /-?_ )]Y/S7_ !H /-?_ )]Y/S7_ !H
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M@ \U_P#GWD_-?\: #S7_ .?>3\U_QH /-?\ Y]Y/S7_&@ \U_P#GWD_-?\:
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MKF6W9[J:*(K-%(&&4E8DY)R<=,;>!BFK<KMMI\_^"*7Q>=W_ %Z';5(PH *
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M_3K^99E>T:YL(6N((M?@A1YY'E E9_+P(ER<G)() X_$TZF\W#SVZ_\ #?\
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MKNSZK\O\_P CK_#2W">'+!;H,)A$,ALY [ YYZ8JY[_UOU(CU]7^>AJU)04
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M30!-0 4 % !0 4 % !0 4 0VMI!91&*W38A=G(R3EF)).3[FCHEV#K<FH *
M"@ H * "@ H * "@"&YM(+R)8KA-Z*ZN!DCE3D=/<"A:.X=+$U $-U:0WMN8
A+A-\1()7)&<'(Z>XHZI]@Z6)J "@ H * "@ H * /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g805243dsp31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp31.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG'_WV?\*
M#=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL_P"% !NG_P"><?\
MWV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG
M'_WV?\* #=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL_P"% !NG
M_P"><?\ WV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X
M4 &Z?_GG'_WV?\* #=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL
M_P"% !NG_P"><?\ WV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P * #=/_P \
MX_\ OL_X4 &Z?_GG'_WV?\* #=/_ ,\X_P#OL_X4 &Z?_GG'_P!]G_"@ W3_
M //./_OL_P"% !NG_P"><?\ WV?\* #=/_SSC_[[/^% !NG_ .><?_?9_P *
M #=/_P \X_\ OL_X4 &Z?_GG'_WV?\* #=/_ ,\X_P#OL_X4 &Z?_GG'_P!]
MG_"@ W3_ //./_OL_P"% !NG_P"><?\ WV?\* #=/_SSC_[[/^% !NG_ .><
M?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG'_WV?\* #=/_ ,\X_P#OL_X4 &Z?
M_GG'_P!]G_"@ W3_ //./_OL_P"% !NG_P"><?\ WV?\* #=/_SSC_[[/^%
M!NG_ .><?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG'_WV?\* #=/_ ,\X_P#O
ML_X4 &Z?_GG'_P!]G_"@ W3_ //./_OL_P"% !NG_P"><?\ WV?\* #=/_SS
MC_[[/^% !NG_ .><?_?9_P * #=/_P \X_\ OL_X4 &Z?_GG'_WV?\* '1.9
M$W$8.2" <]#B@!LO^L@_W_\ V4T 2T % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!%!_JS_ +[?^A&@ E_UD'^__P"RF@"6@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MK\77[U_P?D=7HJW"Z+:+=;_.$8SYGWO;/OC&:3\_Z?42ZVVN_NOH7Z0PH *
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M?]#7K/\ X'R__%4 '_"=^,/^AKUG_P #Y?\ XJ@ _P"$[\8?]#7K/_@?+_\
M%4 '_"=^,/\ H:]9_P# ^7_XJ@ _X3OQA_T->L_^!\O_ ,50 ?\ "=^,/^AK
MUG_P/E_^*H /^$[\8?\ 0UZS_P"!\O\ \50 ?\)WXP_Z&O6?_ ^7_P"*H /^
M$[\8?]#7K/\ X'R__%4 '_"=^,/^AKUG_P #Y?\ XJ@#<\%^-/%5UXZ\/6]Q
MXEU::"74;=)(Y+Z1E=3(H((+8(([4 ?7T'^K/^^W_H1H )?]9!_O_P#LIH E
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H ^0/C;_R5[7?^V'_HB.@# \%Q74_B.*&STFSU*>12 EXA:*,=Y&&0
M, 9Z\5I3M]K;J^R(EI;\NYZC::;X4EU-)](T.RU"QU77AI[%T++%$(U+&/GY
M<L68'T%3&-U&+T34G?KHW8<Y./-);QY5Y:[_ .1S\%EX4CT737N]+2.TM?$)
MM+FY4M))/$$)R3UQTX7TI4W?V<GUB_OTW^8ZR<?:1CT:^Z[_ $_$I_$G2M,M
MM.\/ZA9QZ:D]YYX<Z:K+#)&KC8P# <X)!/?%.E']_&$NO+?UO^3-'RN#:Z/3
MTMU]#T&\^'WAH>.[35UL8$T2WVVMS: ?(UR2BHI'^T)5;_@)ITU[TK]=OO:?
MW<K?S,6^:FDMTKOTLFOO;L<O?_#'P^D$]S<:R+.[N9IY+6!9$"A%F*B,*?F)
MP.HX!Q44XWY(]6HW_P"WK?YCJ3LISZ+FM\BCJW@3PII0U.;[3KEQ#9WO]FA(
M8XVD:?#,6Q_<P  ."3FHYKP4EUO;Y=_ZT1JXVDT^B3?SV+UK\)] <:3:7&OL
MNI77V=Y(DDC)9)>NQ?O#&1R<@X-;2BHS<5TO^";_ $V,%/\ =J?>UOFTOZ\S
MF_"NA:!JGQ(_L^W2YN=-ACED2&ZP'G>-"=AV]BP_*LX2?LIU+;*Z_ UJQY:D
M:=^MF_O.B\,7.F:KIFN:QJ_AO1M,^QV\8CE>PD: YEVD^6#DD?=R/QJG:,+W
MW:_)_G]V@E>53EMLI?A;\B*TBTVPL?#EQ;>'--U7_A(+^9;AWMV(51*%5(AG
M]W\I)]?RJXP3J1I/;E3\]=]?(B<K1G46Z=EVT7;S//O%-A:Z5XKU;3[)]]K;
M74D41SGY0Q YKGI2<H)LWJQ49V19\"?\E#\-?]A2V_\ 1JUH9GVU!_JS_OM_
MZ$: "7_60?[_ /[*: ): "@ H C6>)Y9(ED4R1XWJ#RN>F:.EP\A1+&651(I
M9AD#/4>M "^8F_9O7?C.W/./6@!HGA(4B5"'.%.X<GVH <TB(RJSJ&;[H)Z_
M2@!OGQ!&?S4VH<,=PP#[T 2 Y&1TH HFUO\ RBHU'#^9N#>2O"_W<?UH 62V
MO6,Y34-@?'ECR0?+YY^M #A;W@=2;[Y1%M(\H<OC[W_UJ $CMKU?L^^_W[,^
M9^Z \SGCZ8H 9]DU#R=O]I_/OW;O(7[O]W']: 'O;7K?:-E_LWX\O]T#Y?//
MUS0 &WO3(2+_  OE[=OE#AL?>_/G% !';7J_9]]_OV9\S]T!YG/'TQ0 S[+?
M^1L_M+]YYF[?Y*_=_NX_K0 YK:]/VC;J&W>1Y7[D'R^?UXXYH <;>\WL1?84
MQ;0/*'#X^]_]:@!$M[U6@+7^X)_K!Y0'F?X4 -%K?B(*=1R_F;BWDKRO]W']
M: %>VO2+C;J&TN08SY(/ECN/>@!?L][YCG[?\ICVA?*'#8^]^?.* %CM[Q7@
M+WV]4!\P>4!YG^% $:VFH")%;4\N'W%O(497^[C^OO0 Y[:](N-NH;2Y!C/D
M@^6.X]Z '&WO#)(1?85H]JKY0^5N/F]^_'O0 B6MV'MV?4';RP?,41J!+]>,
MC\#0 Q+*\6*)&U6=F1]S.8X\N/[I^7 'TYH &LKQA<!=5G4R,&0B./\ =#)X
M'R\]NN>E #VM+HR2,-1E56CV*H1,(W'S#CK['CGI0 BVET)(&.I3%8UPZF-,
M2'U/R\?ACI0 U+*\6*)&U6=F1]S.8X\N/[I^7 'TYH 5[*[9)U75)E,C[D81
MQ_NQ_='R\CZY- #FM+HS3.-1E5'3:B"-,1GCYAQDG@]<CF@ 2TNED@9M1E98
MU*NI1,2'GD\<?ACI0 Q;*\$<*G59RR/N=O+CS(/[I^7@?3!H &LKPQS*-5G#
M.^Y&\N/,8_NCY>1]<F@![VETTD[+J,JK(H5%")B,\<CCG\<]: $2SNEFA=M2
MF=$3:Z&-,2'GYC\N0>1TP.* $2RNU2!6U29C&^YV,<?[P?W3\O ^F#0 CV5X
MT4J+JLZLS[E<1QY0?W1\N,?7F@![VETTD[+J,JK(H5%")B,\<CCG\<]: !;2
MZ$D;'492JQ[&4HF';GYCQU]AQQTH 8ME>*+<'59V,;%G)CC_ 'HR.#\O'?IC
MK0 /97C12HNJSJS/N5Q''E!_='RXQ]>: %GL;J4W.S5;B!95PGEI'F$\<KN4
MY/\ O9ZT -CTZZ2>&1M9O76.'RFC9(=LC<_O&Q&#N]@0O'W: &1Z7>1K9AM?
MOY#;LQD+)!_I )R ^(Q@#H-FT\\YH :^DWK6L\(\0Z@CR2[UF$=ONB']Q<Q;
M=OU!/O0!++IUU))>,NLWL8N% C54AQ;X[IF,DD_[>[VQ0 BZ;=+-&YUN]*I!
MY1C*0;7;'^L/[O.[O@$+_LT -BTN\C%F&UZ_E^SLQD+I!_I )X#XC& .@V;?
M?- 'R;\9(7@^+&N))<27#;HCYD@4-@PH0/E & #@<= ,Y.30!RND:YJF@7AN
M])OIK.X*%#)$VTE3V_04U)I6%9,T/^$Y\5":\F&OWPDO%"SL)CEP!@?IQ4V7
M+R]"KNZ?5"6_CCQ19Z=#I]OKU[%:08\N))2 F#D8^AJFVW=DI):(SM5UK4]=
MO?MFJ7TUW<8"AY6R0!V'H/84H^Z[K<IMM699;Q-KTTS,=5NWDDN$N#^\)W2J
M,*WU'&*<;W5O/\=_O)=DG?M;Y(F_X2SQ/9VMSIIUB^ABDE9YH3(P^<G+9';)
MZCUZTD]%;IM\MAM7O?KN1VOBWQ#97%]/:ZS=PRW^3<NDI!E)[GWYZTK+EY.@
M[OFY^I)#XS\2V]C:V46N7J6UJP:&,3'"$=,?3L.U4VV[O^NGY$V5K?UW_,R;
M>\N;6\2\M[B2*Y1MZRHQ5E;U!'>B+Y?A'+W[\QO#X@^+Q?M>CQ'?_:601E_.
M/W1SBDM+VZ@];>1!8^,/$]F;M+'6KZ,WKEYA'*<R,>K?4^HYH^SR]$._O<W4
MPB2S%F))/))[T;";N;_@3_DH?AK_ +"EM_Z-6@#[:@_U9_WV_P#0C0 2_P"L
M@_W_ /V4T 2T % !0!RUI9O'>:J@TN5[-P^\2I'O=R<X5@?F4Y)^;IT]A+5Z
M5ON_'?T*O[]_ZZ;$&G65PCZ*+G1I;?[#"N^<>627"%<$AL[0"3WSD5I*2YI3
M_K^NA%M++O\ K_7],KWVF:CJHFE@L)(I9I&G6:1E4F,P[1$><@YXQT[TDN6U
M^F_G[U_R_(;UO9[[/MY_UW&/H=])>W\R:6T<-XH6VC)0?9&&W+G!XR1GY<_=
M]Z(:6OW3^5V[?UW%+5:+HU\[;_H7-7L[W5YKA[:SD!FC6&WG?:/L[)(Q+\G.
M",$8ZXJ+-K33K\K;?UW+NE9/6UU^7]?(KV^CWL;6T[:4P@@6%)[7*$S,JR N
M.<'EE/)!./85I)IMV6CO;RT7_#$)-1L]^_?5/_@_,ZC1;:6RT:TMIAMDCC *
MYSM]L^W3\*3!=?5_F7Z0PH * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * /D#XV_P#)7M=_[8?^B(Z )?AGKVHV.G>);:WF18;?2Y[N)6A1MLHV -D@
MGIVZ5<W^X;[.*^]ZBBESKSO^3.X0ZAJ.G:,VJV<4GA:?0FN-0N)+9%19CYA#
M*^!A]VW ![]*FM&,?:)Z62Y?6RV*I.Z@UNY2OZ7ZG,^.8M>M=(:UT;3T/@L6
M,#QS+;(8SD*2_F8SYF_(/.?:E5O[27/T>GZ6\@I?!%PW:=_76]_Z]!_A?Q!J
MNG^ (7O%%ZM]=Q6&FV8@CW%58&1@<9/902>IK5ZR@FKMN_R7^;_!&27NSMHD
MFOF_\EJ;GB/78=*F75]5^VVL>J6US!#8WVG0^=:D2(P(7 ^0X(!/(QGFLZ<E
M!J+U^%_<WH_/J:RCSQ;VLVO+5;^=GN<+JVNZ7XE\?:->6-FD+/>?O\0+&),W
M#%20."=A4$]SZU6&C:K'MI]]M2<1).C+OK]UE_P3TG48/"_B[Q)JFD7OF:C>
M:1)<3 ):F$[=X40@19>0)R<CD\>]94TG!5%TLO6[>ORV-*EXSY'I?7TLMOGO
M\C&@\#>#!>);2:?=[;S5VLHGGF>%X5\E)-NU@,G)*C<!UK2VD4M7:3]>5M6^
M:W,V[7>WPKTNM_EN1Z#X%T&_N-1N=5\+WVG- (573/,GFD"L6!EPB[^=N #P
M.IX(I)+D3[O[M$_UZ^@2TFTMDOOUM^'D)-X-\(6=OY*Z3<2RQ:;+J7GRW#H7
M$<Y38R8P,J.?2KI:R3[<G_DRU^[?_@!;W&^[FO3EO8Z_3M*M+#Q;>BTTDZ7
MFK1K'$HQ'*IMYCYB@C@'IQQQ6.OLG?\ O_+1%0LYNW:G_P"E(\_\=^"_#FA>
M#TN;"&[-VOD,MV$E,4X=<MEB/+^FT]L&G5]VIRKNU_7]6"G[T.9]K_C_ %YG
M$^!/^2A^&O\ L*6W_HU:8C[:@_U9_P!]O_0C0 2_ZR#_ '__ &4T 2T % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $4'^K/^^W_ *$:
M "7_ %D'^_\ ^RF@"6@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M6?\ ?;_T(T $O^L@_P!__P!E- $M !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &;J>K?V
M=)&GD>9N&<[L8_2@"C_PD_\ TY_^1/\ ZU !_P )/_TY_P#D3_ZU !_PD_\
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MAM-.S.^^"7_)7M"_[;_^B)*8CZZ@_P!6?]]O_0C0 2_ZR#_?_P#930!+0 4
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M!)\I^7)QZ<\^E #CJ=F'9#-\RQ><1M/W,9STH 1-4LG:!5FR;CF/Y3\WZ<4
M,76;!X%F6?,;2>6#L;[W7'2@!SZM91BX+3X%N0LGRGY2>!VYH 7^U++S'3SO
MF2/S2-IX7&<]/2@!8]3LY'@5)LF<$QC:?FQ^'% $8UO33"DIO(U1W\M2_P N
M6]!GZT .?6--C%P7O85%LP6;+C]V3P ?2@!6U73TDDC:\B#Q1^:ZEN53CYC[
M<B@ CU73Y7MTCO(F:X!,(#?? ZX]: .:\0:OITS6DL5["\<A,:L&&"V>@]Z
M,5M4L$$Q:[B A;;)\WW#Z'\C0 XZA9J[H;F,-&GF,-W1?7Z<T  U&S9XD%S&
M6E7=&-WWAZC\J &KJEB\:2+=Q%)'V*0W!;T'O0!V.G:SIL>D*[WL*K!A)27'
MR-Z'T- %YM6T])IH6O(A+ GF2*6Y1>#D^W(_.@ 35=/DD@C2\B+SJ7B4-RZC
M/(]>AH 8NM:8T<,BWT!2=]D;;QAV]![T #:UIB1S2-?0!('V2-O&$;T/OQ0
M]]5T^.2>-[R)7@4/*I;E%.,$^G44 (FKZ=)-#"E["TDR>9&H89=>>1[<'\J
M$36=-D2!TOH2L[^7$0X^=NF!ZGF@"&3Q+H,5O/<2:WIZ06\OD32-=(%CD_N,
M<X#>QYH D?7M'BFNX9-5LDELT$ERC7" PH0"&<9^48(.3ZT $>O:/+/#!'JM
MD\T\/VB)%N$+/%S^\49Y7@\CCB@")/$_A^1;-DUS3F6]<QVQ6Z0B=P0"J<_,
M<D# ]10 LGB708K>>XDUO3T@MY?(FD:Z0+')_<8YP&]CS0!\*4 =5X#O/#NF
MZTVH:_),K6Z[[0)!YR>;V9UW+D#KC(S5J7+%N._]?B0X\S2>W7_(Z^T\>Z!
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M*O1TW3VO9_-.XKM34NWY6L=-H'B3POX?T;5M'T_7=0@^TO#(M[)ID<NXJ&#
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M"MS*S_K434_#NI:M#<1,((%N9$NF8R$LCB,+Y>,<C(ZYZ$\4+W9)K[+NO/\
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M\?\ CB_X4 ']N:C_ ,_'_CB_X4 >N>&Y7F\.6$DAR[1 DT :E !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M ?VC9?\ /U%_WV* #^T;+_GZB_[[% '7>%IHI],D:*1743$94YYP* -R@ H
M* "@ H * /./B7_Q_P!A_P!<V_G0!PU !0 4 % 'M/A;_D5]._ZXB@#7H *
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M #ZC_OO_ .M0 ?\ "3-_SZC_ +[_ /K4 >Q4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!%!_JS_ +[?^A&@ E_UD'^__P"RF@"6@ H * "@ H * "@ H *
M"@ H * "@"KJ7_(-N?\ KF?Y4 <30 4 % !0!M>&O^/R;_KG_44 =-0 4 %
M!0 4 % ''_$?_D7K?_KZ7_T%J /+Z "@ H * /4/AQ_R+UQ_U]-_Z"M '84
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M_P"(_P#R+UO_ -?2_P#H+4 >7T % !0 4 >H?#C_ )%ZX_Z^F_\ 05H ["@
MH * "@ H * /./B7_P ?]A_US;^= '#4 % !0 4 >T^%O^17T[_KB* ->@ H
M * "@ H * /'_&__ "-]]_P#_P!%K0!S] !0 4 % 'T!0 4 % !0 4 % !0
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M8(EC+#O@8JI.[N2O,MU(PH * ,SQ'_R+>I?]>[_RH \2H * "@ H [7X;?\
M(7O/^N'_ +,* /2Z "@ H * "@ H X_XC_\ (O6__7TO_H+4 >7T % !0 4
M>H?#C_D7KC_KZ;_T%: .PH * "@ H * "@#SCXE_\?\ 8?\ 7-OYT <-0 4
M% !0![3X6_Y%?3O^N(H UZ "@ H * "@ H \?\;_ /(WWW_ /_1:T <_0 4
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M H X_P"(_P#R+UO_ -?2_P#H+4 >7T % !0 4 >H?#C_ )%ZX_Z^F_\ 05H
M["@ H * "@ H * /./B7_P ?]A_US;^= '#4 % !0 4 >T^%O^17T[_KB* -
M>@ H * "@ H * /'_&__ "-]]_P#_P!%K0!S] !0 4 % 'T!0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % $4'^K/^^W_ *$: "7_ %D'^_\ ^RF@"6@ H *
M*][>Q:?:M<3;MH(4*HR68G  'J20*3?8:16_MFW1[5)HKB%KC 7?"P"L>BDX
MP#P?\D55M;+^NI-]+O\ KH-N]?T^QN'BN)63R^'?82BG;NVD^N!G'^-):[%6
ML1MXETZ-&+M*K(3YB&)MT8&"2P[##+S[TTK_ ->=OS$6+O5[.RN$AF=MS!22
MJ$A QVJ6(Z GBEUL'2Y6'B;320JM,SM@QHL3$R+S\RCN/E//M]*.EQVL[&I;
MSQ75O%<0N'BE4.C#N#R#3:<79DIW)*0PH * ,SQ'_P BWJ7_ %[O_*@#Q*@
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M#X<?\B]<?]?3?^@K0!V% !0 4 % !0 4 ><?$O\ X_[#_KFW\Z .&H * "@
MH ]I\+?\BOIW_7$4 :] !0 4 % !0 4 >/\ C?\ Y&^^_P" ?^BUH Y^@ H
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M?_D;[[_@'_HM: .?H * "@ H ^@* "@ H * "@ H * "@ H * "@ H * "@
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M8?\ OT* #_A/M=_YZP_]^A0!]9_#ZYEO/A]H5S,099;1'8@8Y(H Z6@ H *
M"@ H * /EWXN>+M6TOXH:Q9VSQB&/R=H9 3S"A_F: .)_P"$^UW_ )ZP_P#?
MH4 '_"?:[_SUA_[]"@ _X3[7?^>L/_?H4 '_  GVN_\ /6'_ +]"@#[8H *
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M * "@#YU_:6_Y"OA[_KC+_Z$M 'A5 !0 4 % 'VK\-/^2:>'/^O*/^5 '54
M% !0 4 % !0!\@?&W_DKVN_]L/\ T1'0!Y_0 4 % !0!]_T % !0 4 % !0
M4 % !0 4 % !0 4 % !0!%!_JS_OM_Z$: "7_60?[_\ [*: ): "@ H * "@
M H * "@#F8O#EXEP;L75M!<)-YD<<4+"'HX+%=WWF#\X(Z#K0M%9?UZ?<-ZM
M_P!?UV-S3K,:?I\-J'+^6N"Q&-Q[G\Z;\B?,F:")V+-$A/J5%(8GV:#_ )XQ
M_P#?(H /LT'_ #QC_P"^10 ?9H/^>,?_ 'R* #[-!_SQC_[Y% !]F@_YXQ_]
M\B@ ^S0?\\8_^^10 ?9H/^>,?_?(H /LT'_/&/\ [Y% !]F@_P">,?\ WR*
M#[-!_P \8_\ OD4 'V:#_GC'_P!\B@ ^S0?\\8_^^10 ?9H/^>,?_?(H /LT
M'_/&/_OD4 'V:#_GC'_WR* #[-!_SQC_ .^10 ?9H/\ GC'_ -\B@ ^S0?\
M/&/_ +Y% !]F@_YXQ_\ ?(H /LT'_/&/_OD4 'V:#_GC'_WR* #[-!_SQC_[
MY% !]F@_YXQ_]\B@ ^S0?\\8_P#OD4 'V:#_ )XQ_P#?(H /LT'_ #QC_P"^
M10 ?9H/^>,?_ 'R* #[-!_SQC_[Y% !]F@_YXQ_]\B@ ^S0?\\8_^^10 ?9H
M/^>,?_?(H /LT'_/&/\ [Y% !]F@_P">,?\ WR* #[-!_P \8_\ OD4 'V:#
M_GC'_P!\B@ ^S0?\\8_^^10 ?9H/^>,?_?(H /LT'_/&/_OD4 'V:#_GC'_W
MR* #[-!_SQC_ .^10 ?9H/\ GC'_ -\B@ ^S0?\ /&/_ +Y% !]F@_YXQ_\
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MB_.W]?>=!H-S)=Z'9SRR&21T^9B!R?PX/U'7K6DE9DKKZO\ ,T:D84 % !0
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M % !0 4 % !0 4 % "8&,8XH -J[MVT9]<4 +T&!0 4 % !0 4 % !0 4 %
M!0 8'I0 W8G/RCGKQUH =TH * "@ H * "@ H * "@ Q0 A /44 ($48PH&.
M1Q0 Z@ H * "@ H * #'.: $**>J@_44 &T YP,^M  54C! (],4 !52"" 0
M>H(H "JGJH/&.G:@ VJ#D*,].E !M7.=HSC'3M0  !1@  >U "T % !0 4 %
M !0 4 % !0 4 % !0 4 10?ZL_[[?^A&@ E_UD'^_P#^RF@"6@ H * "@ H
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M=C$[B,G#8QT..,9%):Q3&]'8OT % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % $4'^K/^^W_H1H )?]9!_O_P#LIH 22ZMXI#')<1HX7=M9P#CU
M^E $B.DB!T8,AY!4Y!H =0 Q)8Y&=4D5FC.UP#DJ< X/IP0?QH#8?0 4 ,:6
M-"0TBJ5&XY.,#U^E #!=VQ\O%Q$?,&4^<?,/4>M&P#TFB?&R5&^7=PP/'K]*
M 'T % !0 4 % %>^L;/4K1[._M8+JVDQOAGC#HV#D94\'D _A0!F:3H7A>TE
MN)M&TK2H9/FMYGM+>-3VW(Q4?3(/M2M=>3"]GYHL/H^B1Q1VKV%DJ2/\D9C4
M!FQV'<X!_ 56[#8E.CZ9Y;QFPM@CL&8>6,$]C^I_.D&PIL=-O5MYOLUM.L/$
M+;58)@]CVP1^E.^O,+2W*"Z/IB,[+I]L"YRQ\H?,>>OYG\S2MI8J^MQT&EV-
MHK"UM(8"P()C0*>>O\A^5)ZIK^OZU$M'<6VAM=*L+>U1EB@B"Q)O8#/8#ZD_
MJ:IMR8DK(G26.1G6.16:-MKA3G:< X/H<$'\:7F,K3Z3IMS,TUQI]K+*W5WA
M5B>W4B@!TNFV,UT+J6SA>X VB1D!;'IG\318"K'X<TB-9HQ80&&5Q(8FC4H&
M QD#''%'2P=;DQL--BDA46]O%+EA$0JA@2N#M]\#\A2?O77]?U=@K1M_7]:$
M MM%CTVWTR5K62WB50D<K*<@=#S_ #JI/F=V"TT_K^KEA=)TT213)8VP>-=L
M;")?E7&,#T&"?SI/K<%Y"1:-ID,D;Q:?;(\9RK+$ 0:-@L26^FV-G)));6<,
M+R_?9(PI;ZXZ]:.EN@=;D(T+2!$T0TRU$;-N*B%<$^O3W/YT 6/L-INW?9HL
M[MV=@Z[=N?\ OGCZ4/71AL5(/#VE023N+&%FGSN+1J>, ;>G3@<4=+?UO<+6
M?]=K%E-,L8X_+2SA5, 8"#H#N_GS]: (FT32GB,3:;;,A;<5,2D$],T+38!Y
MTG3F,A-C;GS,[_W8^;.,Y_(4!L.73+!(O*6S@$>TIM$8QM)R1^?-._Z?AM]P
MK+^O,M4AB,H=2K %2,$'H: (X[:WA8M%!&C8QE5 XH J'0=(*NO]EVFUVW,/
M)7D\\GCW/YFCI8+]26/2]/AE\V.R@23(.Y8P#D=/YF@+#S8VC0I";:(QQ@A%
M*#"@@@X'T)'XT!?J,ETO3YR#+90.0P8;HP<$# /Y<4=;A;2P1:7I\,IDBLH$
M<MNW+& <\C/_ (\?S-'2P>81Z9812+)'90(Z!0K+& 0%&!^0HOU#^OU_,0Z3
MIS%";&W)1RZ_NQPQ.2?J3S0M-@>NY+;V5K:-(UO;QQ&0[G**!N/O1LK!UN3T
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $4'^K/^^W_H1H )
M?]9!_O\ _LIH P/$GA2UU>&\O+>WC&KR6K6\<[L1A3V/7C\#27NNZ[IOY-,4
MES1L^S2^:L95KX:\0VDMJ(IXHH$:1W6.[=3\YD)!PFT\LO.T8]\"F]5;RM^&
MGW=R[]?/_+_)DC^'?$KPV2+JAA:%64E+IR0=^0S;@=^5P"#COC&>"6K;7;]'
M_P  E65E_73_ ()8T[0M8L=+O%5HUNY;R*X4&\DDW*JQA@9&7/.QN,$<U<I+
MW;=+_C>WW7!>?:WS_0H/H?BF>9D2\,$J0J#-]LE*%BCAE5<8/)7YNHQTX%1&
MR6O_  ^D?NZZA*[;M\O+5_?I;38OQ^'M9$T,QOGC\J0-'$+R5E1?-4LI)^_\
M@8?,.-V.G-5%I.[_ *^+_-?=<5K_ (_?96_%-_,FUK0KR^U.XFM;:T5);=49
MW<AI"KJP5@%Z$#;U/7I41T;?FG]U_P#/\!RUMZ27WF6?!5W.\J7$=H;>Y=7D
M"NP:$":20HG'.0X7/R]S[52=DO+_ .1M;T70<G=W6G]+7UT^^P^W\(:I%IVL
M6+W,30:A;.H&\@I(W0;@,[02W?G/0<Y/LV?1K\/^&7?U'"T*BDMO^#_7SOY6
MD3PYKTEU*LEWY%F_E#RXK^9FPLB$\GD':&&01G/:G%J_O=__ )+_ #7W&=FK
M6[?Y?\$RX=&\57NI:D'FGMXA<GRC]LE4/"&?:.00&Y4Y7(PH!YS41OR)O?\
M7^M^FNFQI)I2LEI;_+\[:==[[FW'HNHZ9X7U:VA,DEY.[21NMTY=R<?Q8!4]
M?N_6F_LI=_PYK_D9JZYGUM^/+;\R!?#WB!KJT#WOEVJF02;+V8NJ,9/EY&&P
M&3!X/'7@4GL_3\;?Y_?\S2Z6RZ_Y?GK]XS3]&\330V5S=WQ$[X>4&=T\HAQT
M09#90 8/ .?4U77^O-M?>[)]EY$6LFEYK\DG^%[=;DMKX=UIM5TZ[U"5)%LF
M10%O9/F 1U9R, 9)9>#GIUHA97;ZI_\ MO\ D_ON*HG*6FU[_C+]&ONL11^%
M-9L]L5G?F.+<64F[E_=DRNS<'(?<I5>>A!(J7?DY?*W_ )+;\];_ .1:LG=]
MV_O=U^'3_,O:GX=O9=$TJUM9&DGM&+.\M[*C%C&ZDB098_,V?I5S=YMQTT:7
MEJK:==A4_=BE+5Z7_4S[WPKKE[N6XO1,JR)(3]LE03;7C8#:!A,!6&1G).:(
MM*7-Z_K^CV".D;/M;\+?B]32TS0=2TRSU"&*X4F> ^4KW$C*LQ:0DYZJ,,GW
M<=*G_EVH]K?DE^C'&RES/N_NO=?\$JVGAW7D6V>XU!A+!)N4"\D9=IF5B#P-
MW[L,.0<9Q[TUH_E_\E_FON)M^OWV5OQ3$&@>(;2T5;:^\V7:"PFO)<%S'(K'
M<02!ED('3Y>U2_AY?E_Z3^J?WEIKVCET_P""_P!&ON%M?#^O&ZG-Y<Q-"TT$
MB+]HD<?)-N)PP^4[<=#C/H *TBTG?S?XIK]40UHEY6_+_)C;_P .:W)K%]=6
M-RL$5Q,LAQ=R+YJ!8P4*@80G8WSCGFHCHDGY_G?\.W4J3OM_6C_6PI\-:ZR%
M_P"U'6;R]D?^ERE4!,O!_O$!XQN(R=N:'MIO_P !?=KJ--)W>U_U7Z%FUTO7
M_P"U+:[N9HU19F9XEO)&0(54<#:,G*D\\#<>#UJDTG]_YM_JON\C))I6]/R5
M_P G_3(CH&N3ZG>-<7FRRFF1@D-Y*#M#L3[KE2H(!P>G Q6:3Y;?UL_UL:3=
MW[O]:Q_R?WB:;X?UJ'6-/NM0N4N1;J-TAN7./W(0J$QM/S[FW'GFM&TW*W5/
M\6G\M%8FHDW'EV3_ /DO\T0Q^%]2ETVVMKB&S22VM+BV5UE+[RZ@*WW1CH?6
MLFFX^=DOR_R-5)*=^G-?Y>]_F6-1TG6;C4[>.SE>&*&UB!E^TNB*P9MP"#AB
M1@<],BKG>3FUUO;YI_K9F<%RP@GTW_\ )?\ @D-QH.NVL:-97DK^3;KM+7<C
M/O"MO&&X?<2.6/'X"BH[\SCYV]+62\K/6^XJ<7[JD^U_OU?S6EBCX?T/Q#+I
MEU/>O+'>M%LCC>^N/+WY^9@#A@,8 R,Y![=7))+3R_/7_@>5DQ1OU\_R27ZW
M\]C0B\,ZQ-'9B^U&8F%41Q%>RKD>8Y;)&-QVE1D\\4G^G_MO_P EJ/7EMYO[
MKJWX71TVE07-MI%G!>2^;=1PJLKY)W,!@G)Z\U4VG)M#LE>VQ;J0"@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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8_P#/Q)^2_P"% #XT$:;02>2<GW.: /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g805243dsp32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805243dsp32.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z "@ H * "@ H * "@ H * "@!DLL<$+S2NJ1HI9F8X
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M=.>YH6KL&R;[!]MM_M_V'S,W/E^;L"DX7.,D]!S0M;VZ ]+%B@ H * "@ H
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MTVXN&N)M/MI)F&UI'A4L1Z$D4+38'KN6!;PK.\XA02NH5G"C<P'0$^G)HZ6
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MH[HM1QQPQ)%$BI&@"JJC 4#H *;;>K!*VPZD 4 % !0 4 % !0 4 % !0 4
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M #[R?FO^- !YK_\ /O)^:_XT 'FO_P ^\GYK_C0 >:__ #[R?FO^- !YK_\
M/O)^:_XT 'FO_P ^\GYK_C0 >:__ #[R?FO^- !YK_\ /O)^:_XT 'FO_P ^
M\GYK_C0 >:__ #[R?FO^- !YK_\ /O)^:_XT 'FO_P ^\GYK_C0 >:__ #[R
M?FO^- !YK_\ /O)^:_XT 'FO_P ^\GYK_C0 >:__ #[R?FO^- !YK_\ /O)^
M:_XT 'FO_P ^\GYK_C0 >:__ #[R?FO^- !YK_\ /O)^:_XT 'FO_P ^\GYK
M_C0 >:__ #[R?FO^- !YK_\ /O)^:_XT 'FO_P ^\GYK_C0 >:__ #[R?FO^
M- !YK_\ /O)^:_XT 'FO_P ^\GYK_C0 >:__ #[R?FO^- !YK_\ /O)^:_XT
M 'FO_P ^\GYK_C0 >:__ #[R?FO^- !YK_\ /O)^:_XT 'FO_P ^\GYK_C0
M>:__ #[R?FO^- !YK_\ /O)^:_XT 2*2R@E2I]#0!FZY9WE[IXBLI-DHE1C^
M_>'<H.2N] 2,CTI=4_ZV'T:,J;4V_P"$+:XM_-MF5Q"S-,963][L8AVY/<@F
MJ>LH]G82]WF757_(R[Q=2@O+E;&_FDM;*Y14C>Y<NS,$;:#SO_B&&.!OSVI1
M;T;[M?U_GTL$DK6\K_FO\G;J=!H&IK=/<6LC3/=1L7D=_N,=Q4A.3A05(Y Z
M9[YIJSC=?UY_/\ =U+7^MM/Q1N4@"@ H * "@"&Z6Y>V=;26.*?^%Y$+J/J
M1G\Z3N-6ZG'Q>(]3254GU73#<+=B!K-8&$S+OVY WYZ<],8JH6E;S_#_ (;J
M*7NW\OZ_X8[:D! UE:.^]K6$OY@EW%!G>!@-]<<9HV#<2WL+.SDEDMK2&!Y3
MF1HXPI<^I(ZT+160;NY8H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@#+\0I"^AW GE,4>5._9N"D,""1W&<9]LTNJMW&MGZ/\BGX?T:YL)#+
M=WL$[JACC6",JH4N6).2<G)JEHK>GX*R(MK?U_$Z"D4% !0 4 <+?6MG+J\/
M^@:):O+=[H[I9=TK%9!GC8.2>.3U-%/1JP3V=SNJ "@ H * "@ H * "@ H
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MY$ .%+D*<Y.?NXR!]: .E^"7A35O"/A_4;76$,4L]P)8T#AE*[%^8$'WP?\
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M#&S8/RMQG(/(![4 :-@T%]I]O=&Q:W,T8<Q31;73(Z,.Q% %C[-!_P \8_\
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MV6ZW!0VY60X*GU% 'MG@CP;I?@C01I^EB5EE?SI9)6W,[$ 9/0#@#@"@#I*
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MH F(R"#T- &+I,J:7=1^'99[J>6. S0SW&#YD>\C;NR2S("H)/)R#SS0!MT
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MI:ZHEQ]FDW/;3-;S*5*LCKU!!]L$>H((X- %V@ H * "@ H * "@ H * "@
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MX/\ C0 ;9_\ GI'_ -\'_&@ VS_\](_^^#_C0 ;9_P#GI'_WP?\ &@ VS_\
M/2/_ +X/^- !MG_YZ1_]\'_&@ VS_P#/2/\ [X/^- !MG_YZ1_\ ?!_QH -L
M_P#STC_[X/\ C0 ;9_\ GI'_ -\'_&@ VS_\](_^^#_C0 ;9_P#GI'_WP?\
M&@ VS_\ /2/_ +X/^- !MG_YZ1_]\'_&@ VS_P#/2/\ [X/^- !MG_YZ1_\
M?!_QH -L_P#STC_[X/\ C0 ;9_\ GI'_ -\'_&@ VS_\](_^^#_C0 ;9_P#G
MI'_WP?\ &@ VS_\ /2/_ +X/^- !MG_YZ1_]\'_&@ VS_P#/2/\ [X/^- $B
M[@HW$$^H&* %H * "@ H I:M/=6^F2R62;IQM"_(6P"0"=HZX!)Q[4NJ0U;5
M^ID^'K_59]0N+?4',@B4[L6QB",'( R>&RN#Q5+6-_3_ (/W$NZE;U_2WWDW
MB329+VV^T6QNS<QE?D@NGBW(&RP #!=V,\FIV=RMU8B\.6T\=[=S"VO[:T=$
M5$OK@R/N!.2!N; P1WJE\.I+W1T5(93U6ZM[/3I9;N(R6W"2+MR-I(!)'H,Y
M/M2=GHQJ^Z,+3=6\'RVL5C9SV44?GYC@#!<N&X.!UR0"/PJU=M6)=E<ZFI&%
M !0 4 % '$?$K_D&67_78_RH \VH ]]A_P!1'_NC^5 #Z "@ H XSXD_\@6U
M_P"OC_V4T >94 >\V7_'A;_]<U_E0!/0 4 ! (((R/2@#&LV;1[\V$S6<&FR
ME(]-CC C8$(=T04#& $W#'8D8XY -F@ H * "@ H * "@ H * "@ H * "@
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MWV'_ %$?^Z/Y4 /H * "@#C/B3_R!;7_ *^/_930!YE0![S9?\>%O_US7^5
M$] !0 4 5[RS@O85CGB20(ZR)O7(5U.5;\"* *VCW5U-9)#J?D)JD2_Z1'"X
M(ZD!P,DA6QD \]NU &C0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M[R?FO^- '%?$=V;3;(&-D_>GKCT]C0!YS0![Q#*_D1_N)/NCNOI]: '^:_\
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M<4_F: /:: "@ H * /ECQ9_R.6N?]?\ /_Z,:@#N/@C_ ,C!J7_7L/\ T(4
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M_P"A"@#V^@ H * "@#YA\=?\CSK7_7RU '1?!G_D=IO^O-__ $)* /?* "@
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M *_)O_0S0!Z%\#_^0GJ__7%/YF@#VF@ H * "@#Y8\6?\CEKG_7_ #_^C&H
M[CX(_P#(P:E_U[#_ -"% 'M] !0 4 % 'S#XZ_Y'G6O^OEJ .B^#/_([3?\
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M[-!_SQC_ .^10 ?9H/\ GC'_ -\B@ ^S0?\ /&/_ +Y% !]F@_YXQ_\ ?(H
M/LT'_/&/_OD4 'V:#_GC'_WR* #[-!_SQC_[Y% !]F@_YXQ_]\B@ ^S0?\\8
M_P#OD4 'V:#_ )XQ_P#?(H /LT'_ #QC_P"^10 ?9H/^>,?_ 'R* #[-!_SQ
MC_[Y% !]F@_YXQ_]\B@ ^S0?\\8_^^10 ?9H/^>,?_?(H /LT'_/&/\ [Y%
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M^:W2WXW_ ,A[*-^NXND7>HSZC?P74MM-#;%4$D,+1Y<C+#EVS@%?SH5G&_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% &/?>*=&TV\DM+N\\N>/&Y?+<XR,CD#'0T 5_\ A-_#O_00_P#(,G_Q- !_
MPF_AW_H(?^09/_B: #_A-_#O_00_\@R?_$T 7H=?TVYTJXU*"<R6MN&\Q@C
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M*1,I"$G #<\<\<T=+AUL)_;.EB&*;^TK3RIFVQOYZ[7/H#GDT6UL&R;[%Z@
MH YO5/'OAG1=2ET_4-2\FZAQO3R)&QD CD*1T(H I_\ "TO!O_09_P#):7_X
MF@ _X6EX-_Z#/_DM+_\ $T '_"TO!O\ T&?_ "6E_P#B: -?1/%6B^(UN6TF
M\^TBV"F7]VZ;<YQ]X#/W32;Y5<:5W8@B\7V;VGVB2SNX0T:2Q*ZIF968*-N&
M(ZD#DCK56=[=?\_^&%M^/X;FA;:M'<7<=JUM<03O$TNR50-H5@I!P3W/;(]Z
M71OM;\;_ .0MK?U_6XEGKFG7JVVVYCCFN%+1P2.HD8<_PYYZ&A:[>HWIOWM]
MVAHT % !0!!>7EMI]G->7DZ06T*EY)'.%51U)- &=X?\5Z%XJMY9]$U**\2%
MMLFS(*GW! (Z'![T ;% %>^NFLK5YUMI;C9R4B*AL>OS$#]:F3Y5=C2N[(HV
MOB&RFTZ&^NC_ &?!/@PF[DC0R C((PQ_+K[5HXV?+U)3NK]![>(M&CN9[>35
M+6.6W ,BO*%VYZ<G\/S%2M5<>Q-#JMK<WJ6T#B7S(?/61"&0KG'!!HMOY6_&
M_P#D*^WG?\+?YE.#Q'!-<!&M+J&%IVMTG<)Y;.I(QPQ(R0<9 H6JOY7'+W6U
MV)K/7;*[G,0;RVV1N"SH5;>6 4%203\IZ4[?U\K_ ) ]'9_UK;\PE\0Z3#>?
M8SJ%N;K:S"(2+D[>",DX!SV)['T-3?1M=!VLTF3)JU@SV\1O($GN$#QPM,N]
M@1G@ \_AD535FUV)3T3'VNI6-\[I:7MO<,@!812JQ4'IG!XI=+C>CLRU0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
7H * "@ H * "@ H * "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
